
<html lang="en"     class="pb-page"  data-request-id="8d649399-696c-4abf-8af0-4f8ffc0b49d7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-2;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b01346;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site" /></meta><meta name="dc.Creator" content="Stacey-Lynn  Paiva" /></meta><meta name="dc.Creator" content="Sara R.  da Silva" /></meta><meta name="dc.Creator" content="Elvin D.  de Araujo" /></meta><meta name="dc.Creator" content="Patrick T.  Gunning" /></meta><meta name="dc.Description" content="The labeling of proteins with ubiquitin/ubiquitin-like (Ubl) proteins is crucial for several physiological processes and in the onset of various diseases. Recently, targeting ubiquitin protein labe..." /></meta><meta name="Description" content="The labeling of proteins with ubiquitin/ubiquitin-like (Ubl) proteins is crucial for several physiological processes and in the onset of various diseases. Recently, targeting ubiquitin protein labe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 28, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01346" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01346" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01346" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01346" /></link>
        
    
    

<title>Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01346" /></meta><meta property="og:title" content="Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/large/jm-2016-01346d_0006.jpeg" /></meta><meta property="og:description" content="The labeling of proteins with ubiquitin/ubiquitin-like (Ubl) proteins is crucial for several physiological processes and in the onset of various diseases. Recently, targeting ubiquitin protein labeling has shifted toward the use of allosteric mechanisms over classical activity-based approaches. Allosteric enzyme regulation offers the potential for greater selectivity and has demonstrated less susceptibility to acquired resistance often associated with active site inhibitors. Furthermore, the isoform diversity among E1 activating, E2 conjugating, E3 ligase, and deubiquitinating (DUB) enzymes offers an ideal platform for modulating activity via allostery. Herein, we have reviewed allosteric inhibitors of the ubiquitin E1-E2-E3 and DUB enzymatic cascade developed over the past decade with a focus on their mechanisms of action. We have highlighted the advantages as well as the challenges associated with designing allosteric modulators of the ubiquitin labeling machinery, and the future promise in targeting these systems using allosteric approaches." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01346"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01346">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01346&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01346&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01346&amp;href=/doi/10.1021/acs.jmedchem.6b01346" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 405-421</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01333" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b00498" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stacey-Lynn++Paiva">Stacey-Lynn Paiva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol "><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sara+R.++da+Silva">Sara R. da Silva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span><span class="author-xref-symbol "><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elvin+D.++de+Araujo">Elvin D. de Araujo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span><span class="author-xref-symbol "><sup>Â§</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+T.++Gunning">Patrick T. Gunning</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0654-735X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Department of Chemistry, University of Toronto, Toronto, ON M5S 3H6, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Department of Chemical and Physical Sciences, University of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada</span></div><div class="corresp-info"><strong>*</strong>Phone: (905) 828-5354. E-mail: <a href="/cdn-cgi/l/email-protection#e898899c9a818b83c68f9d868681868fa89d9c879a87869c87c68b89"><span class="__cf_email__" data-cfemail="ea9a8b9e98838981c48d9f848483848daa9f9e859885849e85c4898b">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01346&amp;href=/doi/10.1021%2Facs.jmedchem.6b01346" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 405â421</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 11, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 September 2016</li><li><span class="item_label"><b>Published</b> online</span>28 February 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 January 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01346" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01346</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D405%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DStacey-Lynn%2BPaiva%252C%2BSara%2BR.%2Bda%2BSilva%252C%2BElvin%2BD.%2Bde%2BAraujo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D2%26contentID%3Dacs.jmedchem.6b01346%26title%3DRegulating%2Bthe%2BMaster%2BRegulator%253A%2BControlling%2BUbiquitination%2Bby%2BThinking%2BOutside%2Bthe%2BActive%2BSite%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D421%26publicationDate%3DJanuary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01346"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3770</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01346" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Stacey-Lynn&quot;,&quot;last_name&quot;:&quot;Paiva&quot;},{&quot;first_name&quot;:&quot;Sara&quot;,&quot;last_name&quot;:&quot;R. da Silva&quot;},{&quot;first_name&quot;:&quot;Elvin&quot;,&quot;last_name&quot;:&quot;D. de Araujo&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;T. Gunning&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;405-421&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01346&quot;},&quot;abstract&quot;:&quot;The labeling of proteins with ubiquitin/ubiquitin-like (Ubl) proteins is crucial for several physiological processes and in the onset of various diseases. Recently, targeting ubiquitin protein labeling has shifted toward the use of allosteric mechanisms over classical activity-based approaches. Allosteric enzyme regulation offers the potential for greater selectivity and has demonstrated less susceptibility to acquired resistance often associated with active site inhibitors. Furthermore, the isoform diversity among E1 activating, E2 conjugating, E3 ligase, and deubiquitinating (DUB) enzymes offers an ideal platform for modulating activity via allostery. Herein, we have reviewed allosteric inhibitors of the ubiquitin E1-E2-E3 and DUB enzymatic cascade developed over the past decade with a focus on their mechanisms of action. We have highlighted the advantages as well as the challenges associated with designing allosteric modulators of the ubiquitin labeling machinery, and the future promise in targeting these &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01346&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01346" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01346&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01346" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01346&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01346" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01346&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01346&amp;href=/doi/10.1021/acs.jmedchem.6b01346" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01346" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01346" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01346%26sid%3Dliteratum%253Aachs%26pmid%3D28076680%26genre%3Darticle%26aulast%3DPaiva%26date%3D2018%26atitle%3DRegulating%2Bthe%2BMaster%2BRegulator%253A%2BControlling%2BUbiquitination%2Bby%2BThinking%2BOutside%2Bthe%2BActive%2BSite%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D2%26spage%3D405%26epage%3D421%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292616" title="Labeling">Labeling</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/jmcmar.2018.61.issue-2/20180125/jmcmar.2018.61.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/medium/jm-2016-01346d_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/large/jm-2016-01346d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01346&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The labeling of proteins with ubiquitin/ubiquitin-like (Ubl) proteins is crucial for several physiological processes and in the onset of various diseases. Recently, targeting ubiquitin protein labeling has shifted toward the use of allosteric mechanisms over classical activity-based approaches. Allosteric enzyme regulation offers the potential for greater selectivity and has demonstrated less susceptibility to acquired resistance often associated with active site inhibitors. Furthermore, the isoform diversity among E1 activating, E2 conjugating, E3 ligase, and deubiquitinating (DUB) enzymes offers an ideal platform for modulating activity via allostery. Herein, we have reviewed allosteric inhibitors of the ubiquitin E1-E2-E3 and DUB enzymatic cascade developed over the past decade with a focus on their mechanisms of action. We have highlighted the advantages as well as the challenges associated with designing allosteric modulators of the ubiquitin labeling machinery, and the future promise in targeting these systems using allosteric approaches.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/61/2"><issue-title>Inducing Protein Degradation as a Therapeutic Strategy</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42507" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42507" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Post-translational modifications (PTMs) extend the functional diversity of the human proteome and are critical for a diverse number of biological processes. One such PTM, ubiquitination, involves the covalent conjugation of ubiquitin or ubiquitin-like (Ubl) proteins to an intracellular protein substrate. The labeling of proteins with ubiquitin is implicated in both proteolytic and nonproteolytic functions including proteome turnover by the 26S proteasome, mediating immune responses, as well as regulating cell proliferation and survival.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a></div><div class="NLM_p">Protein ubiquitination is a multistep process whereby a ubiquitin/Ubl protein is successively relayed between different classes of enzymes (E1, E2, E3), in order to eventually tag a cellular substrate. Despite the broad diversity in ubiquitin/Ubl identity and substrate conjugation, the overall steps catalyzed by the canonical ubiquitin/Ubl conjugation enzyme cascade are conserved among different pathways and in different species.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Initially, the C-terminal carboxylate of ubiquitin is adenylated by the E1 activating enzyme in an ATP-dependent step, accompanied by the release of pyrophosphate (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Subsequently, a conserved nucleophilic cysteine (Cys) residue of the E1 enzyme displaces the AMP from the ubiquitin/Ubl-adenylate, resulting in a covalent ubiquitin/Ubl-E1 thioester conjugate. The binding and ensuing adenylation of a second ubiquitin/Ubl molecule promote the recruitment of an E2 conjugating enzyme to this ternary complex (E1-S-ubiquitin/Ubl*ubiquitin/Ubl-AMP; <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). An active site Cys on the E2 subsequently facilitates the transfer of the covalently linked ubiquitin/Ubl from the E1 to a Cys residue on the E2 through a transthioesterification (transthiolation) reaction. Concomitantly, an E3 ligase recruits a specific downstream target protein and mediates the transfer of the ubiquitin/Ubl from the E2 enzyme to the terminal substrate through either a covalent or noncovalent mechanism (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). To this end, each ubiquitin/Ubl is ligated to a protein through either a peptide bond with the N-terminal amino group or an isopeptide bond formed between a side chain Îµ-amino group of a select lysine (Lys) residue on the target protein and the ubiquitin or Ubl C-terminal Gly carboxylate (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D) .<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Deubiquitinating enzymes (DUBs) are enzymes that specifically cleave the ubiquitin/Ubl protein from the substrate, thereby offering additional mechanism of regulation over the entire labeling pathway (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D).<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/medium/jm-2016-01346d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/large/jm-2016-01346d_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Ubiquitin/Ubl enzymatic cascade for protein labeling with ubiquitin or other Ubls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/large/jm-2016-01346d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01346&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The involvement of ubiquitin and Ubl labeling in a broad spectrum of physiological processes arises in part from the large diversity and assortment of enzymes within ubiquitin/Ubl pathways. In the human proteome, there currently exists 8 known human E1s, â¼40 E2s, >600 E3s, and >100 DUBs and Ubl proteases.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Unsurprisingly, the dysregulation of various enzymes along ubiquitin/Ubl cascades, through either genetic mutations leading to aberrant expression or uncontrolled activity within the diverse pathways in which they are involved, is associated with several disorders including cancer and neurodegenerative diseases.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> For instance, the development of the clinical candidate pevonedistat (((1<i>S</i>,2<i>S</i>,4<i>R</i>)-4-(4-(((<i>S</i>)-2,3-dihydro-1<i>H</i>-inden-1-yl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate,<b>1</b>; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was inspired by the dysregulation of protein labeling with the Ubl, NEDD8 (neural precursor cell expressed developmentally down-regulated protein 8).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Activation of cullin RING (really interesting new gene) E3 ubiquitin ligases via NEDD8 labeling has been associated with aberrant protein turnover often found in various malignancies such as acute myeloid leukemia (AML), multiple myeloma (MM), and diffuse large B-cell lymphoma (DLBCL), among others.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Given the success of <b>1</b> at disrupting NEDD8 labeling through inhibition of the NEDD8 E1 activating enzyme, and inducing disease regression, a large amount of work has focused on investigating the normal and pathophysiology of these labeling pathways and, more recently, in selectively antagonizing specific labeling processes for the mitigation of a selection of human diseases.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Select E1 Activating Enzyme Inhibitors for NAE, UAE, and UBA5<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/medium/jm-2016-01346d_0002.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">Inhibitor represented by orange hexagon and ubiquitin/Ubl represented by light blue circle.</p></div></div><div></div></div><div class="NLM_p">The scope of illnesses that are involved with these enzymatic pathways offers several promising targets for developing inhibitors and therapies and has expanded the druggable portion of the proteome. As such, several parallels have been drawn between protein ubiquitination and phosphorylation, in terms of both their far-reaching implications in cellular physiology and their potential for inhibitor development. As illustrated in an insightful perspective,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> despite their importance, developing clinical drugs that target the ubiquitin/Ubl labeling system has trailed behind targeting protein phosphorylation, likely as a result of the increased complexity and discrete mechanisms of the protein ubiquitination enzymatic cascade.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Since the early 2000s, drug discovery research aimed at targeting the ubiquitin proteasome system (UPS) has only afforded two clinical drugs, Velcade<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and Krypolis,<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a> while the kinase field has yielded â¼30 clinical agents since the emergence of the blockbuster drug Gleevec.<a onclick="showRef(event, 'ref15 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref22 ref23">(15, 22, 23)</a> The conventional inhibitory strategies for kinases has traditionally involved pursuing the orthosteric site, namely, the ATP-binding pocket.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> However, developing kinase inhibitors with high potency, selectivity, and minimal off-target activity has been challenging due to the necessity in outcompeting the millimolar intracellular concentrations of ATP in addition to the high sequence similarity among the ATP pockets and several other classes of ATP-binding proteins.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Significant advancements in kinase inhibitors were realized by extending the targeted site to an allosteric region containing a hydrophobic pocket in close proximity to the ATP cleft.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> Interestingly, this strategy has yielded the first clinically approved lipid kinase drug, idelalisib, for use in the treatment of chronic lymphocytic leukemia (CLL).<a onclick="showRef(event, 'ref23 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref26">(23, 26)</a> Identified from a kinome-wide screen, idelalisib selectively targets PI3KÎ´ (phosphatidylinositide 3-kinase Î´) by simultaneously interacting with the ATP pocket and an adjacent unique hydrophobic pocket.<a onclick="showRef(event, 'ref23 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref23 ref27 ref28 ref29">(23, 27-29)</a> Furthermore, efforts have also focused toward exclusively targeting allosteric sites remote from the ATP pocket. There are several advantages to targeting an allosteric site as opposed to the orthosteric site, including the greater specificity and selectivity that can be achieved through targeting sites unique to a specific kinase from a common family.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> For example, trametinib is one of the few allosteric clinical kinase-targeting drugs used in combination therapies to overcome resistance often observed in the treatment of melanoma using the B-Raf kinase drug dabrafenib.<a onclick="showRef(event, 'ref23 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref23 ref30 ref31 ref32 ref33">(23, 30-33)</a> Trametinib was developed from a structureâactivity relationship (SAR) conducted from a lead identified using a high-throughput screen (HTS), and its selective nature for MEK1/2 inhibition over other kinases is probably due to the proposed binding mode in an allosteric pocket adjacent to the ATP binding pocket.<a onclick="showRef(event, 'ref23 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref23 ref30 ref31">(23, 30, 31)</a></div><div class="NLM_p last">The rational design of allosteric inhibitors is limited by the availability of structural and biophysical information on some enzymes, in addition to the dynamic nature of most enzymes that typically precludes access to cryptic binding sites and pockets in the absence of a substrate or cofactor. This is probably why the few kinase drugs that operate purely through an allosteric mechanism were identified through screening strategies. Similarly, several allosteric inhibitors have been discovered that target protein ubiquitination, mainly against the E2, E3, and DUB enzymes. In this review, we focus on the discovery of allosteric inhibitors that modulate the multienzyme cascade of the ubiquitin pathway identified within this decade and discuss the potential use of these molecules in new therapeutic avenues.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2 Allosteric Inhibition of E1 Enzymes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All E1s are mechanistically related despite their structural differences and contain an ATP binding site, a ubiquitin/Ubl binding pocket, a catalytic Cys residue, and an oligomerization region. The first identified E1 inhibitors were ATP competitive and were composed of a nonhydrolyzable ubiquitin-nucleotide conjugate, namely, the ubiquitin-AMP conjugate adenosyl-phospho-ubiquitinol (APU, <b>2</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> As a mimic of the ubiquitin-adenylate species, <b>2</b> binds to the ATP and ubiquitin pockets simultaneously and effectively prevents further ubiquitin activation (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> An alternative strategy toward E1 inhibition has included the irreversible blockade of downstream thiolation reactions by covalent inhibitors that modify the active site Cys, such as the first cell-permeable E1 inhibitor PYR-41 (4[4-(5-nitrofuran-2-ylmethylene)-3,5-dioxopyrazolidin-1-yl]benzoic acid ethyl ester, <b>3</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Although effective, both modes of inhibition suffer from either the development of resistance, as was observed in cells treated with ATP-competitive inhibitors including compound <b>1</b>, the NAE inhibitor,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> or by the covalent modification and cross-linking of off-target proteins associated with compound <b>3</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">Recently, compound <b>8.5</b> ((2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-<i>N</i>-(6-(1,4,7,10-tetraazacyclododecan-1-yl)-6-oxohexyl)-5-(6-amino-9<i>H</i>-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-carboxamide zinc(II) trifluoromethanesulfonate, <b>4</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), which is composed of an adenosine scaffold appended to a zinc(II) coordination complex, was shown to block the transfer of the Ubl ubiquitin fold modifier 1 (UFM1) from its E1 (UBA5) to its respective E2 (UFC1).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This compound was found to function through a noncompetitive mechanism with respect to ATP (<i>K</i><sub>m</sub>= 24.9 Â± 9.6 Î¼M for ATP with a <i>V</i><sub>MAX</sub> = 0.988 Â± 0.137 pmolÂ·min<sup>â1</sup> in the presence of 5 Î¼M <b>4</b>; <i>K</i><sub>m</sub>= 16.5 Â± 2.5 Î¼M for ATP with a <i>V</i><sub>MAX</sub> = 1.90 Â± 0.10 pmolÂ·min<sup>â1</sup> in the absence of <b>4</b>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The authors hypothesized that <b>4</b> may operate by binding to the inactive ATP pocket of the UBA5 homodimer or to an alternative unidentified allosteric site (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Aside from this molecule, to date there are no other reported allosteric inhibitors that specifically target the E1 enzyme family. This may be due in part to a variety or combination of factors that underlie the mechanisms of these enzymes. Specifically, the dynamics required for the large conformational change indispensable in the formation of the E1âubiquitin/Ubl thioester conjugate by the canonical E1 enzymes may preclude allosteric pockets that are only accessible throughout this reaction.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> While in contrast, the cross-talk between the monomers in the noncanonical E1 enzymes required for substrate binding and transformation may change the accessibility to potential allosteric sites throughout the reaction pathway.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a> In general, the mechanistic complexity and highly dynamic nature of E1 enzymes are probably why there are few allosteric inhibitors reported to date.</div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1 Inhibitors of E2 Enzymes: Halting Ubiquitin Conjugation</h3><div class="NLM_p">Several studies have recently revealed the complex roles that E2 enzymes exert on ubiquitin labeling pathways. These include mediating substrate selection, ubiquitin chain initiation and elongation, and controlling the processivity of ubiquitin chain transfer to a substrate protein for proper proteasomal recognition and degradation within the ubiquitin proteasome system (UPS).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The majority of these E2-mediated processes are governed by proteinâprotein interactions (PPIs) of varying affinity and complexity between E1-E2, E2-E3, and E2-ubiquitin proteins. Thus, E2 enzymes are particularly equipped for allosteric regulation as a result of their modular domains.</div><div class="NLM_p">Functionally, E2s can be divided into two classes: âactiveâ E2 enzymes, which contain a catalytic cysteine within their core ubiquitin conjugating (UBC) domain, and âregulatoryâ E2s that possess a noncatalytic UBC domain lacking an active-site Cys. These regulatory enzymes are labeled as ubiquitin E2 variant (UEV) proteins and often act as cofactors that bind to and regulate the activity or ubiquitin linkage specificity of an active E2.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In total, there are over 40 E2s that process ubiquitin labeling within the human genome through interactions with the ubiquitin-specific E1 enzymes UAE and UBA6 and through interactions with hundreds of E3 ligases.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The E2 scaffold has thus evolved several overlapping binding interfaces that are able to distinguish between protein binding partners so as to facilitate rapid ubiquitin labeling and maintain fidelity for protein substrates.</div><div class="NLM_p">In order to receive and process a ubiquitin molecule for labeling, the E2 must undergo a transient and noncovalent interaction with its cognate E1, which is either UAE or UBA6 for ubiquitin. The affinity of an E2 for an E1 increases significantly after the formation of the E1 ternary complex, described previously.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> The configuration of the ternary complex induces conformational changes in the E1 structure and reveals a negatively charged cryptic binding site within the E1 ubiquitin-fold domain (UFD). This site interacts with two highly conserved lysine residues present on the Î±-helix 1 of all ubiquitin E2s.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Once associated, the E2 accepts the ubiquitin protein bound to the E1 active site cysteine through a transthiolation reaction, resulting in the release of the E1/ubiquitin-adenylate complex and an E2âubiquitin thioester intermediate.</div><div class="NLM_p">The ubiquitin-charged E2 can then interact with several E3 ligase complexes through different subsets of residues and structural folds. Interestingly, E2s recognize and interact with E1 and E3 enzymes through overlapping surfaces, albeit with differing affinities.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> For example, E2s bind to E3 enzymes with weak affinity and often display micromolar dissociation constant (<i>K</i><sub>d</sub>) values in the apo-state compared with the E2-ubiquitin bound state.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> These differing binding affinities have likely evolved in order to ensure the rapid response of protein ubiquitination and degradation to changes in cellular signaling. The higher E1/E2 affinity ensures that the majority of free intracellular E2s are loaded with mono-, di-, or polyubiquitin, whereas the lower affinity displayed by E2/E3 pairs may facilitate rapid E2 exchange that in turn mediates fast protein ubiquitination and chain formation.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">Recently, a high-throughput screen (HTS) was performed to identify small molecule inhibitors of the E3 subunit SCF<sup>Skp2</sup>, whose Skp2 component is often overexpressed in several human cancers leading to aberrant p27 ubiquitination, degradation and resulting in cancer cell proliferation.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Unexpectedly, this study resulted in the discovery of CC0651 (((2<i>R</i>,3<i>S</i>,4<i>S</i>)-5-(3â²,5â²-dichlorobiphenyl-4-yl)-2,3-dihydroxy-4-(2-methoxyacetamido)pentanoic acid), <b>5</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), the first small-molecule inhibitor of the E2, hCdc34A.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Compound <b>5</b> displayed IC<sub>50</sub> = 1.72 Î¼M when evaluated in vitro using an assay that monitored the ubiquitination of p27<sup>Kip1</sup>.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Cocrystallization revealed that <b>5</b> localized in a hydrophobic region of hCdc34A, 19 Ã away from the E2 active site Cys93.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> This resulted in a 2.1 Ã outward displacement of Î±-helix 2, which induced secondary conformational changes at the active site, including a 2.0 Ã shift of the 3<sub>10</sub> helix containing Cys93.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a><b>5</b> did not disrupt E2-Ub conjugate formation (transthiolation reaction) and had no effect on hCdc34/SCF<sup>Skp2</sup> binding in the absence or presence of the Sic1 ubiquitination substrate. However, <b>5</b> strongly reduced the rate of ubiquitin chain initiation on Sic1 in vitro.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In contrast, the ability of hCdc34 to facilitate ubiquitin dimerization and auto-monoubiquitination was greatly increased, indicating that <b>5</b> affected the substrate selectivity and not the catalytic activity of hCdc34.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Allosteric Inhibitors of E2 Conjugating Enzymes<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/medium/jm-2016-01346d_0003.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">Inhibitor represented by orange hexagon and ubiquitin/Ubl represented by light blue circle.</p></div></div><div></div></div><div class="NLM_p">A SAR of compound <b>5</b> was performed and provided some insight into the functional requirements for effective hCdc34 inhibition.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Inhibitor activity, evaluated in a similar in vitro p27 ubiquitination assay, was reduced by protection or removal of the pentanoic acid on <b>5</b> and was completely abolished by separating the biphenyl rings with an amino group. Substituting both chlorine atoms in the dichlorobiphenyl scaffold with methyl groups demonstrated relatively no change in inhibitory activity (IC<sub>50</sub> = 4.4 Â± 2 Î¼M cf. IC<sub>50</sub> for <b>5</b> of 2.5 Â± 1 Î¼M), whereas substitution with fluoro, methoxy, or benzoyl groups completely abolished hCdc34 inhibition.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Furthermore, derivatives CC7094 and CC8993 were able to antagonize p27 degradation within PC-3 prostate cancer cells, resulting in decreased cellular proliferation (EC<sub>50</sub> â 20 Î¼M for both derivatives; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">From the HSQC solution NMR studies with [<sup>15</sup>N]ubiquitin, it was observed that <b>5</b> induced chemical shifts and broadening of peaks corresponding to surface residues that interact with the core catalytic domain of the hCdc34 isoform, Cdc34A, indicating that <b>5</b> likely stabilizes the usually low-affinity E2/ubiquitin interaction.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Chemical shift changes from three surface ubiquitin residues also revealed that the binding affinity of <b>5</b> to Cdc34A increased in the presence of ubiquitin (EC<sub>50</sub> = 267 Î¼M to apo Cdc34A, cf. EC<sub>50</sub>= 19 Î¼M in the presence of Ub). These results further support the cooperative binding of ubiquitin and <b>5</b> to Cdc34A. A 2.6 Ã resolution crystal structure of the ternary Cdc34A-ubiquitin-<b>5</b> complex revealed that <b>5</b> appears to bind within a pocket at the E2-ubiquitin interface.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> As such, <b>5</b> may act as a molecular bridge, strengthening native-like interactions between Cdc34A and ubiquitin (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). This may reduce ubiquitin-Cdc34A reactivity by impeding ubiquitin dissociation from the E2.</div><div class="NLM_p last">Regulating the PPIs within ubiquitin labeling pathways may represent an alternative and effective strategy for abrogating protein ubiquitination through the use of small-molecule stabilizers of E2-ubiquitin interactions. Specifically, as demonstrated above, the targeted stabilization of the weak E2-ubiquitin binding events may provide an interesting avenue for selective therapeutic development in the future.</div></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">3 E3 Ligases: Modulating Ubiquitin Conjugation to Protein Substrates</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The term ligase, from the Latin verb âligareâ (to tie up), describes the functional role of the E3 enzymes, which is to facilitate the final conjugation step in protein ubiquitination.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> The E3 ligases are involved in a wide range of cellular pathways and significantly outnumber the cellular kinases.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> There are three major classes of E3 ligases, including the RING finger and U-box E3s, the HECT (homologous to the E6-AP carboxyl terminus) E3s, and the RING/HECT-hybrid type E3s known as the RING-between-RING E3 ligases, in addition to a minor class classified as the PHD (plant homeo domain)-finger type E3 ubiquitin ligases.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55 ref56">(52-56)</a> With the exception of the active site Cys-containing HECT and RING-between-RING E3s, which act through a discrete two-step mechanism involving the formation of a transient thioester conjugate to ubiquitin (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C), E3 ubiquitin ligases generally promote substrate protein ubiquitination via mechanisms that involve facilitating the appropriate orientation and presentation of a charged E2 (E2âubiquitin) to a target protein substrate amino group for subsequent ubiquitination via an aminolysis reaction (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C).<a onclick="showRef(event, 'ref4 ref5 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref57 ref58">(4, 5, 57, 58)</a></div><div class="NLM_p">RING finger-containing E3 ligases, the most abundant E3s, are composed of two conserved zinc fingers that contribute to the overall globular shape of these proteins necessary to promote the PPIs critical for substrate protein ubiquitination.<a onclick="showRef(event, 'ref59 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61 ref62">(59-62)</a> Despite having a similar fold to RING E3s, an intricate network of hydrogen bonds and salt bridges contribute to the stability of the structure in U-box-containing E3 ligases, in the absence of the Zn<sup>2+</sup>-binding motifs found in the RING E3s.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Both RING-type and U-box E3 ligases have been shown to play important roles in positioning the ubiquitin from E2âubiquitin conjugate in an appropriate orientation for attack by a substrate protein amino group.<a onclick="showRef(event, 'ref54 ref59 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref54 ref59 ref62 ref63">(54, 59, 62, 63)</a></div><div class="NLM_p">Structural investigations of RING-type E3s have revealed these RING domains interact with a hydrophobic patch on ubiquitin, ultimately restricting the conformation of the E2âubiquitin thioester conjugate.<a onclick="showRef(event, 'ref64 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66 ref67">(64-67)</a> This binding event is thought to contribute to the appropriate positioning of the charged E2 for aminolysis by the acceptor amino group from the protein substrate.<a onclick="showRef(event, 'ref64 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66 ref67">(64-67)</a> Additionally, structural data suggest RING-type E3 ubiquitin ligases also interact with E2 enzymes on the face opposite where the active site Cys resides, through discrete mechanisms depending on the RING E3 ligase.<a onclick="showRef(event, 'ref67 ref68 ref69 ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref69 ref70 ref71 ref72">(67-72)</a> Currently, a popular area of research focuses on understanding the intricate and discrete mechanisms by which RING-type E3 ligases promote substrate protein ubiquitination. Finally, since the protein substrate often binds about 50â60 Ã away from the E2âubiquitin binding site, orienting the substrate protein for ubiquitination of the appropriate amino group often requires large conformational change within RING E3 ligases.<a onclick="showRef(event, 'ref61 ref73 ref74 ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref61 ref73 ref74 ref75 ref76 ref77">(61, 73-77)</a></div><div class="NLM_p">Meanwhile, the HECT domain, often located at the C-terminus of HECT E3s, is composed of two lobes separated by a flexible linker region where E2âubiquitin recognition occurs at the N-lobe, while the catalytic Cys resides in the C-lobe for HECT E3âubiquitin conjugate formation.<a onclick="showRef(event, 'ref52 ref53 ref63'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref63">(52, 53, 63)</a> The N-terminal domains of HECT E3s often mediate protein substrate recognition for subsequent ubiquitination, wherein a large conformational change is often necessary for protein ubiquitination.<a onclick="showRef(event, 'ref52 ref53 ref59 ref67 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref59 ref67 ref78 ref79">(52, 53, 59, 67, 78, 79)</a> Alternatively, the canonical RING1 domain of RING-between-RING E3 ligases recruits the E2âubiquitin conjugate just like that in RING-type E3 ligases. However, the noncanonical RING2 domain contains an active site Cys necessary for the transthiolation step which precedes protein ubiquitination.<a onclick="showRef(event, 'ref55 ref63'); return false;" href="javascript:void(0);" class="ref ref55 ref63">(55, 63)</a> Interestingly, these RING-between-RING E3s typically operate through a variety of unique autoinhibitory mechanisms and are often involved in the formation of a linear ubiquitin chain assembly complex.<a onclick="showRef(event, 'ref55 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref55 ref80 ref81">(55, 80, 81)</a></div><div class="NLM_p">Due to the many steps mediated by E3 ligases between E2-ubiquitin/Ubl binding and protein substrate ubiquitination, there are several areas where E3 activity can be manipulated through small-molecule intervention, including (1) the E2-ubiquitin/Ubl binding site, (2) accessory, or (3) substrate protein binding sites, as well as (4) perturbing or inducing a conformational change in one of the several E3 protein subunits. As a result, the majority of molecules that affect ubiquitin labeling have been identified as E3 ligase inhibitors. To date, most of these compete for the protein substrate-binding site with great success in targeting various E3 ligases including the von HippelâLindau (VHL) and MDM2/HDM2 (mouse/human double mutant 2 homolog) ubiquitin ligases, with some preclinical and clinical successes.<a onclick="showRef(event, 'ref82 ref83 ref84 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84 ref85 ref86">(82-86)</a> For example, disrupting XIAP/cIAPs (X-linked and cellular inhibitor of apoptosis proteins, respectively) by mimicking their endogenous antagonist proteins, Smac/DIABLO (cellular second mitochondria-derived activator of caspases or direct IAP binding protein with low pI), has led to the development of several small molecule XIAP/cIAP inhibitors.<a onclick="showRef(event, 'ref87 ref88 ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref87 ref88 ref89 ref90">(87-90)</a> Specifically, AT-406 ((5<i>S</i>,8<i>S</i>,10a<i>R</i>)-<i>N</i>-benzhydryl-5-((<i>S</i>)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-<i>a</i>][1,5]diazocine-8-carboxamide, <b>6</b>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), now licensed as Debio 1143, is currently being evaluated in phase I/II clinical trials in combination with concurrent cisplatin and radiotherapy (CRT) for patients with previously untreated stage III, IVa, or IVb head and neck cancer (ClinicalTrials.gov identifier: NCT02022098).<a onclick="showRef(event, 'ref89 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref89 ref91 ref92">(89, 91, 92)</a> Therefore, targeting E3 ligases by mimicking their protein substrate appears to be an effective strategy toward regulating their activity. However, due to their mechanism of action, these classes of competitive inhibitors are not described herein but are comprehensively reviewed elsewhere.<a onclick="showRef(event, 'ref93 ref94 ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref93 ref94 ref95 ref96">(93-96)</a> Given the clinical successes of this approach, targeting E3 ligases via allostery could present new routes for specific E3 inhibition or activation, considering the potential for achieving greater target selectivity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. E3 Ligase Inhibitors That Modulate Substrate Binding Directly or through an Alternative Mechanism<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/medium/jm-2016-01346d_0004.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last">Inhibitor represented by orange hexagon.</p></div></div><div></div></div><div id="sec1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.1 Small Molecule Allosteric Modulators of Cullin-RING E3 Ligases</h3><div class="NLM_p">The cullin-RING E3 ligases were first discovered as components of the multisubunit Skp1-Cdc53/cullin-F-box (SCF) protein complexes.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Within the SCF ligase, the F-box subunit is responsible for substrate specificity and recruitment mediated by PPIs at Leu-rich motifs or WD40 repeats.<a onclick="showRef(event, 'ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref97 ref98">(97, 98)</a> These WD40 repeats form a Î²-propeller structure that recognizes protein substrates via a phosphorylated sequence, also known as a phosphodegron motif, which promotes substrate recruitment for ubiquitination and subsequent degradation.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> This RING E3 ligase family has been found to play a role in disease progression.<a onclick="showRef(event, 'ref11 ref12 ref58'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref58">(11, 12, 58)</a> For example, the human tumor suppressor cell division control protein 4 (CDC4), a substrate recognition component of an SCF complex, promotes the ubiquitination of a number of important regulatory substrates such as cyclin E, MYC, JUN, NOTCH, SREBP, and presenilin.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> However, it is a haploinsufficient tumor suppressor and is often mutated across various cancer types.<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100, 101)</a> Thus, this E3 complex presents a potential target that can be exploited in the continuous discovery of anticancer agents.</div><div class="NLM_p">In order to identify novel inhibitors of a CDC4-containing SCF ligase, a fluorescence polarization (FP) assay, evaluating the displacement of a fluorescein-labeled CDC4 phosphodegron (CPD) peptide from the yeast CDC4 ortholog, was employed to screen library of 50â¯000 compounds (compound source, Maybridge).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Compound SCF-I2 ([1,1â²-binaphthalene]-2,2â²-dicarboxylic acid; <b>7</b>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) was the only hit identified using FP (IC<sub>50</sub> = 6.4 Î¼M) and also inhibited the interaction between CDC4 and the phosphorylated Sic1 substrate in vitro.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Furthermore, <b>7</b> inhibited SCF<sup>CDC4</sup> binding and subsequent ubiquitination of both Sic1 and an additional substrate Far1 in vitro with IC<sub>50</sub> â 60 Î¼M.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Interestingly, <b>7</b> demonstrated no inhibition of the closely related SCF<sup>Met30</sup> from yeast in vitro.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> The authors postulated that the lack of CDC4 inhibition by <b>7</b> in yeast cells is likely due to poor permeability as a result of its two carboxylic acids.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p">Interestingly, only the <i>R</i>-(+) enantiomer of <b>7</b> cocrystallized with the Skp1<sup>CDC4</sup> complex (2.6 Ã resolution) and was found to bind within the WD40 domain at a distance of 25 Ã from the CPD substrate binding pocket.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Furthermore, it was identified that compound <b>7</b> bound between blades 5 and 6 of the WD40 blade structure, where it induced a 5 Ã shift of the Î²21âÎ²22 linker, displacing His631 outward by 13 Ã.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Altogether, this binding mode induced a conformational change in residues involved in CPD recognition, namely, Tyr574 and Leu634, which also destabilized key interactions with CDC4 residues that are essential for phosphate-group recognition on CPDs.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Furthermore, <b>7</b> failed to inhibit the active CDC4 mutants Arg664Ala and Arg655Ala, highlighting the importance of the carboxylate groups on <b>7</b> in mediating SCF inhibition. Additionally, human CDC4 (FBW7), which contains Lys and Cys in place of Arg655 and Arg664, respectively, displayed resistance to <b>7</b>, further supporting the role of carboxylateâprotein interactions in mediating the inhibitory effects of this compound. Thus, it was apparent that <b>7</b> attenuated SCF<sup>CDC4</sup>-mediated ubiquitination of CPD substrates by disrupting CDC4âCPD binding through an allosteric mechanism (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p">Concurrently, an inhibitor for SCF<sup>Met30</sup> was identified through a chemical genetics screen originally designed to identify inhibitors of the mammalian target of rapamycin (mTOR) kinase.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> A library of 30â¯000 compounds was screened for synthetic lethality in yeast cell growth in combination with suboptimal levels of rapamycin. A small subset of structurally distinct small molecule enhancers of rapamycin (SMERs) that showed no effects on yeast cell growth alone was subjected to a yeast genome-wide expression profiling using DNA microarrays.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The oxadiazolo-pyrazinone containing SMER3 (9<i>H</i>-indeno[1,2-<i>b</i>][1,2,5]oxadiazolo[3,4-<i>e</i>]pyrazin-9-one; <b>8</b>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) was identified as an interesting candidate for mTOR inhibition as observed from hierarchical clustering and principal components analysis.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The target of <b>8</b> was eventually identified as the E3 ligase SCF<sup>Met30</sup>, which monoubiquitinates and inhibits the activity of the Met4 transcriptional activator.<a onclick="showRef(event, 'ref103 ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref103 ref104 ref105">(103-105)</a> The function of Met4 in genetic regulation includes the attenuation of cell proliferation in times of methionine depletion.<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104, 105)</a> Inhibition of SCF<sup>Met30</sup> activity by <b>8</b> prevented Met4 ubiquitination, leading to the up-regulation of <i>MET</i> gene expression and subsequently resulting in cell cycle arrest.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Compound <b>8</b> inhibited SCF<sup>Met30</sup>-mediated Met4 ubiquitination in a reconstituted in vitro ubiquitination assay while maintaining selectivity over the closely related SCF<sup>CDC4</sup> and eliciting no effect on <i>met4Î</i> cell viability.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Similar to the genetic knockdown of SCF<sup>Met30</sup> and its cognate E2 conjugating enzyme, Cdc34, compound <b>8</b> treatment also sensitized cells to the effects of rapamycin.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><div class="NLM_p">Immunoprecipitation of an endogenously expressed Myc-tagged Met30 from yeast cell extracts indicated that <b>8</b> disrupted Skp1-Met30 interactions, which constitute a portion of the multisubunit SCF F-box complex. These results suggest that <b>8</b> inhibits SCF<sup>Met30</sup> assembly or induces the dissociation of the SCF complex.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Using stable isotopic labeling with amino acids in cell culture (SILAC), it was evident through Skp1 pull-down that the binding of Met30 to Skp1 was the only F-box PPI affected by <b>8</b>, supporting the data obtained from immunoprecipitation.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Furthermore, incubation of <b>8</b> with Skp1 and Met30 in vitro led to a dose-dependent decrease in the melting temperature (<i>T</i><sub>m</sub>) of the Met30âSkp1 heterodimer, but had no effect on Skp1 stability alone, as evaluated by differential scanning fluorimetry (DSF). The thermal data suggest that compound <b>8</b> induced a conformational destabilization and therefore lower melting temperature of the heterodimeric complex, which support previous observations recorded in both immunoprecipitation (IP) and SILAC pull-down assays.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Lastly, data obtained from drug affinity responsive target stability (DARTS), used to assess the binding of <b>8</b> to Met30 and Skp1 in yeast cell lysates, suggest that <b>8</b> may mediate its activity by binding to the F-box motif on Met30 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><div class="NLM_p">In addition to promoting the ubiquitin-mediated degradation of cell cycle regulators (SCF<sup>CDC4</sup>) or inhibiting the antiproliferative effects of Met4 via monoubiquitination by SCF<sup>Met30</sup>, cullin-RING ligases, such as APC (anaphase-promoting complex/cyclosome), are intimately involved in regulating the cell cycle. The activity of APC is responsible for facilitating cellular exit from mitosis.<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106, 107)</a> Many chemotherapeutics, namely, microtubule inhibitors, are responsible for disrupting mitosis and promoting the spindle assembly checkpoint, which effectively halts progression of mitosis at the metaphase stage.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Since microtubule inhibitors are often associated with dramatic side effects such as peripheral neuropathy, developing an inhibitor of the APC E3 ligase could help evade these undesired responses while still preventing the proliferation of diseased cells.<a onclick="showRef(event, 'ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref109 ref110">(109, 110)</a></div><div class="NLM_p">APC consists of 11 subunits including the proteins Cdh1 and Cdc20, which bind to and promote APC activity at various stages throughout the cell cycle.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Cdh1 binds to APC during the G1 phase to promote substrate ubiquitination during interphase, whereas Cdc20 is required for the initiation of anaphase and exit from mitosis by promoting the ubiquitination and subsequent proteasome-mediated degradation of securin and mitotic cyclins such as cyclin B1.<a onclick="showRef(event, 'ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref110 ref111">(110, 111)</a> RNA interference (RNAi) experiments against Cdc20 showed that significant knockdown was required to achieve mitotic arrest, suggesting that APC inhibition might offer an alternative therapeutic avenue to conventional microtubule inhibitors such as the taxanes.<a onclick="showRef(event, 'ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref110 ref111">(110, 111)</a></div><div class="NLM_p">Previous reports have demonstrated the ability of the small molecule TAME (methyl tosyl-<span class="smallcaps smallerCapital">l</span>-argininate, <b>9</b>; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) to abrogate ubiquitin-dependent cyclin proteolysis in <i>Xenopus</i> extracts, isolated from mitotic and interphase cell cycle stages.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Upon SAR analysis of compound <b>9</b> activity, it appeared that the tosyl group, Arg side chain, and the methyl ester were all important for APC inhibition. Compound <b>9</b> also inhibited APC E3 ligase activity in a reconstituted ubiquitination reaction while reducing proteolysis of cyclin B1 from interphase cell extracts.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Furthermore, <b>9</b> dose-dependently decreased both Cdc20- and Cdh1-APC association in mitotic <i>Xenopus</i> extracts, suggesting that this molecule may impede the association between APC and its activator protein subunits.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> A radiolabeled <sup>3</sup>H-<b>9</b> analogue was subsequently incubated with <i>Xenopus</i> cells and was detected in IP pull-down of the APC subunit Cdc27 from <i>Xenopus</i> interphase extracts, as well as Cdc27 IP from HeLa cells.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> These findings support the hypothesis that compound <b>9</b> inhibits APC by preventing the association of activator proteins, possibly by interacting with Cdc27 and disrupting its PPI with other APC subunits.</div><div class="NLM_p">Since APC requires a C-terminal Ile-Arg tail on activator proteins for binding, pull-down experiments with a C-terminal Ile-Arg tail model were subsequently conducted with APC. It was found that <b>9</b> inhibited APC interactions with the Ile-Arg C-terminal motif, suggesting this as a possible binding region (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Furthermore, by use of cryoelectron microscopy, <b>9</b> was recently identified to bind areas on APC that are critical for activator binding including the previously described Ile-Arg tail binding site and the C-box binding site, a crucial conserved motif in both Cdc20 and Cdh1.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Interestingly, despite mitigating APC association to both activators Cdc20 and Cdh1,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Zhang et al. found that <b>9</b> is more potent against Cdc20-mediated APC activation.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> These results suggest that a small molecule approach, with inhibitor discovery facilitated by the use of HTS, can be exploited to selectively inhibit the association of one APC activator protein over another in order to elicit the desired downstream effect, such as mitigating cellular proliferation.</div><div class="NLM_p last">Considering that <b>9</b> is not cell permeable, a prodrug, namely, proTAME ((<i>S</i>,<i>E</i>)-5-((5-methoxy-4-((4-methylphenyl)sulfonamido)-5-oxopentyl)amino)-3,7-dioxo-2,8-dioxa-4,6-diazanon-4-ene-1,9-diyl bis(2-phenylacetate), <b>10</b>; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), was synthesized by modifying the Arg side chain to a <i>N</i>,<i>N</i>â²-bis(acyloxymethycarbamate) derivative. Treatment of HeLa cells with 12 Î¼M <b>10</b> led to the disruption of Cdh1-APC association and delayed mitotic entry.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> It was observed that using Cdc20 small interfering RNA (siRNA) or treatment with compound <b>10</b> (4 Î¼M) increased the duration of mitosis in HeLa cells from 1.0 to 1.6 and 4.8 h, respectively. Combining Cdc20 siRNA treatment with compound <b>10</b> resulted in a synergistic increase of mitotic duration to 19.4 h, surpassing the additive effect of the individual agents.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Furthermore, there was an observed decrease in the degradation of various APC substrates in HeLa cells treated with <b>10</b>, while mitotic spindle morphology was unaffected.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> This work highlighted the potential use of agents such as <b>10</b> to sensitize cells to mitotic arrest-inducing drugs and suggests that mitotic arrest can be achieved through the allosteric inhibition of specific E3 ligase complexes.</div></div><div id="sec1_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.2 Thalidomide: A Story Spanning over 60 Years</h3><div class="NLM_p">Thalidomide ((<i>S</i>)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, <b>11</b>; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) is famously known for its antiemetic properties. However, it is more infamously known by its effects at inducing the onset of debilitating teratogenic birth defects, as unexpectedly experienced by infants born to mothers who had taken this drug to treat morning sickness in the mid-20th century.<a onclick="showRef(event, 'ref115 ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref115 ref116 ref117">(115-117)</a> Although <b>11</b> was swiftly discontinued as an antinausea treatment, it has since returned to the clinic for the treatment of multiple myeloma and erythema nodosum.<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118, 119)</a> Efforts to understand its molecular mechanism of action have revealed its cellular target as cereblon (CRBN), a protein that forms an E3 ubiquitin ligase complex with the cullin-RING 4a (Cul4a), resulting in a CRL4 complex.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Interestingly, CRBN has been found to play a crucial role in fetal limb development, explaining the teratogenicity and abnormal limb formation that occurred in children born of mothers who had used this drug.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><div class="NLM_p">Compound <b>11</b> and its derivatives, lenalidomide ((<i>S</i>)-3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione, <b>12</b>; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) and pomalidomide ((<i>S</i>)-4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, <b>13</b>; <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), are all known as immunomodulatory drugs (IMiDs) and have been effectively used in the treatment of several hematological cancers due to their immunomodulatory and anti-inflammatory properties.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121, 122)</a> Recently, CRBN isolated from <i>Gallus gallus domesticus</i> was cocrystallized with human DNA damage-binding protein 1 (DDB1) bound to <b>11</b>, <b>12</b>, or <b>13</b>. CRBN is composed of three domains: a seven-stranded Î²-sheet at the N-terminus (NTD), a seven Î±-helical bundle domain (HBD) that mediates DDB1 binding, and a C-terminal domain (CTD) composed of 8 Î²-sheets.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> This CTD hosts a conserved Zn<sup>2+</sup>-binding motif 18 Ã distal from the ubiquitination substrate-binding site, which was identified as the motif to where the IMiDs were cocrystallized with similar binding modes and affinities (<i>K</i><sub>d</sub> = 250 nM for <b>11</b>, <i>K</i><sub>d</sub> = 178 nM for <b>12</b>, and <i>K</i><sub>d</sub> = 157 nM for <b>13</b>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The glutarimide functionality is the main pharmacophore of the IMiD compounds and was found to bind in a cavity on CRBN between Î²10 and Î²13, where the carbonyls and the amide nitrogen of glutarimide engage in interactions with the proximal Trp382 and His380 through hydrogen bonds.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Furthermore, the aliphatic ring of all three IMiDs appears to be buried in a hydrophobic pocket consisting of Trp382, Trp388, Trp402, and Phe404 in the crystal structure. Interestingly, when evaluated for displacement of a Cy5-labeled <b>11</b> from CRBN in an FP experiment, the binding of <b>11</b>â<b>13</b> to the Trp mutant variants CRBN<sup>Y384A</sup>, CRBN<sup>W386A</sup><sub>,</sub> and CRBN<sup>YW/AA</sup> was not observed, suggesting that this interaction may be important for inhibitor activity.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The C1 carbonyl of the phthalimide ring in all three molecules was observed to form a water-mediated H-bond to His359, while the phythaloyl ring was found to make favorable contacts with the aliphatic face of Pro354.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> It is possible that these additional interactions help mediate the tight binding of IMiDs to CRBN and enhance their subsequent effect on CRBN-mediated ubiquitination.</div><div class="NLM_p last">Interestingly, both the aniline-containing <b>12</b> and <b>13</b> agents promoted the ubiquitination and subsequent degradation of the transcription factors IKZF1 and IKZF3 by CRL4<sup>CRBN</sup>.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Compound <b>13</b> alone and two derivatives of compound <b>11</b> (containing a substitution of the phthaloyl ring C4 position with -CH<sub>3</sub> and -Cl) also promoted the recruitment and subsequent degradation of IKZF1.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> In contrast, the intracellular levels of MEIS2, an endogenous substrate of CRL4<sup>CRBN</sup>, were stabilized by treatment with <b>12</b>, presumably by inhibiting MEIS2-CRBN binding and the ensuing CRBN-mediated MEIS2 polyubiquitination and eventual degradation.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Thus, it is evident that IMiDs can either promote or inhibit protein substrate binding and subsequent ubiquitination (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Due to the plasticity of these phenotypes, IMiDs provide a prime example of how allosteric modulation of E3 ligases can either positively or negatively affect E3 enzymatic activity.</div></div><div id="sec1_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.3 PROTACs: The Era of Molecular Machines</h3><div class="NLM_p last">Fifteen years ago, Sakamoto et al. successfully hijacked the activity of E3 ligases in order to trigger specific protein degradation.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> They reported the first proteolysis-targeting chimera (PROTAC), consisting of a ligand capable of recruiting a specific E3 appended to a certain protein of interest (POI) binding motif, in order to promote POI ubiquitination and subsequent degradation in cellulo.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Since this discovery, several advancements have been made in designing new PROTACs for recruiting various POIs to a specific E3, as well as varying the E3-recruiting motifs from peptides to small molecule derivatives.<a onclick="showRef(event, 'ref125 ref126 ref127 ref128 ref129 ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref125 ref126 ref127 ref128 ref129 ref130 ref131">(125-131)</a> This has resulted in the discovery of PROTACs with promising activity in vivo.<a onclick="showRef(event, 'ref127 ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref127 ref128 ref129">(127-129)</a></div></div><div id="sec1_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.4 The Future of Modulating E3 Ligase Enzymatic Activity</h3><div class="NLM_p last">As demonstrated by the E3 ligase inhibitors and activators reviewed, the allosteric modulation of E3 enzymes can be achieved through various mechanisms. We have highlighted the tempering of E3 ligase activity by (1) directly impeding or promoting substrate protein binding, (2) inducing a conformational change which precludes binding to substrate proteins, or (3) disrupting or enhancing the binding of activator protein subunits. Developing selective small molecule agents of E3 ligases that operate through allosteric mechanisms may provide mechanistic insight into the discrete steps involved in protein substrate ubiquitination among the various classes of E3 ligases. Furthermore, this mechanistic insight might lead to the development of novel therapeutic strategies when targeting E3 ubiquitin ligase. Given the success of the unique E3 ligase recruiters highlighted in PROTACs, it is apparent that the use and discovery of allosteric modulators can broaden the scope of future UPS drug development strategies through the production of artificial E3 ligase regulators.</div></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">4 Deubiquitinating Enzymes (DUBs) and Ubiquitin-like Proteases (ULPs)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein labeling with ubiquitin and Ubls is largely regulated by the activity of DUBs and ULPs. These enzymes play a dual role in ubiquitin or Ubl conjugation pathways: they are responsible for the processing of proubiquitin and pro-Ubls into their mature polypeptide forms, as well as for the removal of ubiquitin/Ubl monomers or polymers from proteins once signaling is complete.</div><div id="sec1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.1 The DUB Step of Ubiquitin Processing</h3><div class="NLM_p">Prior to its use in protein labeling, proubiquitin must be processed and transformed into its mature form to reveal Gly76 through the cleavage of a C-terminal peptide extension.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Furthermore, single ubiquitin molecules or its polymers must eventually be removed from substrates, particularly those targeted for degradation by the 26S proteasome. This process ensures the reversibility of ubiquitin modification and maintains the homeostatic levels of free and bound ubiquitin within the cell.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> DUBs function by catalyzing the hydrolysis of the peptide, isopeptide, or thioester bonds made between ubiquitin Gly76 and other substrates. This includes removal of the proubiquitin terminal peptide, hydrolysis of bonds made between Gly76 and the Îµ-amino groups of lysine residues on protein substrates, and the removal of small intracellular nucleophiles such as glutathione that mislabel ubiquitin through the nucleophilic attack of ubiquitin thioester intermediates.<a onclick="showRef(event, 'ref6 ref133'); return false;" href="javascript:void(0);" class="ref ref6 ref133">(6, 133)</a> These actions of DUBs ensure the proper activity, recycling, and extended lifetime of ubiquitin within the cell, which are vital processes that contribute to sustaining normal rates of proteolysis that mediate normal cell growth and survival.</div><div class="NLM_p">DUBs can be subdivided into 6 subfamilies based on their mode of action and sequence similarities. Five of these families, including the ubiquitin-specific processing protease group (UBP or USP), the ubiquitin carboxy-terminal hydrolase (UCH), the ovarian tumor-related protease (OTU), the ataxin-3/Josephin domain proteases, and the recently identified motif interacting with ubiquitin-containing novel family (MINDY), are cysteine proteases that promote hydrolysis through the action of a catalytic triad containing Cys, His, and Asp residues.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Interestingly, the MINDY DUB enzymes preferentially catalyze the hydrolysis of polyubiquitin chains,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> as opposed to USP and UCH enzymes that operate on terminal ubiquitin monomers or cleaving small functional groups from the ubiquitin C-terminus, respectively. The sixth DUB family includes Jab1/Mov34/Mpr1 Pad1 N-terminal+ (JAMM/MPN+) proteases, which contain a metalloprotease motif composed of one Asp and two His residues that coordinate a Zn<sup>2+</sup> ion crucial for their proteolytic activity.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><div class="NLM_p last">The USP category is the largest of these subfamilies, and USP proteases contain two conserved motifs, namely, Cys and His boxes, that are essential for ubiquitin recognition and chain/C-terminal proteolysis. USPs share common structural features with the UCH proteases, which are smaller in size and catalyze the hydrolysis of small ubiquitin C-terminal amides and esters.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> The active sites of both types of proteases assume catalytically incompetent conformations in the absence of ubiquitin, while ubiquitin binding stimulates the reorganization of residues within the active site to induce proteolysis. The revelation of cryptic active sites solely in the presence of ubiquitin ensures that apo-DUBs remain proteolytically inert toward other cellular proteins while promoting fine-tuned temporal and spatial regulation of signaling pathways, protein degradation, and correct ubiquitin chain formation on target substrates.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Therefore, the conformational flexibility in the DUB active site may facilitate the design of molecules capable of regulating their enzymatic activity through the allosteric regulation of protein conformation, in either the presence or absence of ubiquitin.</div></div><div id="sec1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.2 Avoiding the Active Site for Selective DUB Inhibition</h3><div class="NLM_p">Although few inhibitors have been identified for UCH and USP enzymes that function through mechanisms of uncompetitive and noncompetitive inhibition, they generally display impressive potency and moderate selectivity for their target protease.</div><div class="NLM_p">There are several excellent reviews and articles that discuss recent efforts in the discovery of small molecule and protein-based DUB inhibitors.<a onclick="showRef(event, 'ref136 ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref136 ref137 ref138">(136-138)</a> These agents vary in structure, mode of action, cellular effects, and selectivity among DUB enzymes and other proteases. The first reported cell-permeable DUB inhibitor was the cyclopentenone prostaglandin Î12-PGJ<sub>2</sub> (((<i>Z</i>)-7-((<i>S</i>,<i>E</i>)-5-((<i>S</i>)-3-hydroxyoctylidene)-4-oxocyclopent-2-en-1-yl)hept-5-enoic acid, <b>14</b>), which induced apoptosis as indicated by nucleosomal fragmentation and caspase-3 activation in RKO colon carcinoma cells.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> The cellular activity of <b>14</b> (EC<sub>50</sub> between 20 and 60 Î¼M) mirrored that of the proteasome inhibitor MG115, including the accumulation of polyubiquitinated substrates.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> These observations supported the hypothesis that the main target of <b>14</b> was in fact a protein or enzyme associated with the UPS. The mode of action of <b>14</b> inhibition likely resulted from Michael-type attack of the Î±,Î²-unsaturated carbonyl within its core scaffold by the cysteine sulfhydrl group of a DUB active site, classifying this compound as an irreversible competitive inhibitor.<a onclick="showRef(event, 'ref139 ref140'); return false;" href="javascript:void(0);" class="ref ref139 ref140">(139, 140)</a> This compound was later found to also inhibit the DUB isoforms UCH-L1 and UCH-L3.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div><div class="NLM_p">The revelation of DUB inhibition by <b>14</b> stimulated the pursuit of novel competitive inhibitors and the development of drug-discovery screens specifically tailored for monitoring DUB inactivation. Although this review will not focus its discussion on competitive DUB inhibition, it should be noted that a large challenge presented in the discovery of isoform-specific competitive DUB inhibitors lies in ensuring selectivity among proteases within the same family, as a result of the conserved architecture of their active and substrate binding sites.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div><div class="NLM_p">Over the past decade, research efforts have started to focus on alternative approaches to DUB regulation by targeting pockets distal to the catalytic active site in order to counter the misregulated activity of disease-inducing DUBs, such as the USP7 protease. USP7 mediates the deubiquitination of several cellular substrates, including the E3 mouse double minute 2 (MDM2) and its ubiquitination substrate p53. Silencing USP7 leads to antiproliferative effects in cancer cells, the induction of cell cycle arrest, an increase in steady-state WT p53 levels, and the promotion of ubiquitin-dependent MDM2 degradation.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Furthermore, USP7 overexpression has been linked to prostate cancer proliferation, while its down-regulation has been implicated in the suppression of colon cancer cell division in vitro and tumor growth in vivo.<a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144, 145)</a> Thus, the USP7 protease is an attractive drug target for the extenuation of cancer cell growth and disease progression.</div><div class="NLM_p">From an ubiquitin-7-amino-4-methylcoumarin (ubiquitin-AMC) screen of 65â¯092 compounds against USP7 DUB activity, a lead inhibitor, HBX 41,108 (7-chloro-9-oxo-9<i>H</i>-indeno[1,2-<i>b</i>]pyrazine-2,3-dicarbonitrile, <b>15</b>, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), was derived through modifications performed on the most potent hits. The ubiquitin-AMC assay incorporates a 7-amido-4-methylcoumarin C (AMC) chromophore appended to a ubiquitin molecule.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Upon C-terminal hydrolysis by UCH enzymes, the AMC is released into solution and exhibits enhanced fluorescence intensity (Î»<sub>ex</sub>/Î»<sub>em</sub> = 380/460 nm).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Thus, the kinetic activity and inhibition of DUBs can be determined by measuring increases in AMC fluorescence intensity over time. Compound <b>15</b> contained a cyanoindenopyrazine scaffold and demonstrated inhibition of USP7 in vitro at an IC<sub>50</sub> = 424 nM.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Using EadieâHofstee enzyme kinetic analysis, it was found that compound <b>15</b> inactivates USP7 through a reversible uncompetitive mechanism. Thus, inhibitor binding likely occurs after formation of the enzymeâsubstrate (DUB*ubiquitin-AMC) complex and not to the apoenzyme alone.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Deubiquitinating Enzyme Inhibitors That Mediate Their Activity outside the Active Site<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/medium/jm-2016-01346d_0005.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>Table a</sup><p class="last">Inhibitor represented by orange hexagon and ubiquitin/Ubl represented by light blue circle.</p></div></div><div></div></div><div class="NLM_p">Using the molecular modeling and docking software Sybyl6.8 (Tripos) ParaDocks, it was observed that <b>15</b> preferentially interacted with a hydrophobic pocket on USP7 in close proximity to the covalently bound ubiquitin substrate, indicating potential allosteric regulation of USP7 activity (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). However, it should be noted that these docking studies were performed on X-ray crystal structures of the apo-USP7 and USP7 cocrystallized with ubiquitin-aldehyde covalently bound to the active site cysteine. Thus, it is possible that the conformation of the enzyme sampled in the docking studies does not accurately reflect the dynamic sampling of conformations that DUBs reportedly undergo when revealing cryptic binding sites for substrates. To this end, the hypothesized binding site for <b>15</b> on USP7 should be taken as a potential, and not absolute, binding conformation. However, despite some observed cellular activity, <b>15</b> also inhibited various other DUBs including USP5, USP8, UCH-L3, and the cysteine protease caspase-3, with IC<sub>50</sub> values ranging between 70 and 200 nM.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></div><div class="NLM_p">Recently, pimozide (1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2-one, <b>16</b>, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) and GW7647 (2-((4-(2-(3-cyclohexyl-1-(4-cyclohexylbutyl)ureido)ethyl)phenyl)thio)-2-methylpropanoic acid, <b>17</b>, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) were identified as the first noncompetitive inhibitors of USP1/UAF1, a DUB involved in the DNA damage response (DDR) by regulating the deubiquitination of the proliferating cell nuclear antigen (PCNA) and the Fanconi anemia complementation group D2 (FANCD2) proteins.<a onclick="showRef(event, 'ref148 ref149'); return false;" href="javascript:void(0);" class="ref ref148 ref149">(148, 149)</a> Compounds <b>16</b> and <b>17</b> were selected as top hits from a quantitative HTS (qHTS) of 9525 small molecules, in which the inhibition of USP1/UAF1 activity was measured in a ubiquitin-AMC-like assay wherein a rhodamine replaced the AMC group (ubiquitin-Rho).<a onclick="showRef(event, 'ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref150 ref151">(150, 151)</a> Kinetic studies of Lys63 diubiquitin hydrolysis revealed that <b>15</b> and <b>16</b> abrogated DUB activity through noncompetitive inhibition mechanisms (<i>K</i><sub>i</sub> = 0.5 and 0.7 Î¼M, respectively).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Both <b>16</b> and <b>17</b> displayed impressive selectivity for USP1/UAF1 over other USPs including USP7, USP2, USP5, and USP8, with IC<sub>50</sub> values ranging from 44 to >114 Î¼M.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Furthermore, <b>16</b> did not inhibit the USP46 enzyme (IC<sub>50</sub> > 114 Î¼M), whose activity is also stimulated by forming a complex to the UAF1 protein; however, <b>17</b> induced modest inhibition of USP46/UAF1 (IC<sub>50</sub> = 12 Î¼M). Both compounds also displayed no activity against the UCH proteases UCH-L1 and UCH-L3 (IC<sub>50</sub> > 200 Î¼M) as well as against caspase-3 (IC<sub>50</sub> > 250 Î¼M).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><div class="NLM_p">Treatment of HEK293T cells with either compound resulted in a significant increase in the levels of monoubiquitinated PCNA and FANCD2. These compounds were also evaluated within the cisplatin-resistant (H596) and cisplatin-sensitive (H460) non-small-cell lung cancer (NSCLC) cell lines. Cisplatin exerts its apoptotic and antiproliferative effects due, in part, to the induction of DNA lesions and the DDR through the formation of intra- and interstrand cross-links.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> However, prolonged treatment with cisplatin has resulted in acquired drug resistance through a variety of cellular mechanisms.<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153, 154)</a> Thus, as pathways involving PCNA and FANCD2 are involved in translesion synthesis and other facets of the DDR, the effects of <b>16</b> and <b>17</b> were evaluated on cell viability in combination with cisplatin. Synergy was observed between these USP1/UAF1 inhibitors and cisplatin, as cisplatin/<b>16</b> or cisplatin/<b>17</b> (in a 1:4 ratio) led to a significant increase in cytotoxicity in H596 (EC<sub>50</sub> = 5.1 and EC<sub>50</sub> = 2.8 Î¼M, respectively).<a onclick="showRef(event, 'ref150 ref155'); return false;" href="javascript:void(0);" class="ref ref150 ref155">(150, 155)</a> This combination of inhibitors did not affect the cytotoxicity of the cisplatin-sensitive H460 cells, supporting the hypothesis that USP1/UAF1-mediated DDR may be involved in the onset of cellular chemoresistance to cisplatin.</div><div class="NLM_p">It should be noted, however, that a recent study by Ritorto et al. further evaluated the selectivity of select DUB inhibitors using a quantitative MALDI-TOF mass spectrometry based DUB assay, which measured the relative hydrolysis rates of <sup>15</sup>N-labeled diubiquitin.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> On the basis of these data, it was observed that <b>15</b> displayed strong promiscuous inhibitory activity against a panel of 32 DUBs, where over half of the DUBs assessed were inhibited at 10 and 1 Î¼M. When evaluated in further detail, it was found that <b>15</b> displayed an IC<sub>50</sub> of 0.21 Â± 0.04 Î¼M against USP8 cf. an IC<sub>50</sub> of 5.97 Â± 3.19 Î¼M against its intended target, USP7.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Similarly, using this method, it was observed that <b>16</b> was found to be considerably less selective for USP1/UAF1 than previously reported but displayed less activity against the 32 enzymes than <b>15</b>. An advantage of using the MALDI-TOF method of screening for DUB inhibition includes the rapid sampling time (6â9 s per sample) and the ability to screen inhibitor activity against diubiquitin chains and ubiquitinated substrates instead of modified fluorophore-labeled ubiquitin substrates. Thus, it can be argued that the MALDI-TOF assay presents a more physiologically relevant environment for inhibitor assessment against DUB activity.</div><div class="NLM_p">Further work by Liang et al. led to the discovery of a third reversible inhibitor of USP1/UAF1, ML323 (<i>N</i>-(4-(1<i>H</i>-1,2,3-triazol-1-yl)benzyl)-2-(2-isopropylphenyl)-5-methylpyrimidin-4-amine, <b>18</b>, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>; IC<sub>50</sub> = 76 nM), which was obtained through the chemical modification of a hit identified by an ubiquitin-Rho qHTS (402â¯701 molecules screened).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Compound <b>18</b> also displayed activity against diubiquitin hydrolysis (IC<sub>50</sub> = 174 nM) and the deubiquitination of ubiquitin-PCNA (IC<sub>50</sub> = 820 nM).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Through kinetic analysis, it was discovered that <b>18</b> inhibits USP1/UAF1 activity by a mixed inhibition mechanism (<i>K</i><sub>i</sub> = 68 nM, free enzyme; <i>K</i>â²<sub>i</sub> = 183 nM, enzymeâsubstrate complex).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Furthermore, like compounds <b>16</b> and <b>17</b>, compound <b>18</b> does not inhibit USP1/UAF1 by disrupting dimer formation, as assessed using native gel electrophoresis and hydrogenâdeuterium exchange (HDX) experiments, which indicated that dimer assembly was not affected by <b>18</b>. Using HDX, it was also observed that incubating USP1/UAF1 with <b>18</b> induced conformational changes to protein regions encompassing the ubiquitin-binding site, as well as rigidification of certain regions of the UAF1 subunit. These results support the hypothesis that <b>18</b>, like <b>16</b> and <b>17</b>, likely inhibits DUB activity by binding to an allosteric site (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), possibly on the UAF1 subunit.<a onclick="showRef(event, 'ref150 ref157'); return false;" href="javascript:void(0);" class="ref ref150 ref157">(150, 157)</a></div><div class="NLM_p">The selectivity of <b>18</b> for USP1/UAF1 was evaluated against 18 DUBs, related de-SUMOylase (SENP1, for the Ubl small ubiquitin-like modifier, or SUMO) and de-NEDDylase (NEDP1) enzymes, 70 proteases, and 451 kinases through different screening platforms.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Encouragingly, <b>18</b> had no noticeable effect on any other proteases or kinases, including the USP, UCH, OTU, or MachadoâJoseph domain DUBs. This selectivity was also observed within HEK293T cells, where <b>18</b> prevented the labeling of USP1, but not other DUBs, by the covalent DUB modifier ubiquitin vinyl methyl ester (Ub-VME). These data indicate that <b>18</b> may induce conformational changes within USP1/UAF1, thereby discouraging ubiquitin binding. Furthermore, treatment of U2OS osteosarcoma, HEK293T, or H596 NSCLC cells with <b>18</b> resulted in the accumulation of monoubiquitinated PCNA and FANCD2, both of which are downstream substrates of USP1/UAF1.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><div class="NLM_p last">Similar to the work conducted by Chen et al.,<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> the ability of compound <b>18</b> to sensitize cancer cells to the DDR induced by cisplatin was evaluated in the H596 cisplatin-resistant cell line. Treatment of H596 cells with a combination of cisplatin/<b>18</b> (in a 1:4 ratio) resulted in a dramatic decrease in cell viability, with a resulting EC<sub>50</sub> = 59 nM as compared to cisplatin or <b>18</b> alone (EC<sub>50</sub> = 486 nM and EC<sub>50</sub> = 10 Î¼M, respectively).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Analysis using the CalcuSyn software supports these data and suggests a strong synergistic effect of <b>18</b> and cisplatin on cytotoxicity.<a onclick="showRef(event, 'ref155 ref157'); return false;" href="javascript:void(0);" class="ref ref155 ref157">(155, 157)</a> Furthermore, both siRNA-mediated knockdown of USP1 or treatment with <b>18</b> sensitized cells to lethal doses of UV-induced DNA damage. These data support that inhibition of USP1/UAF1 activity may only impair the DDR once damage has occurred, by either agents like cisplatin or UV damage.</div></div><div id="sec1_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">4.3 The Future of DUB Inhibition</h3><div class="NLM_p last">Several challenges need to be overcome in the pursuit of selective and potent inhibitors targeting DUB enzymes. The incomplete biophysical characterization of binding between identified small molecules and their respective enzyme targets has hampered quantitative comparisons of affinity and potency among inhibitors.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Recent advances in DUB research have included the identification of molecules that target protease activity through alternative mechanisms. These molecules, specifically <b>18</b>, display marked selectivity for USP1/UAF1 in vitro and within a cellular environment as compared to covalent DUB inhibitors and have demonstrated synergism with cisplatin against various cancer cell line viabilities. This cumulative in vitro evidence supports the therapeutic potential in achieving effective DUB inhibition by exploiting allosteric sites.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">5 Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The conventional pipeline for the discovery of allosteric inhibitors of the ubiquitin labeling pathways has mostly relied on structure-based approaches, HTS technologies, or simply serendipity. While structure-based design has driven the discovery of some clinically promising agents, as demonstrated by the activity of <b>6</b> against XIAP, limitations do exist. For example, the crystallographic data generated for E1, E2, E3, and DUB enzymes, from which de novo design typically has its origin, are limited in their usefulness, as they have been solved in either the apo or substrate-bound state, both of which potentially overlook a tractable allosteric pocket due to the dynamic nature of these enzymes. In contrast, although the use of HTS has historically given rise to hit compounds that lack target enzyme selectivity, several potent and target-specific molecules have been successfully derived from such screens for enzymes within the ubiquitin labeling cascade, such as the selective E2 inhibitor <b>5</b> or the DUB inhibitor <b>18</b>.</div><div class="NLM_p last">Additionally, increased efforts in developing allosteric inhibitors for the ubiquitin pathway have offered greater selectivity than some activity-based inhibitors, due to the inherent unique sequences in modulatory domains distal from the active site. Furthermore, a number of specific DUB inhibitors have demonstrated synergism with cisplatin, a commonly administered chemotherapeutic. Given the cases of acquired resistance to anticancer agents like cisplatin, modulating ubiquitin labeling through allosteric mechanisms may shift the paradigm to develop adjuvant therapies using this approach. Altogether, it is evident that targeting protein ubiquitination outside the orthosteric sites of enzymes involved in this labeling cascade is currently in its infancy. Thus, it is necessary for future research endeavors to explore novel modes of modulating this enzymatic cascade in order to develop chemical tools to further study the roles of UPS enzymes in cellular physiology and to fuel the discovery and development of target- and disease-specific treatments.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01346" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick T. Gunning</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Toronto, Toronto, ON M5S 3H6, Canada</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Chemical and Physical Sciences, University
of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0654-735X" title="Orcid link">http://orcid.org/0000-0003-0654-735X</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b0c0d1c4c2d9d3db9ed7c5deded9ded7f0c5c4dfc2dfdec4df9ed3d1"><span class="__cf_email__" data-cfemail="eb9b8a9f99828880c58c9e858582858cab9e9f849984859f84c5888a">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stacey-Lynn Paiva</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Toronto, Toronto, ON M5S 3H6, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sara R. da Silva</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Physical Sciences, University
of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elvin D. de Araujo</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Physical Sciences, University
of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.-L.P., S.R.d.S., and E.D.d.A. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Stacey-Lynn Paiva</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01346&amp;id=BIO-d93e1998-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Stacey-Lynn Paiva</b> obtained her Honours Bachelor of Science in Biochemistry from Queenâs University (Kingston, ON, Canada) and is currently a Ph.D. student in Prof. Gunningâs laboratory at the University of Toronto (Toronto, ON, Canada). Her current research efforts include targeting E1 activating enzymes selectively through small-molecule inhibition with a particular focus on the SUMO activating enzyme (SAE) and the UFM1 activating enzyme (UBA5).</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Sara R. da Silva</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01346&amp;id=BIO-d93e2003-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sara R. da Silva</b> obtained an Honours Bachelor of Science in Biology and a Ph.D. in Chemistry from the University of Toronto. Her doctoral work in the Gunning research group focused on identifying novel inhibitors of ubiquitin-like activating enzymes, specifically of the NEDD8-activating enzyme (NAE) and the UFM1 activating enzyme, UBA5. Her work culminated in the discovery of the first presumed allosteric inhibitor of the UBA5 enzyme. Dr. da Silva is currently a Postdoctoral Fellow in the Department of Biology (University of Toronto Mississauga), where she is studying the roles of insulin on metabolic pathways in the Chagas disease vector, <i>Rhodnius prolixus</i>.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Elvin D. de Araujo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01346&amp;id=BIO-d93e2011-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Elvin D. de Araujo</b> received his Honours Bachelor of Science in Biological Chemistry in 2010 and a Ph.D. in Chemistry in 2015 from the University of Toronto (Toronto, Canada). After graduating, he pursued a postdoctoral fellowship in the laboratory of Prof. Patrick T. Gunning (Toronto, Canada) whose team develops small molecule inhibitors for cancer therapy. Currently, Elvin is developing strategies to optimize testing of these inhibitors with recombinant STAT3 and STAT5 protein targets.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Patrick T. Gunning</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01346&amp;id=BIO-d93e2016-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Patrick T. Gunning</b> received his B.Sc. (2001) and Ph.D. (2005) from the University of Glasgow. He then pursued postdoctoral studies with Professor Andrew D. Hamilton (Yale University) before joining the University of Toronto, Department of Chemistry, as an Assistant Professor (Canada, 2007). Patrick was promoted to Associate Professor in 2012 and to Full Professor in 2016. Patrickâs medicinal chemistry research program investigates the development of small molecule inhibitors targeting Stat3 and Stat5; PTP1B; UBA1, -3, and -5 as well as development of SH2 domain mimetics and proteinâmembrane anchorage drug modalities. Patrick was the recipient of the 2010 Boehringer Ingelheim Young Investigator Award, the 2012 Royal Society for Chemistry MedChemComm Emerging Investigator Lectureship Award, and Canadian Society for Chemistryâs Bernard Bealleau Award for medicinal chemistry, among many others.</p></figure></div><div class="ack" id="ACK-d93e2021-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge financial support provided by grants from the Canadian Cancer Society Research Innovation to Impact Grant 703963 for S.-L.P. and S.R.d.S., Mitacs Accelerate for E.D.d.A., and Canada Research Chair for P.T.G.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> Abbreviations Used</h2><tr><td class="NLM_term">Ubl</td><td class="NLM_def"><p class="first last">ubiquitin-like protein</p></td></tr><tr><td class="NLM_term">PTM</td><td class="NLM_def"><p class="first last">post-translational modification</p></td></tr><tr><td class="NLM_term">DUB</td><td class="NLM_def"><p class="first last">deubiquitinating enzyme</p></td></tr><tr><td class="NLM_term">NEDD8</td><td class="NLM_def"><p class="first last">neural precursor cell expressed developmentally down-regulated</p></td></tr><tr><td class="NLM_term">RING</td><td class="NLM_def"><p class="first last">really interesting new gene</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">MM</td><td class="NLM_def"><p class="first last">multiple myeloma</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">PI3KÎ´</td><td class="NLM_def"><p class="first last">phosphatidylinositide 3-kinase Î´</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screen</p></td></tr><tr><td class="NLM_term">CLL</td><td class="NLM_def"><p class="first last">chronic lymphocytic leukemia</p></td></tr><tr><td class="NLM_term">APU</td><td class="NLM_def"><p class="first last">adenosyl-phospho-ubiquitinol</p></td></tr><tr><td class="NLM_term">UFM1</td><td class="NLM_def"><p class="first last">ubiquitin-fold modifier 1</p></td></tr><tr><td class="NLM_term">UBA5</td><td class="NLM_def"><p class="first last">UFM1 E1 activating enzyme</p></td></tr><tr><td class="NLM_term">UFC1</td><td class="NLM_def"><p class="first last">UFM1 E2 conjugating enzyme</p></td></tr><tr><td class="NLM_term">UPS</td><td class="NLM_def"><p class="first last">ubiquitin proteasome system</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">proteinâprotein interaction</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">HECT</td><td class="NLM_def"><p class="first last">homologous to the E6-AP carboxyl terminus</p></td></tr><tr><td class="NLM_term">PHD</td><td class="NLM_def"><p class="first last">plant homeodomain</p></td></tr><tr><td class="NLM_term">VHL</td><td class="NLM_def"><p class="first last">von HippelâLindau</p></td></tr><tr><td class="NLM_term">MDM2/HDM2</td><td class="NLM_def"><p class="first last">mouse/human double mutant homologue</p></td></tr><tr><td class="NLM_term">XIAP/cIAP</td><td class="NLM_def"><p class="first last">X-linked/cellular inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">Smac/DIABLO</td><td class="NLM_def"><p class="first last">cellular second mitochondria-derived activator of caspases/direct IAP binding protein with low pI</p></td></tr><tr><td class="NLM_term">CRT</td><td class="NLM_def"><p class="first last">cisplatin and radiotherapy</p></td></tr><tr><td class="NLM_term">SCF</td><td class="NLM_def"><p class="first last">Skp1-Cdc53/cullin-F-box</p></td></tr><tr><td class="NLM_term">CDC4</td><td class="NLM_def"><p class="first last">cell division control protein 4</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">CPD</td><td class="NLM_def"><p class="first last">CDC4 phosphodegron</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">SMER</td><td class="NLM_def"><p class="first last">small molecule enhancer of rapamycin</p></td></tr><tr><td class="NLM_term">SILAC</td><td class="NLM_def"><p class="first last">stable isotopic labeling with amino acids in cell culture</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>m</sub></td><td class="NLM_def"><p class="first last">melting temperature</p></td></tr><tr><td class="NLM_term">DSF</td><td class="NLM_def"><p class="first last">differential scanning fluorimetry</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">immunoprecipitation</p></td></tr><tr><td class="NLM_term">DARTS</td><td class="NLM_def"><p class="first last">drug affinity responsive target stability</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">anaphase-promoting complex/cyclosome</p></td></tr><tr><td class="NLM_term">CRBN</td><td class="NLM_def"><p class="first last">cereblon</p></td></tr><tr><td class="NLM_term">Cul4a</td><td class="NLM_def"><p class="first last">cullin-RING 4a</p></td></tr><tr><td class="NLM_term">IMiD</td><td class="NLM_def"><p class="first last">immunomodulatory drug</p></td></tr><tr><td class="NLM_term">DDB1</td><td class="NLM_def"><p class="first last">DNA damage-binding protein 1</p></td></tr><tr><td class="NLM_term">NTD</td><td class="NLM_def"><p class="first last">N-terminus domain</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">Î±-helical domain</p></td></tr><tr><td class="NLM_term">CTD</td><td class="NLM_def"><p class="first last">C-terminal domain</p></td></tr><tr><td class="NLM_term">PROTAC</td><td class="NLM_def"><p class="first last">proteolysis-targeting chimera</p></td></tr><tr><td class="NLM_term">POI</td><td class="NLM_def"><p class="first last">protein of interest</p></td></tr><tr><td class="NLM_term">BCR-ABL</td><td class="NLM_def"><p class="first last">break point cluster-Abelson</p></td></tr><tr><td class="NLM_term">TKI</td><td class="NLM_def"><p class="first last">tyrosine kinase inhibitor</p></td></tr><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myeloid leukemia</p></td></tr><tr><td class="NLM_term">LSC</td><td class="NLM_def"><p class="first last">leukemic stem cell</p></td></tr><tr><td class="NLM_term">ULP</td><td class="NLM_def"><p class="first last">ubiquitin-like protein protease</p></td></tr><tr><td class="NLM_term">UBP/USP</td><td class="NLM_def"><p class="first last">ubiquitin-specific processing protease</p></td></tr><tr><td class="NLM_term">UCH</td><td class="NLM_def"><p class="first last">ubiquitin carboxy-terminal hydrolase</p></td></tr><tr><td class="NLM_term">OTU</td><td class="NLM_def"><p class="first last">ovarian tumor-related protease</p></td></tr><tr><td class="NLM_term">AMC</td><td class="NLM_def"><p class="first last">7-amino-4-methylcoumarin C</p></td></tr><tr><td class="NLM_term">DDR</td><td class="NLM_def"><p class="first last">DNA damage response</p></td></tr><tr><td class="NLM_term">PCNA</td><td class="NLM_def"><p class="first last">proliferating cell nuclear antigen</p></td></tr><tr><td class="NLM_term">FANCD2</td><td class="NLM_def"><p class="first last">Fanconi anemia complementation group D2</p></td></tr><tr><td class="NLM_term">qHTS</td><td class="NLM_def"><p class="first last">quantitative high-througput screen</p></td></tr><tr><td class="NLM_term">Rho</td><td class="NLM_def"><p class="first last">rhodamine</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">SENP1</td><td class="NLM_def"><p class="first last">deubiquitinating enzyme for the small ubiquitin-like modifier protein</p></td></tr><tr><td class="NLM_term">NEDP1</td><td class="NLM_def"><p class="first last">deubiquitinating enzyme for NEDD8</p></td></tr><tr><td class="NLM_term">VME</td><td class="NLM_def"><p class="first last">vinyl methyl ester</p></td></tr><tr><td class="NLM_term">RNAi</td><td class="NLM_def"><p class="first last">RNA interference</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">short interfering RNA</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 157 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kerscher, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felberbaum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, M.</span><span> </span><span class="NLM_article-title">Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">â</span> <span class="NLM_lpage">180</span><span class="refDoi">Â DOI: 10.1146/annurev.cellbio.22.010605.093503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1146%2Fannurev.cellbio.22.010605.093503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16753028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yjs7vI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=159-180&author=O.+Kerscherauthor=R.+Felberbaumauthor=M.+Hochstrasser&title=Modification+of+Proteins+by+Ubiquitin+and+Ubiquitin-Like+Proteins&doi=10.1146%2Fannurev.cellbio.22.010605.093503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of proteins by ubiquitin and ubiquitin-like proteins</span></div><div class="casAuthors">Kerscher, Oliver; Felberbaum, Rachael; Hochstrasser, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-180</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Following the discovery of protein modification by the small, highly conserved ubiquitin polypeptide, a no. of distinct ubiquitin-like proteins (Ubls) have been found to function as protein modifiers as well.  These Ubls, which include SUMO, ISG15, Nedd8, and Atg8, function as crit. regulators of many cellular processes, including transcription, DNA repair, signal transduction, autophagy, and cell-cycle control.  A growing body of data also implicates the dysregulation of Ubl-substrate modification and mutations in the Ubl-conjugation machinery in the etiol. and progression of a no. of human diseases.  The primary aim of this review is to summarize the latest developments in the understanding of the different Ubl-protein modification systems, including the shared and unique features of these related pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6upobPhWlRrVg90H21EOLACvtfcHk0lj8jYe6-FVlCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yjs7vI&md5=a57eca21879c93167a900caa0b72d008</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.22.010605.093503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.22.010605.093503%26sid%3Dliteratum%253Aachs%26aulast%3DKerscher%26aufirst%3DO.%26aulast%3DFelberbaum%26aufirst%3DR.%26aulast%3DHochstrasser%26aufirst%3DM.%26atitle%3DModification%2520of%2520Proteins%2520by%2520Ubiquitin%2520and%2520Ubiquitin-Like%2520Proteins%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2006%26volume%3D22%26spage%3D159%26epage%3D180%26doi%3D10.1146%2Fannurev.cellbio.22.010605.093503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hershko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciechanover, A.</span><span> </span><span class="NLM_article-title">The Ubiquitin System</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">â</span> <span class="NLM_lpage">479</span><span class="refDoi">Â DOI: 10.1146/annurev.biochem.67.1.425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1146%2Fannurev.biochem.67.1.425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=9759494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFOmsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1998&pages=425-479&author=A.+Hershkoauthor=A.+Ciechanover&title=The+Ubiquitin+System&doi=10.1146%2Fannurev.biochem.67.1.425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin system</span></div><div class="casAuthors">Hershko, Avram; Ciechanover, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">425-479</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with â¼298 refs.  The selective degrdn. of many short-lived proteins in eukaryotic cells is carried out by the ubiquitin system.  In this pathway, proteins are targeted for degrdn. by covalent ligation to ubiquitin, a highly conserved small protein.  Ubiquitin-mediated degrdn. of regulatory proteins plays important roles in the control of numerous processes, including cell-cycle progression, signal transduction, transcriptional regulation, receptor down-regulation, and endocytosis.  The ubiquitin system has been implicated in the immune response, development, and programmed cell death.  Abnormalities in ubiquitin-mediated processes have been shown to cause pathol. conditions, including malignant transformation.  In this review we discuss recent information on functions and mechanisms of the ubiquitin system.  Since the selectivity of protein degrdn. is detd. mainly at the stage of ligation to ubiquitin, special attention is focused on what we know, and would like to know, about the mode of action of ubiquitin-protein ligation systems and about signals in proteins recognized by these systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqo5VhDx0kSLVg90H21EOLACvtfcHk0lgYnTRVa3Qc7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFOmsLc%253D&md5=7c3c0a6df9c07baf55b5000eae13ef49</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.67.1.425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.67.1.425%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DA.%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DThe%2520Ubiquitin%2520System%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1998%26volume%3D67%26spage%3D425%26epage%3D479%26doi%3D10.1146%2Fannurev.biochem.67.1.425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pickart, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, M. J.</span><span> </span><span class="NLM_article-title">Ubiquitin: Structures, Functions, Mechanisms</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1695</span><span class="NLM_x"> (</span><span class="NLM_issue">1â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">72</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2004.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbamcr.2004.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15571809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1695&publication_year=2004&pages=55-72&issue=1%E2%80%933&author=C.+M.+Pickartauthor=M.+J.+Eddins&title=Ubiquitin%3A+Structures%2C+Functions%2C+Mechanisms&doi=10.1016%2Fj.bbamcr.2004.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin: structures, functions, mechanisms</span></div><div class="casAuthors">Pickart, Cecile M.; Eddins, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1695</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">55-72</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ubiquitin (Ub) is the founding member of a family of structurally conserved proteins that regulate a host of processes in eukaryotic cells.  Ub and its relatives carry out their functions through covalent attachment to other cellular proteins, thereby changing the stability, localization, or activity of the target protein.  Here, the authors review the basic biochem. of these protein conjugation reactions, focusing on Ub itself and emphasizing recent insights into mechanism and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZlvpyTnAFurVg90H21EOLACvtfcHk0lgYnTRVa3Qc7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzO&md5=05bee85acf076fed3ade4b76109d8f7d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2004.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2004.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DPickart%26aufirst%3DC.%2BM.%26aulast%3DEddins%26aufirst%3DM.%2BJ.%26atitle%3DUbiquitin%253A%2520Structures%252C%2520Functions%252C%2520Mechanisms%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2004%26volume%3D1695%26issue%3D1%25E2%2580%25933%26spage%3D55%26epage%3D72%26doi%3D10.1016%2Fj.bbamcr.2004.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsischky, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roelofs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span> </span><span class="NLM_article-title">A Proteomics Approach to Understanding Protein Ubiquitination</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">921</span><span class="NLM_x">â</span> <span class="NLM_lpage">926</span><span class="refDoi">Â DOI: 10.1038/nbt849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnbt849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=12872131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVKgur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=921-926&issue=8&author=J.+Pengauthor=D.+Schwartzauthor=J.+E.+Eliasauthor=C.+C.+Thoreenauthor=D.+Chengauthor=G.+Marsischkyauthor=J.+Roelofsauthor=D.+Finleyauthor=S.+P.+Gygi&title=A+Proteomics+Approach+to+Understanding+Protein+Ubiquitination&doi=10.1038%2Fnbt849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A proteomics approach to understanding protein ubiquitination</span></div><div class="casAuthors">Peng, Junmin; Schwartz, Daniel; Elias, Joshua E.; Thoreen, Carson C.; Cheng, Dongmei; Marsischky, Gerald; Roelofs, Jeroen; Finley, Daniel; Gygi, Steven P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-926</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">There is a growing need for techniques that can identify and characterize protein modifications on a large or global scale.  We report here a proteomics approach to enrich, recover, and identify ubiquitin conjugates from Saccharomyces cerevisiae lysate.  Ubiquitin conjugates from a strain expressing 6xHis-tagged ubiquitin were isolated, proteolyzed with trypsin and analyzed by multidimensional liq. chromatog. coupled with tandem mass spectrometry (LC/LC-MS/MS) for amino acid sequence detn.  We identified 1,075 proteins from the sample.  In addn., we detected 110 precise ubiquitination sites present in 72 ubiquitin-protein conjugates.  Finally, ubiquitin itself was found to be modified at seven lysine residues providing evidence for unexpected diversity in polyubiquitin chain topol. in vivo.  The methodol. described here provides a general tool for the large-scale anal. and characterization of protein ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl8rBjGO_qrLVg90H21EOLACvtfcHk0lgYnTRVa3Qc7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVKgur0%253D&md5=391327b0d4d6c74bac31e01ee5b20a65</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnbt849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt849%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DSchwartz%26aufirst%3DD.%26aulast%3DElias%26aufirst%3DJ.%2BE.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DMarsischky%26aufirst%3DG.%26aulast%3DRoelofs%26aufirst%3DJ.%26aulast%3DFinley%26aufirst%3DD.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26atitle%3DA%2520Proteomics%2520Approach%2520to%2520Understanding%2520Protein%2520Ubiquitination%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26issue%3D8%26spage%3D921%26epage%3D926%26doi%3D10.1038%2Fnbt849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Scheffner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuber, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huibregtse, J. M.</span><span> </span><span class="NLM_article-title">Protein Ubiquitination Involving an E1-E2-E3 Enzyme Ubiquitin Thioester Cascade</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x"> (</span><span class="NLM_issue">6509</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">â</span> <span class="NLM_lpage">83</span><span class="refDoi">Â DOI: 10.1038/373081a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2F373081a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=1995&pages=81-83&issue=6509&author=M.+Scheffnerauthor=U.+Nuberauthor=J.+M.+Huibregtse&title=Protein+Ubiquitination+Involving+an+E1-E2-E3+Enzyme+Ubiquitin+Thioester+Cascade&doi=10.1038%2F373081a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F373081a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F373081a0%26sid%3Dliteratum%253Aachs%26aulast%3DScheffner%26aufirst%3DM.%26aulast%3DNuber%26aufirst%3DU.%26aulast%3DHuibregtse%26aufirst%3DJ.%2BM.%26atitle%3DProtein%2520Ubiquitination%2520Involving%2520an%2520E1-E2-E3%2520Enzyme%2520Ubiquitin%2520Thioester%2520Cascade%26jtitle%3DNature%26date%3D1995%26volume%3D373%26issue%3D6509%26spage%3D81%26epage%3D83%26doi%3D10.1038%2F373081a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wilkinson, K. D.</span><span> </span><span class="NLM_article-title">Regulation of Ubiquitin-Dependent Processes by Deubiquitinating Enzymes</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">1245</span><span class="NLM_x">â</span> <span class="NLM_lpage">1256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=1245-1256&issue=14&author=K.+D.+Wilkinson&title=Regulation+of+Ubiquitin-Dependent+Processes+by+Deubiquitinating+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DK.%2BD.%26atitle%3DRegulation%2520of%2520Ubiquitin-Dependent%2520Processes%2520by%2520Deubiquitinating%2520Enzymes%26jtitle%3DFASEB%2520J.%26date%3D1997%26volume%3D11%26issue%3D14%26spage%3D1245%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Clague, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heride, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">UrbÃ©, S.</span><span> </span><span class="NLM_article-title">The Demographics of the Ubiquitin System</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">417</span><span class="NLM_x">â</span> <span class="NLM_lpage">426</span><span class="refDoi">Â DOI: 10.1016/j.tcb.2015.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.tcb.2015.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25906909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVGqtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=417-426&issue=7&author=M.+J.+Clagueauthor=C.+Herideauthor=S.+Urb%C3%A9&title=The+Demographics+of+the+Ubiquitin+System&doi=10.1016%2Fj.tcb.2015.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The demographics of the ubiquitin system</span></div><div class="casAuthors">Clague, Michael J.; Heride, Claire; Urbe, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">417-426</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The ubiquitin system is a major coordinator of cellular physiol. through regulation of both protein degrdn. and signalling pathways.  A key building block of a systems-level understanding has been generated by global proteomic studies, which provide copy no. ests. for each component.  The aggregate of ubiquitin, conjugating enzymes (E1, E2, and E3s), and deubiquitylases (DUBs) represents â¼1.3% of total cellular protein.  Complementary approaches have generated quant. measurements of various ubiquitin pools and further subdivision into different ubiquitin chain topologies.  Systematic studies aimed at assocg. specific enzymes (E2s and DUBs) with the dynamics of these different pools have also made significant progress.  Here, we delineate the emerging picture of the most significant determinants of the cellular ubiquitin economy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQMwzCvXv5bVg90H21EOLACvtfcHk0lg24xxNMdcB2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVGqtbw%253D&md5=38563c26b5d83eab2bb0dc193041d1e5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2015.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2015.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DClague%26aufirst%3DM.%2BJ.%26aulast%3DHeride%26aufirst%3DC.%26aulast%3DUrb%25C3%25A9%26aufirst%3DS.%26atitle%3DThe%2520Demographics%2520of%2520the%2520Ubiquitin%2520System%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D417%26epage%3D426%26doi%3D10.1016%2Fj.tcb.2015.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Michelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vourcâh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, C. R.</span><span> </span><span class="NLM_article-title">What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor?</span> <span class="citation_source-journal">J. Mol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">616</span><span class="NLM_x">â</span> <span class="NLM_lpage">628</span><span class="refDoi">Â DOI: 10.1007/s00239-009-9225-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1007%2Fs00239-009-9225-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=616-628&issue=6&author=C.+Michelleauthor=P.+Vourc%E2%80%99hauthor=L.+Mignonauthor=C.+R.+Andres&title=What+Was+the+Set+of+Ubiquitin+and+Ubiquitin-Like+Conjugating+Enzymes+in+the+Eukaryote+Common+Ancestor%3F&doi=10.1007%2Fs00239-009-9225-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00239-009-9225-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00239-009-9225-6%26sid%3Dliteratum%253Aachs%26aulast%3DMichelle%26aufirst%3DC.%26aulast%3DVourc%25E2%2580%2599h%26aufirst%3DP.%26aulast%3DMignon%26aufirst%3DL.%26aulast%3DAndres%26aufirst%3DC.%2BR.%26atitle%3DWhat%2520Was%2520the%2520Set%2520of%2520Ubiquitin%2520and%2520Ubiquitin-Like%2520Conjugating%2520Enzymes%2520in%2520the%2520Eukaryote%2520Common%2520Ancestor%253F%26jtitle%3DJ.%2520Mol.%2520Evol.%26date%3D2009%26volume%3D68%26issue%3D6%26spage%3D616%26epage%3D628%26doi%3D10.1007%2Fs00239-009-9225-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtson, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulbrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batalov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joazeiro, C. A. P.</span><span> </span><span class="NLM_article-title">Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 That Regulates the Organelleâs Dynamics and Signaling</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">e1487</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0001487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1371%2Fjournal.pone.0001487" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e1487&issue=1&author=W.+Liauthor=M.+H.+Bengtsonauthor=A.+Ulbrichauthor=A.+Matsudaauthor=V.+A.+Reddyauthor=A.+Orthauthor=S.+K.+Chandaauthor=S.+Batalovauthor=C.+A.+P.+Joazeiro&title=Genome-Wide+and+Functional+Annotation+of+Human+E3+Ubiquitin+Ligases+Identifies+MULAN%2C+a+Mitochondrial+E3+That+Regulates+the+Organelle%E2%80%99s+Dynamics+and+Signaling&doi=10.1371%2Fjournal.pone.0001487"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001487%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DBengtson%26aufirst%3DM.%2BH.%26aulast%3DUlbrich%26aufirst%3DA.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DV.%2BA.%26aulast%3DOrth%26aufirst%3DA.%26aulast%3DChanda%26aufirst%3DS.%2BK.%26aulast%3DBatalov%26aufirst%3DS.%26aulast%3DJoazeiro%26aufirst%3DC.%2BA.%2BP.%26atitle%3DGenome-Wide%2520and%2520Functional%2520Annotation%2520of%2520Human%2520E3%2520Ubiquitin%2520Ligases%2520Identifies%2520MULAN%252C%2520a%2520Mitochondrial%2520E3%2520That%2520Regulates%2520the%2520Organelle%25E2%2580%2599s%2520Dynamics%2520and%2520Signaling%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26issue%3D1%26spage%3De1487%26doi%3D10.1371%2Fjournal.pone.0001487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, A. L.</span><span> </span><span class="NLM_article-title">Human Disorders of Ubiquitination and Proteasomal Degradation</span> <span class="citation_source-journal">Curr. Opin. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">â</span> <span class="NLM_lpage">426</span><span class="refDoi">Â DOI: 10.1097/01.mop.0000133634.79661.cd</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1097%2F01.mop.0000133634.79661.cd" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15273504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A280%3ADC%252BD2czntVKhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=419-426&issue=4&author=Y.-H.+Jiangauthor=A.+L.+Beaudet&title=Human+Disorders+of+Ubiquitination+and+Proteasomal+Degradation&doi=10.1097%2F01.mop.0000133634.79661.cd"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Human disorders of ubiquitination and proteasomal degradation</span></div><div class="casAuthors">Jiang Yong-hui; Beaudet Arthur L</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in pediatrics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-26</span>
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  The goal of this review is to provide an overview of rapidly evolving information on a new group of genetic inborn errors affecting ubiquitination and proteasomal degradation of proteins and to suggest a classification scheme for these disorders.  The relevant genes encode ubiquitin, ubiquitin enzymes (E1 and many E2s and E3s), deubiquitinating enzymes, proteasomal subunits, and substrates undergoing ubiquitination.  RECENT FINDINGS:  Since the initial recognition that Angelman syndrome is caused by maternal deficiency of the E6-AP ubiquitin E3 ligase (gene symbol UBE3A), several. other disorders of E3 ligases have been identified, including autosomal recessive juvenile Parkinson disease, the APECED form of autoimmune polyendocrinopathy syndrome, von Hippel-Lindau syndrome, and congenital polycythemia.  Disorders that disturb ubiquitin regulatory signaling include at least two subtypes of Fanconi anemia, the BRCA1 and BRCA2 forms of breast and ovarian cancer susceptibility, incontinentia pigmenti, and cylindromatosis.  Many disorders affect ubiquitin pathways secondarily.  SUMMARY:  The authors propose both a genetic and a functional classification for disorders of ubiquitination and proteasomal degradation, as follows.  Genetic classes include mutations in (1) the UBB ubiquitin gene; (2) enzymes of ubiquitination including E1, E2, E3, and related proteins; (3) deubiquitinases; (4) proteasomal subunits; and (5) substrates of ubiquitination.  Functional classes include defects in (1) proteolytic degradation, (2) ubiquitin signaling, and (3) subcellular localization of substrates.  Additional functional classes are likely to be defined, and individual disorders may involve multiple functional defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTybSvsnOaHrBBrI9DTGjC0fW6udTcc2eaD3_fgo4xlGrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czntVKhtg%253D%253D&md5=809667f28ec41bae34e2e20af8984a2b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1097%2F01.mop.0000133634.79661.cd&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.mop.0000133634.79661.cd%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.-H.%26aulast%3DBeaudet%26aufirst%3DA.%2BL.%26atitle%3DHuman%2520Disorders%2520of%2520Ubiquitination%2520and%2520Proteasomal%2520Degradation%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2004%26volume%3D16%26issue%3D4%26spage%3D419%26epage%3D426%26doi%3D10.1097%2F01.mop.0000133634.79661.cd" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Popovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikic, I.</span><span> </span><span class="NLM_article-title">Ubiquitination in Disease Pathogenesis and Treatment</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1242</span><span class="NLM_x">â</span> <span class="NLM_lpage">1253</span><span class="refDoi">Â DOI: 10.1038/nm.3739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnm.3739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25375928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyku73J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1242-1253&issue=11&author=D.+Popovicauthor=D.+Vucicauthor=I.+Dikic&title=Ubiquitination+in+Disease+Pathogenesis+and+Treatment&doi=10.1038%2Fnm.3739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitination in disease pathogenesis and treatment</span></div><div class="casAuthors">Popovic, Doris; Vucic, Domagoj; Dikic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1242-1253</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ubiquitination is crucial for a plethora of physiol. processes, including cell survival and differentiation and innate and adaptive immunity.  In recent years, considerable progress has been made in the understanding of the mol. action of ubiquitin in signaling pathways and how alterations in the ubiquitin system lead to the development of distinct human diseases.  Here we describe the role of ubiquitination in the onset and progression of cancer, metabolic syndromes, neurodegenerative diseases, autoimmunity, inflammatory disorders, infection and muscle dystrophies.  Moreover, we indicate how current knowledge could be exploited for the development of new clin. therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTMeFCgBByjbVg90H21EOLACvtfcHk0licbyLtEyiY_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyku73J&md5=3d943ec2721c980b971d02d4905d5348</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm.3739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3739%26sid%3Dliteratum%253Aachs%26aulast%3DPopovic%26aufirst%3DD.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DDikic%26aufirst%3DI.%26atitle%3DUbiquitination%2520in%2520Disease%2520Pathogenesis%2520and%2520Treatment%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26issue%3D11%26spage%3D1242%26epage%3D1253%26doi%3D10.1038%2Fnm.3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Genschik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumara, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, E.</span><span> </span><span class="NLM_article-title">The Emerging Family of CULLIN3-RING Ubiquitin Ligases (CRL3s): Cellular Functions and Disease Implications</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2307</span><span class="NLM_x">â</span> <span class="NLM_lpage">2320</span><span class="refDoi">Â DOI: 10.1038/emboj.2013.173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Femboj.2013.173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23912815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Srsr7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2307-2320&issue=17&author=P.+Genschikauthor=I.+Sumaraauthor=E.+Lechner&title=The+Emerging+Family+of+CULLIN3-RING+Ubiquitin+Ligases+%28CRL3s%29%3A+Cellular+Functions+and+Disease+Implications&doi=10.1038%2Femboj.2013.173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications</span></div><div class="casAuthors">Genschik, Pascal; Sumara, Izabela; Lechner, Esther</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2307-2320</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein ubiquitylation is a post-translational modification that controls all aspects of eukaryotic cell functionality, and its defective regulation is manifested in various human diseases.  The ubiquitylation process requires a set of enzymes, of which the ubiquitin ligases (E3s) are the substrate recognition components.  Modular CULLIN-RING ubiquitin ligases (CRLs) are the most prevalent class of E3s, comprising hundreds of distinct CRL complexes with the potential to recruit as many and even more protein substrates.  Best understood at both structural and functional levels are CRL1 or SCF (SKP1/CUL1/F-box protein) complexes, representing the founding member of this class of multimeric E3s.  Another CRL subfamily, called CRL3, is composed of the mol. scaffold CULLIN3 and the RING protein RBX1, in combination with one of numerous BTB domain proteins acting as substrate adaptors.  Recent work has firmly established CRL3s as major regulators of different cellular and developmental processes as well as stress responses in both metazoans and higher plants.  In humans, functional alterations of CRL3s have been assocd. with various pathologies, including metabolic disorders, muscle, and nerve degeneration, as well as cancer.  In this review, we summarize recent discoveries on the function of CRL3s in both metazoans and plants, and discuss their mode of regulation and specificities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9a4_A8lI_TrVg90H21EOLACvtfcHk0ljofCGNBG_adw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Srsr7J&md5=1828d71b4c75b110ba16b7c52afeb600</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Femboj.2013.173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2013.173%26sid%3Dliteratum%253Aachs%26aulast%3DGenschik%26aufirst%3DP.%26aulast%3DSumara%26aufirst%3DI.%26aulast%3DLechner%26aufirst%3DE.%26atitle%3DThe%2520Emerging%2520Family%2520of%2520CULLIN3-RING%2520Ubiquitin%2520Ligases%2520%2528CRL3s%2529%253A%2520Cellular%2520Functions%2520and%2520Disease%2520Implications%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26issue%3D17%26spage%3D2307%26epage%3D2320%26doi%3D10.1038%2Femboj.2013.173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Soucy, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhollen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doucette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnsey, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaulin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershman, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lublinsky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peluso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talreja, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyskocil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, S. P.</span><span> </span><span class="NLM_article-title">An Inhibitor of NEDD8-Activating Enzyme as a New Approach to Treat Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x"> (</span><span class="NLM_issue">7239</span><span class="NLM_x">) </span> <span class="NLM_fpage">732</span><span class="NLM_x">â</span> <span class="NLM_lpage">736</span><span class="refDoi">Â DOI: 10.1038/nature07884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature07884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19360080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVenu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=732-736&issue=7239&author=T.+A.+Soucyauthor=P.+G.+Smithauthor=M.+A.+Milhollenauthor=A.+J.+Bergerauthor=J.+M.+Gavinauthor=S.+Adhikariauthor=J.+E.+Brownellauthor=K.+E.+Burkeauthor=D.+P.+Cardinauthor=S.+Critchleyauthor=C.+A.+Cullisauthor=A.+Doucetteauthor=J.+J.+Garnseyauthor=J.+L.+Gaulinauthor=R.+E.+Gershmanauthor=A.+R.+Lublinskyauthor=A.+McDonaldauthor=H.+Mizutaniauthor=U.+Narayananauthor=E.+J.+Olhavaauthor=S.+Pelusoauthor=M.+Rezaeiauthor=M.+D.+Sintchakauthor=T.+Talrejaauthor=M.+P.+Thomasauthor=T.+Traoreauthor=S.+Vyskocilauthor=G.+S.+Weatherheadauthor=J.+Yuauthor=J.+Zhangauthor=L.+R.+Dickauthor=C.+F.+Claiborneauthor=M.+Rolfeauthor=J.+B.+Bolenauthor=S.+P.+Langston&title=An+Inhibitor+of+NEDD8-Activating+Enzyme+as+a+New+Approach+to+Treat+Cancer&doi=10.1038%2Fnature07884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer</span></div><div class="casAuthors">Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.; Berger, Allison J.; Gavin, James M.; Adhikari, Sharmila; Brownell, James E.; Burke, Kristine E.; Cardin, David P.; Critchley, Stephen; Cullis, Courtney A.; Doucette, Amanda; Garnsey, James J.; Gaulin, Jeffrey L.; Gershman, Rachel E.; Lublinsky, Anna R.; McDonald, Alice; Mizutani, Hirotake; Narayanan, Usha; Olhava, Edward J.; Peluso, Stephane; Rezaei, Mansoureh; Sintchak, Michael D.; Talreja, Tina; Thomas, Michael P.; Traore, Tary; Vyskocil, Stepan; Weatherhead, Gabriel S.; Yu, Jie; Zhang, Julie; Dick, Lawrence R.; Claiborne, Christopher F.; Rolfe, Mark; Bolen, Joseph B.; Langston, Steven P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7239</span>),
    <span class="NLM_cas:pages">732-736</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. development of an inhibitor of cellular proteasome function suggests that compds. targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies.  NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome.  Substrates of cullin-RING ligases have important roles in cellular processes assocd. with cancer cell growth and survival pathways.  Here we describe MLN4924, a potent and selective inhibitor of NAE.  MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumor cells by a new mechanism of action, the deregulation of S-phase DNA synthesis.  MLN4924 suppressed the growth of human tumor xenografts in mice at compd. exposures that were well tolerated.  Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8fx7OnZtYjbVg90H21EOLACvtfcHk0ljofCGNBG_adw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVenu7Y%253D&md5=365d4b4feac3994849050e00f1aae5e0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature07884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07884%26sid%3Dliteratum%253Aachs%26aulast%3DSoucy%26aufirst%3DT.%2BA.%26aulast%3DSmith%26aufirst%3DP.%2BG.%26aulast%3DMilhollen%26aufirst%3DM.%2BA.%26aulast%3DBerger%26aufirst%3DA.%2BJ.%26aulast%3DGavin%26aufirst%3DJ.%2BM.%26aulast%3DAdhikari%26aufirst%3DS.%26aulast%3DBrownell%26aufirst%3DJ.%2BE.%26aulast%3DBurke%26aufirst%3DK.%2BE.%26aulast%3DCardin%26aufirst%3DD.%2BP.%26aulast%3DCritchley%26aufirst%3DS.%26aulast%3DCullis%26aufirst%3DC.%2BA.%26aulast%3DDoucette%26aufirst%3DA.%26aulast%3DGarnsey%26aufirst%3DJ.%2BJ.%26aulast%3DGaulin%26aufirst%3DJ.%2BL.%26aulast%3DGershman%26aufirst%3DR.%2BE.%26aulast%3DLublinsky%26aufirst%3DA.%2BR.%26aulast%3DMcDonald%26aufirst%3DA.%26aulast%3DMizutani%26aufirst%3DH.%26aulast%3DNarayanan%26aufirst%3DU.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DPeluso%26aufirst%3DS.%26aulast%3DRezaei%26aufirst%3DM.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DTalreja%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DTraore%26aufirst%3DT.%26aulast%3DVyskocil%26aufirst%3DS.%26aulast%3DWeatherhead%26aufirst%3DG.%2BS.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DLangston%26aufirst%3DS.%2BP.%26atitle%3DAn%2520Inhibitor%2520of%2520NEDD8-Activating%2520Enzyme%2520as%2520a%2520New%2520Approach%2520to%2520Treat%2520Cancer%26jtitle%3DNature%26date%3D2009%26volume%3D458%26issue%3D7239%26spage%3D732%26epage%3D736%26doi%3D10.1038%2Fnature07884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nawrocki, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carew, J. S.</span><span> </span><span class="NLM_article-title">MLN4924: a Novel First-in-Class Inhibitor of NEDD8-Activating Enzyme for Cancer Therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1563</span><span class="NLM_x">â</span> <span class="NLM_lpage">1573</span><span class="refDoi">Â DOI: 10.1517/13543784.2012.707192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1517%2F13543784.2012.707192" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=1563-1573&issue=10&author=S.+T.+Nawrockiauthor=P.+Griffinauthor=K.+R.+Kellyauthor=J.+S.+Carew&title=MLN4924%3A+a+Novel+First-in-Class+Inhibitor+of+NEDD8-Activating+Enzyme+for+Cancer+Therapy&doi=10.1517%2F13543784.2012.707192"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543784.2012.707192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2012.707192%26sid%3Dliteratum%253Aachs%26aulast%3DNawrocki%26aufirst%3DS.%2BT.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DK.%2BR.%26aulast%3DCarew%26aufirst%3DJ.%2BS.%26atitle%3DMLN4924%253A%2520a%2520Novel%2520First-in-Class%2520Inhibitor%2520of%2520NEDD8-Activating%2520Enzyme%2520for%2520Cancer%2520Therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26issue%3D10%26spage%3D1563%26epage%3D1573%26doi%3D10.1517%2F13543784.2012.707192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tcherpakov, M.</span><span> </span><span class="NLM_article-title">Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">686</span><span class="NLM_x">â</span> <span class="NLM_lpage">693</span><span class="refDoi">Â DOI: 10.1016/j.cell.2010.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2010.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=21111230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVygsLbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2010&pages=686-693&issue=5&author=P.+Cohenauthor=M.+Tcherpakov&title=Will+the+Ubiquitin+System+Furnish+as+Many+Drug+Targets+as+Protein+Kinases%3F&doi=10.1016%2Fj.cell.2010.11.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?</span></div><div class="casAuthors">Cohen, Philip; Tcherpakov, Marianna</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">686-693</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Protein phosphorylation and protein ubiquitination regulate most aspects of cell life, and defects in these control mechanisms cause cancer and many other diseases.  In the past decade, protein kinases have become one of the most important classes of drug targets for the pharmaceutical industry.  In contrast, drug discovery programs that target components of the ubiquitin system have lagged behind.  In this Perspective, we discuss the reasons for the delay in this pipeline, the drugs targeting the ubiquitin system that have been developed, and new approaches that may popularize this area of drug discovery in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqocw2eBP5US7Vg90H21EOLACvtfcHk0lj6S_aSG33rKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVygsLbI&md5=b273310afef9fd544a534d9f39b0afb2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DTcherpakov%26aufirst%3DM.%26atitle%3DWill%2520the%2520Ubiquitin%2520System%2520Furnish%2520as%2520Many%2520Drug%2520Targets%2520as%2520Protein%2520Kinases%253F%26jtitle%3DCell%26date%3D2010%26volume%3D143%26issue%3D5%26spage%3D686%26epage%3D693%26doi%3D10.1016%2Fj.cell.2010.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Adams, J.</span><span> </span><span class="NLM_article-title">Development of the Proteasome Inhibitor PS-341</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span><span class="refDoi">Â DOI: 10.1634/theoncologist.7-1-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1634%2Ftheoncologist.7-1-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=9-16&issue=1&author=J.+Adams&title=Development+of+the+Proteasome+Inhibitor+PS-341&doi=10.1634%2Ftheoncologist.7-1-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.7-1-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.7-1-9%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520the%2520Proteasome%2520Inhibitor%2520PS-341%26jtitle%3DOncologist%26date%3D2002%26volume%3D7%26issue%3D1%26spage%3D9%26epage%3D16%26doi%3D10.1634%2Ftheoncologist.7-1-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">From Epoxomicin to Carfilzomib: Chemistry, Biology, and Medical Outcomes</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">600</span><span class="NLM_x">â</span> <span class="NLM_lpage">604</span><span class="refDoi">Â DOI: 10.1039/c3np20126k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1039%2Fc3np20126k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23575525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVWqsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=600-604&issue=5&author=K.+B.+Kimauthor=C.+M.+Crews&title=From+Epoxomicin+to+Carfilzomib%3A+Chemistry%2C+Biology%2C+and+Medical+Outcomes&doi=10.1039%2Fc3np20126k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes</span></div><div class="casAuthors">Kim, Kyung Bo; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">600-604</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 1992 to 2012The initial enthusiasm following the discovery of a pharmacol. active natural product is often fleeting due to the poor prospects for its ultimate clin. application.  Despite this, the ever-changing landscape of modern biol. has a const. need for mol. probes that can aid in our understanding of biol. processes.  After its initial discovery by Bristol-Myers Squibb as a microbial anti-tumor natural product, epoxomicin was deemed unfit for development due to its peptide structure and potentially labile epoxyketone pharmacophore.  Despite its drawbacks, epoxomicin's pharmacophore was found to provide unprecedented selectivity for the proteasome.  Epoxomicin also served as a scaffold for the generation of a synthetic tetrapeptide epoxyketone with improved activity, YU-101, which became the parent lead compd. of carfilzomib (KyprolisÂ®), the recently approved therapeutic agent for multiple myeloma.  In this era of rational drug design and high-throughput screening, the prospects for turning an active natural product into an approved therapy are often slim.  However, by understanding the journey that began with the discovery of epoxomicin and ended with the successful use of carfilzomib in the clinic, we may find new insights into the keys for success in natural product-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ZmojYh4VybVg90H21EOLACvtfcHk0lj6S_aSG33rKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVWqsrY%253D&md5=fa9d90ac327e5383f6d80512ecec8db4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2Fc3np20126k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3np20126k%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DFrom%2520Epoxomicin%2520to%2520Carfilzomib%253A%2520Chemistry%252C%2520Biology%252C%2520and%2520Medical%2520Outcomes%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2013%26volume%3D30%26issue%3D5%26spage%3D600%26epage%3D604%26doi%3D10.1039%2Fc3np20126k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Elofsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Splittgerber, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Towards Subunit-Specific Proteasome Inhibitors: Synthesis and Evaluation of Peptide Alphaâ,Beta-âEpoxyketones</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">811</span><span class="NLM_x">â</span> <span class="NLM_lpage">822</span><span class="refDoi">Â DOI: 10.1016/S1074-5521(99)80128-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS1074-5521%2899%2980128-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10574782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1MXnsVGmsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=811-822&issue=11&author=M.+Elofssonauthor=U.+Splittgerberauthor=J.+Myungauthor=R.+Mohanauthor=C.+M.+Crews&title=Towards+Subunit-Specific+Proteasome+Inhibitors%3A+Synthesis+and+Evaluation+of+Peptide+Alpha%E2%80%9C%2CBeta-%E2%80%9DEpoxyketones&doi=10.1016%2FS1074-5521%2899%2980128-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide Î±',Î²'-epoxyketones</span></div><div class="casAuthors">Elofsson, Mikael; Splittgerber, Ute; Myung, Jayhyuk; Mohan, Royce; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">811-822</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Background: The proteasome is a large multicatalytic protease complex (700 kDa) involved in a no. of highly regulated processes.  It has three major catalytic activities: a chymotrypsin-like activity, a trypsin-like activity and a post-glutamyl peptide hydrolyzing (PGPH) activity.  To be useful as mol. probes which could help dissect the cellular functions of the proteasome, inhibitors should be specific for the proteasome, active in vivo, and selectively block only one of the three catalytic activities.  To date, few inhibitors fulfill these requirements so we set out to make novel proteasome inhibitors that incorporate these characteristics.  Results: A panel of amino-terminally acetylated peptide Î±',Î²'-epoxyketones with leucine in P1 and various aliph. or arom. amino acids in P2-P4 were prepd. and evaluated.  Most compds. selectively inhibited the chymotrypsin-like activity, while only weakly inhibiting the trypsin-like and PGPH activities.  After optimization, one inhibitor, Ac-hFLFL-epoxide, was found to be more potent and selective for the inhibition of the chymotrypsin-like activity than several previously described inhibitors.  This inhibitor also exhibited strong in vivo anti-inflammatory activity.  Conclusions: Optimization of amino-terminally acetylated peptide Î±',Î²'-epoxyketones furnished a potent proteasome inhibitor, Ac-hFLFL-epoxide, that has an excellent selectivity for the chymotrypsin-like activity.  The inhibitor also proved to be a potent antiproliferative and anti-inflammatory agent.  The strong in vivo and in vitro activities suggest that this class of proteasome inhibitors could be both mol. probes and therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAHPwh58N7j7Vg90H21EOLACvtfcHk0lhag9tWhFm1Jw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsVGmsrg%253D&md5=3c64b736004246226d33ce7f6dfefbed</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980128-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980128-8%26sid%3Dliteratum%253Aachs%26aulast%3DElofsson%26aufirst%3DM.%26aulast%3DSplittgerber%26aufirst%3DU.%26aulast%3DMyung%26aufirst%3DJ.%26aulast%3DMohan%26aufirst%3DR.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTowards%2520Subunit-Specific%2520Proteasome%2520Inhibitors%253A%2520Synthesis%2520and%2520Evaluation%2520of%2520Peptide%2520Alpha%25E2%2580%259C%252CBeta-%25E2%2580%259DEpoxyketones%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26issue%3D11%26spage%3D811%26epage%3D822%26doi%3D10.1016%2FS1074-5521%2899%2980128-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Siegel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vij, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowiak, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukreti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahlis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanan-Khan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reu, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadtmauer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wear, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span> </span><span class="NLM_article-title">A Phase 2 Study of Single-Agent Carfilzomib (PX-171-003-A1) in Patients with Relapsed and Refractory Multiple Myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2817</span><span class="NLM_x">â</span> <span class="NLM_lpage">2825</span><span class="refDoi">Â DOI: 10.1182/blood-2012-05-425934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1182%2Fblood-2012-05-425934" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2817-2825&issue=14&author=D.+S.+Siegelauthor=T.+Martinauthor=M.+Wangauthor=R.+Vijauthor=A.+J.+Jakubowiakauthor=S.+Lonialauthor=S.+Trudelauthor=V.+Kukretiauthor=N.+Bahlisauthor=M.+Alsinaauthor=A.+Chanan-Khanauthor=F.+Buadiauthor=F.+J.+Reuauthor=G.+Somloauthor=J.+Zonderauthor=K.+Songauthor=A.+K.+Stewartauthor=E.+Stadtmauerauthor=L.+Kunkelauthor=S.+Wearauthor=A.+F.+Wongauthor=R.+Z.+Orlowskiauthor=S.+Jagannath&title=A+Phase+2+Study+of+Single-Agent+Carfilzomib+%28PX-171-003-A1%29+in+Patients+with+Relapsed+and+Refractory+Multiple+Myeloma&doi=10.1182%2Fblood-2012-05-425934"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-05-425934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-05-425934%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DVij%26aufirst%3DR.%26aulast%3DJakubowiak%26aufirst%3DA.%2BJ.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DKukreti%26aufirst%3DV.%26aulast%3DBahlis%26aufirst%3DN.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DChanan-Khan%26aufirst%3DA.%26aulast%3DBuadi%26aufirst%3DF.%26aulast%3DReu%26aufirst%3DF.%2BJ.%26aulast%3DSomlo%26aufirst%3DG.%26aulast%3DZonder%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DStadtmauer%26aufirst%3DE.%26aulast%3DKunkel%26aufirst%3DL.%26aulast%3DWear%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%2BF.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DJagannath%26aufirst%3DS.%26atitle%3DA%2520Phase%25202%2520Study%2520of%2520Single-Agent%2520Carfilzomib%2520%2528PX-171-003-A1%2529%2520in%2520Patients%2520with%2520Relapsed%2520and%2520Refractory%2520Multiple%2520Myeloma%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26issue%3D14%26spage%3D2817%26epage%3D2825%26doi%3D10.1182%2Fblood-2012-05-425934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Vij, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowiak, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukreti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonagh, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahlis, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reu, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrail, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matous, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesole, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wear, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D. S.</span><span> </span><span class="NLM_article-title">An Open-Label, Single-Arm, Phase 2 (PX-171-004) Study of Single-Agent Carfilzomib in Bortezomib-Naive Patients with Relapsed and/or Refractory Multiple Myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">5661</span><span class="NLM_x">â</span> <span class="NLM_lpage">5670</span><span class="refDoi">Â DOI: 10.1182/blood-2012-03-414359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1182%2Fblood-2012-03-414359" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=5661-5670&issue=24&author=R.+Vijauthor=M.+Wangauthor=J.+L.+Kaufmanauthor=S.+Lonialauthor=A.+J.+Jakubowiakauthor=A.+K.+Stewartauthor=V.+Kukretiauthor=S.+Jagannathauthor=K.+T.+McDonaghauthor=M.+Alsinaauthor=N.+J.+Bahlisauthor=F.+J.+Reuauthor=N.+Y.+Gabrailauthor=A.+Belchauthor=J.+V.+Matousauthor=P.+Leeauthor=P.+Rosenauthor=M.+Sebagauthor=D.+H.+Vesoleauthor=L.+A.+Kunkelauthor=S.+M.+Wearauthor=A.+F.+Wongauthor=R.+Z.+Orlowskiauthor=D.+S.+Siegel&title=An+Open-Label%2C+Single-Arm%2C+Phase+2+%28PX-171-004%29+Study+of+Single-Agent+Carfilzomib+in+Bortezomib-Naive+Patients+with+Relapsed+and%2For+Refractory+Multiple+Myeloma&doi=10.1182%2Fblood-2012-03-414359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-03-414359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-03-414359%26sid%3Dliteratum%253Aachs%26aulast%3DVij%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DKaufman%26aufirst%3DJ.%2BL.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DJakubowiak%26aufirst%3DA.%2BJ.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DKukreti%26aufirst%3DV.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DMcDonagh%26aufirst%3DK.%2BT.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DBahlis%26aufirst%3DN.%2BJ.%26aulast%3DReu%26aufirst%3DF.%2BJ.%26aulast%3DGabrail%26aufirst%3DN.%2BY.%26aulast%3DBelch%26aufirst%3DA.%26aulast%3DMatous%26aufirst%3DJ.%2BV.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DRosen%26aufirst%3DP.%26aulast%3DSebag%26aufirst%3DM.%26aulast%3DVesole%26aufirst%3DD.%2BH.%26aulast%3DKunkel%26aufirst%3DL.%2BA.%26aulast%3DWear%26aufirst%3DS.%2BM.%26aulast%3DWong%26aufirst%3DA.%2BF.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26atitle%3DAn%2520Open-Label%252C%2520Single-Arm%252C%2520Phase%25202%2520%2528PX-171-004%2529%2520Study%2520of%2520Single-Agent%2520Carfilzomib%2520in%2520Bortezomib-Naive%2520Patients%2520with%2520Relapsed%2520and%252For%2520Refractory%2520Multiple%2520Myeloma%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26issue%3D24%26spage%3D5661%26epage%3D5670%26doi%3D10.1182%2Fblood-2012-03-414359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vij, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowiak, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahlis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D. S.</span><span> </span><span class="NLM_article-title">An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma</span> <span class="citation_source-journal">Clin Lymphoma Myeloma Leuk</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">310</span><span class="NLM_x">â</span> <span class="NLM_lpage">318</span><span class="refDoi">Â DOI: 10.1016/j.clml.2012.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.clml.2012.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23040437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVyhsbrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=310-318&issue=5&author=S.+Jagannathauthor=R.+Vijauthor=A.+K.+Stewartauthor=S.+Trudelauthor=A.+J.+Jakubowiakauthor=T.+Reimanauthor=G.+Somloauthor=N.+Bahlisauthor=S.+Lonialauthor=L.+A.+Kunkelauthor=A.+Wongauthor=R.+Z.+Orlowskiauthor=D.+S.+Siegel&title=An+Open-Label+Single-Arm+Pilot+Phase+II+Study+%28PX-171-003-A0%29+of+Low-Dose%2C+Single-Agent+Carfilzomib+in+Patients+with+Relapsed+and+Refractory+Multiple+Myeloma&doi=10.1016%2Fj.clml.2012.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma</span></div><div class="casAuthors">Jagannath, Sundar; Vij, Ravi; Stewart, A. Keith; Trudel, Suzanne; Jakubowiak, Andrzej J.; Reiman, Tony; Somlo, George; Bahlis, Nizar; Lonial, Sagar; Kunkel, Lori A.; Wong, Alvin; Orlowski, Robert Z.; Siegel, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Lymphoma, Myeloma & Leukemia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">310-318</span>CODEN:
                <span class="NLM_cas:coden">CLMLCQ</span>;
        ISSN:<span class="NLM_cas:issn">2152-2669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Carfilzomib is a next-generation selective proteasome inhibitor that irreversibly binds its target and has demonstrated single-agent activity in patients with bortezomib-resistant multiple myeloma (MM).  PX-171-003-A0, an open-label single-arm multicenter pilot phase II study, enrolled 46 patients with relapsed MM after â¥ 2 previous therapies including bortezomib and an immunomodulator (thalidomide or lenalidomide) and disease refractory to the last treatment regimen preceding study entry.  Patients received carfilzomib 20 mg/m2 i.v. on days 1, 2, 8, 9, 15, and 16 every 28 days for up to 12 cycles.  Responses in 42 evaluable patients were assessed per International Myeloma Working Group Uniform Response Criteria, with minimal response assessed per European Group for Blood and Marrow Transplantation (EBMT) criteria.  The primary endpoint of best ORR was 16.7%, including 7 partial responses.  Median duration of response was 7.2 mo.  Clin. benefit response (CBR) rate was 23.8% with a median duration of response of 13.8 mo.  The most common treatment-emergent adverse events (AEs) of any grade were anemia (73.9%), fatigue (69.6%), and thrombocytopenia (50.0%).  Notably, peripheral neuropathy and neuropathy-related AEs were generally mild and infrequent.  This pilot study was the first phase II single-agent trial conducted with carfilzomib.  Based on these findings, the study was amended to test a higher carfilzomib dose in an addnl. 250 patients (PX-171-003-A1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPRBkDDHNX8bVg90H21EOLACvtfcHk0ljTCWB2ccROXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVyhsbrP&md5=66d006c6d3b3324cbb198d8426f294d9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.clml.2012.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clml.2012.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DVij%26aufirst%3DR.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DJakubowiak%26aufirst%3DA.%2BJ.%26aulast%3DReiman%26aufirst%3DT.%26aulast%3DSomlo%26aufirst%3DG.%26aulast%3DBahlis%26aufirst%3DN.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DKunkel%26aufirst%3DL.%2BA.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26atitle%3DAn%2520Open-Label%2520Single-Arm%2520Pilot%2520Phase%2520II%2520Study%2520%2528PX-171-003-A0%2529%2520of%2520Low-Dose%252C%2520Single-Agent%2520Carfilzomib%2520in%2520Patients%2520with%2520Relapsed%2520and%2520Refractory%2520Multiple%2520Myeloma%26jtitle%3DClin%2520Lymphoma%2520Myeloma%2520Leuk%26date%3D2012%26volume%3D12%26issue%3D5%26spage%3D310%26epage%3D318%26doi%3D10.1016%2Fj.clml.2012.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Kinase Drug Discovery--Whatâs Next in the Field?</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">96</span><span class="NLM_x">â</span> <span class="NLM_lpage">104</span><span class="refDoi">Â DOI: 10.1021/cb300610s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300610s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvF2q" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=96-104&issue=1&author=P.+Cohenauthor=D.+R.+Alessi&title=Kinase+Drug+Discovery%2D%2DWhat%E2%80%99s+Next+in+the+Field%3F&doi=10.1021%2Fcb300610s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Drug Discovery - What's Next in the Field?</span></div><div class="casAuthors">Cohen, Philip; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-104</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past 15 years protein kinases have become the pharmaceutical industry's most important class of drug target in the field of cancer.  Some 20 drugs that target kinases have been approved for clin. use over the past decade, and hundreds more are undergoing clin. trials.  However, the recent approval of the first protein kinase inhibitors for the treatment of inflammatory diseases, coupled with an enhanced understanding of the signaling networks that control the immune system, suggests that there will be a surge of interest in this area over the next 10 years.  In this connection, we discuss opportunities for targeting protein kinases in the MyD88 signaling network for the development of drugs to treat chronic inflammatory and autoimmune diseases.  Activating mutations in protein kinases underlie many other diseases and conditions, and we also discuss why the protein kinases SPAK/OSR1 and LRRK2 have recently become interesting targets for the treatment of hypertension and Parkinson's disease, resp., and the progress that has been made in developing LRRK2 inhibitors.  Finally we suggest that more focus on the identification of inhibitors of kinase activation, rather than kinase activity, may pay dividends in identifying exquisitely specific inhibitors of signal transduction cascades, and we also highlight "pseudo-kinases" as an attractive and unexplored area for drug development that merits much more attention in the years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9qmfkcqZ3ILVg90H21EOLACvtfcHk0liLn6D7h_0NaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvF2q&md5=5bf2ced4163b6ae70e604b2916a6a068</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcb300610s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300610s%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKinase%2520Drug%2520Discovery--What%25E2%2580%2599s%2520Next%2520in%2520the%2520Field%253F%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D1%26spage%3D96%26epage%3D104%26doi%3D10.1021%2Fcb300610s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, M. H.</span><span> </span><span class="NLM_article-title">FDA-Approved Small-Molecule Kinase Inhibitors</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">422</span><span class="NLM_x">â</span> <span class="NLM_lpage">439</span><span class="refDoi">Â DOI: 10.1016/j.tips.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.tips.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25975227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=422-439&issue=7&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=FDA-Approved+Small-Molecule+Kinase+Inhibitors&doi=10.1016%2Fj.tips.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">FDA-approved small-molecule kinase inhibitors</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">422-439</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinases have emerged as one of the most intensively pursued targets in current pharmacol. research, esp. for cancer, due to their crit. roles in cellular signaling.  To date, the US FDA has approved 28 small-mol. kinase inhibitors, half of which were approved in the past 3 years.  While the clin. data of these approved mols. are widely presented and structure-activity relationship (SAR) has been reported for individual mols., an updated review that analyzes all approved mols. and summarizes current achievements and trends in the field has yet to be found.  Here we present all approved small-mol. kinase inhibitors with an emphasis on binding mechanism and structural features, summarize current challenges, and discuss future directions in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrudyvM3eO09bVg90H21EOLACvtfcHk0liLn6D7h_0NaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D&md5=a6aa3dbb11e6fe3001fa5fa03a4c950a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DFDA-Approved%2520Small-Molecule%2520Kinase%2520Inhibitors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26issue%3D7%26spage%3D422%26epage%3D439%26doi%3D10.1016%2Fj.tips.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span> </span><span class="NLM_article-title">The Druggable Genome</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">727</span><span class="NLM_x">â</span> <span class="NLM_lpage">730</span><span class="refDoi">Â DOI: 10.1038/nrd892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrd892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=12209152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD38XmslamtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=727-730&issue=9&author=A.+L.+Hopkinsauthor=C.+R.+Groom&title=The+Druggable+Genome&doi=10.1038%2Fnrd892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: The druggable genome</span></div><div class="casAuthors">Hopkins, Andrew L.; Groom, Colin R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">727-730</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  An assessment of the no. of mol. targets that represent an opportunity for therapeutic intervention is crucial to the development of post-genomic research strategies within the pharmaceutical industry.  Now that we know the size of the human genome, it is interesting to consider just how many mol. targets this opportunity represents.  We start from the position that we understand the properties that are required for a good drug, and therefore must be able to understand what makes a good drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Uvqi8O9wzrVg90H21EOLACvtfcHk0liLn6D7h_0NaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmslamtrY%253D&md5=d6dc7c67822661fe03e920695def1329</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrd892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd892%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26atitle%3DThe%2520Druggable%2520Genome%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26issue%3D9%26spage%3D727%26epage%3D730%26doi%3D10.1038%2Fnrd892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">MÃ¼ller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The Ins and Outs of Selective Kinase Inhibitor Development</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">818</span><span class="NLM_x">â</span> <span class="NLM_lpage">821</span><span class="refDoi">Â DOI: 10.1038/nchembio.1938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=26485069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=818-821&issue=11&author=S.+M%C3%BCllerauthor=A.+Chaikuadauthor=N.+S.+Grayauthor=S.+Knapp&title=The+Ins+and+Outs+of+Selective+Kinase+Inhibitor+Development&doi=10.1038%2Fnchembio.1938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The ins and outs of selective kinase inhibitor development</span></div><div class="casAuthors">Muller, Susanne; Chaikuad, Apirat; Gray, Nathanael S.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-821</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases have emerged as one of the most successful families of drug targets.  To date, most selective kinase inhibitors have been discovered serendipitously either through broad selectivity screening or through the discovery of unique binding modes.  Here the authors discuss design strategies that could lead to a broader coverage of the kinome with selective inhibitors and to a more rational approach for developing them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQzaMrxSYx_rVg90H21EOLACvtfcHk0lhavps4SWM3uQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF&md5=f5adf0bbaa388c87b26bae23cfad0bae</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1938%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520Ins%2520and%2520Outs%2520of%2520Selective%2520Kinase%2520Inhibitor%2520Development%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D11%26spage%3D818%26epage%3D821%26doi%3D10.1038%2Fnchembio.1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Furman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutre, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelenetz, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipps, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eradat, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ervin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamanna, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coiffier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettitt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilgenbauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahn, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansey, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, S. M.</span><span> </span><span class="NLM_article-title">Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">997</span><span class="NLM_x">â</span> <span class="NLM_lpage">1007</span><span class="refDoi">Â DOI: 10.1056/NEJMoa1315226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1056%2FNEJMoa1315226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24450857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVyqtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=997-1007&issue=11&author=R.+R.+Furmanauthor=J.+P.+Sharmanauthor=S.+E.+Coutreauthor=B.+D.+Chesonauthor=J.+M.+Pagelauthor=P.+Hillmenauthor=J.+C.+Barrientosauthor=A.+D.+Zelenetzauthor=T.+J.+Kippsauthor=I.+Flinnauthor=P.+Ghiaauthor=H.+Eradatauthor=T.+Ervinauthor=N.+Lamannaauthor=B.+Coiffierauthor=A.+R.+Pettittauthor=S.+Maauthor=S.+Stilgenbauerauthor=P.+Cramerauthor=M.+Aielloauthor=D.+M.+Johnsonauthor=L.+L.+Millerauthor=D.+Liauthor=T.+M.+Jahnauthor=R.+D.+Danseyauthor=M.+Hallekauthor=S.+M.+O%E2%80%99Brien&title=Idelalisib+and+Rituximab+in+Relapsed+Chronic+Lymphocytic+Leukemia&doi=10.1056%2FNEJMoa1315226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Idelalisib and rituximab in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Furman, Richard R.; Sharman, Jeff P.; Coutre, Steven E.; Cheson, Bruce D.; Pagel, John M.; Hillmen, Peter; Barrientos, Jacqueline C.; Zelenetz, Andrew D.; Kipps, Thomas J.; Flinn, Ian; Ghia, Paolo; Eradat, Herbert; Ervin, Thomas; Lamanna, Nicole; Coiffier, Bertrand; Pettitt, Andrew R.; Ma, Shuo; Stilgenbauer, Stephan; Cramer, Paula; Aiello, Maria; Johnson, Dave M.; Miller, Langdon L.; Li, Daniel; Jahn, Thomas M.; Dansey, Roger D.; Hallek, Michael; O'Brien, Susan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">997-1007</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Patients with relapsed chronic lymphocytic leukemia (CLL) who have clin. significant coexisting medical conditions are less able to undergo std. chemotherapy.  Effective therapies with acceptable side-effect profiles are needed for this patient population.  In this multicenter, randomized, double-blind, placebo-controlled, phase 3 study, the authors assessed the efficacy and safety of idelalisib, an oral inhibitor of the delta isoform of phosphatidylinositol 3-kinase, in combination with rituximab vs. rituximab plus placebo.  The authors randomly assigned 220 patients with decreased renal function, previous therapy-induced myelosuppression, or major coexisting illnesses to receive rituximab and either idelalisib (at a dose of 150 mg) or placebo twice daily.  The primary end point was progression-free survival.  At the first prespecified interim anal., the study was stopped early on the recommendation of the data and safety monitoring board owing to overwhelming efficacy.  The median progression-free survival was 5.5 mo in the placebo group and was not reached in the idelalisib group (hazard ratio for progression or death in the idelalisib group, 0.15; P<0.001).  Patients receiving idelalisib vs. those receiving placebo had improved rates of overall response (81% vs. 13%; odds ratio, 29.92; P<0.001) and overall survival at 12 mo (92% vs. 80%; hazard ratio for death, 0.28; P = 0.02).  Serious adverse events occurred in 40% of the patients receiving idelalisib and rituximab and in 35% of those receiving placebo and rituximab.  The combination of idelalisib and rituximab, as compared with placebo and rituximab, significantly improved progression-free survival, response rate, and overall survival among patients with relapsed CLL who were less able to undergo chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhnTsUaIOybVg90H21EOLACvtfcHk0lhavps4SWM3uQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVyqtLs%253D&md5=4bce9ab0dae94360abfcd4f312691503</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1315226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1315226%26sid%3Dliteratum%253Aachs%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26aulast%3DCheson%26aufirst%3DB.%2BD.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DEradat%26aufirst%3DH.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DLamanna%26aufirst%3DN.%26aulast%3DCoiffier%26aufirst%3DB.%26aulast%3DPettitt%26aufirst%3DA.%2BR.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DStilgenbauer%26aufirst%3DS.%26aulast%3DCramer%26aufirst%3DP.%26aulast%3DAiello%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BM.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DJahn%26aufirst%3DT.%2BM.%26aulast%3DDansey%26aufirst%3DR.%2BD.%26aulast%3DHallek%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BM.%26atitle%3DIdelalisib%2520and%2520Rituximab%2520in%2520Relapsed%2520Chronic%2520Lymphocytic%2520Leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26issue%3D11%26spage%3D997%26epage%3D1007%26doi%3D10.1056%2FNEJMoa1315226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Berndt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hon, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¼ckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">The P110 Delta Structure: Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">117</span><span class="NLM_x">â</span> <span class="NLM_lpage">124</span><span class="refDoi">Â DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&issue=2&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+R%C3%BCckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williams&title=The+P110+Delta+Structure%3A+Mechanisms+for+Selectivity+and+Potency+of+New+PI%283%29K+Inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The p110Î´ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110Î´.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110Î´ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110Î´ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0lhr6DkXY7s6Ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DThe%2520P110%2520Delta%2520Structure%253A%2520Mechanisms%2520for%2520Selectivity%2520and%2520Potency%2520of%2520New%2520PI%25283%2529K%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D2%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lannutti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, S. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span> </span><span class="NLM_article-title">CAL-101, a P110delta Selective Phosphatidylinositol-3-Kinase Inhibitor for the Treatment of B-Cell Malignancies, Inhibits PI3K Signaling and Cellular Viability</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">591</span><span class="NLM_x">â</span> <span class="NLM_lpage">594</span><span class="refDoi">Â DOI: 10.1182/blood-2010-03-275305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1182%2Fblood-2010-03-275305" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=591-594&issue=2&author=B.+J.+Lannuttiauthor=S.+A.+Meadowsauthor=S.+E.+M.+Hermanauthor=A.+Kashishianauthor=B.+Steinerauthor=A.+J.+Johnsonauthor=J.+C.+Byrdauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=M.+Deiningerauthor=B.+J.+Drukerauthor=K.+D.+Puriauthor=R.+G.+Ulrichauthor=N.+A.+Giese&title=CAL-101%2C+a+P110delta+Selective+Phosphatidylinositol-3-Kinase+Inhibitor+for+the+Treatment+of+B-Cell+Malignancies%2C+Inhibits+PI3K+Signaling+and+Cellular+Viability&doi=10.1182%2Fblood-2010-03-275305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-03-275305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-03-275305%26sid%3Dliteratum%253Aachs%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DHerman%26aufirst%3DS.%2BE.%2BM.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDeininger%26aufirst%3DM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26atitle%3DCAL-101%252C%2520a%2520P110delta%2520Selective%2520Phosphatidylinositol-3-Kinase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520B-Cell%2520Malignancies%252C%2520Inhibits%2520PI3K%2520Signaling%2520and%2520Cellular%2520Viability%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26issue%3D2%26spage%3D591%26epage%3D594%26doi%3D10.1182%2Fblood-2010-03-275305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koditek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VillaseÃ±or, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novikov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liclican, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagpacan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papalia, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span> </span><span class="NLM_article-title">Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase Î</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">8439</span><span class="NLM_x">â</span> <span class="NLM_lpage">8446</span><span class="refDoi">Â DOI: 10.1074/jbc.M114.634683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1074%2Fjbc.M114.634683" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=8439-8446&issue=13&author=J.+R.+Somozaauthor=D.+Koditekauthor=A.+G.+Villase%C3%B1orauthor=N.+Novikovauthor=M.+H.+Wongauthor=A.+Liclicanauthor=W.+Xingauthor=L.+Lagpacanauthor=R.+Wangauthor=B.+E.+Schultzauthor=G.+A.+Papaliaauthor=D.+Samuelauthor=L.+Ladauthor=M.+E.+McGrath&title=Structural%2C+Biochemical%2C+and+Biophysical+Characterization+of+Idelalisib+Binding+to+Phosphoinositide+3-Kinase+%CE%94&doi=10.1074%2Fjbc.M114.634683"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.634683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.634683%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DXing%26aufirst%3DW.%26aulast%3DLagpacan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DPapalia%26aufirst%3DG.%2BA.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26atitle%3DStructural%252C%2520Biochemical%252C%2520and%2520Biophysical%2520Characterization%2520of%2520Idelalisib%2520Binding%2520to%2520Phosphoinositide%25203-Kinase%2520%25CE%2594%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D13%26spage%3D8439%26epage%3D8446%26doi%3D10.1074%2Fjbc.M114.634683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakefuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurachi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakegawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmartin, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquerre, S. G.</span><span> </span><span class="NLM_article-title">Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">320</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span><span class="refDoi">Â DOI: 10.1021/ml200004g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200004g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=320-324&issue=4&author=H.+Abeauthor=S.+Kikuchiauthor=K.+Hayakawaauthor=T.+Iidaauthor=N.+Nagahashiauthor=K.+Maedaauthor=J.+Sakamotoauthor=N.+Matsumotoauthor=T.+Miuraauthor=K.+Matsumuraauthor=N.+Sekiauthor=T.+Inabaauthor=H.+Kawasakiauthor=T.+Yamaguchiauthor=R.+Kakefudaauthor=T.+Nanayamaauthor=H.+Kurachiauthor=Y.+Horiauthor=T.+Yoshidaauthor=J.+Kakegawaauthor=Y.+Watanabeauthor=A.+G.+Gilmartinauthor=M.+C.+Richterauthor=K.+G.+Mossauthor=S.+G.+Laquerre&title=Discovery+of+a+Highly+Potent+and+Selective+MEK+Inhibitor%3A+GSK1120212+%28JTP-74057+DMSO+Solvate%29&doi=10.1021%2Fml200004g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fml200004g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200004g%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DS.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DIida%26aufirst%3DT.%26aulast%3DNagahashi%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DSakamoto%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DInaba%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DKakefuda%26aufirst%3DR.%26aulast%3DNanayama%26aufirst%3DT.%26aulast%3DKurachi%26aufirst%3DH.%26aulast%3DHori%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKakegawa%26aufirst%3DJ.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DRichter%26aufirst%3DM.%2BC.%26aulast%3DMoss%26aufirst%3DK.%2BG.%26aulast%3DLaquerre%26aufirst%3DS.%2BG.%26atitle%3DDiscovery%2520of%2520a%2520Highly%2520Potent%2520and%2520Selective%2520MEK%2520Inhibitor%253A%2520GSK1120212%2520%2528JTP-74057%2520DMSO%2520Solvate%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26issue%3D4%26spage%3D320%26epage%3D324%26doi%3D10.1021%2Fml200004g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Dong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halkowycz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanouni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span> </span><span class="NLM_article-title">Discovery of TAK-733, a Potent and Selective MEK Allosteric Site Inhibitor for the Treatment of Cancer</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1315</span><span class="NLM_x">â</span> <span class="NLM_lpage">1319</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.01.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bmcl.2011.01.071" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1315-1319&issue=5&author=Q.+Dongauthor=D.+R.+Douganauthor=X.+Gongauthor=P.+Halkowyczauthor=B.+Jinauthor=T.+Kanouniauthor=S.+M.+O%E2%80%99Connellauthor=N.+Scorahauthor=L.+Shiauthor=M.+B.+Wallaceauthor=F.+Zhou&title=Discovery+of+TAK-733%2C+a+Potent+and+Selective+MEK+Allosteric+Site+Inhibitor+for+the+Treatment+of+Cancer&doi=10.1016%2Fj.bmcl.2011.01.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.071%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DHalkowycz%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DB.%26aulast%3DKanouni%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DS.%2BM.%26aulast%3DScorah%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DZhou%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520TAK-733%252C%2520a%2520Potent%2520and%2520Selective%2520MEK%2520Allosteric%2520Site%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D5%26spage%3D1315%26epage%3D1319%26doi%3D10.1016%2Fj.bmcl.2011.01.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Flaherty, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kefford, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuchter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudchadkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchook, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Algazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzanov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebowitz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allred, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J.</span><span> </span><span class="NLM_article-title">Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1694</span><span class="NLM_x">â</span> <span class="NLM_lpage">1703</span><span class="refDoi">Â DOI: 10.1056/NEJMoa1210093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1056%2FNEJMoa1210093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23020132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eksLrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=1694-1703&issue=18&author=K.+T.+Flahertyauthor=J.+R.+Infanteauthor=A.+Daudauthor=R.+Gonzalezauthor=R.+F.+Keffordauthor=J.+Sosmanauthor=O.+Hamidauthor=L.+Schuchterauthor=J.+Cebonauthor=N.+Ibrahimauthor=R.+Kudchadkarauthor=H.+A.+Burrisauthor=G.+Falchookauthor=A.+Algaziauthor=K.+Lewisauthor=G.+V.+Longauthor=I.+Puzanovauthor=P.+Lebowitzauthor=A.+Singhauthor=S.+Littleauthor=P.+Sunauthor=A.+Allredauthor=D.+Ouelletauthor=K.+B.+Kimauthor=K.+Patelauthor=J.+Weber&title=Combined+BRAF+and+MEK+Inhibition+in+Melanoma+with+BRAF+V600+Mutations&doi=10.1056%2FNEJMoa1210093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations</span></div><div class="casAuthors">Flaherty, Keith T.; Infante, Jeffery R.; Daud, Adil; Gonzalez, Rene; Kefford, Richard F.; Sosman, Jeffrey; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Ibrahim, Nageatte; Kudchadkar, Ragini; Burris, Howard A., III; Falchook, Gerald; Algazi, Alain; Lewis, Karl; Long, Georgina V.; Puzanov, Igor; Lebowitz, Peter; Singh, Ajay; Little, Shonda; Sun, Peng; Allred, Alicia; Ouellet, Daniele; Kim, Kevin B.; Patel, Kiran; Weber, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1694-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Resistance to therapy with BRAF kinase inhibitors is assocd. with reactivation of the mitogen-activated protein kinase (MAPK) pathway.  To address this problem, we conducted a phase 1 and 2 trial of combined treatment with dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK) inhibitor.  METHODS In this open-label study involving 247 patients with metastatic melanoma and BRAF V600 mutations, we evaluated the pharmacokinetic activity and safety of oral dabrafenib (75 or 150 mg twice daily) and trametinib (1, 1.5, or 2 mg daily) in 85 patients and then randomly assigned 162 patients to receive combination therapy with dabrafenib (150 mg) plus trametinib (1 or 2 mg) or dabrafenib monotherapy.  The primary end points were the incidence of cutaneous squamous-cell carcinoma, survival free of melanoma progression, and response.  Secondary end points were overall survival and pharmacokinetic activity.  RESULTS Dose-limiting toxic effects were infrequently obsd. in patients receiving combination therapy with 150 mg of dabrafenib and 2 mg of trametinib (combination 150/2).  Cutaneous squamous-cell carcinoma was seen in 7% of patients receiving combination 150/2 and in 19% receiving monotherapy (P = 0.09), whereas pyrexia was more common in the combination 150/2 group than in the monotherapy group (71% vs. 26%).  Median progression-free survival in the combination 150/2 group was 9.4 mo, as compared with 5.8 mo in the monotherapy group (hazard ratio for progression or death, 0.39; 95% confidence interval, 0.25 to 0.62; P<0.001).  The rate of complete or partial response with combination 150/2 therapy was 76%, as compared with 54% with monotherapy (P = 0.03).  CONCLUSIONS Dabrafenib and trametinib were safely combined at full monotherapy doses.  The rate of pyrexia was increased with combination therapy, whereas the rate of proliferative skin lesions was nonsignificantly reduced.  Progression-free survival was significantly improved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk7I8zrGTVbVg90H21EOLACvtfcHk0ljVVLhFcWcB_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eksLrJ&md5=199ae281d44c3b41309b934d88674cd3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1210093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1210093%26sid%3Dliteratum%253Aachs%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DDaud%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DR.%26aulast%3DKefford%26aufirst%3DR.%2BF.%26aulast%3DSosman%26aufirst%3DJ.%26aulast%3DHamid%26aufirst%3DO.%26aulast%3DSchuchter%26aufirst%3DL.%26aulast%3DCebon%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DN.%26aulast%3DKudchadkar%26aufirst%3DR.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DFalchook%26aufirst%3DG.%26aulast%3DAlgazi%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DK.%26aulast%3DLong%26aufirst%3DG.%2BV.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DLebowitz%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DLittle%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DAllred%26aufirst%3DA.%26aulast%3DOuellet%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DJ.%26atitle%3DCombined%2520BRAF%2520and%2520MEK%2520Inhibition%2520in%2520Melanoma%2520with%2520BRAF%2520V600%2520Mutations%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26issue%3D18%26spage%3D1694%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1210093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Long, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroyakovskiy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levchenko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Braud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jouary, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauschild, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarion Sileni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MandalÃ , M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millward, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arance, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarenko, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanen, J. B. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utikal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraresi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovalenko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probachai, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadendorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMarini, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irani, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, K.</span><span> </span><span class="NLM_article-title">Combined BRAF and MEK Inhibition Versus BRAF Inhibition Alone in Melanoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">1877</span><span class="NLM_x">â</span> <span class="NLM_lpage">1888</span><span class="refDoi">Â DOI: 10.1056/NEJMoa1406037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1056%2FNEJMoa1406037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25265492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslGnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=1877-1888&issue=20&author=G.+V.+Longauthor=D.+Stroyakovskiyauthor=H.+Gogasauthor=E.+Levchenkoauthor=F.+de+Braudauthor=J.+Larkinauthor=C.+Garbeauthor=T.+Jouaryauthor=A.+Hauschildauthor=J.+J.+Grobauthor=V.+Chiarion+Sileniauthor=C.+Lebbeauthor=M.+Mandal%C3%A0author=M.+Millwardauthor=A.+Aranceauthor=I.+Bondarenkoauthor=J.+B.+A.+G.+Haanenauthor=J.+Hanssonauthor=J.+Utikalauthor=V.+Ferraresiauthor=N.+Kovalenkoauthor=P.+Mohrauthor=V.+Probachaiauthor=D.+Schadendorfauthor=P.+Nathanauthor=C.+Robertauthor=A.+Ribasauthor=D.+J.+DeMariniauthor=J.+G.+Iraniauthor=M.+Caseyauthor=D.+Ouelletauthor=A.-M.+Martinauthor=N.+Leauthor=K.+Patelauthor=K.+Flaherty&title=Combined+BRAF+and+MEK+Inhibition+Versus+BRAF+Inhibition+Alone+in+Melanoma&doi=10.1056%2FNEJMoa1406037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma</span></div><div class="casAuthors">Long, G. V.; Stroyakovskiy, D.; Gogas, H.; Levchenko, E.; de Braud, F.; Larkin, J.; Garbe, C.; Jouary, T.; Hauschild, A.; Grob, J. J.; Sileni, V. Chiarion; Lebbe, C.; Mandala, M.; Millward, M.; Arance, A.; Bondarenko, I.; Haanen, J. B. A. G.; Hansson, J.; Utikal, J.; Ferraresi, V.; Kovalenko, N.; Mohr, P.; Probachai, V.; Schadendorf, D.; Nathan, P.; Robert, C.; Ribas, A.; De Marini, D. J.; Irani, J. G.; Casey, M.; Ouellet, D.; Martin, A.-M.; Le, N.; Patel, K.; Flaherty, K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1877-1888, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Combined BRAF and MEK inhibition, as compared with BRAF inhibition alone, delays the emergence of resistance and reduces toxic effects in patients who have melanoma with BRAF V600E or V600K mutations.  Methods: In this phase 3 trial, we randomly assigned 423 previously untreated patients who had unresectable stage IIIC or stage IV melanoma with a BRAF V600E or V600K mutation to receive a combination of dabrafenib (150 mg orally twice daily) and trametinib (2 mg orally once daily) or dabrafenib and placebo.  The primary end point was progression-free survival.  Secondary end points included overall survival, response rate, response duration, and safety.  A preplanned interim overall survival anal. was conducted. Results: The median progression-free survival was 9.3 mo in the dabrafenib-trametinib group and 8.8 mo in the dabrafenib-only group (hazard ratio for progression or death in the dabrafenib-trametinib group, 0.75; 95% confidence interval [CI], 0.57 to 0.99; P = 0.03).  The overall response rate was 67% in the dabrafenib-trametinib group and 51% in the dabrafenib-only group (P = 0.002).  At 6 mo, the interim overall survival rate was 93% with dabrafenib-trametinib and 85% with dabrafenib alone (hazard ratio for death, 0.63; 95% CI, 0.42 to 0.94; P = 0.02).  However, a specified efficacy-stopping boundary (two-sided P = 0.00028) was not crossed.  Rates of adverse events were similar in the two groups, although more dose modifications occurred in the dabrafenib-trametinib group.  The rate of cutaneous squamous-cell carcinoma was lower in the dabrafenib-trametinib group than in the dabrafenib-only group (2% vs. 9%), whereas pyrexia occurred in more patients (51% vs. 28%) and was more often severe (grade 3, 6% vs. 2%) in the dabrafenib-trametinib group. Conclusions: A combination of dabrafenib and trametinib, as compared with dabrafenib alone, improved the rate of progression-free survival in previously untreated patients who had metastatic melanoma with BRAF V600E or V600K mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV_cVsKKBhY7Vg90H21EOLACvtfcHk0ljB3gzOm1mZoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslGnuw%253D%253D&md5=65dbfbb0d9d16017ac58729326835724</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1406037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1406037%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DG.%2BV.%26aulast%3DStroyakovskiy%26aufirst%3DD.%26aulast%3DGogas%26aufirst%3DH.%26aulast%3DLevchenko%26aufirst%3DE.%26aulast%3Dde%2BBraud%26aufirst%3DF.%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DGarbe%26aufirst%3DC.%26aulast%3DJouary%26aufirst%3DT.%26aulast%3DHauschild%26aufirst%3DA.%26aulast%3DGrob%26aufirst%3DJ.%2BJ.%26aulast%3DChiarion%2BSileni%26aufirst%3DV.%26aulast%3DLebbe%26aufirst%3DC.%26aulast%3DMandal%25C3%25A0%26aufirst%3DM.%26aulast%3DMillward%26aufirst%3DM.%26aulast%3DArance%26aufirst%3DA.%26aulast%3DBondarenko%26aufirst%3DI.%26aulast%3DHaanen%26aufirst%3DJ.%2BB.%2BA.%2BG.%26aulast%3DHansson%26aufirst%3DJ.%26aulast%3DUtikal%26aufirst%3DJ.%26aulast%3DFerraresi%26aufirst%3DV.%26aulast%3DKovalenko%26aufirst%3DN.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DProbachai%26aufirst%3DV.%26aulast%3DSchadendorf%26aufirst%3DD.%26aulast%3DNathan%26aufirst%3DP.%26aulast%3DRobert%26aufirst%3DC.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DDeMarini%26aufirst%3DD.%2BJ.%26aulast%3DIrani%26aufirst%3DJ.%2BG.%26aulast%3DCasey%26aufirst%3DM.%26aulast%3DOuellet%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DA.-M.%26aulast%3DLe%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DFlaherty%26aufirst%3DK.%26atitle%3DCombined%2520BRAF%2520and%2520MEK%2520Inhibition%2520Versus%2520BRAF%2520Inhibition%2520Alone%2520in%2520Melanoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26issue%3D20%26spage%3D1877%26epage%3D1888%26doi%3D10.1056%2FNEJMoa1406037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Wilkinson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taggart, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berges, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, T.</span><span> </span><span class="NLM_article-title">A Specific Inhibitor of the Ubiquitin Activating Enzyme: Synthesis and Characterization of Adenosyl-Phospho-Ubiquitinol, a Nonhydrolyzable Ubiquitin Adenylate Analog</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">32</span><span class="NLM_x">) </span> <span class="NLM_fpage">7373</span><span class="NLM_x">â</span> <span class="NLM_lpage">7380</span><span class="refDoi">Â DOI: 10.1021/bi00484a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00484a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=7373-7380&issue=32&author=K.+D.+Wilkinsonauthor=S.+E.+Smithauthor=L.+O%E2%80%99Connorauthor=E.+Sternbergauthor=J.+J.+Taggartauthor=D.+A.+Bergesauthor=T.+Butt&title=A+Specific+Inhibitor+of+the+Ubiquitin+Activating+Enzyme%3A+Synthesis+and+Characterization+of+Adenosyl-Phospho-Ubiquitinol%2C+a+Nonhydrolyzable+Ubiquitin+Adenylate+Analog&doi=10.1021%2Fbi00484a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi00484a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00484a004%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DK.%2BD.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%26aulast%3DSternberg%26aufirst%3DE.%26aulast%3DTaggart%26aufirst%3DJ.%2BJ.%26aulast%3DBerges%26aufirst%3DD.%2BA.%26aulast%3DButt%26aufirst%3DT.%26atitle%3DA%2520Specific%2520Inhibitor%2520of%2520the%2520Ubiquitin%2520Activating%2520Enzyme%253A%2520Synthesis%2520and%2520Characterization%2520of%2520Adenosyl-Phospho-Ubiquitinol%252C%2520a%2520Nonhydrolyzable%2520Ubiquitin%2520Adenylate%2520Analog%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26issue%3D32%26spage%3D7373%26epage%3D7380%26doi%3D10.1021%2Fbi00484a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorick, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davydov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberoi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenten, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beutler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vousden, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">9472</span><span class="NLM_x">â</span> <span class="NLM_lpage">9481</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-0568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F0008-5472.CAN-07-0568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=17909057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnurvI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=9472-9481&issue=19&author=Y.+Yangauthor=J.+Kitagakiauthor=R.+M.+Daiauthor=Y.+C.+Tsaiauthor=K.+L.+Lorickauthor=R.+L.+Ludwigauthor=S.+A.+Pierreauthor=J.+P.+Jensenauthor=I.+V.+Davydovauthor=P.+Oberoiauthor=C.+C.+H.+Liauthor=J.+H.+Kentenauthor=J.+A.+Beutlerauthor=K.+H.+Vousdenauthor=A.+M.+Weissman&title=Inhibitors+of+Ubiquitin-Activating+Enzyme+%28E1%29%2C+a+New+Class+of+Potential+Cancer+Therapeutics&doi=10.1158%2F0008-5472.CAN-07-0568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics</span></div><div class="casAuthors">Yang, Yili; Kitagaki, Jirouta; Dai, Ren-Ming; Tsai, Yien Che; Lorick, Kevin L.; Ludwig, Robert L.; Pierre, Shervon A.; Jensen, Jane P.; Davydov, Ilia V.; Oberoi, Pankaj; Li, Chou-Chi H.; Kenten, John H.; Beutler, John A.; Vousden, Karen H.; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9472-9481</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The conjugation of proteins with ubiquitin plays numerous regulatory roles through both proteasomal-dependent and nonproteasomal-dependent functions.  Alterations in ubiquitylation are obsd. in a wide range of pathol. conditions, including numerous malignancies.  For this reason, there is great interest in targeting the ubiquitin-proteasome system in cancer.  Several classes of proteasome inhibitors, which block degrdn. of ubiquitylated proteins, are widely used in research, and one, Bortezomib, is now in clin. use.  Despite the well-defined and central role of the ubiquitin-activating enzyme (E1), no cell permeable inhibitors of E1 have been identified.  Such inhibitors should, in principle, block all functions of ubiquitylation.  We now report 4[4-(5-nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl]-benzoic acid Et ester (PYR-41) as the first such inhibitor.  Unexpectedly, in addn. to blocking ubiquitylation, PYR-41 increased total sumoylation in cells.  The mol. basis for this is unknown; however, increased sumoylation was also obsd. in cells harboring temp.-sensitive E1.  Functionally, PYR-41 attenuates cytokine-mediated nuclear factor-ÎºB activation.  This correlates with inhibition of nonproteasomal (Lys-63) ubiquitylation of TRAF6, which is essential to IÎºB kinase activation.  PYR-41 also prevents the downstream ubiquitylation and proteasomal degrdn. of IÎºBÎ±.  Furthermore, PYR-41 inhibits degrdn. of p53 and activates the transcriptional activity of this tumor suppressor.  Consistent with this, it differentially kills transformed p53-expressing cells.  Thus, PYR-41 and related pyrazones provide proof of principle for the capacity to differentially kill transformed cells, suggesting the potential for E1 inhibitors as therapeutics in cancer.  These inhibitors can also be valuable tools for studying ubiquitylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMJJHvHs0qWLVg90H21EOLACvtfcHk0ljB3gzOm1mZoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnurvI&md5=6d75d1f0131d6d84db1b896743726119</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0568%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DKitagaki%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DR.%2BM.%26aulast%3DTsai%26aufirst%3DY.%2BC.%26aulast%3DLorick%26aufirst%3DK.%2BL.%26aulast%3DLudwig%26aufirst%3DR.%2BL.%26aulast%3DPierre%26aufirst%3DS.%2BA.%26aulast%3DJensen%26aufirst%3DJ.%2BP.%26aulast%3DDavydov%26aufirst%3DI.%2BV.%26aulast%3DOberoi%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DC.%2BC.%2BH.%26aulast%3DKenten%26aufirst%3DJ.%2BH.%26aulast%3DBeutler%26aufirst%3DJ.%2BA.%26aulast%3DVousden%26aufirst%3DK.%2BH.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DInhibitors%2520of%2520Ubiquitin-Activating%2520Enzyme%2520%2528E1%2529%252C%2520a%2520New%2520Class%2520of%2520Potential%2520Cancer%2520Therapeutics%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D19%26spage%3D9472%26epage%3D9481%26doi%3D10.1158%2F0008-5472.CAN-07-0568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Toth, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, M. D.</span><span> </span><span class="NLM_article-title">A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">309</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span><span class="refDoi">Â DOI: 10.1016/j.celrep.2012.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.celrep.2012.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kns7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=309-316&issue=4&author=J.+I.+Tothauthor=L.+Yangauthor=R.+Dahlauthor=M.+D.+Petroski&title=A+Gatekeeper+Residue+for+NEDD8-Activating+Enzyme+Inhibition+by+MLN4924&doi=10.1016%2Fj.celrep.2012.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A gatekeeper residue for NEDD8-activating enzyme inhibition by MLN4924</span></div><div class="casAuthors">Toth, Julia I.; Yang, Li; Dahl, Russell; Petroski, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-316</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of NEDD8-activating enzyme (NAE) has emerged as a highly promising approach to treat cancer through the adenosine sulfamate analog MLN4924.  Here, we show that selective pressure results in HCT116 colorectal carcinoma cells with decreased MLN4924 sensitivity and identify a single-nucleotide transition that changes alanine 171 to threonine (A171T) of the NAE subunit UBA3.  This reduces the enzyme's affinity for MLN4924 and ATP while increasing NEDD8 activation at physiol. ATP concns.  Expression of UBA3 A171T is sufficient to decrease MLN4924 sensitivity of naive HCT116 cells, indicating that it is a dominant suppressor of MLN4924-mediated cell death.  Our data suggest that the on-target potency of MLN4924 selects for a point mutation in NAE that overcomes the mol.'s inhibitory effects, allowing cancer cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocylKrTKZGhbVg90H21EOLACvtfcHk0lio58MbiZY6uA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kns7g%253D&md5=344f4226d224d51611f693985e89df4a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DJ.%2BI.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DPetroski%26aufirst%3DM.%2BD.%26atitle%3DA%2520Gatekeeper%2520Residue%2520for%2520NEDD8-Activating%2520Enzyme%2520Inhibition%2520by%2520MLN4924%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D1%26issue%3D4%26spage%3D309%26epage%3D316%26doi%3D10.1016%2Fj.celrep.2012.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">da Silva, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paiva, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bancerz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geletu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukkarila, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">A Selective Inhibitor of the UFM1-Activating Enzyme, UBA5</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4542</span><span class="NLM_x">â</span> <span class="NLM_lpage">4547</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bmcl.2015.10.015" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4542-4547&issue=18&author=S.+R.+da+Silvaauthor=S.-L.+Paivaauthor=M.+Bancerzauthor=M.+Geletuauthor=A.+M.+Lewisauthor=J.+Chenauthor=Y.+Caiauthor=J.+L.+Lukkarilaauthor=H.+Liauthor=P.+T.+Gunning&title=A+Selective+Inhibitor+of+the+UFM1-Activating+Enzyme%2C+UBA5&doi=10.1016%2Fj.bmcl.2015.10.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.015%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BSilva%26aufirst%3DS.%2BR.%26aulast%3DPaiva%26aufirst%3DS.-L.%26aulast%3DBancerz%26aufirst%3DM.%26aulast%3DGeletu%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLukkarila%26aufirst%3DJ.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DA%2520Selective%2520Inhibitor%2520of%2520the%2520UFM1-Activating%2520Enzyme%252C%2520UBA5%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D18%26spage%3D4542%26epage%3D4547%26doi%3D10.1016%2Fj.bmcl.2015.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capili, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cisar, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. S.</span><span> </span><span class="NLM_article-title">Designed Semisynthetic Protein Inhibitors of Ub/Ubl E1 Activating Enzymes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1748</span><span class="NLM_x">â</span> <span class="NLM_lpage">1749</span><span class="refDoi">Â DOI: 10.1021/ja9088549</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9088549" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSiurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=1748-1749&issue=6&author=X.+Luauthor=S.+K.+Olsenauthor=A.+D.+Capiliauthor=J.+S.+Cisarauthor=C.+D.+Limaauthor=D.+S.+Tan&title=Designed+Semisynthetic+Protein+Inhibitors+of+Ub%2FUbl+E1+Activating+Enzymes&doi=10.1021%2Fja9088549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Semisynthetic Protein Inhibitors of Ub/Ubl E1 Activating Enzymes</span></div><div class="casAuthors">Lu, Xuequan; Olsen, Shaun K.; Capili, Allan D.; Cisar, Justin S.; Lima, Christopher D.; Tan, Derek S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1748-1749</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Semisynthetic, mechanism-based protein inhibitors of ubiquitin (Ub) and ubiquitin-like modifier (Ubl) activating enzymes (E1s) have been developed to target E1-catalyzed adenylation and thioesterification of the Ub/Ubl C-terminus during the processes of protein SUMOylation and ubiquitination.  The inhibitors were generated by intein-mediated expressed protein ligation using a truncated Ub/Ubl protein (SUMO residues 1-94; Ub residues 1-71) with a C-terminal thioester and synthetic tripeptides having a C-terminal adenosine analog and an N-terminal cysteine residue.  SUMO-AMSN (4a) and Ub-AMSN (4b) contain a sulfamide group as a nonhydrolyzable mimic of the phosphate group in the cognate Ub/Ubl-AMP adenylate intermediate in the first half-reaction, and these constructs selectively inhibit SUMO E1 and Ub E1, resp., in a dose-dependent manner.  SUMO-AVSN (5a) and Ub-AVSN (5b) contain an electrophilic vinyl sulfonamide designed to trap the incoming E1 cysteine nucleophile (Uba2 Cys173 in SUMO E1; Uba1 Cys593 in Ub E1) in the second half-reaction, and these constructs selectively, covalently, and stably cross-link to SUMO E1 and Ub E1, resp., in a cysteine nucleophile-dependent manner.  These inhibitors are powerful tools to probe outstanding mechanistic questions in E1 function and can also be used to study the biol. functions of E1 enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFrlstIrtwC7Vg90H21EOLACvtfcHk0lio58MbiZY6uA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSiurY%253D&md5=2c7015f7594aa5fb6f540c8679101fce</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja9088549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9088549%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DOlsen%26aufirst%3DS.%2BK.%26aulast%3DCapili%26aufirst%3DA.%2BD.%26aulast%3DCisar%26aufirst%3DJ.%2BS.%26aulast%3DLima%26aufirst%3DC.%2BD.%26aulast%3DTan%26aufirst%3DD.%2BS.%26atitle%3DDesigned%2520Semisynthetic%2520Protein%2520Inhibitors%2520of%2520Ub%252FUbl%2520E1%2520Activating%2520Enzymes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26issue%3D6%26spage%3D1748%26epage%3D1749%26doi%3D10.1021%2Fja9088549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Olsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capili, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, C. D.</span><span> </span><span class="NLM_article-title">Active Site Remodelling Accompanies Thioester Bond Formation in the SUMO E1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x"> (</span><span class="NLM_issue">7283</span><span class="NLM_x">) </span> <span class="NLM_fpage">906</span><span class="NLM_x">â</span> <span class="NLM_lpage">912</span><span class="refDoi">Â DOI: 10.1038/nature08765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature08765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=20164921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=906-912&issue=7283&author=S.+K.+Olsenauthor=A.+D.+Capiliauthor=X.+Luauthor=D.+S.+Tanauthor=C.+D.+Lima&title=Active+Site+Remodelling+Accompanies+Thioester+Bond+Formation+in+the+SUMO+E1&doi=10.1038%2Fnature08765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Active site remodelling accompanies thioester bond formation in the SUMO E1</span></div><div class="casAuthors">Olsen, Shaun K.; Capili, Allan D.; Lu, Xuequan; Tan, Derek S.; Lima, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7283</span>),
    <span class="NLM_cas:pages">906-912</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">E1 enzymes activate ubiquitin (Ub) and ubiquitin-like (Ubl) proteins in two steps by carboxy-terminal adenylation and thioester bond formation to a conserved catalytic cysteine in the E1 Cys domain.  The structural basis for these intermediates remains unknown.  Here we report crystal structures for human SUMO E1 in complex with SUMO adenylate and tetrahedral intermediate analogs at 2.45 and 2.6 Ã, resp.  These structures show that side chain contacts to ATPÂ·Mg are released after adenylation to facilitate a 130 degree rotation of the Cys domain during thioester bond formation that is accompanied by remodeling of key structural elements including the helix that contains the E1 catalytic cysteine, the crossover and re-entry loops, and refolding of two helixes that are required for adenylation.  These changes displace side chains required for adenylation with side chains required for thioester bond formation.  Mutational and biochem. analyses indicate these mechanisms are conserved in other E1s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9k1BOu5nwaLVg90H21EOLACvtfcHk0lg3Dh9D65LLRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsr8%253D&md5=1c21dabaaa4d831db0bb9bb343ffe555</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnature08765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08765%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DS.%2BK.%26aulast%3DCapili%26aufirst%3DA.%2BD.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DTan%26aufirst%3DD.%2BS.%26aulast%3DLima%26aufirst%3DC.%2BD.%26atitle%3DActive%2520Site%2520Remodelling%2520Accompanies%2520Thioester%2520Bond%2520Formation%2520in%2520the%2520SUMO%2520E1%26jtitle%3DNature%26date%3D2010%26volume%3D463%26issue%3D7283%26spage%3D906%26epage%3D912%26doi%3D10.1038%2Fnature08765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hong, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H. K.</span><span> </span><span class="NLM_article-title">Insights Into Noncanonical E1 Enzyme Activation From the Structure of Autophagic E1 Atg7 with Atg8</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1323</span><span class="NLM_x">â</span> <span class="NLM_lpage">1330</span><span class="refDoi">Â DOI: 10.1038/nsmb.2165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnsmb.2165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22056771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1323-1330&issue=12&author=S.+B.+Hongauthor=B.-W.+Kimauthor=K.-E.+Leeauthor=S.+W.+Kimauthor=H.+Jeonauthor=J.+Kimauthor=H.+K.+Song&title=Insights+Into+Noncanonical+E1+Enzyme+Activation+From+the+Structure+of+Autophagic+E1+Atg7+with+Atg8&doi=10.1038%2Fnsmb.2165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into noncanonical E1 enzyme activation from the structure of autophagic E1 Atg7 with Atg8</span></div><div class="casAuthors">Hong, Seung Beom; Kim, Byeong-Won; Lee, Kyung-Eun; Kim, Se Woong; Jeon, Hyesung; Kim, Joon; Song, Hyun Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1323-1330</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagy is the degrdn. of cellular organelles via the lysosomal pathway.  The autophagic ubiquitin-like (Ubl) mol. Atg8 is activated by the E1-like enzyme Atg7.  As this noncanonical E1 enzyme's domain organization is unique among Ubl-activating E1 enzymes, the structural basis for its interactions with Atg8 and partner E2 enzymes remains obscure.  Here we present the structure of the N-terminal domain of Atg7, revealing a unique protein fold and interactions with both autophagic E2 enzymes Atg3 and Atg10.  The structure of the C-terminal domain of Atg7 in complex with Atg8 shows the mode of dimerization and mechanism of recognition of Atg8.  Notably, the catalytic cysteine residue in Atg7 is positioned close to the C-terminal glycine of Atg8, its target for thioester formation, potentially eliminating the need for large conformational rearrangements characteristic of other E1s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-uZfo9Vpv4LVg90H21EOLACvtfcHk0lg3Dh9D65LLRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtbvE&md5=2023d2b2c6c395e5bfdd6845424b317a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2165%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%2BB.%26aulast%3DKim%26aufirst%3DB.-W.%26aulast%3DLee%26aufirst%3DK.-E.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DH.%2BK.%26atitle%3DInsights%2520Into%2520Noncanonical%2520E1%2520Enzyme%2520Activation%2520From%2520the%2520Structure%2520of%2520Autophagic%2520E1%2520Atg7%2520with%2520Atg8%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26issue%3D12%26spage%3D1323%26epage%3D1330%26doi%3D10.1038%2Fnsmb.2165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Noda, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumeta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, F.</span><span> </span><span class="NLM_article-title">Structural Basis of Atg8 Activation by a Homodimeric E1, Atg7</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">462</span><span class="NLM_x">â</span> <span class="NLM_lpage">475</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2011.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2011.08.035" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=462-475&issue=3&author=N.+N.+Nodaauthor=K.+Satooauthor=Y.+Fujiokaauthor=H.+Kumetaauthor=K.+Oguraauthor=H.+Nakatogawaauthor=Y.+Ohsumiauthor=F.+Inagaki&title=Structural+Basis+of+Atg8+Activation+by+a+Homodimeric+E1%2C+Atg7&doi=10.1016%2Fj.molcel.2011.08.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DNoda%26aufirst%3DN.%2BN.%26aulast%3DSatoo%26aufirst%3DK.%26aulast%3DFujioka%26aufirst%3DY.%26aulast%3DKumeta%26aufirst%3DH.%26aulast%3DOgura%26aufirst%3DK.%26aulast%3DNakatogawa%26aufirst%3DH.%26aulast%3DOhsumi%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DF.%26atitle%3DStructural%2520Basis%2520of%2520Atg8%2520Activation%2520by%2520a%2520Homodimeric%2520E1%252C%2520Atg7%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26issue%3D3%26spage%3D462%26epage%3D475%26doi%3D10.1016%2Fj.molcel.2011.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Oweis, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassouna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Kfir, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndsen, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiener, R.</span><span> </span><span class="NLM_article-title">Trans-Binding Mechanism of Ubiquitin-Like Protein Activation Revealed by a UBA5-UFM1 Complex</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3113</span><span class="NLM_x">â</span> <span class="NLM_lpage">3120</span><span class="refDoi">Â DOI: 10.1016/j.celrep.2016.08.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.celrep.2016.08.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=27653677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2rsrvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=3113-3120&issue=12&author=W.+Oweisauthor=P.+Padalaauthor=F.+Hassounaauthor=E.+Cohen-Kfirauthor=D.+R.+Gibbsauthor=E.+A.+Toddauthor=C.+E.+Berndsenauthor=R.+Wiener&title=Trans-Binding+Mechanism+of+Ubiquitin-Like+Protein+Activation+Revealed+by+a+UBA5-UFM1+Complex&doi=10.1016%2Fj.celrep.2016.08.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Trans-Binding Mechanism of Ubiquitin-like Protein Activation Revealed by a UBA5-UFM1 Complex</span></div><div class="casAuthors">Oweis, Walaa; Padala, Prasanth; Hassouna, Fouad; Cohen-Kfir, Einav; Gibbs, Dalton R.; Todd, Emily A.; Berndsen, Christopher E.; Wiener, Reuven</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3113-3120</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Modification of proteins by ubiquitin or ubiquitin-like proteins (UBLs) is a crit. cellular process implicated in a variety of cellular states and outcomes.  A prerequisite for target protein modification by a UBL is the activation of the latter by activating enzymes (E1s).  Here, we present the crystal structure of the non-canonical homodimeric E1, UBA5, in complex with its cognate UBL, UFM1, and supporting biochem. expts.  We find that UBA5 binds to UFM1 via a trans-binding mechanism in which UFM1 interacts with distinct sites in both subunits of the UBA5 dimer.  This binding mechanism requires a region C-terminal to the adenylation domain that brings UFM1 to the active site of the adjacent UBA5 subunit.  We also find that transfer of UFM1 from UBA5 to the E2, UFC1, occurs via a trans mechanism, thereby requiring a homodimer of UBA5.  These findings explicitly elucidate the role of UBA5 dimerization in UFM1 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoofFrTwO-4RLVg90H21EOLACvtfcHk0lg3Dh9D65LLRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2rsrvP&md5=91095efef92e9253ec45908fbbd4654f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.08.067%26sid%3Dliteratum%253Aachs%26aulast%3DOweis%26aufirst%3DW.%26aulast%3DPadala%26aufirst%3DP.%26aulast%3DHassouna%26aufirst%3DF.%26aulast%3DCohen-Kfir%26aufirst%3DE.%26aulast%3DGibbs%26aufirst%3DD.%2BR.%26aulast%3DTodd%26aufirst%3DE.%2BA.%26aulast%3DBerndsen%26aufirst%3DC.%2BE.%26aulast%3DWiener%26aufirst%3DR.%26atitle%3DTrans-Binding%2520Mechanism%2520of%2520Ubiquitin-Like%2520Protein%2520Activation%2520Revealed%2520by%2520a%2520UBA5-UFM1%2520Complex%26jtitle%3DCell%2520Rep.%26date%3D2016%26volume%3D16%26issue%3D12%26spage%3D3113%26epage%3D3120%26doi%3D10.1016%2Fj.celrep.2016.08.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Stewart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritterhoff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzovic, P. S.</span><span> </span><span class="NLM_article-title">E2 Enzymes: More Than Just Middle Men</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">423</span><span class="NLM_x">â</span> <span class="NLM_lpage">440</span><span class="refDoi">Â DOI: 10.1038/cr.2016.35</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fcr.2016.35" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=27002219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVyhs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=423-440&issue=4&author=M.+D.+Stewartauthor=T.+Ritterhoffauthor=R.+E.+Klevitauthor=P.+S.+Brzovic&title=E2+Enzymes%3A+More+Than+Just+Middle+Men&doi=10.1038%2Fcr.2016.35"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">E2 enzymes: more than just middle men</span></div><div class="casAuthors">Stewart, Mikaela D.; Ritterhoff, Tobias; Klevit, Rachel E.; Brzovic, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">423-440</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Ubiquitin-conjugating enzymes (E2s) are the central players in the trio of enzymes responsible for the attachment of ubiquitin (Ub) to cellular proteins.  Humans have â¼40 E2s that are involved in the transfer of Ub or Ub-like (Ubl) proteins (e.g., SUMO and NEDD8).  Although the majority of E2s are only twice the size of Ub, this remarkable family of enzymes performs a variety of functional roles.  In this review, we summarize common functional and structural features that define unifying themes among E2s and highlight emerging concepts in the mechanism and regulation of E2s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3nz4HNwXLKLVg90H21EOLACvtfcHk0ljC09IE0MuYvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVyhs7s%253D&md5=de200ea92123a8aeabd2ecc3d0c3cf65</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fcr.2016.35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2016.35%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DM.%2BD.%26aulast%3DRitterhoff%26aufirst%3DT.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26aulast%3DBrzovic%26aufirst%3DP.%2BS.%26atitle%3DE2%2520Enzymes%253A%2520More%2520Than%2520Just%2520Middle%2520Men%26jtitle%3DCell%2520Res.%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D423%26epage%3D440%26doi%3D10.1038%2Fcr.2016.35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rape, M.</span><span> </span><span class="NLM_article-title">Building Ubiquitin Chains: E2 Enzymes at Work</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">755</span><span class="NLM_x">â</span> <span class="NLM_lpage">764</span><span class="refDoi">Â DOI: 10.1038/nrm2780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm2780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19851334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSjtbfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=755-764&issue=11&author=Y.+Yeauthor=M.+Rape&title=Building+Ubiquitin+Chains%3A+E2+Enzymes+at+Work&doi=10.1038%2Fnrm2780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Building ubiquitin chains: E2 enzymes at work</span></div><div class="casAuthors">Ye, Yihong; Rape, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">755-764</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The modification of proteins with ubiquitin chains can change their localization, activity and/or stability.  Although ubiquitination requires the concerted action of ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin ligases (E3s), it is the E2s that have recently emerged as key mediators of chain assembly.  These enzymes are able to govern the switch from ubiquitin chain initiation to elongation, regulate the processivity of chain formation, and establish the topol. of assembled chains, thereby detg. the consequences of ubiquitination for the modified proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2haRlZHjrzrVg90H21EOLACvtfcHk0ljC09IE0MuYvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSjtbfM&md5=49c663b981cbdb877a5c2b592d9f4112</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrm2780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2780%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DRape%26aufirst%3DM.%26atitle%3DBuilding%2520Ubiquitin%2520Chains%253A%2520E2%2520Enzymes%2520at%2520Work%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26issue%3D11%26spage%3D755%26epage%3D764%26doi%3D10.1038%2Fnrm2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hershko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciechanover, A.</span><span> </span><span class="NLM_article-title">Components of Ubiquitin-Protein Ligase System. Resolution, Affinity Purification, and Role in Protein Breakdown</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">8206</span><span class="NLM_x">â</span> <span class="NLM_lpage">8214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1983&pages=8206-8214&issue=13&author=A.+Hershkoauthor=H.+Hellerauthor=S.+Eliasauthor=A.+Ciechanover&title=Components+of+Ubiquitin-Protein+Ligase+System.+Resolution%2C+Affinity+Purification%2C+and+Role+in+Protein+Breakdown"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DA.%26aulast%3DHeller%26aufirst%3DH.%26aulast%3DElias%26aufirst%3DS.%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DComponents%2520of%2520Ubiquitin-Protein%2520Ligase%2520System.%2520Resolution%252C%2520Affinity%2520Purification%252C%2520and%2520Role%2520in%2520Protein%2520Breakdown%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1983%26volume%3D258%26issue%3D13%26spage%3D8206%26epage%3D8214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Haas, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, V. E.</span><span> </span><span class="NLM_article-title">Functional Diversity Among Putative E2 Isozymes in the Mechanism of Ubiquitin-Histone Ligation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">13268</span><span class="NLM_x">â</span> <span class="NLM_lpage">13275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1988&pages=13268-13275&issue=26&author=A.+L.+Haasauthor=P.+M.+Brightauthor=V.+E.+Jackson&title=Functional+Diversity+Among+Putative+E2+Isozymes+in+the+Mechanism+of+Ubiquitin-Histone+Ligation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaas%26aufirst%3DA.%2BL.%26aulast%3DBright%26aufirst%3DP.%2BM.%26aulast%3DJackson%26aufirst%3DV.%2BE.%26atitle%3DFunctional%2520Diversity%2520Among%2520Putative%2520E2%2520Isozymes%2520in%2520the%2520Mechanism%2520of%2520Ubiquitin-Histone%2520Ligation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1988%26volume%3D263%26issue%3D26%26spage%3D13268%26epage%3D13275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Lee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindelin, H.</span><span> </span><span class="NLM_article-title">Structural Insights Into E1-Catalyzed Ubiquitin Activation and Transfer to Conjugating Enzymes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">268</span><span class="NLM_x">â</span> <span class="NLM_lpage">278</span><span class="refDoi">Â DOI: 10.1016/j.cell.2008.05.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2008.05.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=18662542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlalur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=268-278&issue=2&author=I.+Leeauthor=H.+Schindelin&title=Structural+Insights+Into+E1-Catalyzed+Ubiquitin+Activation+and+Transfer+to+Conjugating+Enzymes&doi=10.1016%2Fj.cell.2008.05.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes</span></div><div class="casAuthors">Lee, Imsang; Schindelin, Hermann</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-278</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ubiquitin (Ub) and ubiquitin-like proteins (Ubls) are conjugated to their targets by specific cascades involving three classes of enzymes, E1, E2, and E3.  Each E1 adenylates the C terminus of its cognate Ubl, forms a E1â¼Ubl thioester intermediate, and ultimately generates a thioester-linked E2â¼Ubl product.  We have detd. the crystal structure of yeast Uba1, revealing a modular architecture with individual domains primarily mediating these specific activities.  The neg. charged C-terminal ubiquitin-fold domain (UFD) is primed for binding of E2s and recognizes their pos. charged first Î± helix via electrostatic interactions.  In addn., a mobile loop from the domain harboring the E1 catalytic cysteine contributes to E2 binding.  Significant, exptl. obsd. motions in the UFD around a hinge in the linker connecting this domain to the rest of the enzyme suggest a conformation-dependent mechanism for the transthioesterification function of Uba1; however, this mechanism clearly differs from that of other E1 enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppxkaPQW_VQLVg90H21EOLACvtfcHk0ljC09IE0MuYvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlalur8%253D&md5=1721bdfa7bc015eb5e69203aae1ad081</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.05.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.05.046%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DI.%26aulast%3DSchindelin%26aufirst%3DH.%26atitle%3DStructural%2520Insights%2520Into%2520E1-Catalyzed%2520Ubiquitin%2520Activation%2520and%2520Transfer%2520to%2520Conjugating%2520Enzymes%26jtitle%3DCell%26date%3D2008%26volume%3D134%26issue%3D2%26spage%3D268%26epage%3D278%26doi%3D10.1016%2Fj.cell.2008.05.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Eletr, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhlman, B.</span><span> </span><span class="NLM_article-title">E2 Conjugating Enzymes Must Disengage From Their E1 Enzymes Before E3-Dependent Ubiquitin and Ubiquitin-Like Transfer</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">933</span><span class="NLM_x">â</span> <span class="NLM_lpage">934</span><span class="refDoi">Â DOI: 10.1038/nsmb984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnsmb984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16142244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKnsrjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=933-934&issue=10&author=Z.+M.+Eletrauthor=D.+T.+Huangauthor=D.+M.+Dudaauthor=B.+A.+Schulmanauthor=B.+Kuhlman&title=E2+Conjugating+Enzymes+Must+Disengage+From+Their+E1+Enzymes+Before+E3-Dependent+Ubiquitin+and+Ubiquitin-Like+Transfer&doi=10.1038%2Fnsmb984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer</span></div><div class="casAuthors">Eletr, Ziad M.; Huang, Danny T.; Duda, David M.; Schulman, Brenda A.; Kuhlman, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">933-934</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">During ubiquitin ligation, an E2 conjugating enzyme receives ubiquitin from an E1 enzyme and then interacts with an E3 ligase to modify substrates.  Competitive binding expts. with three human E2-E3 protein pairs show that the binding of E1s and of E3s to E2s are mutually exclusive.  These results imply that polyubiquitination requires recycling of E2 for addn. of successive ubiquitins to substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEmLtN6jJ_bVg90H21EOLACvtfcHk0lgCCuwJ25uppQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKnsrjM&md5=2123d3087230cca0b2b5f2581c981945</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnsmb984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb984%26sid%3Dliteratum%253Aachs%26aulast%3DEletr%26aufirst%3DZ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BT.%26aulast%3DDuda%26aufirst%3DD.%2BM.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26aulast%3DKuhlman%26aufirst%3DB.%26atitle%3DE2%2520Conjugating%2520Enzymes%2520Must%2520Disengage%2520From%2520Their%2520E1%2520Enzymes%2520Before%2520E3-Dependent%2520Ubiquitin%2520and%2520Ubiquitin-Like%2520Transfer%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D10%26spage%3D933%26epage%3D934%26doi%3D10.1038%2Fnsmb984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Gstaiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catzavelos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingerland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krek, W.</span><span> </span><span class="NLM_article-title">Skp2 Is Oncogenic and Overexpressed in Human Cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">5043</span><span class="NLM_x">â</span> <span class="NLM_lpage">5048</span><span class="refDoi">Â DOI: 10.1073/pnas.081474898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1073%2Fpnas.081474898" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=5043-5048&issue=9&author=M.+Gstaigerauthor=R.+Jordanauthor=M.+Limauthor=C.+Catzavelosauthor=J.+Mestanauthor=J.+Slingerlandauthor=W.+Krek&title=Skp2+Is+Oncogenic+and+Overexpressed+in+Human+Cancers&doi=10.1073%2Fpnas.081474898"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.081474898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.081474898%26sid%3Dliteratum%253Aachs%26aulast%3DGstaiger%26aufirst%3DM.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DM.%26aulast%3DCatzavelos%26aufirst%3DC.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DSlingerland%26aufirst%3DJ.%26aulast%3DKrek%26aufirst%3DW.%26atitle%3DSkp2%2520Is%2520Oncogenic%2520and%2520Overexpressed%2520in%2520Human%2520Cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26issue%3D9%26spage%3D5043%26epage%3D5048%26doi%3D10.1073%2Fpnas.081474898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Ceccarelli, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlicky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plantevin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neculai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogunjimi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Hakim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varelas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koszela, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasney, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durocher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloche, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1075</span><span class="NLM_x">â</span> <span class="NLM_lpage">1087</span><span class="refDoi">Â DOI: 10.1016/j.cell.2011.05.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2011.05.039" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2011&pages=1075-1087&issue=7&author=D.+F.+Ceccarelliauthor=X.+Tangauthor=B.+Pelletierauthor=S.+Orlickyauthor=W.+Xieauthor=V.+Plantevinauthor=D.+Neculaiauthor=Y.-C.+Chouauthor=A.+Ogunjimiauthor=A.+Al-Hakimauthor=X.+Varelasauthor=J.+Koszelaauthor=G.+A.+Wasneyauthor=M.+Vedadiauthor=S.+Dhe-Paganonauthor=S.+Coxauthor=S.+Xuauthor=A.+Lopez-Gironaauthor=F.+Mercurioauthor=J.+Wranaauthor=D.+Durocherauthor=S.+Melocheauthor=D.+R.+Webbauthor=M.+Tyersauthor=F.+Sicheri&title=An+Allosteric+Inhibitor+of+the+Human+Cdc34+Ubiquitin-Conjugating+Enzyme&doi=10.1016%2Fj.cell.2011.05.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.05.039%26sid%3Dliteratum%253Aachs%26aulast%3DCeccarelli%26aufirst%3DD.%2BF.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DPelletier%26aufirst%3DB.%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DPlantevin%26aufirst%3DV.%26aulast%3DNeculai%26aufirst%3DD.%26aulast%3DChou%26aufirst%3DY.-C.%26aulast%3DOgunjimi%26aufirst%3DA.%26aulast%3DAl-Hakim%26aufirst%3DA.%26aulast%3DVarelas%26aufirst%3DX.%26aulast%3DKoszela%26aufirst%3DJ.%26aulast%3DWasney%26aufirst%3DG.%2BA.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DCox%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DMercurio%26aufirst%3DF.%26aulast%3DWrana%26aufirst%3DJ.%26aulast%3DDurocher%26aufirst%3DD.%26aulast%3DMeloche%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DAn%2520Allosteric%2520Inhibitor%2520of%2520the%2520Human%2520Cdc34%2520Ubiquitin-Conjugating%2520Enzyme%26jtitle%3DCell%26date%3D2011%26volume%3D145%26issue%3D7%26spage%3D1075%26epage%3D1087%26doi%3D10.1016%2Fj.cell.2011.05.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarelli, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlicky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Cyr, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plamondon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">E2 Enzyme Inhibition by Stabilization of a Low-Affinity Interface with Ubiquitin</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">156</span><span class="NLM_x">â</span> <span class="NLM_lpage">163</span><span class="refDoi">Â DOI: 10.1038/nchembio.1412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24316736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=156-163&issue=2&author=H.+Huangauthor=D.+F.+Ceccarelliauthor=S.+Orlickyauthor=D.+J.+St-Cyrauthor=A.+Ziembaauthor=P.+Gargauthor=S.+Plamondonauthor=M.+Auerauthor=S.+Sidhuauthor=A.+Marinierauthor=G.+Kleigerauthor=M.+Tyersauthor=F.+Sicheri&title=E2+Enzyme+Inhibition+by+Stabilization+of+a+Low-Affinity+Interface+with+Ubiquitin&doi=10.1038%2Fnchembio.1412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin</span></div><div class="casAuthors">Huang, Hao; Ceccarelli, Derek F.; Orlicky, Stephen; St-Cyr, Daniel J.; Ziemba, Amy; Garg, Pankaj; Plamondon, Serge; Auer, Manfred; Sidhu, Sachdev; Marinier, Anne; Kleiger, Gary; Tyers, Mike; Sicheri, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-163</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Weak protein interactions between ubiquitin and the ubiquitin-proteasome system (UPS) enzymes that mediate its covalent attachment to substrates serve to position ubiquitin for optimal catalytic transfer.  We show that a small-mol. inhibitor of the E2 ubiquitin-conjugating enzyme Cdc34A, called CC0651, acts by trapping a weak interaction between ubiquitin and the E2 donor ubiquitin-binding site.  A structure of the ternary CC0651-Cdc34A-ubiquitin complex reveals that the inhibitor engages a composite binding pocket formed from Cdc34A and ubiquitin.  CC0651 also suppresses the spontaneous hydrolysis rate of the Cdc34A-ubiquitin thioester without decreasing the interaction between Cdc34A and the RING domain subunit of the E3 enzyme.  Stabilization of the numerous other weak interactions between ubiquitin and UPS enzymes by small mols. may be a feasible strategy to selectively inhibit different UPS activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprbECDLrogwbVg90H21EOLACvtfcHk0lgCCuwJ25uppQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3F&md5=a2c97bdba9beb82c2e7efb0aeb83705e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1412%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DCeccarelli%26aufirst%3DD.%2BF.%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DSt-Cyr%26aufirst%3DD.%2BJ.%26aulast%3DZiemba%26aufirst%3DA.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DPlamondon%26aufirst%3DS.%26aulast%3DAuer%26aufirst%3DM.%26aulast%3DSidhu%26aufirst%3DS.%26aulast%3DMarinier%26aufirst%3DA.%26aulast%3DKleiger%26aufirst%3DG.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DE2%2520Enzyme%2520Inhibition%2520by%2520Stabilization%2520of%2520a%2520Low-Affinity%2520Interface%2520with%2520Ubiquitin%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D2%26spage%3D156%26epage%3D163%26doi%3D10.1038%2Fnchembio.1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Metzger, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hristova, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">HECT and RING Finger Families of E3 Ubiquitin Ligases at a Glance</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">531</span><span class="NLM_x">â</span> <span class="NLM_lpage">537</span><span class="refDoi">Â DOI: 10.1242/jcs.091777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1242%2Fjcs.091777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22389392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Oltbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=531-537&issue=3&author=M.+B.+Metzgerauthor=V.+A.+Hristovaauthor=A.+M.+Weissman&title=HECT+and+RING+Finger+Families+of+E3+Ubiquitin+Ligases+at+a+Glance&doi=10.1242%2Fjcs.091777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">HECT and RING finger families of E3 ubiquitin ligases at a glance</span></div><div class="casAuthors">Metzger, Meredith B.; Hristova, Ventzislava A.; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">531-537</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  This article is part of a Minifocus on Ubiquitin.  The authors review the HECT and RING finger families of E3 ubiquitin ligases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD1zjEVIxdpbVg90H21EOLACvtfcHk0lgEbF2c5mtJBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Oltbc%253D&md5=80112ede647eb3742c268e63ebd0ce88</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1242%2Fjcs.091777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.091777%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DM.%2BB.%26aulast%3DHristova%26aufirst%3DV.%2BA.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DHECT%2520and%2520RING%2520Finger%2520Families%2520of%2520E3%2520Ubiquitin%2520Ligases%2520at%2520a%2520Glance%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2012%26volume%3D125%26issue%3D3%26spage%3D531%26epage%3D537%26doi%3D10.1242%2Fjcs.091777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Rotin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span> </span><span class="NLM_article-title">Physiological Functions of the HECT Family of Ubiquitin Ligases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">398</span><span class="NLM_x">â</span> <span class="NLM_lpage">409</span><span class="refDoi">Â DOI: 10.1038/nrm2690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm2690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19436320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslGntbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=398-409&issue=6&author=D.+Rotinauthor=S.+Kumar&title=Physiological+Functions+of+the+HECT+Family+of+Ubiquitin+Ligases&doi=10.1038%2Fnrm2690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological functions of the HECT family of ubiquitin ligases</span></div><div class="casAuthors">Rotin, Daniela; Kumar, Sharad</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">398-409</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The ubiquitination of proteins is carried out by E1, E2, and E3 (ubiquitin ligase) enzymes, and targets them for degrdn. or for other cellular fates.  The HECT enzymes, including Nedd4 family members, are a major group of E3 enzymes that dictate the specificity of ubiquitination.  In addn. to ubiquitinating proteins for degrdn. by the 26S proteasome, HECT E3 enzymes regulate the trafficking of many receptors, channels, transporters, and viral proteins.  The physiol. functions of yeast HECT E3 ligase Rsp5 are the best known, but the functions of HECT E3 enzymes in metazoans are now becoming clearer from in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBtUzlKovNi7Vg90H21EOLACvtfcHk0lgEbF2c5mtJBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslGntbw%253D&md5=8f09fb0d84b7f3cd55bf65aab1fc882c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnrm2690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2690%26sid%3Dliteratum%253Aachs%26aulast%3DRotin%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DPhysiological%2520Functions%2520of%2520the%2520HECT%2520Family%2520of%2520Ubiquitin%2520Ligases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26issue%3D6%26spage%3D398%26epage%3D409%26doi%3D10.1038%2Fnrm2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K. I.</span><span> </span><span class="NLM_article-title">U Box Proteins as a New Family of Ubiquitin-Protein Ligases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">33111</span><span class="NLM_x">â</span> <span class="NLM_lpage">33120</span><span class="refDoi">Â DOI: 10.1074/jbc.M102755200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1074%2Fjbc.M102755200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=33111-33120&issue=35&author=S.+Hatakeyamaauthor=M.+Yadaauthor=M.+Matsumotoauthor=N.+Ishidaauthor=K.+I.+Nakayama&title=U+Box+Proteins+as+a+New+Family+of+Ubiquitin-Protein+Ligases&doi=10.1074%2Fjbc.M102755200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M102755200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M102755200%26sid%3Dliteratum%253Aachs%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DYada%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DN.%26aulast%3DNakayama%26aufirst%3DK.%2BI.%26atitle%3DU%2520Box%2520Proteins%2520as%2520a%2520New%2520Family%2520of%2520Ubiquitin-Protein%2520Ligases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D35%26spage%3D33111%26epage%3D33120%26doi%3D10.1074%2Fjbc.M102755200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Dove, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">RING-Between-RINGsâKeeping the Safety on Loaded Guns</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">3792</span><span class="NLM_x">â</span> <span class="NLM_lpage">3794</span><span class="refDoi">Â DOI: 10.1038/emboj.2012.260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Femboj.2012.260" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3792-3794&issue=19&author=K.+K.+Doveauthor=R.+E.+Klevit&title=RING-Between-RINGs%E2%80%94Keeping+the+Safety+on+Loaded+Guns&doi=10.1038%2Femboj.2012.260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.260%26sid%3Dliteratum%253Aachs%26aulast%3DDove%26aufirst%3DK.%2BK.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DRING-Between-RINGs%25E2%2580%2594Keeping%2520the%2520Safety%2520on%2520Loaded%2520Guns%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26issue%3D19%26spage%3D3792%26epage%3D3794%26doi%3D10.1038%2Femboj.2012.260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Coscoy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganem, D.</span><span> </span><span class="NLM_article-title">PHD Domains and E3 Ubiquitin Ligases: Viruses Make the Connection</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">12</span><span class="refDoi">Â DOI: 10.1016/S0962-8924(02)00005-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS0962-8924%2802%2900005-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=12480335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A280%3ADC%252BD38jhvFWjtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=7-12&issue=1&author=L.+Coscoyauthor=D.+Ganem&title=PHD+Domains+and+E3+Ubiquitin+Ligases%3A+Viruses+Make+the+Connection&doi=10.1016%2FS0962-8924%2802%2900005-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">PHD domains and E3 ubiquitin ligases: viruses make the connection</span></div><div class="casAuthors">Coscoy Laurent; Ganem Don</div><div class="citationInfo"><span class="NLM_cas:title">Trends in cell biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-12</span>
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    </div><div class="casAbstract">PHD domains constitute a widely distributed subfamily of zinc fingers whose biochemical functions have been unclear until now.  Recently, several PHD-containing viral proteins have been identified that promote immune evasion by downregulating proteins that govern immune recognition.  Studies show that these viral regulators lead to ubiquitination of their targets by functioning as E3 ubiquitin ligases -- an activity that requires the PHD motif.  These are the first examples linking the PHD domain to E3 activity, but the recent discovery of PHD-dependent E3 activity in the cellular kinase MEKK1 and the close structural relation of PHD domains to RING fingers hint that many other PHD proteins might share this activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9v4qmAzG4Kk2yPDyEFiigfW6udTcc2ebt2FRz2NvPp7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jhvFWjtQ%253D%253D&md5=a391e86e8a68bca16daf28151f68e71c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2802%2900005-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252802%252900005-3%26sid%3Dliteratum%253Aachs%26aulast%3DCoscoy%26aufirst%3DL.%26aulast%3DGanem%26aufirst%3DD.%26atitle%3DPHD%2520Domains%2520and%2520E3%2520Ubiquitin%2520Ligases%253A%2520Viruses%2520Make%2520the%2520Connection%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2003%26volume%3D13%26issue%3D1%26spage%3D7%26epage%3D12%26doi%3D10.1016%2FS0962-8924%2802%2900005-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Vittal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzovic, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">21244</span><span class="NLM_x">â</span> <span class="NLM_lpage">21251</span><span class="refDoi">Â DOI: 10.1074/jbc.R115.675165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1074%2Fjbc.R115.675165" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=21244-21251&issue=35&author=V.+Vittalauthor=M.+D.+Stewartauthor=P.+S.+Brzovicauthor=R.+E.+Klevit&title=Regulating+the+Regulators%3A+Recent+Revelations+in+the+Control+of+E3+Ubiquitin+Ligases&doi=10.1074%2Fjbc.R115.675165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R115.675165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R115.675165%26sid%3Dliteratum%253Aachs%26aulast%3DVittal%26aufirst%3DV.%26aulast%3DStewart%26aufirst%3DM.%2BD.%26aulast%3DBrzovic%26aufirst%3DP.%2BS.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DRegulating%2520the%2520Regulators%253A%2520Recent%2520Revelations%2520in%2520the%2520Control%2520of%2520E3%2520Ubiquitin%2520Ligases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D35%26spage%3D21244%26epage%3D21251%26doi%3D10.1074%2Fjbc.R115.675165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Nakayama, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span> </span><span class="NLM_article-title">Ubiquitin Ligases: Cell-Cycle Control and Cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">369</span><span class="NLM_x">â</span> <span class="NLM_lpage">381</span><span class="refDoi">Â DOI: 10.1038/nrc1881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrc1881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16633365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslGitb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=369-381&issue=5&author=K.+I.+Nakayamaauthor=K.+Nakayama&title=Ubiquitin+Ligases%3A+Cell-Cycle+Control+and+Cancer&doi=10.1038%2Fnrc1881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin ligases: cell-cycle control and cancer</span></div><div class="casAuthors">Nakayama, Keiichi I.; Nakayama, Keiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">369-381</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A driving force of the cell cycle is the activation of cyclin-dependent kinases (CDKs), the activities of which are controlled by the ubiquitin-mediated proteolysis of key regulators such as cyclins and CDK inhibitors.  Two ubiquitin ligases, the SKP1-CUL1-F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), are responsible for the specific ubiquitylation of many of these regulators.  Deregulation of the proteolytic system might result in uncontrolled proliferation, genomic instability and cancer.  Cumulative clin. evidence shows alterations in the ubiquitylation of cell-cycle regulators in the etiol. of many human malignancies.  A better understanding of the ubiquitylation machinery will provide new insights into the regulatory biol. of cell-cycle transitions and the development of anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQVKJ7pAqq7Vg90H21EOLACvtfcHk0ljIKPSkBuRg4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslGitb4%253D&md5=23f2eff17be746153edf5be9e733bb21</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnrc1881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1881%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DK.%2BI.%26aulast%3DNakayama%26aufirst%3DK.%26atitle%3DUbiquitin%2520Ligases%253A%2520Cell-Cycle%2520Control%2520and%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26issue%3D5%26spage%3D369%26epage%3D381%26doi%3D10.1038%2Fnrc1881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Metzger, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneda, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">RING-Type E3 Ligases: Master Manipulators of E2 Ubiquitin-Conjugating Enzymes and Ubiquitination</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1843</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">â</span> <span class="NLM_lpage">60</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2013.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbamcr.2013.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23747565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgsbzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1843&publication_year=2014&pages=47-60&issue=1&author=M.+B.+Metzgerauthor=J.+N.+Prunedaauthor=R.+E.+Klevitauthor=A.+M.+Weissman&title=RING-Type+E3+Ligases%3A+Master+Manipulators+of+E2+Ubiquitin-Conjugating+Enzymes+and+Ubiquitination&doi=10.1016%2Fj.bbamcr.2013.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination</span></div><div class="casAuthors">Metzger, Meredith B.; Pruneda, Jonathan N.; Klevit, Rachel E.; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1843</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-60</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  RING finger domain and RING finger-like ubiquitin ligases (E3s), such as U-box proteins, constitute the vast majority of known E3s.  RING-type E3s function together with ubiquitin-conjugating enzymes (E2s) to mediate ubiquitination and are implicated in numerous cellular processes.  In part because of their importance in human physiol. and disease, these proteins and their cellular functions represent an intense area of study.  Here we review recent advances in RING-type E3 recognition of substrates, their cellular regulation, and their varied architecture.  Addnl., recent structural insights into RING-type E3 function, with a focus on important interactions with E2s and ubiquitin, are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbslkCQsg5BrVg90H21EOLACvtfcHk0ljIKPSkBuRg4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgsbzO&md5=3ecbadbe2b6eb405d47b89211607306b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2013.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2013.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DM.%2BB.%26aulast%3DPruneda%26aufirst%3DJ.%2BN.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DRING-Type%2520E3%2520Ligases%253A%2520Master%2520Manipulators%2520of%2520E2%2520Ubiquitin-Conjugating%2520Enzymes%2520and%2520Ubiquitination%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2014%26volume%3D1843%26issue%3D1%26spage%3D47%26epage%3D60%26doi%3D10.1016%2Fj.bbamcr.2013.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Brown, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderLinden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, C. R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dube, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ei Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Actis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span> </span><span class="NLM_article-title">RING E3 Mechanism for Ubiquitin Ligation to a Disordered Substrate Visualized for Human Anaphase-Promoting Complex</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5272</span><span class="NLM_x">â</span> <span class="NLM_lpage">5279</span><span class="refDoi">Â DOI: 10.1073/pnas.1504161112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1073%2Fpnas.1504161112" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=5272-5279&issue=17&author=N.+G.+Brownauthor=R.+VanderLindenauthor=E.+R.+Watsonauthor=R.+Qiaoauthor=C.+R.+R.+Graceauthor=M.+Yamaguchiauthor=F.+Weissmannauthor=J.+J.+Fryeauthor=P.+Dubeauthor=S.+Ei+Choauthor=M.+L.+Actisauthor=P.+Rodriguesauthor=N.+Fujiiauthor=J.-M.+Petersauthor=H.+Starkauthor=B.+A.+Schulman&title=RING+E3+Mechanism+for+Ubiquitin+Ligation+to+a+Disordered+Substrate+Visualized+for+Human+Anaphase-Promoting+Complex&doi=10.1073%2Fpnas.1504161112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1504161112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1504161112%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BG.%26aulast%3DVanderLinden%26aufirst%3DR.%26aulast%3DWatson%26aufirst%3DE.%2BR.%26aulast%3DQiao%26aufirst%3DR.%26aulast%3DGrace%26aufirst%3DC.%2BR.%2BR.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DWeissmann%26aufirst%3DF.%26aulast%3DFrye%26aufirst%3DJ.%2BJ.%26aulast%3DDube%26aufirst%3DP.%26aulast%3DEi%2BCho%26aufirst%3DS.%26aulast%3DActis%26aufirst%3DM.%2BL.%26aulast%3DRodrigues%26aufirst%3DP.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DJ.-M.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26atitle%3DRING%2520E3%2520Mechanism%2520for%2520Ubiquitin%2520Ligation%2520to%2520a%2520Disordered%2520Substrate%2520Visualized%2520for%2520Human%2520Anaphase-Promoting%2520Complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D17%26spage%3D5272%26epage%3D5279%26doi%3D10.1073%2Fpnas.1504161112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Deshaies, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joazeiro, C. A. P.</span><span> </span><span class="NLM_article-title">RING Domain E3 Ubiquitin Ligases</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">399</span><span class="NLM_x">â</span> <span class="NLM_lpage">434</span><span class="refDoi">Â DOI: 10.1146/annurev.biochem.78.101807.093809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1146%2Fannurev.biochem.78.101807.093809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19489725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Ghur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=399-434&issue=1&author=R.+J.+Deshaiesauthor=C.+A.+P.+Joazeiro&title=RING+Domain+E3+Ubiquitin+Ligases&doi=10.1146%2Fannurev.biochem.78.101807.093809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">RING domain E3 ubiquitin ligases</span></div><div class="casAuthors">Deshaies, Raymond J.; Joazeiro, Claudio A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">399-434</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  E3 ubiquitin ligases confer specificity to ubiquitination by recognizing target substrates and mediating the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to the substrate.  The activity of most E3 enzymes is specified by a RING domain, which binds to an E2-ubiquitin thioester and activates discharge of its ubiquitin cargo.  E2-E3 complexes can either monoubiquitinate a substrate protein Lys residue or synthesize polyubiquitin chains assembled via different Lys residues of ubiquitin.  These modifications can have diverse effects on the substrate, ranging from proteasome-dependent proteolysis to modulation of protein function, structure, assembly, and/or localization.  Not surprisingly, RING E3-mediated ubiquitination can be regulated in a no. of ways.  RING-based E3 enzymes are specified by >600 human genes, surpassing the 518 protein kinase genes.  Accordingly, RING E3 enzymes have been linked to the control of many cellular processes and to multiple human diseases.  Despite their crit. importance, a knowledge of the physiol. partners, biol. functions, substrates, and mechanism of action for most RING E3 enzymess remains at a rudimentary stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMbk3gX4ei9LVg90H21EOLACvtfcHk0libqqKwwBvrRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Ghur4%253D&md5=f51600c73ae9a74e4e0212d5f25eefc0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.78.101807.093809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.78.101807.093809%26sid%3Dliteratum%253Aachs%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DJoazeiro%26aufirst%3DC.%2BA.%2BP.%26atitle%3DRING%2520Domain%2520E3%2520Ubiquitin%2520Ligases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2009%26volume%3D78%26issue%3D1%26spage%3D399%26epage%3D434%26doi%3D10.1146%2Fannurev.biochem.78.101807.093809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Lipkowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">RINGs of Good and Evil: RING Finger Ubiquitin Ligases at the Crossroads of Tumour Suppression and Oncogenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">629</span><span class="NLM_x">â</span> <span class="NLM_lpage">643</span><span class="refDoi">Â DOI: 10.1038/nrc3120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrc3120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=21863050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKit73E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=629-643&issue=9&author=S.+Lipkowitzauthor=A.+M.+Weissman&title=RINGs+of+Good+and+Evil%3A+RING+Finger+Ubiquitin+Ligases+at+the+Crossroads+of+Tumour+Suppression+and+Oncogenesis&doi=10.1038%2Fnrc3120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis</span></div><div class="casAuthors">Lipkowitz, Stanley; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">629-643</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome system has numerous crucial roles in physiol. and pathophysiol.  Fundamental to the specificity of this system are ubiquitin-protein ligases (E3s).  Of these, the majority are RING finger and RING finger-related E3s.  Many RING finger E3s have roles in processes that are central to the maintenance of genomic integrity and cellular homeostasis, such as the anaphase promoting complex/cyclosome (APC/C), the SKP1-cullin 1-F-box protein (SCF) E3s, MDM2, BRCA1, Fanconi anemia proteins, CBL proteins, von Hippel-Lindau tumor suppressor (VHL) and SIAH proteins.  As a result, many RING finger E3s are implicated in either the suppression or the progression of cancer.  This Review summarizes current knowledge in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7dkRvaNdibLVg90H21EOLACvtfcHk0libqqKwwBvrRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKit73E&md5=9f722fc9920bd2a0b8d29cc959271ad4</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrc3120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3120%26sid%3Dliteratum%253Aachs%26aulast%3DLipkowitz%26aufirst%3DS.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DRINGs%2520of%2520Good%2520and%2520Evil%253A%2520RING%2520Finger%2520Ubiquitin%2520Ligases%2520at%2520the%2520Crossroads%2520of%2520Tumour%2520Suppression%2520and%2520Oncogenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D9%26spage%3D629%26epage%3D643%26doi%3D10.1038%2Fnrc3120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Morreale, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, H.</span><span> </span><span class="NLM_article-title">Types of Ubiquitin Ligases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">248</span><span class="NLM_x">â</span> <span class="NLM_lpage">248.e1</span><span class="refDoi">Â DOI: 10.1016/j.cell.2016.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2016.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=27015313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVamurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=248-248.e1&issue=1&author=F.+E.+Morrealeauthor=H.+Walden&title=Types+of+Ubiquitin+Ligases&doi=10.1016%2Fj.cell.2016.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Types of ubiquitin ligases</span></div><div class="casAuthors">Morreale, Francesca Ester; Walden, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-248.e1</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Ubiquitination is a post-translational modification of proteins involved in a variety of cellular processes.  Ubiquitination requires the sequential action of 3 enzymes: E1 (ubiquitin-activating enzymes), E2 (ubiquitin-conjugating enzymes), and E3 (ubiquitin ligases).  Here, the authors highlight the main types of E3 ubiquitin ligases, which can be classified in 3 families depending on the presence of characteristic domains and on the mechanism of ubiquitin transfer to the substrate protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaGjtLCe1p8LVg90H21EOLACvtfcHk0libqqKwwBvrRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVamurg%253D&md5=f819525b60b95ed16340612d6bf51a13</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DMorreale%26aufirst%3DF.%2BE.%26aulast%3DWalden%26aufirst%3DH.%26atitle%3DTypes%2520of%2520Ubiquitin%2520Ligases%26jtitle%3DCell%26date%3D2016%26volume%3D165%26issue%3D1%26spage%3D248%26epage%3D248.e1%26doi%3D10.1016%2Fj.cell.2016.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Pruneda, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlefield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soss, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordquist, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chazin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzovic, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">Structure of an E3:E2$Ub Complex Reveals an Allosteric Mechanism Sharedamong RING/U-Box Ligases</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">933</span><span class="NLM_x">â</span> <span class="NLM_lpage">942</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2012.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2012.07.001" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=933-942&issue=6&author=J.+N.+Prunedaauthor=P.+J.+Littlefieldauthor=S.+E.+Sossauthor=K.+A.+Nordquistauthor=W.+J.+Chazinauthor=P.+S.+Brzovicauthor=R.+E.+Klevit&title=Structure+of+an+E3%3AE2%24Ub+Complex+Reveals+an+Allosteric+Mechanism+Sharedamong+RING%2FU-Box+Ligases&doi=10.1016%2Fj.molcel.2012.07.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DPruneda%26aufirst%3DJ.%2BN.%26aulast%3DLittlefield%26aufirst%3DP.%2BJ.%26aulast%3DSoss%26aufirst%3DS.%2BE.%26aulast%3DNordquist%26aufirst%3DK.%2BA.%26aulast%3DChazin%26aufirst%3DW.%2BJ.%26aulast%3DBrzovic%26aufirst%3DP.%2BS.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DStructure%2520of%2520an%2520E3%253AE2%2524Ub%2520Complex%2520Reveals%2520an%2520Allosteric%2520Mechanism%2520Sharedamong%2520RING%252FU-Box%2520Ligases%26jtitle%3DMol.%2520Cell%26date%3D2012%26volume%3D47%26issue%3D6%26spage%3D933%26epage%3D942%26doi%3D10.1016%2Fj.molcel.2012.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">PlechanovovÃ¡, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffray, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatham, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naismith, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, R. T.</span><span> </span><span class="NLM_article-title">Structure of a RING E3 Ligase and Ubiquitin-Loaded E2 Primed for Catalysis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">489</span><span class="NLM_x"> (</span><span class="NLM_issue">7414</span><span class="NLM_x">) </span> <span class="NLM_fpage">115</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span><span class="refDoi">Â DOI: 10.1038/nature11376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature11376" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=489&publication_year=2012&pages=115-120&issue=7414&author=A.+Plechanovov%C3%A1author=E.+G.+Jaffrayauthor=M.+H.+Tathamauthor=J.+H.+Naismithauthor=R.+T.+Hay&title=Structure+of+a+RING+E3+Ligase+and+Ubiquitin-Loaded+E2+Primed+for+Catalysis&doi=10.1038%2Fnature11376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fnature11376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11376%26sid%3Dliteratum%253Aachs%26aulast%3DPlechanovov%25C3%25A1%26aufirst%3DA.%26aulast%3DJaffray%26aufirst%3DE.%2BG.%26aulast%3DTatham%26aufirst%3DM.%2BH.%26aulast%3DNaismith%26aufirst%3DJ.%2BH.%26aulast%3DHay%26aufirst%3DR.%2BT.%26atitle%3DStructure%2520of%2520a%2520RING%2520E3%2520Ligase%2520and%2520Ubiquitin-Loaded%2520E2%2520Primed%2520for%2520Catalysis%26jtitle%3DNature%26date%3D2012%26volume%3D489%26issue%3D7414%26spage%3D115%26epage%3D120%26doi%3D10.1038%2Fnature11376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Dou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buetow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibbet, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. T.</span><span> </span><span class="NLM_article-title">BIRC7-E2 Ubiquitin Conjugate Structure Reveals the Mechanism of Ubiquitin Transfer by a RING Dimer</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">876</span><span class="NLM_x">â</span> <span class="NLM_lpage">883</span><span class="refDoi">Â DOI: 10.1038/nsmb.2379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnsmb.2379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22902369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Wkt77E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=876-883&issue=9&author=H.+Douauthor=L.+Buetowauthor=G.+J.+Sibbetauthor=K.+Cameronauthor=D.+T.+Huang&title=BIRC7-E2+Ubiquitin+Conjugate+Structure+Reveals+the+Mechanism+of+Ubiquitin+Transfer+by+a+RING+Dimer&doi=10.1038%2Fnsmb.2379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer</span></div><div class="casAuthors">Dou, Hao; Buetow, Lori; Sibbet, Gary J.; Cameron, Kenneth; Huang, Danny T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">876-883</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Certain RING ubiquitin ligases (E3s) dimerize to facilitate ubiquitin (Ub) transfer from ubiquitin-conjugating enzyme (E2) to substrate, but structural evidence on how this process promotes Ub transfer is lacking.  Here we report the structure of the human dimeric RING domain from BIRC7 in complex with the E2 UbcH5B covalently linked to Ub (UbcH5Bâ¼Ub).  The structure reveals extensive noncovalent donor Ub interactions with UbcH5B and both subunits of the RING domain dimer that stabilize the globular body and C-terminal tail of Ub.  Mutations that disrupt these noncovalent interactions or RING dimerization reduce UbcH5Bâ¼Ub binding affinity and ubiquitination activity.  Moreover, NMR analyses demonstrate that BIRC7 binding to UbcH5Bâ¼Ub induces peak-shift perturbations in the donor Ub consistent with the crystallog.-obsd. Ub interactions.  Our results provide structural insights into how dimeric RING E3s recruit E2â¼Ub and optimize the donor Ub configuration for transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxnWgmAyO2_LVg90H21EOLACvtfcHk0lhP-CSs9EL3GQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Wkt77E&md5=ef021a79ae5e914838bc7f8ad7e43942</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2379%26sid%3Dliteratum%253Aachs%26aulast%3DDou%26aufirst%3DH.%26aulast%3DBuetow%26aufirst%3DL.%26aulast%3DSibbet%26aufirst%3DG.%2BJ.%26aulast%3DCameron%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DD.%2BT.%26atitle%3DBIRC7-E2%2520Ubiquitin%2520Conjugate%2520Structure%2520Reveals%2520the%2520Mechanism%2520of%2520Ubiquitin%2520Transfer%2520by%2520a%2520RING%2520Dimer%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D9%26spage%3D876%26epage%3D883%26doi%3D10.1038%2Fnsmb.2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Berndsen, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span> </span><span class="NLM_article-title">New Insights Into Ubiquitin E3 Ligase Mechanism</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">301</span><span class="NLM_x">â</span> <span class="NLM_lpage">307</span><span class="refDoi">Â DOI: 10.1038/nsmb.2780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnsmb.2780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24699078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1aisrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=301-307&issue=4&author=C.+E.+Berndsenauthor=C.+Wolberger&title=New+Insights+Into+Ubiquitin+E3+Ligase+Mechanism&doi=10.1038%2Fnsmb.2780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into ubiquitin E3 ligase mechanism</span></div><div class="casAuthors">Berndsen, Christopher E.; Wolberger, Cynthia</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-307</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  E3 ligases carry out the final step in the ubiquitination cascade, catalyzing transfer of ubiquitin from an E2 enzyme to form a covalent bond with a substrate lysine.  Three distinct classes of E3 ligases have been identified that stimulate transfer of ubiquitin and ubiquitin-like proteins through either a direct or an indirect mechanism.  Only recently have the catalytic mechanisms of E3 ligases begun to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovYmD2sLo2RrVg90H21EOLACvtfcHk0lhP-CSs9EL3GQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1aisrk%253D&md5=fd44f6d69f85067b70322ca304aed507</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2780%26sid%3Dliteratum%253Aachs%26aulast%3DBerndsen%26aufirst%3DC.%2BE.%26aulast%3DWolberger%26aufirst%3DC.%26atitle%3DNew%2520Insights%2520Into%2520Ubiquitin%2520E3%2520Ligase%2520Mechanism%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D21%26issue%3D4%26spage%3D301%26epage%3D307%26doi%3D10.1038%2Fnsmb.2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Das, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalathur, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarasov, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFeeters, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">Allosteric Activation of E2-RING Finger-Mediated Ubiquitylation by a Structurally Defined Specific E2-Binding Region of Gp78</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">674</span><span class="NLM_x">â</span> <span class="NLM_lpage">685</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2009.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2009.05.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=674-685&issue=6&author=R.+Dasauthor=J.+Marianoauthor=Y.+C.+Tsaiauthor=R.+C.+Kalathurauthor=Z.+Kostovaauthor=J.+Liauthor=S.+G.+Tarasovauthor=R.+L.+McFeetersauthor=A.+S.+Altieriauthor=X.+Jiauthor=R.+A.+Byrdauthor=A.+M.+Weissman&title=Allosteric+Activation+of+E2-RING+Finger-Mediated+Ubiquitylation+by+a+Structurally+Defined+Specific+E2-Binding+Region+of+Gp78&doi=10.1016%2Fj.molcel.2009.05.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DR.%26aulast%3DMariano%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DY.%2BC.%26aulast%3DKalathur%26aufirst%3DR.%2BC.%26aulast%3DKostova%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTarasov%26aufirst%3DS.%2BG.%26aulast%3DMcFeeters%26aufirst%3DR.%2BL.%26aulast%3DAltieri%26aufirst%3DA.%2BS.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DByrd%26aufirst%3DR.%2BA.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DAllosteric%2520Activation%2520of%2520E2-RING%2520Finger-Mediated%2520Ubiquitylation%2520by%2520a%2520Structurally%2520Defined%2520Specific%2520E2-Binding%2520Region%2520of%2520Gp78%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D34%26issue%3D6%26spage%3D674%26epage%3D685%26doi%3D10.1016%2Fj.molcel.2009.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Brzovic, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lissounov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyt, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">A UbcH5/Ubiquitin Noncovalent Complex Is Required for Processive BRCA1-Directed Ubiquitination</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">873</span><span class="NLM_x">â</span> <span class="NLM_lpage">880</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2006.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2006.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16543155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVyisr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=873-880&issue=6&author=P.+S.+Brzovicauthor=A.+Lissounovauthor=D.+E.+Christensenauthor=D.+W.+Hoytauthor=R.+E.+Klevit&title=A+UbcH5%2FUbiquitin+Noncovalent+Complex+Is+Required+for+Processive+BRCA1-Directed+Ubiquitination&doi=10.1016%2Fj.molcel.2006.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination</span></div><div class="casAuthors">Brzovic, Peter S.; Lissounov, Alexei; Christensen, Devin E.; Hoyt, David W.; Klevit, Rachel E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">873-880</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protein ubiquitination is a powerful regulatory modification that influences nearly every aspect of eukaryotic cell biol.  The general pathway for ubiquitin (Ub) modification requires the sequential activities of a Ub-activating enzyme (E1), a Ub transfer enzyme (E2), and a Ub ligase (E3).  The E2 must recognize both the E1 and a cognate E3 in addn. to carrying activated Ub.  These central functions are performed by a topol. conserved Î±/Î²-fold core domain of â¼ 150 residues shared by all E2s.  However, as presented herein, the UbcH5 family of E2s can also bind Ub noncovalently on a surface well removed from the E2 active site.  We present the soln. structure of the UbcH5c/Ub noncovalent complex and demonstrate that this noncovalent interaction permits self-assembly of activated UbcH5c â¼ Ub mols.  Self-assembly has profound consequences for the processive formation of polyubiquitin (poly-Ub) chains in ubiquitination reactions directed by the breast and ovarian cancer tumor susceptibility protein BRCA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlYVF7MSoZiLVg90H21EOLACvtfcHk0lg5fCCWE6wJzg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVyisr4%253D&md5=f2b21298bc25b43ad9c1fcefe9959d9f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DBrzovic%26aufirst%3DP.%2BS.%26aulast%3DLissounov%26aufirst%3DA.%26aulast%3DChristensen%26aufirst%3DD.%2BE.%26aulast%3DHoyt%26aufirst%3DD.%2BW.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DA%2520UbcH5%252FUbiquitin%2520Noncovalent%2520Complex%2520Is%2520Required%2520for%2520Processive%2520BRCA1-Directed%2520Ubiquitination%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D21%26issue%3D6%26spage%3D873%26epage%3D880%26doi%3D10.1016%2Fj.molcel.2006.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Das, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarasov, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, R. A.</span><span> </span><span class="NLM_article-title">Allosteric Regulation of E2:E3 Interactions Promote a Processive Ubiquitination Machine</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">2504</span><span class="NLM_x">â</span> <span class="NLM_lpage">2516</span><span class="refDoi">Â DOI: 10.1038/emboj.2013.174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Femboj.2013.174" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2504-2516&issue=18&author=R.+Dasauthor=Y.+H.+Liangauthor=J.+Marianoauthor=J.+Liauthor=T.+Huangauthor=A.+Kingauthor=S.+G.+Tarasovauthor=A.+M.+Weissmanauthor=X.+Jiauthor=R.+A.+Byrd&title=Allosteric+Regulation+of+E2%3AE3+Interactions+Promote+a+Processive+Ubiquitination+Machine&doi=10.1038%2Femboj.2013.174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Femboj.2013.174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2013.174%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DY.%2BH.%26aulast%3DMariano%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DTarasov%26aufirst%3DS.%2BG.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DByrd%26aufirst%3DR.%2BA.%26atitle%3DAllosteric%2520Regulation%2520of%2520E2%253AE3%2520Interactions%2520Promote%2520a%2520Processive%2520Ubiquitination%2520Machine%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26issue%3D18%26spage%3D2504%26epage%3D2516%26doi%3D10.1038%2Femboj.2013.174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Notenboom, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbert, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rossum-Fikkert, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, T. K.</span><span> </span><span class="NLM_article-title">Functional Characterization of Rad18 Domains for Rad6, Ubiquitin, DNA Binding and PCNA Modification</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5819</span><span class="NLM_x">â</span> <span class="NLM_lpage">5830</span><span class="refDoi">Â DOI: 10.1093/nar/gkm615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1093%2Fnar%2Fgkm615" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=5819-5830&issue=17&author=V.+Notenboomauthor=R.+G.+Hibbertauthor=S.+E.+van+Rossum-Fikkertauthor=J.+V.+Olsenauthor=M.+Mannauthor=T.+K.+Sixma&title=Functional+Characterization+of+Rad18+Domains+for+Rad6%2C+Ubiquitin%2C+DNA+Binding+and+PCNA+Modification&doi=10.1093%2Fnar%2Fgkm615"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm615%26sid%3Dliteratum%253Aachs%26aulast%3DNotenboom%26aufirst%3DV.%26aulast%3DHibbert%26aufirst%3DR.%2BG.%26aulast%3Dvan%2BRossum-Fikkert%26aufirst%3DS.%2BE.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DMann%26aufirst%3DM.%26aulast%3DSixma%26aufirst%3DT.%2BK.%26atitle%3DFunctional%2520Characterization%2520of%2520Rad18%2520Domains%2520for%2520Rad6%252C%2520Ubiquitin%252C%2520DNA%2520Binding%2520and%2520PCNA%2520Modification%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26issue%3D17%26spage%3D5819%26epage%3D5830%26doi%3D10.1093%2Fnar%2Fgkm615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Metzger, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">A Structurally Unique E2-Binding Domain Activates Ubiquitination by the ERAD E2, Ubc7p, Through Multiple Mechanisms</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">516</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2013.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2013.04.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2013&pages=516-527&issue=4&author=M.+B.+Metzgerauthor=Y.+H.+Liangauthor=R.+Dasauthor=J.+Marianoauthor=S.+Liauthor=J.+Liauthor=Z.+Kostovaauthor=R.+A.+Byrdauthor=X.+Jiauthor=A.+M.+Weissman&title=A+Structurally+Unique+E2-Binding+Domain+Activates+Ubiquitination+by+the+ERAD+E2%2C+Ubc7p%2C+Through+Multiple+Mechanisms&doi=10.1016%2Fj.molcel.2013.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DM.%2BB.%26aulast%3DLiang%26aufirst%3DY.%2BH.%26aulast%3DDas%26aufirst%3DR.%26aulast%3DMariano%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKostova%26aufirst%3DZ.%26aulast%3DByrd%26aufirst%3DR.%2BA.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DA%2520Structurally%2520Unique%2520E2-Binding%2520Domain%2520Activates%2520Ubiquitination%2520by%2520the%2520ERAD%2520E2%252C%2520Ubc7p%252C%2520Through%2520Multiple%2520Mechanisms%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D50%26issue%3D4%26spage%3D516%26epage%3D527%26doi%3D10.1016%2Fj.molcel.2013.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koepp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF Ubiquitin Ligase Complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x"> (</span><span class="NLM_issue">6882</span><span class="NLM_x">) </span> <span class="NLM_fpage">703</span><span class="NLM_x">â</span> <span class="NLM_lpage">709</span><span class="refDoi">Â DOI: 10.1038/416703a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2F416703a" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2002&pages=703-709&issue=6882&author=N.+Zhengauthor=B.+A.+Schulmanauthor=L.+Songauthor=J.+J.+Millerauthor=P.+D.+Jeffreyauthor=P.+Wangauthor=C.+Chuauthor=D.+M.+Koeppauthor=S.+J.+Elledgeauthor=M.+Paganoauthor=R.+C.+Conawayauthor=J.+W.+Conawayauthor=J.+W.+Harperauthor=N.+P.+Pavletich&title=Structure+of+the+Cul1-Rbx1-Skp1-F+boxSkp2+SCF+Ubiquitin+Ligase+Complex&doi=10.1038%2F416703a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2F416703a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F416703a%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DJ.%2BJ.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DChu%26aufirst%3DC.%26aulast%3DKoepp%26aufirst%3DD.%2BM.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520Cul1-Rbx1-Skp1-F%2520boxSkp2%2520SCF%2520Ubiquitin%2520Ligase%2520Complex%26jtitle%3DNature%26date%3D2002%26volume%3D416%26issue%3D6882%26spage%3D703%26epage%3D709%26doi%3D10.1038%2F416703a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of a C-Cbl-UbcH7 Complex: RING Domain Function in Ubiquitin-Protein Ligases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">533</span><span class="NLM_x">â</span> <span class="NLM_lpage">539</span><span class="refDoi">Â DOI: 10.1016/S0092-8674(00)00057-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS0092-8674%2800%2900057-X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=533-539&issue=4&author=N.+Zhengauthor=P.+Wangauthor=P.+D.+Jeffreyauthor=N.+P.+Pavletich&title=Structure+of+a+C-Cbl-UbcH7+Complex%3A+RING+Domain+Function+in+Ubiquitin-Protein+Ligases&doi=10.1016%2FS0092-8674%2800%2900057-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900057-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900057-X%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520a%2520C-Cbl-UbcH7%2520Complex%253A%2520RING%2520Domain%2520Function%2520in%2520Ubiquitin-Protein%2520Ligases%26jtitle%3DCell%26date%3D2000%26volume%3D102%26issue%3D4%26spage%3D533%26epage%3D539%26doi%3D10.1016%2FS0092-8674%2800%2900057-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Orlicky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">Structural Basis for Phosphodependent Substrate Selection and Orientation by the SCFCdc4 Ubiquitin Ligase</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">243</span><span class="NLM_x">â</span> <span class="NLM_lpage">256</span><span class="refDoi">Â DOI: 10.1016/S0092-8674(03)00034-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS0092-8674%2803%2900034-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=243-256&issue=2&author=S.+Orlickyauthor=X.+Tangauthor=A.+Willemsauthor=M.+Tyersauthor=F.+Sicheri&title=Structural+Basis+for+Phosphodependent+Substrate+Selection+and+Orientation+by+the+SCFCdc4+Ubiquitin+Ligase&doi=10.1016%2FS0092-8674%2803%2900034-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900034-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900034-5%26sid%3Dliteratum%253Aachs%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWillems%26aufirst%3DA.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DStructural%2520Basis%2520for%2520Phosphodependent%2520Substrate%2520Selection%2520and%2520Orientation%2520by%2520the%2520SCFCdc4%2520Ubiquitin%2520Ligase%26jtitle%3DCell%26date%3D2003%26volume%3D112%26issue%3D2%26spage%3D243%26epage%3D256%26doi%3D10.1016%2FS0092-8674%2803%2900034-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Hao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of a Fbw7-Skp1-Cyclin E Complex: Multisite-Phosphorylated Substrate Recognition by SCF Ubiquitin Ligases</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">143</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2007.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2007.02.022" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=131-143&issue=1&author=B.+Haoauthor=S.+Oehlmannauthor=M.+E.+Sowaauthor=J.+W.+Harperauthor=N.+P.+Pavletich&title=Structure+of+a+Fbw7-Skp1-Cyclin+E+Complex%3A+Multisite-Phosphorylated+Substrate+Recognition+by+SCF+Ubiquitin+Ligases&doi=10.1016%2Fj.molcel.2007.02.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DB.%26aulast%3DOehlmann%26aufirst%3DS.%26aulast%3DSowa%26aufirst%3DM.%2BE.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520a%2520Fbw7-Skp1-Cyclin%2520E%2520Complex%253A%2520Multisite-Phosphorylated%2520Substrate%2520Recognition%2520by%2520SCF%2520Ubiquitin%2520Ligases%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D26%26issue%3D1%26spage%3D131%26epage%3D143%26doi%3D10.1016%2Fj.molcel.2007.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Hao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structural Basis of the Cks1-Dependent Recognition of P27(Kip1) by the SCF(Skp2) Ubiquitin Ligase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">19</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2005.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2005.09.003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=9-19&issue=1&author=B.+Haoauthor=N.+Zhengauthor=B.+A.+Schulmanauthor=G.+Wuauthor=J.+J.+Millerauthor=M.+Paganoauthor=N.+P.+Pavletich&title=Structural+Basis+of+the+Cks1-Dependent+Recognition+of+P27%28Kip1%29+by+the+SCF%28Skp2%29+Ubiquitin+Ligase&doi=10.1016%2Fj.molcel.2005.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DJ.%2BJ.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructural%2520Basis%2520of%2520the%2520Cks1-Dependent%2520Recognition%2520of%2520P27%2528Kip1%2529%2520by%2520the%2520SCF%2528Skp2%2529%2520Ubiquitin%2520Ligase%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D20%26issue%3D1%26spage%3D9%26epage%3D19%26doi%3D10.1016%2Fj.molcel.2005.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Kamadurai, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Actis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souphron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurinov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhlman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span> </span><span class="NLM_article-title">Mechanism of Ubiquitin Ligation and Lysine Prioritization by a HECT E3</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">â</span> <span class="NLM_lpage">26</span><span class="refDoi">Â DOI: 10.7554/eLife.00828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.7554%2FeLife.00828" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=10-26&author=H.+B.+Kamaduraiauthor=Y.+Qiuauthor=A.+Dengauthor=J.+S.+Harrisonauthor=C.+MacDonaldauthor=M.+Actisauthor=P.+Rodriguesauthor=D.+J.+Millerauthor=J.+Souphronauthor=S.+M.+Lewisauthor=I.+Kurinovauthor=N.+Fujiiauthor=M.+Hammelauthor=R.+Piperauthor=B.+Kuhlmanauthor=B.+A.+Schulman&title=Mechanism+of+Ubiquitin+Ligation+and+Lysine+Prioritization+by+a+HECT+E3&doi=10.7554%2FeLife.00828"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.7554%2FeLife.00828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.00828%26sid%3Dliteratum%253Aachs%26aulast%3DKamadurai%26aufirst%3DH.%2BB.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DJ.%2BS.%26aulast%3DMacDonald%26aufirst%3DC.%26aulast%3DActis%26aufirst%3DM.%26aulast%3DRodrigues%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DD.%2BJ.%26aulast%3DSouphron%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DS.%2BM.%26aulast%3DKurinov%26aufirst%3DI.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DHammel%26aufirst%3DM.%26aulast%3DPiper%26aufirst%3DR.%26aulast%3DKuhlman%26aufirst%3DB.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26atitle%3DMechanism%2520of%2520Ubiquitin%2520Ligation%2520and%2520Lysine%2520Prioritization%2520by%2520a%2520HECT%2520E3%26jtitle%3DeLife%26date%3D2013%26volume%3D2%26spage%3D10%26epage%3D26%26doi%3D10.7554%2FeLife.00828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Bernassola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciechanover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melino, G.</span><span> </span><span class="NLM_article-title">The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">10</span><span class="NLM_x">â</span> <span class="NLM_lpage">21</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.ccr.2008.06.001" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=10-21&issue=1&author=F.+Bernassolaauthor=M.+Karinauthor=A.+Ciechanoverauthor=G.+Melino&title=The+HECT+Family+of+E3+Ubiquitin+Ligases%3A+Multiple+Players+in+Cancer+Development&doi=10.1016%2Fj.ccr.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBernassola%26aufirst%3DF.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DMelino%26aufirst%3DG.%26atitle%3DThe%2520HECT%2520Family%2520of%2520E3%2520Ubiquitin%2520Ligases%253A%2520Multiple%2520Players%2520in%2520Cancer%2520Development%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26issue%3D1%26spage%3D10%26epage%3D21%26doi%3D10.1016%2Fj.ccr.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Spratt, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, G. S.</span><span> </span><span class="NLM_article-title">RBR E3 Ubiquitin Ligases: New Structures, New Insights, New Questions</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">421</span><span class="NLM_x">â</span> <span class="NLM_lpage">437</span><span class="refDoi">Â DOI: 10.1042/BJ20140006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1042%2FBJ20140006" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2014&pages=421-437&issue=3&author=D.+E.+Sprattauthor=H.+Waldenauthor=G.+S.+Shaw&title=RBR+E3+Ubiquitin+Ligases%3A+New+Structures%2C+New+Insights%2C+New+Questions&doi=10.1042%2FBJ20140006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1042%2FBJ20140006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20140006%26sid%3Dliteratum%253Aachs%26aulast%3DSpratt%26aufirst%3DD.%2BE.%26aulast%3DWalden%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DG.%2BS.%26atitle%3DRBR%2520E3%2520Ubiquitin%2520Ligases%253A%2520New%2520Structures%252C%2520New%2520Insights%252C%2520New%2520Questions%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D458%26issue%3D3%26spage%3D421%26epage%3D437%26doi%3D10.1042%2FBJ20140006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Eisenhaber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhaber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, M.-T.</span><span> </span><span class="NLM_article-title">The Ring Between Ring Fingers (RBR) Protein Family</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">209</span><span class="refDoi">Â DOI: 10.1186/gb-2007-8-3-209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1186%2Fgb-2007-8-3-209" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=209&issue=3&author=B.+Eisenhaberauthor=N.+Chumakauthor=F.+Eisenhaberauthor=M.-T.+Hauser&title=The+Ring+Between+Ring+Fingers+%28RBR%29+Protein+Family&doi=10.1186%2Fgb-2007-8-3-209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1186%2Fgb-2007-8-3-209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2007-8-3-209%26sid%3Dliteratum%253Aachs%26aulast%3DEisenhaber%26aufirst%3DB.%26aulast%3DChumak%26aufirst%3DN.%26aulast%3DEisenhaber%26aufirst%3DF.%26aulast%3DHauser%26aufirst%3DM.-T.%26atitle%3DThe%2520Ring%2520Between%2520Ring%2520Fingers%2520%2528RBR%2529%2520Protein%2520Family%26jtitle%3DGenome%2520Biol.%26date%3D2007%26volume%3D8%26issue%3D3%26spage%3D209%26doi%3D10.1186%2Fgb-2007-8-3-209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Molle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gareiss, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tae, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noblin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Targeting the Von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules to Disrupt the VHL/HIF-1Î± Interaction</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">4465</span><span class="NLM_x">â</span> <span class="NLM_lpage">4468</span><span class="refDoi">Â DOI: 10.1021/ja209924v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja209924v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOgurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=4465-4468&issue=10&author=D.+L.+Buckleyauthor=I.+Van+Molleauthor=P.+C.+Gareissauthor=H.+S.+Taeauthor=J.+Michelauthor=D.+J.+Noblinauthor=W.+L.+Jorgensenauthor=A.+Ciulliauthor=C.+M.+Crews&title=Targeting+the+Von+Hippel-Lindau+E3+Ubiquitin+Ligase+Using+Small+Molecules+to+Disrupt+the+VHL%2FHIF-1%CE%B1+Interaction&doi=10.1021%2Fja209924v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1Î± Interaction</span></div><div class="casAuthors">Buckley, Dennis L.; Van Molle, Inge; Gareiss, Peter C.; Tae, Hyun Seop; Michel, Julien; Noblin, Devin J.; Jorgensen, William L.; Ciulli, Alessio; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4465-4468</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases, which bind protein targets, leading to their ubiquitination and subsequent degrdn., are attractive drug targets due to their exquisite substrate specificity.  However, the development of small-mol. inhibitors has proven extraordinarily challenging as modulation of E3 ligase activities requires the targeting of protein-protein interactions.  Using rational design, we have generated the first small mol. targeting the von Hippel-Lindau protein (VHL), the substrate recognition subunit of an E3 ligase, and an important target in cancer, chronic anemia, and ischemia.  We have also obtained the crystal structure of VHL bound to our most potent inhibitor, confirming that the compd. mimics the binding mode of the transcription factor HIF-1Î±, a substrate of VHL.  These results have the potential to guide future development of improved lead compds. as therapeutics for the treatment of chronic anemia and ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolmBVM_mfWzrVg90H21EOLACvtfcHk0ljreeSblSxuPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOgurw%253D&md5=60f7384b6bc932c9828dc12999283a1e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fja209924v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja209924v%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DGareiss%26aufirst%3DP.%2BC.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DMichel%26aufirst%3DJ.%26aulast%3DNoblin%26aufirst%3DD.%2BJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTargeting%2520the%2520Von%2520Hippel-Lindau%2520E3%2520Ubiquitin%2520Ligase%2520Using%2520Small%2520Molecules%2520to%2520Disrupt%2520the%2520VHL%252FHIF-1%25CE%25B1%2520Interaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26issue%3D10%26spage%3D4465%26epage%3D4468%26doi%3D10.1021%2Fja209924v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Molle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tae, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gareiss, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of the Interaction Between the E3 Ligase VHL and HIF1Î±</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">46</span><span class="NLM_x">) </span> <span class="NLM_fpage">11463</span><span class="NLM_x">â</span> <span class="NLM_lpage">11467</span><span class="refDoi">Â DOI: 10.1002/anie.201206231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2Fanie.201206231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rs7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=11463-11467&issue=46&author=D.+L.+Buckleyauthor=J.+L.+Gustafsonauthor=I.+Van+Molleauthor=A.+G.+Rothauthor=H.+S.+Taeauthor=P.+C.+Gareissauthor=W.+L.+Jorgensenauthor=A.+Ciulliauthor=C.+M.+Crews&title=Small-Molecule+Inhibitors+of+the+Interaction+Between+the+E3+Ligase+VHL+and+HIF1%CE%B1&doi=10.1002%2Fanie.201206231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1Î±</span></div><div class="casAuthors">Buckley, Dennis L.; Gustafson, Jeffrey L.; Van Molle, Inge; Roth, Anke G.; Tae, Hyun Seop; Gareiss, Peter C.; Jorgensen, William L.; Ciulli, Alessio; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">11463-11467</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This study reports the structure-based design and synthesis of novel VHL ligands, illustrating structure-activity relationships and improving potency.  Two fragments of the ligands were individually optimized, arriving at a new class of N-terminal benzamide fragments.  The interactions made by this new class were then elucidated through X-ray crystallog. of the protein-ligand complex.  Structural studies of this ligand class revealed both a new binding mode as well as a novel water-mediated' hydrogen bond.  Finally, using these optimized fragments, we assembled new VHL ligands in a combinatorial fashion, arriving at (I), the first small-mol. submicromolar inhibitor of the interaction between VHL and a peptide derived from HIF1Î±.  While no cell-based activity has yet been obsd.,we hope to take advantage of the interactions highlighted by the crystal structure of I to design more drug-like inhibitors of VHL with improved cell permeability.  These ligands and the novel interactions and binding modes highlighted have the potential to guide the development of future chem. probes that can target the E3 ligase VHL or stabilize HIF1Î± proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0HINAsXwwLVg90H21EOLACvtfcHk0ljreeSblSxuPg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rs7nL&md5=eefeb63a3491737738e94c00be083cfd</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fanie.201206231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201206231%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DGareiss%26aufirst%3DP.%2BC.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520the%2520Interaction%2520Between%2520the%2520E3%2520Ligase%2520VHL%2520and%2520HIF1%25CE%25B1%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26issue%3D46%26spage%3D11463%26epage%3D11467%26doi%3D10.1002%2Fanie.201206231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">In Vivo Activation of the P53 Pathway by Small-Molecule Antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x"> (</span><span class="NLM_issue">5659</span><span class="NLM_x">) </span> <span class="NLM_fpage">844</span><span class="NLM_x">â</span> <span class="NLM_lpage">848</span><span class="refDoi">Â DOI: 10.1126/science.1092472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.1092472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=14704432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&issue=5659&author=L.+T.+Vassilev&title=In+Vivo+Activation+of+the+P53+Pathway+by+Small-Molecule+Antagonists+of+MDM2&doi=10.1126%2Fscience.1092472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2</span></div><div class="casAuthors">Vassilev, Lyubomir T.; Vu, Binh T.; Graves, Bradford; Carvajal, Daisy; Podlaski, Frank; Filipovic, Zoran; Kong, Norman; Kammlott, Ursula; Lukacs, Christine; Klein, Christian; Fotouhi, Nader; Liu, Emily A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5659</span>),
    <span class="NLM_cas:pages">844-848</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">MDM2 binds the p53 tumor suppressor protein with high affinity and neg. modulates its transcriptional activity and stability.  Overexpression of MDM2, found in many human tumors, effectively impairs p53 function.  Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy.  Here, we identify potent and selective small-mol. antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes.  These compds. bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzumitGD6V4bVg90H21EOLACvtfcHk0lgV_ssBNZGDlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D&md5=cf80c399e8eca8766be1023cda438df3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1126%2Fscience.1092472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1092472%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DIn%2520Vivo%2520Activation%2520of%2520the%2520P53%2520Pathway%2520by%2520Small-Molecule%2520Antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26issue%3D5659%26spage%3D844%26epage%3D848%26doi%3D10.1126%2Fscience.1092472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">Small-Molecule Antagonists of P53-MDM2 Binding: Research Tools and Potential Therapeutics</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">417</span><span class="NLM_x">â</span> <span class="NLM_lpage">419</span><span class="refDoi">Â DOI: 10.4161/cc.3.4.801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.4161%2Fcc.3.4.801" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=417-419&issue=4&author=L.+T.+Vassilev&title=Small-Molecule+Antagonists+of+P53-MDM2+Binding%3A+Research+Tools+and+Potential+Therapeutics&doi=10.4161%2Fcc.3.4.801"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.4161%2Fcc.3.4.801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.3.4.801%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DSmall-Molecule%2520Antagonists%2520of%2520P53-MDM2%2520Binding%253A%2520Research%2520Tools%2520and%2520Potential%2520Therapeutics%26jtitle%3DCell%2520Cycle%26date%3D2004%26volume%3D3%26issue%3D4%26spage%3D417%26epage%3D419%26doi%3D10.4161%2Fcc.3.4.801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of the MDM2-P53 Protein-Protein Interaction to Reactivate P53 Function: a Novel Approach for Cancer Therapy</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">241</span><span class="refDoi">Â DOI: 10.1146/annurev.pharmtox.48.113006.094723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1146%2Fannurev.pharmtox.48.113006.094723" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=223-241&issue=1&author=S.+Shangaryauthor=S.+Wang&title=Small-Molecule+Inhibitors+of+the+MDM2-P53+Protein-Protein+Interaction+to+Reactivate+P53+Function%3A+a+Novel+Approach+for+Cancer+Therapy&doi=10.1146%2Fannurev.pharmtox.48.113006.094723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.48.113006.094723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.48.113006.094723%26sid%3Dliteratum%253Aachs%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520the%2520MDM2-P53%2520Protein-Protein%2520Interaction%2520to%2520Reactivate%2520P53%2520Function%253A%2520a%2520Novel%2520Approach%2520for%2520Cancer%2520Therapy%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2009%26volume%3D49%26issue%3D1%26spage%3D223%26epage%3D241%26doi%3D10.1146%2Fannurev.pharmtox.48.113006.094723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckett, C. S.</span><span> </span><span class="NLM_article-title">IAP Proteins: Blocking the Road to Deathâs Door</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">401</span><span class="NLM_x">â</span> <span class="NLM_lpage">410</span><span class="refDoi">Â DOI: 10.1038/nrm830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=12042762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=401-410&issue=6&author=G.+S.+Salvesenauthor=C.+S.+Duckett&title=IAP+Proteins%3A+Blocking+the+Road+to+Death%E2%80%99s+Door&doi=10.1038%2Fnrm830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: IAP proteins: blocking the road to death's door</span></div><div class="casAuthors">Salvesen, Guy S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-410</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'inhibitor of apoptosis' (IAP) gene family, which was discovered less than a decade ago, encodes a group of structurally related proteins that, in addn. to their ability to suppress apoptotic cell death, are involved in an increasing no. of seemingly unrelated cellular functions.  Here, we review the functional and structural properties of this fascinating group of proteins, and of several recently identified IAP-binding factors that regulate IAP function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMWLW8mAr_LVg90H21EOLACvtfcHk0lgV_ssBNZGDlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D&md5=0f967aad318a34d988ad40486950ed62</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnrm830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm830%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520Proteins%253A%2520Blocking%2520the%2520Road%2520to%2520Death%25E2%2580%2599s%2520Door%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26issue%3D6%26spage%3D401%26epage%3D410%26doi%3D10.1038%2Fnrm830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Holcik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korneluk, R. G.</span><span> </span><span class="NLM_article-title">XIAP: Apoptotic Brake and Promising Therapeutic Target</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">253</span><span class="NLM_x">â</span> <span class="NLM_lpage">261</span><span class="refDoi">Â DOI: 10.1023/A:1011379307472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1023%2FA%3A1011379307472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=11445667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsF2qu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=253-261&issue=4&author=M.+Holcikauthor=H.+Gibsonauthor=R.+G.+Korneluk&title=XIAP%3A+Apoptotic+Brake+and+Promising+Therapeutic+Target&doi=10.1023%2FA%3A1011379307472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">XIAP: apoptotic brake and promising therapeutic target</span></div><div class="casAuthors">Holcik, Martin; Gibson, Hilary; Korneluk, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-261</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  The X-linked Inhibitor of Apoptosis, XIAP, is a key member of the newly discovered family of intrinsic inhibitors of apoptosis (IAP) proteins.  IAPs block cell death both in vitro and in vivo by virtue of inhibition of distinct caspases.  Although other proteins were identified which inhibit upstream caspases, only the IAPs were demonstrated to be endogenous repressors of the terminal caspase cascade.  In turn, the caspase inhibiting activity of XIAP is neg. regulated by at least 2 XIAP-interacting proteins, XAF1 and Smac/DIABLO.  In addn. to the inhibition of caspases, recent discoveries from several labs. suggest that XIAP is also involved in a no. of other biol. significant cellular activities including modulation of receptor-mediated signal transduction and protein ubiquitination.  XIAP is also translated by a rare cap-independent mechanism mediated by a specific sequence called IRES (for Internal Ribosome Entry Site) which is found in the XIAP 5' UTR.  XIAP protein is thus synthesized under various conditions of cellular stress such as serum starvation and low dose Î³-irradn. induced apoptosis, conditions that lead to the inhibition of cellular protein synthesis.  The multiple biol. activities of XIAP, its unique translational and post-translational control and the centrality of the caspase cascade make the control of XIAP expression an exceptionally promising mol. target for modulating apoptosis.  Therapeutic benefits can be derived from both the suppression of inappropriate cell death such as in neurodegenerative disorders and ischemic injury or in the activation of latent cell death pathways such as in autoimmune disease and cancer where apoptosis induction is the desired outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqewyDCMlelK7Vg90H21EOLACvtfcHk0lgV_ssBNZGDlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsF2qu7g%253D&md5=fa50ae4bab9721c40942d0268085e5a4</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1023%2FA%3A1011379307472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1011379307472%26sid%3Dliteratum%253Aachs%26aulast%3DHolcik%26aufirst%3DM.%26aulast%3DGibson%26aufirst%3DH.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26atitle%3DXIAP%253A%2520Apoptotic%2520Brake%2520and%2520Promising%2520Therapeutic%2520Target%26jtitle%3DApoptosis%26date%3D2001%26volume%3D6%26issue%3D4%26spage%3D253%26epage%3D261%26doi%3D10.1023%2FA%3A1011379307472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A Potent and Orally Active Antagonist (SM-406/at-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2714</span><span class="NLM_x">â</span> <span class="NLM_lpage">2726</span><span class="refDoi">Â DOI: 10.1021/jm101505d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&issue=8&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.-Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+Potent+and+Orally+Active+Antagonist+%28SM-406%2Fat-406%29+of+Multiple+Inhibitor+of+Apoptosis+Proteins+%28IAPs%29+in+Clinical+Development+for+Cancer+Treatment&doi=10.1021%2Fjm101505d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0ljYPlyLzBGBRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520Potent%2520and%2520Orally%2520Active%2520Antagonist%2520%2528SM-406%252Fat-406%2529%2520of%2520Multiple%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520%2528IAPs%2529%2520in%2520Clinical%2520Development%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D2714%26epage%3D2726%26doi%3D10.1021%2Fjm101505d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheeti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisner, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Um, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4101</span><span class="NLM_x">â</span> <span class="NLM_lpage">4113</span><span class="refDoi">Â DOI: 10.1021/jm300060k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300060k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4101-4113&issue=9&author=J.+A.+Flygareauthor=M.+Beresiniauthor=N.+Budhaauthor=H.+Chanauthor=I.+T.+Chanauthor=S.+Cheetiauthor=F.+Cohenauthor=K.+Deshayesauthor=K.+Doernerauthor=S.+G.+Eckhardtauthor=L.+O.+Elliottauthor=B.+Fengauthor=M.+C.+Franklinauthor=S.+F.+Reisnerauthor=L.+Gazzardauthor=J.+Halladayauthor=S.+G.+Hymowitzauthor=H.+Laauthor=P.+LoRussoauthor=B.+Maurerauthor=L.+Murrayauthor=E.+Pliseauthor=C.+Quanauthor=J.-P.+Stephanauthor=S.+G.+Youngauthor=J.+Tomauthor=V.+Tsuiauthor=J.+Umauthor=E.+Varfolomeevauthor=D.+Vucicauthor=A.+J.+Wagnerauthor=H.+J.+A.+Wallweberauthor=L.+Wangauthor=J.+Wareauthor=Z.+Wenauthor=H.+Wongauthor=J.+M.+Wongauthor=M.+Wongauthor=S.+Wongauthor=R.+Yuauthor=K.+Zobelauthor=W.+J.+Fairbrother&title=Discovery+of+a+Potent+Small-Molecule+Antagonist+of+Inhibitor+of+Apoptosis+%28IAP%29+Proteins+and+Clinical+Candidate+for+the+Treatment+of+Cancer+%28GDC-0152%29&doi=10.1021%2Fjm300060k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span></div><div class="casAuthors">Flygare, John A.; Beresini, Maureen; Budha, Nageshwar; Chan, Helen; Chan, Iris T.; Cheeti, Sravanthi; Cohen, Frederick; Deshayes, Kurt; Doerner, Karl; Eckhardt, S. Gail; Elliott, Linda O.; Feng, Bainian; Franklin, Matthew C.; Reisner, Stacy Frankovitz; Gazzard, Lewis; Halladay, Jason; Hymowitz, Sarah G.; La, Hank; LoRusso, Patricia; Maurer, Brigitte; Murray, Lesley; Plise, Emile; Quan, Clifford; Stephan, Jean-Philippe; Young, Shin G.; Tom, Jeffrey; Tsui, Vickie; Um, Joanne; Varfolomeev, Eugene; Vucic, Domagoj; Wagner, Andrew J.; Wallweber, Heidi J. A.; Wang, Lan; Ware, Joseph; Wen, Zhaoyang; Wong, Harvey; Wong, Jonathan M.; Wong, Melisa; Wong, Susan; Yu, Ron; Zobel, Kerry; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4101-4113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac.  Compd. (I) (GDC-0152) has the best profile of these compds.; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with Ki values of 28, 14, 17, and 43 nM, resp.  These compds. promote degrdn. of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Compd. I inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model.  Compd. I was advanced to human clin. trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested.  Mean plasma clearance in humans was 9 Â± 3 mL/min/kg, and the vol. of distribution was 0.6 Â± 0.2 L/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZSPNVJ5gVWrVg90H21EOLACvtfcHk0liHww3jlqWHtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D&md5=19452878ea834d3c324d567b39a78fb2</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm300060k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300060k%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBudha%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DI.%2BT.%26aulast%3DCheeti%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDoerner%26aufirst%3DK.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DReisner%26aufirst%3DS.%2BF.%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DJ.-P.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DTom%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DJ.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Small-Molecule%2520Antagonist%2520of%2520Inhibitor%2520of%2520Apoptosis%2520%2528IAP%2529%2520Proteins%2520and%2520Clinical%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Cancer%2520%2528GDC-0152%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D9%26spage%3D4101%26epage%3D4113%26doi%3D10.1021%2Fjm300060k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.-C.</span><span> </span><span class="NLM_article-title">AT-406, an IAP Inhibitor, Activates Apoptosis and Induces Radiosensitization of Normoxic and Hypoxic Cervical Cancer Cells</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">56</span><span class="NLM_x">â</span> <span class="NLM_lpage">65</span><span class="refDoi">Â DOI: 10.1254/jphs.14079FP</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1254%2Fjphs.14079FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25168470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OgsLzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2014&pages=56-65&issue=1&author=J.+Luauthor=Q.+Qinauthor=L.-L.+Zhanauthor=J.+Liuauthor=H.-C.+Zhuauthor=X.+Yangauthor=C.+Zhangauthor=L.-P.+Xuauthor=Z.-M.+Liuauthor=D.+Wangauthor=H.-Q.+Cuiauthor=C.-C.+Mengauthor=J.+Caiauthor=H.-Y.+Chengauthor=X.-C.+Sun&title=AT-406%2C+an+IAP+Inhibitor%2C+Activates+Apoptosis+and+Induces+Radiosensitization+of+Normoxic+and+Hypoxic+Cervical+Cancer+Cells&doi=10.1254%2Fjphs.14079FP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">AT-406, an IAP inhibitor, activates apoptosis and induces radiosensitization of normoxic and hypoxic cervical cancer cells</span></div><div class="casAuthors">Lu, Jing; Qin, Qin; Zhan, Liang-Liang; Liu, Jia; Zhu, Hong-Cheng; Yang, Xi; Zhang, Chi; Xu, Li-Ping; Liu, Zhe-Ming; Wang, Di; Cui, He-Qing; Meng, Ciu-Ciu; Cai, Jing; Cheng, Hong-Yan; Sun, Xin-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-65</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">IAP antagonists increased the antitumor efficacy of X-irradn. in some types of cancers, but their effects on hypoxic cancer cells remain unclarified.  We aims to investigate the radiosensitizing effect of an IAP inhibitor AT-406 on cervical cancer cell lines under both normoxia and hypoxia conditions.  Hela and Siha cells were treated to investigate the effects of drug administration on cell proliferation, apoptosis, and radiosensitivity.  Western blot anal. was used to det. the role of AT-406 in inhibition of IAPs.  The pathway of apoptosis was characterized by caspases activity assay.  AT-406 potently sensitized Hela cells but not Siha cells to radiation under normoxia.  Notably, the radiosensitizing effect of AT-406 on hypoxic cells was more evident than on normoxic cells in both cell lines.  Further mechanism studies by western blot showed that under normoxia AT-406 decreased the level of cIAP1 in Hela cells in a dose-dependent manner; while addnl. downregulation of XIAP expression was induced by AT-406 treatment under hypoxia in both cell lines.  Finally, AT-406 works on both extrinsic death receptor and intrinsic mitochondrial apoptosis pathways to activate apoptosis.  Totally, AT-406 acts as a strong radiosensitizer in human cervical cancer cells, esp. in hypoxic condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsFijv1awbnLVg90H21EOLACvtfcHk0lixSS8BWmBfSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OgsLzO&md5=39d6a5c2fa6e37133ea0b04b86199e76</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1254%2Fjphs.14079FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.14079FP%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DQ.%26aulast%3DZhan%26aufirst%3DL.-L.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.-C.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DL.-P.%26aulast%3DLiu%26aufirst%3DZ.-M.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DH.-Q.%26aulast%3DMeng%26aufirst%3DC.-C.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSun%26aufirst%3DX.-C.%26atitle%3DAT-406%252C%2520an%2520IAP%2520Inhibitor%252C%2520Activates%2520Apoptosis%2520and%2520Induces%2520Radiosensitization%2520of%2520Normoxic%2520and%2520Hypoxic%2520Cervical%2520Cancer%2520Cells%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D126%26issue%3D1%26spage%3D56%26epage%3D65%26doi%3D10.1254%2Fjphs.14079FP" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Brunckhorst, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span> </span><span class="NLM_article-title">AT-406, an Orally Active Antagonist of Multiple Inhibitor of Apoptosis Proteins, Inhibits Progression of Human Ovarian Cancer</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">804</span><span class="NLM_x">â</span> <span class="NLM_lpage">811</span><span class="refDoi">Â DOI: 10.4161/cbt.20563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.4161%2Fcbt.20563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22669575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Chtr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=804-811&issue=9&author=M.+K.+Brunckhorstauthor=D.+Lernerauthor=S.+Wangauthor=Q.+Yu&title=AT-406%2C+an+Orally+Active+Antagonist+of+Multiple+Inhibitor+of+Apoptosis+Proteins%2C+Inhibits+Progression+of+Human+Ovarian+Cancer&doi=10.4161%2Fcbt.20563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer</span></div><div class="casAuthors">Brunckhorst, Melissa K.; Lerner, Dimitry; Wang, Shaomeng; Yu, Qin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">804-811</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Ovarian carcinoma is the most deadly gynecol. malignancy.  Current chemotherapeutic drugs are only transiently effective and patients with advance disease often develop resistance despite significant initial responses.  Mounting evidence suggests that anti-apoptotic proteins, including those of the inhibitor of apoptosis protein (IAP) family, play important roles in the chemoresistance.  There has been a recent emergence of compds. that block the IAP functions.  Here, we evaluated AT-406, a novel and orally active antagonist of multiple IAP proteins, in ovarian cancer cells as a single agent and in the combination with carboplatin for therapeutic efficacy and mechanism of action.  We demonstrate that AT-406 has significant single agent activity in 60% of human ovarian cancer cell lines examd. in vitro and inhibits ovarian cancer progression in vivo and that three out of five carboplatinresistant cell lines are sensitive to AT-406, highlighting the therapeutic potential of AT-406 for patients with inherent or acquired platinum resistance.  Addnl., our in vivo studies show that AT-406 enhances the carboplatin-induced ovarian cancer cell death and increases survival of the exptl. mice, suggesting that AT-406 sensitizes the response of these cells to carboplatin.  Mechanistically, we demonstrate that AT-406 induced apoptosis is correlated with its ability to downregulate XIAP whereas AT-406 induces cIAP1 degrdn. in both AT-406 sensitive and resistance cell lines.  Together, these results demonstrate, for the first time, the anti-ovarian cancer efficacy of AT-406 as a single agent and in the combination with carboplatin, suggesting that AT-406 has potential as a novel therapy for ovarian cancer patients, esp. for patients exhibiting resistance to the platinum-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQv634B1Chy7Vg90H21EOLACvtfcHk0lixSS8BWmBfSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Chtr7F&md5=bbd34f31d48d33b7a3ddffa3744a7861</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.4161%2Fcbt.20563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.20563%26sid%3Dliteratum%253Aachs%26aulast%3DBrunckhorst%26aufirst%3DM.%2BK.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3DAT-406%252C%2520an%2520Orally%2520Active%2520Antagonist%2520of%2520Multiple%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%252C%2520Inhibits%2520Progression%2520of%2520Human%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2012%26volume%3D13%26issue%3D9%26spage%3D804%26epage%3D811%26doi%3D10.4161%2Fcbt.20563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Dickens, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of MDM2 as New Anticancer Therapeutics</span> <span class="citation_source-journal">Semin. Cancer Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">10</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span><span class="refDoi">Â DOI: 10.1016/j.semcancer.2009.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.semcancer.2009.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19897042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFSisLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=10-18&issue=1&author=M.+P.+Dickensauthor=R.+Fitzgeraldauthor=P.+M.+Fischer&title=Small-Molecule+Inhibitors+of+MDM2+as+New+Anticancer+Therapeutics&doi=10.1016%2Fj.semcancer.2009.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of MDM2 as new anticancer therapeutics</span></div><div class="casAuthors">Dickens, Michael P.; Fitzgerald, Ross; Fischer, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-18</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  It has long been known that traditional anticancer radio- and chemotherapies in part work through direct or indirect activation of the p53 tumor suppressor pathway.  However, many of these strategies are nonselective and genotoxic.  The emerging understanding of the pathways that regulate p53 has led to the notion that it should be possible to activate the p53 pathway in ways that are inherently nongenotoxic.  Important targets for pharmacol. interference in this respect are MDM2 and MDMX, key neg. regulators of p53.  Genetic and pharmacol. studies suggest that blocking the phys. interaction of these proteins with p53, or inhibiting the catalytic role of MDM2 in tagging p53 for proteasomal degrdn., both of which lead to an increase in the transcriptional activity of p53, may indeed be an efficient and safe way to eradicate tumor cells that retain wild-type p53.  Here we review the rationale for such strategies, as well as the current state in the discovery and development of drugs that reactivate p53 by inhibiting its inhibitors MDM2 and MDMX.  The first compds. that have been shown in model systems to be able selectively to kill cancer cells in this way are now entering clin. trials and the promise of MDM2 inhibitors as a new therapeutic anticancer modality should therefore become clear in the not-too-distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtUHhypCp7zbVg90H21EOLACvtfcHk0lixSS8BWmBfSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFSisLY%253D&md5=7366b3fc42ff3b5d5b063187ad600f89</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2009.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2009.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DDickens%26aufirst%3DM.%2BP.%26aulast%3DFitzgerald%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520MDM2%2520as%2520New%2520Anticancer%2520Therapeutics%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D10%26epage%3D18%26doi%3D10.1016%2Fj.semcancer.2009.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-Molecule Control of Intracellular Protein Levels Through Modulation of the Ubiquitin Proteasome System</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2312</span><span class="NLM_x">â</span> <span class="NLM_lpage">2330</span><span class="refDoi">Â DOI: 10.1002/anie.201307761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2Fanie.201307761" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=2312-2330&issue=9&author=D.+L.+Buckleyauthor=C.+M.+Crews&title=Small-Molecule+Control+of+Intracellular+Protein+Levels+Through+Modulation+of+the+Ubiquitin+Proteasome+System&doi=10.1002%2Fanie.201307761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307761%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-Molecule%2520Control%2520of%2520Intracellular%2520Protein%2520Levels%2520Through%2520Modulation%2520of%2520the%2520Ubiquitin%2520Proteasome%2520System%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D9%26spage%3D2312%26epage%3D2330%26doi%3D10.1002%2Fanie.201307761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Small-Molecule SMAC Mimetics as New Cancer Therapeutics</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">82</span><span class="NLM_x">â</span> <span class="NLM_lpage">95</span><span class="refDoi">Â DOI: 10.1016/j.pharmthera.2014.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.pharmthera.2014.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24841289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2ju7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2014&pages=82-95&issue=1&author=L.+Baiauthor=D.+C.+Smithauthor=S.+Wang&title=Small-Molecule+SMAC+Mimetics+as+New+Cancer+Therapeutics&doi=10.1016%2Fj.pharmthera.2014.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule SMAC mimetics as new cancer therapeutics</span></div><div class="casAuthors">Bai, Longchuan; Smith, David C.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-95</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Apoptosis is a tightly regulated cellular process and faulty regulation of apoptosis is a hallmark of human cancers.  Targeting key apoptosis regulators with the goal to restore apoptosis in tumor cells has been pursued as a new cancer therapeutic strategy.  XIAP, cIAP1, and cIAP2, members of inhibitor of apoptosis (IAP) proteins, are crit. regulators of cell death and survival and are attractive targets for new cancer therapy.  The SMAC/DIABLO protein is an endogenous antagonist of XIAP, cIAP1, and cIAP2.  In the last decade, intense research efforts have resulted in the design and development of several small-mol. SMAC mimetics now in clin. trials for cancer treatment.  In this review, we will discuss the roles of XIAP, cIAP1, and cIAP2 in regulation of cell death and survival, and the design and development of small-mol. SMAC mimetics as novel cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJ1zuCJO_xrVg90H21EOLACvtfcHk0lgRHZ7xFIb3TA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2ju7k%253D&md5=92404daa1b37f65bee87fa699858a5bf</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-Molecule%2520SMAC%2520Mimetics%2520as%2520New%2520Cancer%2520Therapeutics%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D144%26issue%3D1%26spage%3D82%26epage%3D95%26doi%3D10.1016%2Fj.pharmthera.2014.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Fulda, S.</span><span> </span><span class="NLM_article-title">Promises and Challenges of Smac Mimetics as Cancer Therapeutics</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">5030</span><span class="NLM_x">â</span> <span class="NLM_lpage">5036</span><span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-15-0365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F1078-0432.CCR-15-0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=26567362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=5030-5036&issue=22&author=S.+Fulda&title=Promises+and+Challenges+of+Smac+Mimetics+as+Cancer+Therapeutics&doi=10.1158%2F1078-0432.CCR-15-0365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Promises and Challenges of Smac Mimetics as Cancer Therapeutics</span></div><div class="casAuthors">Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5030-5036</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Inhibitor of Apoptosis (IAP) proteins block programmed cell death and are expressed at high levels in various human cancers, thus making them attractive targets for cancer drug development.  Second mitochondrial activator of caspases (Smac) mimetics are small-mol. inhibitors that mimic Smac, an endogenous antagonist of IAP proteins.  Preclin. studies have shown that Smac mimetics can directly trigger cancer cell death or, even more importantly, sensitize tumor cells for various cytotoxic therapies, including conventional chemotherapy, radiotherapy, or novel agents.  Currently, several Smac mimetics are under evaluation in early clin. trials as monotherapy or in rational combinations (i.e., GDC-0917/CUDC-427, LCL161, AT-406/Debio1143, HGS1029, and TL32711/birinapant).  This review discusses the promise as well as some challenges at the translational interface of exploiting Smac mimetics as cancer therapeutics.  Clin Cancer Res; 21(22); 5030-6. Â©2015 AACR.  See all articles in this CCR Focus section, "Cell Death and Cancer Therapy.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWYAR8vIR6lbVg90H21EOLACvtfcHk0lgRHZ7xFIb3TA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbjL&md5=646d75e8baac70c57aaaed3451cd96a9</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-0365%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DPromises%2520and%2520Challenges%2520of%2520Smac%2520Mimetics%2520as%2520Cancer%2520Therapeutics%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26issue%3D22%26spage%3D5030%26epage%3D5036%26doi%3D10.1158%2F1078-0432.CCR-15-0365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Willems, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span> </span><span class="NLM_article-title">A Hitchhikerâs Guide to the Cullin Ubiquitin Ligases: SCF and Its Kin</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1695</span><span class="NLM_x"> (</span><span class="NLM_issue">1â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">170</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2004.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbamcr.2004.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15571813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1695&publication_year=2004&pages=133-170&issue=1%E2%80%933&author=A.+R.+Willemsauthor=M.+Schwabauthor=M.+Tyers&title=A+Hitchhiker%E2%80%99s+Guide+to+the+Cullin+Ubiquitin+Ligases%3A+SCF+and+Its+Kin&doi=10.1016%2Fj.bbamcr.2004.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin</span></div><div class="casAuthors">Willems, Andrew R.; Schwab, Michael; Tyers, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1695</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">133-170</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase family was discovered through genetic requirements for cell cycle progression in budding yeast.  In these multisubunit enzymes, an invariant core complex, composed of the Skp1 linker protein, the Cdc53/Cul1 scaffold protein, and the Rbx1/Roc1/Hrt1 RING domain protein, engages one of a suite of substrate adaptors called F-box proteins that in turn recruit substrates for ubiquitination by an assocd. E2 enzyme.  The cullin-RING domain-adaptor architecture has diversified through evolution, such that in total many hundreds of distinct SCF and SCF-like complexes enable degrdn. of myriad substrates.  Substrate recognition by adaptors often depends on post-translational modification of the substrate, which thus places substrate stability under dynamic regulation by intracellular signaling events.  SCF complexes control cell proliferation through degrdn. of crit. regulators such as cyclins, CDK inhibitors, and transcription factors.  A plethora of other processes in development and disease are controlled by other SCF-like complexes, including those based on Cul2-SOCS-box adaptor protein and Cul3-BTB domain adaptor protein combinations.  Recent structural insights into SCF-like complexes have begun to illuminate aspects of substrate recognition and catalytic reaction mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWQKFJ6Lc__LVg90H21EOLACvtfcHk0lgRHZ7xFIb3TA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzL&md5=1831bf96a473e0974584d685eaeb0856</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2004.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2004.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DWillems%26aufirst%3DA.%2BR.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DTyers%26aufirst%3DM.%26atitle%3DA%2520Hitchhiker%25E2%2580%2599s%2520Guide%2520to%2520the%2520Cullin%2520Ubiquitin%2520Ligases%253A%2520SCF%2520and%2520Its%2520Kin%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2004%26volume%3D1695%26issue%3D1%25E2%2580%25933%26spage%3D133%26epage%3D170%26doi%3D10.1016%2Fj.bbamcr.2004.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Petroski, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span> </span><span class="NLM_article-title">Function and Regulation of Cullin-RING Ubiquitin Ligases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">20</span><span class="refDoi">Â DOI: 10.1038/nrm1547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm1547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15688063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVWg" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=9-20&issue=1&author=M.+D.+Petroskiauthor=R.+J.+Deshaies&title=Function+and+Regulation+of+Cullin-RING+Ubiquitin+Ligases&doi=10.1038%2Fnrm1547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Function and regulation of cullin-RING ubiquitin ligases</span></div><div class="casAuthors">Petroski, Matthew D.; Deshaies, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-20</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cullin-RING complexes comprise the largest known class of ubiquitin ligases.  Owing to the great diversity of their substrate-receptor subunits, it is possible that there are hundreds of distinct cullin-RING ubiquitin ligases in eukaryotic cells, which establishes these enzymes as key mediators of post-translational protein regulation.  Here, the authors focus on the compn., regulation, and function of cullin-RING ligases, and describe how these enzymes can be characterized by a set of general principles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFw5LuMMHZoLVg90H21EOLACvtfcHk0lgRHZ7xFIb3TA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVWg&md5=297f142f44f971c6858306b1adb36254</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fnrm1547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1547%26sid%3Dliteratum%253Aachs%26aulast%3DPetroski%26aufirst%3DM.%2BD.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DFunction%2520and%2520Regulation%2520of%2520Cullin-RING%2520Ubiquitin%2520Ligases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D6%26issue%3D1%26spage%3D9%26epage%3D20%26doi%3D10.1038%2Fnrm1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Verma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huddleston, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span> </span><span class="NLM_article-title">Phosphorylation of Sic1p by G1 Cdk Required for Its Degradation and Entry Into S Phase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x"> (</span><span class="NLM_issue">5337</span><span class="NLM_x">) </span> <span class="NLM_fpage">455</span><span class="NLM_x">â</span> <span class="NLM_lpage">460</span><span class="refDoi">Â DOI: 10.1126/science.278.5337.455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.278.5337.455" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=455-460&issue=5337&author=R.+Vermaauthor=R.+S.+Annanauthor=M.+J.+Huddlestonauthor=S.+A.+Carrauthor=G.+Reynardauthor=R.+J.+Deshaies&title=Phosphorylation+of+Sic1p+by+G1+Cdk+Required+for+Its+Degradation+and+Entry+Into+S+Phase&doi=10.1126%2Fscience.278.5337.455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1126%2Fscience.278.5337.455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.278.5337.455%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DR.%26aulast%3DAnnan%26aufirst%3DR.%2BS.%26aulast%3DHuddleston%26aufirst%3DM.%2BJ.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DReynard%26aufirst%3DG.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DPhosphorylation%2520of%2520Sic1p%2520by%2520G1%2520Cdk%2520Required%2520for%2520Its%2520Degradation%2520and%2520Entry%2520Into%2520S%2520Phase%26jtitle%3DScience%26date%3D1997%26volume%3D278%26issue%3D5337%26spage%3D455%26epage%3D460%26doi%3D10.1126%2Fscience.278.5337.455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Welcker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clurman, B. E.</span><span> </span><span class="NLM_article-title">FBW7 Ubiquitin Ligase: a Tumour Suppressor at the Crossroads of Cell Division, Growth and Differentiation</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">93</span><span class="refDoi">Â DOI: 10.1038/nrc2290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrc2290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=18094723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGhs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=83-93&issue=2&author=M.+Welckerauthor=B.+E.+Clurman&title=FBW7+Ubiquitin+Ligase%3A+a+Tumour+Suppressor+at+the+Crossroads+of+Cell+Division%2C+Growth+and+Differentiation&doi=10.1038%2Fnrc2290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation</span></div><div class="casAuthors">Welcker, Markus; Clurman, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-93</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  FBW7 (F-box and WD repeat domain-contg. 7) is the substrate recognition component of an evolutionary conserved SCF (complex of SKP1, CUL1 and F-box protein)-type ubiquitin ligase.  SCFFBW7 degrades several proto-oncogenes that function in cellular growth and division pathways, including MYC, cyclin E, Notch and JUN.  FBW7 is also a tumor suppressor, the regulatory network of which is perturbed in many human malignancies.  Numerous cancer-assocd. mutations in FBW7 and its substrates have been identified, and loss of FBW7 function causes chromosomal instability and tumorigenesis.  This Review focuses on structural and functional aspects of FBW7 and its role in the development of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHyKIRjKOCsLVg90H21EOLACvtfcHk0lgMZrHMtrMDlg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVGhs7Y%253D&md5=b053f23d02a77d471723c9e919b9af1f</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fnrc2290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2290%26sid%3Dliteratum%253Aachs%26aulast%3DWelcker%26aufirst%3DM.%26aulast%3DClurman%26aufirst%3DB.%2BE.%26atitle%3DFBW7%2520Ubiquitin%2520Ligase%253A%2520a%2520Tumour%2520Suppressor%2520at%2520the%2520Crossroads%2520of%2520Cell%2520Division%252C%2520Growth%2520and%2520Differentiation%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26issue%3D2%26spage%3D83%26epage%3D93%26doi%3D10.1038%2Fnrc2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Rajagopalan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jallepalli, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span> </span><span class="NLM_article-title">Inactivation of hCDC4 Can Cause Chromosomal Instability</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x"> (</span><span class="NLM_issue">6978</span><span class="NLM_x">) </span> <span class="NLM_fpage">77</span><span class="NLM_x">â</span> <span class="NLM_lpage">81</span><span class="refDoi">Â DOI: 10.1038/nature02313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature02313" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=77-81&issue=6978&author=H.+Rajagopalanauthor=P.+V.+Jallepalliauthor=C.+Ragoauthor=V.+E.+Velculescuauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+Lengauer&title=Inactivation+of+hCDC4+Can+Cause+Chromosomal+Instability&doi=10.1038%2Fnature02313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fnature02313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02313%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopalan%26aufirst%3DH.%26aulast%3DJallepalli%26aufirst%3DP.%2BV.%26aulast%3DRago%26aufirst%3DC.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DC.%26atitle%3DInactivation%2520of%2520hCDC4%2520Can%2520Cause%2520Chromosomal%2520Instability%26jtitle%3DNature%26date%3D2004%26volume%3D428%26issue%3D6978%26spage%3D77%26epage%3D81%26doi%3D10.1038%2Fnature02313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Orlicky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neduva, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elowe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span> </span><span class="NLM_article-title">An Allosteric Inhibitor of Substrate Recognition by the SCFCdc4 Ubiquitin Ligase</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">733</span><span class="NLM_x">â</span> <span class="NLM_lpage">737</span><span class="refDoi">Â DOI: 10.1038/nbt.1646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnbt.1646" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=733-737&issue=7&author=S.+Orlickyauthor=X.+Tangauthor=V.+Neduvaauthor=N.+Eloweauthor=E.+D.+Brownauthor=F.+Sicheriauthor=M.+Tyers&title=An+Allosteric+Inhibitor+of+Substrate+Recognition+by+the+SCFCdc4+Ubiquitin+Ligase&doi=10.1038%2Fnbt.1646"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1646%26sid%3Dliteratum%253Aachs%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DNeduva%26aufirst%3DV.%26aulast%3DElowe%26aufirst%3DN.%26aulast%3DBrown%26aufirst%3DE.%2BD.%26aulast%3DSicheri%26aufirst%3DF.%26aulast%3DTyers%26aufirst%3DM.%26atitle%3DAn%2520Allosteric%2520Inhibitor%2520of%2520Substrate%2520Recognition%2520by%2520the%2520SCFCdc4%2520Ubiquitin%2520Ligase%26jtitle%3DNat.%2520Biotechnol.%26date%3D2010%26volume%3D28%26issue%3D7%26spage%3D733%26epage%3D737%26doi%3D10.1038%2Fnbt.1646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Aghajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lomenick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damoiseaux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Moral, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span> </span><span class="NLM_article-title">Chemical Genetics Screen for Enhancers of Rapamycin Identifies a Specific Inhibitor of an SCF Family E3 Ubiquitin Ligase</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">738</span><span class="NLM_x">â</span> <span class="NLM_lpage">742</span><span class="refDoi">Â DOI: 10.1038/nbt.1645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnbt.1645" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=738-742&issue=7&author=M.+Aghajanauthor=N.+Jonaiauthor=K.+Flickauthor=F.+Fuauthor=M.+Luoauthor=X.+Caiauthor=I.+Ouniauthor=N.+Pierceauthor=X.+Tangauthor=B.+Lomenickauthor=R.+Damoiseauxauthor=R.+Haoauthor=P.+M.+del+Moralauthor=R.+Vermaauthor=Y.+Liauthor=C.+Liauthor=K.+N.+Houkauthor=M.+E.+Jungauthor=N.+Zhengauthor=L.+Huangauthor=R.+J.+Deshaiesauthor=P.+Kaiserauthor=J.+Huang&title=Chemical+Genetics+Screen+for+Enhancers+of+Rapamycin+Identifies+a+Specific+Inhibitor+of+an+SCF+Family+E3+Ubiquitin+Ligase&doi=10.1038%2Fnbt.1645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1645%26sid%3Dliteratum%253Aachs%26aulast%3DAghajan%26aufirst%3DM.%26aulast%3DJonai%26aufirst%3DN.%26aulast%3DFlick%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DOuni%26aufirst%3DI.%26aulast%3DPierce%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DLomenick%26aufirst%3DB.%26aulast%3DDamoiseaux%26aufirst%3DR.%26aulast%3DHao%26aufirst%3DR.%26aulast%3Ddel%2BMoral%26aufirst%3DP.%2BM.%26aulast%3DVerma%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DKaiser%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DJ.%26atitle%3DChemical%2520Genetics%2520Screen%2520for%2520Enhancers%2520of%2520Rapamycin%2520Identifies%2520a%2520Specific%2520Inhibitor%2520of%2520an%2520SCF%2520Family%2520E3%2520Ubiquitin%2520Ligase%26jtitle%3DNat.%2520Biotechnol.%26date%3D2010%26volume%3D28%26issue%3D7%26spage%3D738%26epage%3D742%26doi%3D10.1038%2Fnbt.1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Kaiser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, K.</span><span> </span><span class="NLM_article-title">The Yeast Ubiquitin Ligase SCFMet30: Connecting Environmental and Intracellular Conditions to Cell Division</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi">Â DOI: 10.1186/1747-1028-1-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1186%2F1747-1028-1-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16895602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A280%3ADC%252BD28rns1Sruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=16&author=P.+Kaiserauthor=N.-Y.+Suauthor=J.+L.+Yenauthor=I.+Ouniauthor=K.+Flick&title=The+Yeast+Ubiquitin+Ligase+SCFMet30%3A+Connecting+Environmental+and+Intracellular+Conditions+to+Cell+Division&doi=10.1186%2F1747-1028-1-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">The yeast ubiquitin ligase SCFMet30: connecting environmental and intracellular conditions to cell division</span></div><div class="casAuthors">Kaiser Peter; Su Ning-Yuan; Yen James L; Ouni Ikram; Flick Karin</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ubiquitination regulates a host of cellular processes and is well known for its role in progression through the cell division cycle.  In budding yeast, cadmium and arsenic stress, the availability of sulfur containing amino acids, and the intracellular concentration of S-adenosylmethionine are linked to cell cycle regulation through the ubiquitin ligase SCFMet30.  Regulation is achieved by ubiquitination of the transcription factor Met4.  Met4 activity is controlled by a regulatory K48-linked ubiquitin chain that is synthesized by Cdc34/SCFMet30.  A ubiquitin-interacting-motif (UIM) present in Met4 prevents degradation of ubiquitinated Met4 allowing the ubiquitin chain to function as a reversible switch of Met4 activity.  Here we discuss mechanisms of Met4 and SCFMet30 regulation in response to intracellular and environmental conditions, and describe the integration of these signals with cell cycle control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpYW_Qqu2Npo3yKPtYViAGfW6udTcc2eY-zweMudEEArntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rns1Sruw%253D%253D&md5=deab9cd6ca4eeea4962dbe097a79e19d</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-1-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-1-16%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DN.-Y.%26aulast%3DYen%26aufirst%3DJ.%2BL.%26aulast%3DOuni%26aufirst%3DI.%26aulast%3DFlick%26aufirst%3DK.%26atitle%3DThe%2520Yeast%2520Ubiquitin%2520Ligase%2520SCFMet30%253A%2520Connecting%2520Environmental%2520and%2520Intracellular%2520Conditions%2520to%2520Cell%2520Division%26jtitle%3DCell%2520Div.%26date%3D2006%26volume%3D1%26spage%3D16%26doi%3D10.1186%2F1747-1028-1-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Patton, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyraud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouillon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerjan, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D.</span><span> </span><span class="NLM_article-title">SCFMet30-Mediated Control of the Transcriptional Activator Met4 Is Required for the G1âS Transition</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1613</span><span class="NLM_x">â</span> <span class="NLM_lpage">1624</span><span class="refDoi">Â DOI: 10.1093/emboj/19.7.1613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1093%2Femboj%2F19.7.1613" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1613-1624&issue=7&author=E.+E.+Pattonauthor=C.+Peyraudauthor=A.+Rouillonauthor=Y.+S.+Kerjanauthor=M.+Tyersauthor=D.+Thomas&title=SCFMet30-Mediated+Control+of+the+Transcriptional+Activator+Met4+Is+Required+for+the+G1%E2%80%93S+Transition&doi=10.1093%2Femboj%2F19.7.1613"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.7.1613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.7.1613%26sid%3Dliteratum%253Aachs%26aulast%3DPatton%26aufirst%3DE.%2BE.%26aulast%3DPeyraud%26aufirst%3DC.%26aulast%3DRouillon%26aufirst%3DA.%26aulast%3DKerjan%26aufirst%3DY.%2BS.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DD.%26atitle%3DSCFMet30-Mediated%2520Control%2520of%2520the%2520Transcriptional%2520Activator%2520Met4%2520Is%2520Required%2520for%2520the%2520G1%25E2%2580%2593S%2520Transition%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26issue%3D7%26spage%3D1613%26epage%3D1624%26doi%3D10.1093%2Femboj%2F19.7.1613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Palframan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meehl, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaspersen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A. W.</span><span> </span><span class="NLM_article-title">Anaphase Inactivation of the Spindle Checkpoint</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x"> (</span><span class="NLM_issue">5787</span><span class="NLM_x">) </span> <span class="NLM_fpage">680</span><span class="NLM_x">â</span> <span class="NLM_lpage">684</span><span class="refDoi">Â DOI: 10.1126/science.1127205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.1127205" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2006&pages=680-684&issue=5787&author=W.+J.+Palframanauthor=J.+B.+Meehlauthor=S.+L.+Jaspersenauthor=M.+Wineyauthor=A.+W.+Murray&title=Anaphase+Inactivation+of+the+Spindle+Checkpoint&doi=10.1126%2Fscience.1127205"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1126%2Fscience.1127205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1127205%26sid%3Dliteratum%253Aachs%26aulast%3DPalframan%26aufirst%3DW.%2BJ.%26aulast%3DMeehl%26aufirst%3DJ.%2BB.%26aulast%3DJaspersen%26aufirst%3DS.%2BL.%26aulast%3DWiney%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DA.%2BW.%26atitle%3DAnaphase%2520Inactivation%2520of%2520the%2520Spindle%2520Checkpoint%26jtitle%3DScience%26date%3D2006%26volume%3D313%26issue%3D5787%26spage%3D680%26epage%3D684%26doi%3D10.1126%2Fscience.1127205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Yu, H.</span><span> </span><span class="NLM_article-title">Cdc20: a WD40 Activator for a Cell Cycle Degradation Machine</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2007.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2007.06.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=3-16&issue=1&author=H.+Yu&title=Cdc20%3A+a+WD40+Activator+for+a+Cell+Cycle+Degradation+Machine&doi=10.1016%2Fj.molcel.2007.06.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26atitle%3DCdc20%253A%2520a%2520WD40%2520Activator%2520for%2520a%2520Cell%2520Cycle%2520Degradation%2520Machine%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26issue%3D1%26spage%3D3%26epage%3D16%26doi%3D10.1016%2Fj.molcel.2007.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossella, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span> </span><span class="NLM_article-title">Docetaxel for Treatment of Solid Tumours: a Systematic Review of Clinical Data</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">239</span><span class="refDoi">Â DOI: 10.1016/S1470-2045(05)70094-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS1470-2045%2805%2970094-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15811618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWjtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=229-239&issue=4&author=A.+Monteroauthor=F.+Fossellaauthor=G.+Hortobagyiauthor=V.+Valero&title=Docetaxel+for+Treatment+of+Solid+Tumours%3A+a+Systematic+Review+of+Clinical+Data&doi=10.1016%2FS1470-2045%2805%2970094-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Docetaxel for treatment of solid tumours: a systematic review of clinical data</span></div><div class="casAuthors">Montero, Alberto; Fossella, Frank; Hortobagyi, Gabriel; Valero, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-239</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Docetaxel is a semisynthetic taxane, a class of anticancer agents that bind to Î² tubulin, thereby stabilizing microtubules and inducing cell-cycle arrest and apoptosis.  Docetaxel was first approved for the treatment of anthracycline-refractory metastatic breast cancer in the mid-1990s.  Since then, several randomized trials have reported improved time-to-progression, overall survival, or both in metastatic breast cancer treated with single-agent docetaxel or docetaxel-based combination regimens.  Data from two adjuvant trials have shown a survival benefit with the addn. of docetaxel to std. anthracycline-based regimens in patients with high-risk early breast cancer.  In four randomized studies, docetaxel improved survival in locally advanced or metastatic non-small-cell lung cancer.  Moreover, two trials have shown that docetaxel combined with estramustine or corticosteroids improves survival in metastatic androgen-independent prostate cancer.  Here, we review major randomized phase III trials with docetaxel in the treatment of solid malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmwW4zmyYunbVg90H21EOLACvtfcHk0ljf0tom8rYdZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWjtLk%253D&md5=d591943c6c6608e2a5915fc616b37056</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2805%2970094-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252805%252970094-2%26sid%3Dliteratum%253Aachs%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DFossella%26aufirst%3DF.%26aulast%3DHortobagyi%26aufirst%3DG.%26aulast%3DValero%26aufirst%3DV.%26atitle%3DDocetaxel%2520for%2520Treatment%2520of%2520Solid%2520Tumours%253A%2520a%2520Systematic%2520Review%2520of%2520Clinical%2520Data%26jtitle%3DLancet%2520Oncol.%26date%3D2005%26volume%3D6%26issue%3D4%26spage%3D229%26epage%3D239%26doi%3D10.1016%2FS1470-2045%2805%2970094-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Bekier, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischbach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. R.</span><span> </span><span class="NLM_article-title">Length of Mitotic Arrest Induced by Microtubule-Stabilizing Drugs Determines Cell Death After Mitotic Exit</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1646</span><span class="NLM_x">â</span> <span class="NLM_lpage">1654</span><span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-08-1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F1535-7163.MCT-08-1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19509263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVKgtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1646-1654&issue=6&author=M.+E.+Bekierauthor=R.+Fischbachauthor=J.+Leeauthor=W.+R.+Taylor&title=Length+of+Mitotic+Arrest+Induced+by+Microtubule-Stabilizing+Drugs+Determines+Cell+Death+After+Mitotic+Exit&doi=10.1158%2F1535-7163.MCT-08-1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit</span></div><div class="casAuthors">Bekier, Michael E.; Fischbach, Robert; Lee, Jennifer; Taylor, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1646-1654</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cell death induced by agents that disrupt microtubules can kill cells by inducing a prolonged mitotic block.  This mitotic block is dependent on the spindle assembly checkpoint, a surveillance system that ensures the bipolar attachment of chromosomes to the mitotic spindle before the onset of anaphase.  Under some conditions, the spindle assembly checkpoint can become weakened, allowing cells to exit mitosis despite the presence of chromosomes that are not properly attached to the mitotic spindle.  Here, we use an Aurora kinase inhibitor to drive mitotic exit and test the effect of mitotic arrest length on death in the subsequent interphase.  Cells that are blocked in mitosis for >15 h die shortly after exiting from mitosis, whereas cells that exit after being blocked for <15 h show variable fates, with some living for days after exiting mitosis.  Cells blocked in mitosis by either Taxol or epothilone B are acutely sensitive to the death ligand tumor necrosis factor-related apoptosis-inducing ligand, suggesting that prolonged mitosis allows the gradual accumulation of internal death signals, rendering cells hypersensitive to addnl. prodeath cues.  Death under these conditions is initiated while cyclin B1 is still present, indicating that cells are in mitosis.  Our expts. suggest that there is a point of no return during prolonged mitotic block after which mitotic exit can no longer block death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpedusWfuBQ_rVg90H21EOLACvtfcHk0lgVA2OuC49yLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVKgtrY%253D&md5=acac784a389aa8766b79c12fc35f40ce</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1084%26sid%3Dliteratum%253Aachs%26aulast%3DBekier%26aufirst%3DM.%2BE.%26aulast%3DFischbach%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DW.%2BR.%26atitle%3DLength%2520of%2520Mitotic%2520Arrest%2520Induced%2520by%2520Microtubule-Stabilizing%2520Drugs%2520Determines%2520Cell%2520Death%2520After%2520Mitotic%2520Exit%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D6%26spage%3D1646%26epage%3D1654%26doi%3D10.1158%2F1535-7163.MCT-08-1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, T. J.</span><span> </span><span class="NLM_article-title">Evidence That Mitotic Exit Is a Better Cancer Therapeutic Target Than Spindle Assembly</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">358</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2009.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.ccr.2009.08.020" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=347-358&issue=4&author=H.-C.+Huangauthor=J.+Shiauthor=J.+D.+Orthauthor=T.+J.+Mitchison&title=Evidence+That+Mitotic+Exit+Is+a+Better+Cancer+Therapeutic+Target+Than+Spindle+Assembly&doi=10.1016%2Fj.ccr.2009.08.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2009.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2009.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DJ.%2BD.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DEvidence%2520That%2520Mitotic%2520Exit%2520Is%2520a%2520Better%2520Cancer%2520Therapeutic%2520Target%2520Than%2520Spindle%2520Assembly%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26issue%3D4%26spage%3D347%26epage%3D358%26doi%3D10.1016%2Fj.ccr.2009.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Wolthuis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay-Farrace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zon, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yekezare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koop, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pines, J.</span><span> </span><span class="NLM_article-title">Cdc20 and Cks Direct the Spindle Checkpoint-Independent Destruction of Cyclin a</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">290</span><span class="NLM_x">â</span> <span class="NLM_lpage">302</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2008.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2008.02.027" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=290-302&issue=3&author=R.+Wolthuisauthor=L.+Clay-Farraceauthor=W.+van+Zonauthor=M.+Yekezareauthor=L.+Koopauthor=J.+Oginkauthor=R.+Medemaauthor=J.+Pines&title=Cdc20+and+Cks+Direct+the+Spindle+Checkpoint-Independent+Destruction+of+Cyclin+a&doi=10.1016%2Fj.molcel.2008.02.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DWolthuis%26aufirst%3DR.%26aulast%3DClay-Farrace%26aufirst%3DL.%26aulast%3Dvan%2BZon%26aufirst%3DW.%26aulast%3DYekezare%26aufirst%3DM.%26aulast%3DKoop%26aufirst%3DL.%26aulast%3DOgink%26aufirst%3DJ.%26aulast%3DMedema%26aufirst%3DR.%26aulast%3DPines%26aufirst%3DJ.%26atitle%3DCdc20%2520and%2520Cks%2520Direct%2520the%2520Spindle%2520Checkpoint-Independent%2520Destruction%2520of%2520Cyclin%2520a%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D30%26issue%3D3%26spage%3D290%26epage%3D302%26doi%3D10.1016%2Fj.molcel.2008.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Verma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâOnofrio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochtrop, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffino, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fushman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span> </span><span class="NLM_article-title">Ubistatins Inhibit Proteasome-Dependent Degradation by Binding the Ubiquitin Chain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x"> (</span><span class="NLM_issue">5693</span><span class="NLM_x">) </span> <span class="NLM_fpage">117</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span><span class="refDoi">Â DOI: 10.1126/science.1100946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.1100946" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2004&pages=117-120&issue=5693&author=R.+Vermaauthor=N.+R.+Petersauthor=M.+D%E2%80%99Onofrioauthor=G.+P.+Tochtropauthor=K.+M.+Sakamotoauthor=R.+Varadanauthor=M.+Zhangauthor=P.+Coffinoauthor=D.+Fushmanauthor=R.+J.+Deshaiesauthor=R.+W.+King&title=Ubistatins+Inhibit+Proteasome-Dependent+Degradation+by+Binding+the+Ubiquitin+Chain&doi=10.1126%2Fscience.1100946"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1126%2Fscience.1100946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1100946%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DN.%2BR.%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DM.%26aulast%3DTochtrop%26aufirst%3DG.%2BP.%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26aulast%3DVaradan%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DCoffino%26aufirst%3DP.%26aulast%3DFushman%26aufirst%3DD.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26atitle%3DUbistatins%2520Inhibit%2520Proteasome-Dependent%2520Degradation%2520by%2520Binding%2520the%2520Ubiquitin%2520Chain%26jtitle%3DScience%26date%3D2004%26volume%3D306%26issue%3D5693%26spage%3D117%26epage%3D120%26doi%3D10.1126%2Fscience.1100946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Zeng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigoillot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaff, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hathaway, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span> </span><span class="NLM_article-title">Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces a Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle Damage</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">382</span><span class="NLM_x">â</span> <span class="NLM_lpage">395</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2010.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.ccr.2010.08.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=382-395&issue=4&author=X.+Zengauthor=F.+Sigoillotauthor=S.+Gaurauthor=S.+Choiauthor=K.+L.+Pfaffauthor=D.-C.+Ohauthor=N.+Hathawayauthor=N.+Dimovaauthor=G.+D.+Cunyauthor=R.+W.+King&title=Pharmacologic+Inhibition+of+the+Anaphase-Promoting+Complex+Induces+a+Spindle+Checkpoint-Dependent+Mitotic+Arrest+in+the+Absence+of+Spindle+Damage&doi=10.1016%2Fj.ccr.2010.08.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DSigoillot%26aufirst%3DF.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DPfaff%26aufirst%3DK.%2BL.%26aulast%3DOh%26aufirst%3DD.-C.%26aulast%3DHathaway%26aufirst%3DN.%26aulast%3DDimova%26aufirst%3DN.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DKing%26aufirst%3DR.%2BW.%26atitle%3DPharmacologic%2520Inhibition%2520of%2520the%2520Anaphase-Promoting%2520Complex%2520Induces%2520a%2520Spindle%2520Checkpoint-Dependent%2520Mitotic%2520Arrest%2520in%2520the%2520Absence%2520of%2520Spindle%2520Damage%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26issue%3D4%26spage%3D382%26epage%3D395%26doi%3D10.1016%2Fj.ccr.2010.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skehel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barford, D.</span><span> </span><span class="NLM_article-title">Molecular Mechanism of APC/C Activation by Mitotic Phosphorylation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">533</span><span class="NLM_x"> (</span><span class="NLM_issue">7602</span><span class="NLM_x">) </span> <span class="NLM_fpage">260</span><span class="NLM_x">â</span> <span class="NLM_lpage">264</span><span class="refDoi">Â DOI: 10.1038/nature17973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature17973" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=260-264&issue=7602&author=S.+Zhangauthor=L.+Changauthor=C.+Alfieriauthor=Z.+Zhangauthor=J.+Yangauthor=S.+Maslenauthor=M.+Skehelauthor=D.+Barford&title=Molecular+Mechanism+of+APC%2FC+Activation+by+Mitotic+Phosphorylation&doi=10.1038%2Fnature17973"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnature17973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17973%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DAlfieri%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMaslen%26aufirst%3DS.%26aulast%3DSkehel%26aufirst%3DM.%26aulast%3DBarford%26aufirst%3DD.%26atitle%3DMolecular%2520Mechanism%2520of%2520APC%252FC%2520Activation%2520by%2520Mitotic%2520Phosphorylation%26jtitle%3DNature%26date%3D2016%26volume%3D533%26issue%3D7602%26spage%3D260%26epage%3D264%26doi%3D10.1038%2Fnature17973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Miller, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">StrÃ¶mland, K.</span><span> </span><span class="NLM_article-title">Teratogen Update: Thalidomide: a Review, with a Focus on Ocular Findings and New Potential Uses</span> <span class="citation_source-journal">Teratology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">306</span><span class="NLM_x">â</span> <span class="NLM_lpage">321</span><span class="refDoi">Â DOI: 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2F%28SICI%291096-9926%28199911%2960%3A5%3C306%3A%3AAID-TERA11%3E3.0.CO%3B2-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10525208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSgtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1999&pages=306-321&issue=5&author=M.+T.+Millerauthor=K.+Str%C3%B6mland&title=Teratogen+Update%3A+Thalidomide%3A+a+Review%2C+with+a+Focus+on+Ocular+Findings+and+New+Potential+Uses&doi=10.1002%2F%28SICI%291096-9926%28199911%2960%3A5%3C306%3A%3AAID-TERA11%3E3.0.CO%3B2-Y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses</span></div><div class="casAuthors">Miller, Marilyn T.; Stromland, Kerstin</div><div class="citationInfo"><span class="NLM_cas:title">Teratology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">306-321</span>CODEN:
                <span class="NLM_cas:coden">TJADAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-3709</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review and discussion with many refs.  Period of greatest sensitivity, phenotypic affects, and thalidomide uses in 1990s, etc., are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7l2YrrF9-17Vg90H21EOLACvtfcHk0lhv_ZkkbFNveQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSgtLo%253D&md5=a486c12fd88acc49bddcc0830182721c</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9926%28199911%2960%3A5%3C306%3A%3AAID-TERA11%3E3.0.CO%3B2-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9926%2528199911%252960%253A5%253C306%253A%253AAID-TERA11%253E3.0.CO%253B2-Y%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BT.%26aulast%3DStr%25C3%25B6mland%26aufirst%3DK.%26atitle%3DTeratogen%2520Update%253A%2520Thalidomide%253A%2520a%2520Review%252C%2520with%2520a%2520Focus%2520on%2520Ocular%2520Findings%2520and%2520New%2520Potential%2520Uses%26jtitle%3DTeratology%26date%3D1999%26volume%3D60%26issue%3D5%26spage%3D306%26epage%3D321%26doi%3D10.1002%2F%28SICI%291096-9926%28199911%2960%3A5%3C306%3A%3AAID-TERA11%3E3.0.CO%3B2-Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Melchert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">List, A.</span><span> </span><span class="NLM_article-title">The Thalidomide Saga</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">7â8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1489</span><span class="NLM_x">â</span> <span class="NLM_lpage">1499</span><span class="refDoi">Â DOI: 10.1016/j.biocel.2007.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.biocel.2007.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=17369076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWltbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=1489-1499&issue=7%E2%80%938&author=M.+Melchertauthor=A.+List&title=The+Thalidomide+Saga&doi=10.1016%2Fj.biocel.2007.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">The thalidomide saga</span></div><div class="casAuthors">Melchert, Magda; List, Alan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1489-1499</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past 50 years, thalidomide has been a target of active investigation in both malignant and inflammatory conditions.  Although initially developed for its sedative properties, decades of investigation have identified a multitude of biol. effects that led to its classification as an immunomodulatory drug (IMiD).  In addn. to suppression of tumor necrosis factor-alpha (TNF-Î±), thalidomide effects the generation and elaboration of a cascade of pro-inflammatory cytokines that activate cytotoxic T-cells even in the absence of co-stimulatory signals.  Furthermore, vascular endothelial growth factor (VEGF) and beta fibroblast growth factor (bFGF) secretion and cellular response are suppressed by thalidomide, thus antagonizing neoangiogenesis and altering the bone marrow stromal microenvironment in hematol. malignancies.  The thalidomide analogs, lenalidomide (CC-5013; Revlimid) and CC-4047 (Actimid), have enhanced potency as inhibitors of TNF-Î± and other inflammatory cytokines, as well as greater capacity to promote T-cell activation and suppress angiogenesis.  Both thalidomide and lenalidomide are effective in the treatment of multiple myeloma and myelodysplastic syndromes for which the Food and Drug Administration granted recent approval.  Nonetheless, each of these IMiDs remains the subject of active investigation in solid tumors, hematol. malignancies, and other inflammatory conditions.  This review will explore the pharmacokinetic and biol. effects of thalidomide and its progeny compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWmbOezWOSg7Vg90H21EOLACvtfcHk0lhv_ZkkbFNveQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWltbk%253D&md5=40ef03568f8da5a4d15a908d71d33373</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2007.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2007.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DMelchert%26aufirst%3DM.%26aulast%3DList%26aufirst%3DA.%26atitle%3DThe%2520Thalidomide%2520Saga%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2007%26volume%3D39%26issue%3D7%25E2%2580%25938%26spage%3D1489%26epage%3D1499%26doi%3D10.1016%2Fj.biocel.2007.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Knobloch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¼ther, U.</span><span> </span><span class="NLM_article-title">Shedding Light on an Old Mystery: Thalidomide Suppresses Survival Pathways to Induce Limb Defects</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1121</span><span class="NLM_x">â</span> <span class="NLM_lpage">1127</span><span class="refDoi">Â DOI: 10.4161/cc.7.9.5793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.4161%2Fcc.7.9.5793" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1121-1127&issue=9&author=J.+Knoblochauthor=U.+R%C3%BCther&title=Shedding+Light+on+an+Old+Mystery%3A+Thalidomide+Suppresses+Survival+Pathways+to+Induce+Limb+Defects&doi=10.4161%2Fcc.7.9.5793"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.4161%2Fcc.7.9.5793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.7.9.5793%26sid%3Dliteratum%253Aachs%26aulast%3DKnobloch%26aufirst%3DJ.%26aulast%3DR%25C3%25BCther%26aufirst%3DU.%26atitle%3DShedding%2520Light%2520on%2520an%2520Old%2520Mystery%253A%2520Thalidomide%2520Suppresses%2520Survival%2520Pathways%2520to%2520Induce%2520Limb%2520Defects%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26issue%3D9%26spage%3D1121%26epage%3D1127%26doi%3D10.4161%2Fcc.7.9.5793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">SHESKIN, J.</span><span> </span><span class="NLM_article-title">Thalidomide in the Treatment of Lepra Reactions</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">â</span> <span class="NLM_lpage">306</span><span class="refDoi">Â DOI: 10.1002/cpt196563303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2Fcpt196563303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=14296027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A280%3ADyaF2M7gtVKgtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1965&pages=303-306&author=J.+SHESKIN&title=Thalidomide+in+the+Treatment+of+Lepra+Reactions&doi=10.1002%2Fcpt196563303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS</span></div><div class="casAuthors">SHESKIN J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">303-6</span>
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuQWQYmYA2ef69nzq6467DfW6udTcc2ebzwnYk9qZ1Zbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2M7gtVKgtg%253D%253D&md5=51c996c9092f27ac78643f0af03e53ad</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1002%2Fcpt196563303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt196563303%26sid%3Dliteratum%253Aachs%26aulast%3DSHESKIN%26aufirst%3DJ.%26atitle%3DThalidomide%2520in%2520the%2520Treatment%2520of%2520Lepra%2520Reactions%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1965%26volume%3D6%26spage%3D303%26epage%3D306%26doi%3D10.1002%2Fcpt196563303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desikan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddlemon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anaissie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhodapkar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeldis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span> </span><span class="NLM_article-title">Antitumor Activity of Thalidomide in Refractory Multiple Myeloma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">1565</span><span class="NLM_x">â</span> <span class="NLM_lpage">1571</span><span class="refDoi">Â DOI: 10.1056/NEJM199911183412102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1056%2FNEJM199911183412102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10564685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1MXotVSgs78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=1565-1571&issue=21&author=S.+Singhalauthor=J.+Mehtaauthor=R.+Desikanauthor=D.+Ayersauthor=P.+Robersonauthor=P.+Eddlemonauthor=N.+Munshiauthor=E.+Anaissieauthor=C.+Wilsonauthor=M.+Dhodapkarauthor=J.+Zeldisauthor=D.+Siegelauthor=J.+Crowleyauthor=B.+Barlogie&title=Antitumor+Activity+of+Thalidomide+in+Refractory+Multiple+Myeloma&doi=10.1056%2FNEJM199911183412102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of thalidomide in refractory multiple myeloma</span></div><div class="casAuthors">Singhal, Seema; Mehta, Jayesh; Desikan, Raman; Ayers, Dan; Roberson, Paula; Eddlemon, Paul; Munshi, Nikhil; Anaissie, Elias; Wilson, Carla; Dhodapkar, Madhav; Zeldis, Jerome; Barlogie, Bart</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1565-1571</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Patients with myeloma who relapse after high-dose chemotherapy have few therapeutic options.  Since increased bone marrow vascularity imparts a poor prognosis in myeloma, we evaluated the efficacy of thalidomide, which has antiangiogenic properties, in patients with refractory disease.  Methods: Eighty-four previously treated patients with refractory myeloma (76 with a relapse after high-dose chemotherapy) received oral thalidomide as a single agent for a median of 80 days (range, 2 to 465).  The starting dose was 200 mg daily, and the dose was increased by 200 mg every two weeks until it reached 800 mg per day.  Response was assessed on the basis of a redn. of the myeloma protein in serum or Bence Jones protein in urine that lasted for at least six weeks.  Results: The serum or urine levels of paraprotein were reduced by at least 90 % in eight patients (two had a complete remission), at least 75 % in six patients, at least 50 % in seven patients, and at least 25 % in six patients, for a total rate of response of 32 %.  Redns. in the paraprotein levels were apparent within two months in 78 % of the patients with a response and were assocd. with decreased nos. of plasma cells in bone marrow and increased Hb levels.  The microvascular d. of bone marrow did not change significantly in patients with a response.  At least one third of the patients had mild or moderate constipation, weakness or fatigue, or somnolence.  More severe adverse effects were infrequent (occurring in less than 10 % of patients), and hematol. effects were rare.  As of the most recent follow-up, 36 patients had died (30 with no response and 6 with a response).  After 12 mo of follow-up, Kaplan-Meier ests. of the mean (Â±SE) rates of event-free survival and overall survival for all patients were 22Â±5 % and 58Â±5 %, resp.  Conclusions: Thalidomide is active against advanced myeloma.  It can induce marked and durable responses in some patients with multiple myeloma, including those who relapse after high-dose chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIQfXLedh12LVg90H21EOLACvtfcHk0liGTPIx-3eaUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVSgs78%253D&md5=bc018ca21eec485ca7cbf873e7219813</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1056%2FNEJM199911183412102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199911183412102%26sid%3Dliteratum%253Aachs%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DMehta%26aufirst%3DJ.%26aulast%3DDesikan%26aufirst%3DR.%26aulast%3DAyers%26aufirst%3DD.%26aulast%3DRoberson%26aufirst%3DP.%26aulast%3DEddlemon%26aufirst%3DP.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DAnaissie%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDhodapkar%26aufirst%3DM.%26aulast%3DZeldis%26aufirst%3DJ.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DCrowley%26aufirst%3DJ.%26aulast%3DBarlogie%26aufirst%3DB.%26atitle%3DAntitumor%2520Activity%2520of%2520Thalidomide%2520in%2520Refractory%2520Multiple%2520Myeloma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26issue%3D21%26spage%3D1565%26epage%3D1571%26doi%3D10.1056%2FNEJM199911183412102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span> </span><span class="NLM_article-title">Identification of a Primary Target of Thalidomide Teratogenicity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x"> (</span><span class="NLM_issue">5971</span><span class="NLM_x">) </span> <span class="NLM_fpage">1345</span><span class="NLM_x">â</span> <span class="NLM_lpage">1350</span><span class="refDoi">Â DOI: 10.1126/science.1177319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.1177319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=20223979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=1345-1350&issue=5971&author=T.+Itoauthor=H.+Andoauthor=T.+Suzukiauthor=T.+Oguraauthor=K.+Hottaauthor=Y.+Imamuraauthor=Y.+Yamaguchiauthor=H.+Handa&title=Identification+of+a+Primary+Target+of+Thalidomide+Teratogenicity&doi=10.1126%2Fscience.1177319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Primary Target of Thalidomide Teratogenicity</span></div><div class="casAuthors">Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">5971</span>),
    <span class="NLM_cas:pages">1345-1350</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects.  Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown.  Here, we identified cereblon (CRBN) as a thalidomide-binding protein.  CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.  Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the assocd. ubiquitin ligase activity.  This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivs. without teratogenic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPC_7RXLkfabVg90H21EOLACvtfcHk0liGTPIx-3eaUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D&md5=4565a67837e0ec34ede2c93c1036f312</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1126%2Fscience.1177319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1177319%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DHanda%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520Primary%2520Target%2520of%2520Thalidomide%2520Teratogenicity%26jtitle%3DScience%26date%3D2010%26volume%3D327%26issue%3D5971%26spage%3D1345%26epage%3D1350%26doi%3D10.1126%2Fscience.1177319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmoudi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span> </span><span class="NLM_article-title">Cereblon Is a Direct Protein Target for Immunomodulatory and Antiproliferative Activities of Lenalidomide and Pomalidomide</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2326</span><span class="NLM_x">â</span> <span class="NLM_lpage">2335</span><span class="refDoi">Â DOI: 10.1038/leu.2012.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fleu.2012.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22552008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Giur%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=2326-2335&issue=11&author=A.+Lopez-Gironaauthor=D.+Mendyauthor=T.+Itoauthor=K.+Millerauthor=A.+K.+Gandhiauthor=J.+Kangauthor=S.+Karasawaauthor=G.+Carmelauthor=P.+Jacksonauthor=M.+Abbasianauthor=A.+Mahmoudiauthor=B.+Cathersauthor=E.+Rychakauthor=S.+Gaidarovaauthor=R.+Chenauthor=P.+H.+Schaferauthor=H.+Handaauthor=T.+O.+Danielauthor=J.+F.+Evansauthor=R.+Chopra&title=Cereblon+Is+a+Direct+Protein+Target+for+Immunomodulatory+and+Antiproliferative+Activities+of+Lenalidomide+and+Pomalidomide&doi=10.1038%2Fleu.2012.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide</span></div><div class="casAuthors">Lopez-Girona, A.; Mendy, D.; Ito, T.; Miller, K.; Gandhi, A. K.; Kang, J.; Karasawa, S.; Carmel, G.; Jackson, P.; Abbasian, M.; Mahmoudi, A.; Cathers, B.; Rychak, E.; Gaidarova, S.; Chen, R.; Schafer, P. H.; Handa, H.; Daniel, T. O.; Evans, J. F.; Chopra, R.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2326-2335</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thalidomide and the immunomodulatory drug, lenalidomide, are therapeutically active in hematol. malignancies.  The ubiquitously expressed E3 ligase protein cereblon (CRBN) has been identified as the primary teratogenic target of thalidomide.  Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.  CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells, as well as lenalidomide- and pomalidomide-induced cytokine prodn. in T cells.  Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBNYW/AA.  Overexpression of CRBN wild-type protein, but not CRBNYW/AA mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated redns. in c-myc and IRF4 expression and increases in p21WAF-1 expression.  Long-term selection for lenalidomide resistance in H929 myeloma cell lines was accompanied by a redn. in CRBN, while in DF15R myeloma cells resistant to both pomalidomide and lenalidomide, CRBN protein was undetectable.  Our biophys., biochem. and gene silencing studies show that CRBN is a proximate, therapeutically important mol. target of lenalidomide and pomalidomide.  Leukemia (2012) 26, 2326-2335; doi:10.1038/leu.2012.119; published online 15 June 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp85RvB33HGjbVg90H21EOLACvtfcHk0lhgYr4OTGdRiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Giur%252FI&md5=81f83b5f6c4c043a35a049df3b4d63ae</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fleu.2012.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2012.119%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DMendy%26aufirst%3DD.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKarasawa%26aufirst%3DS.%26aulast%3DCarmel%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DP.%26aulast%3DAbbasian%26aufirst%3DM.%26aulast%3DMahmoudi%26aufirst%3DA.%26aulast%3DCathers%26aufirst%3DB.%26aulast%3DRychak%26aufirst%3DE.%26aulast%3DGaidarova%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DSchafer%26aufirst%3DP.%2BH.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DChopra%26aufirst%3DR.%26atitle%3DCereblon%2520Is%2520a%2520Direct%2520Protein%2520Target%2520for%2520Immunomodulatory%2520and%2520Antiproliferative%2520Activities%2520of%2520Lenalidomide%2520and%2520Pomalidomide%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26issue%3D11%26spage%3D2326%26epage%3D2335%26doi%3D10.1038%2Fleu.2012.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Zhu, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span> </span><span class="NLM_article-title">Cereblon Expression Is Required for the Antimyeloma Activity of Lenalidomide and Pomalidomide</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4771</span><span class="NLM_x">â</span> <span class="NLM_lpage">4779</span><span class="refDoi">Â DOI: 10.1182/blood-2011-05-356063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1182%2Fblood-2011-05-356063" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=4771-4779&issue=18&author=Y.+X.+Zhuauthor=E.+Braggioauthor=C.-X.+Shiauthor=L.+A.+Bruinsauthor=J.+E.+Schmidtauthor=S.+Van+Wierauthor=X.-B.+Changauthor=C.+C.+Bjorklundauthor=R.+Fonsecaauthor=P.+L.+Bergsagelauthor=R.+Z.+Orlowskiauthor=A.+K.+Stewart&title=Cereblon+Expression+Is+Required+for+the+Antimyeloma+Activity+of+Lenalidomide+and+Pomalidomide&doi=10.1182%2Fblood-2011-05-356063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-05-356063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-05-356063%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%2BX.%26aulast%3DBraggio%26aufirst%3DE.%26aulast%3DShi%26aufirst%3DC.-X.%26aulast%3DBruins%26aufirst%3DL.%2BA.%26aulast%3DSchmidt%26aufirst%3DJ.%2BE.%26aulast%3DVan%2BWier%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DX.-B.%26aulast%3DBjorklund%26aufirst%3DC.%2BC.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26atitle%3DCereblon%2520Expression%2520Is%2520Required%2520for%2520the%2520Antimyeloma%2520Activity%2520of%2520Lenalidomide%2520and%2520Pomalidomide%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26issue%3D18%26spage%3D4771%26epage%3D4779%26doi%3D10.1182%2Fblood-2011-05-356063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Fischer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BÃ¶hm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydeard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavadini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serluca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingaraju, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichkule, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schebesta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckwith, R. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ThomÃ¤, N. H.</span><span> </span><span class="NLM_article-title">Structure of the DDB1-CRBN E3 Ubiquitin Ligase in Complex with Thalidomide</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">512</span><span class="NLM_x"> (</span><span class="NLM_issue">7512</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span><span class="refDoi">Â DOI: 10.1038/nature13527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature13527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25043012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12ms7%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=512&publication_year=2014&pages=49-53&issue=7512&author=E.+S.+Fischerauthor=K.+B%C3%B6hmauthor=J.+R.+Lydeardauthor=H.+Yangauthor=M.+B.+Stadlerauthor=S.+Cavadiniauthor=J.+Nagelauthor=F.+Serlucaauthor=V.+Ackerauthor=G.+M.+Lingarajuauthor=R.+B.+Tichkuleauthor=M.+Schebestaauthor=W.+C.+Forresterauthor=M.+Schirleauthor=U.+Hassiepenauthor=J.+Ottlauthor=M.+Hildauthor=R.+E.+J.+Beckwithauthor=J.+W.+Harperauthor=J.+L.+Jenkinsauthor=N.+H.+Thom%C3%A4&title=Structure+of+the+DDB1-CRBN+E3+Ubiquitin+Ligase+in+Complex+with+Thalidomide&doi=10.1038%2Fnature13527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide</span></div><div class="casAuthors">Fischer, Eric S.; Bohm, Kerstin; Lydeard, John R.; Yang, Haidi; Stadler, Michael B.; Cavadini, Simone; Nagel, Jane; Serluca, Fabrizio; Acker, Vincent; Lingaraju, Gondichatnahalli M.; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hassiepen, Ulrich; Ottl, Johannes; Hild, Marc; Beckwith, Rohan E. J.; Harper, J. Wade; Jenkins, Jeremy L.; Thoma, Nicolas H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">512</span>
        (<span class="NLM_cas:issue">7512</span>),
    <span class="NLM_cas:pages">49-53</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects.  Despite the teratogenicity of thalidomide and its derivs. lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-assocd. dysplasia.  IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4CRBN.  Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide.  The structure establishes that CRBN is a substrate receptor within CRL4CRBN and enantioselectively binds IMiDs.  Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4CRBN.  Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4CRBN while the ligase complex is recruiting IKZF1 or IKZF3 for degrdn.  This dual activity implies that small mols. can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGt2Y9GecKr7Vg90H21EOLACvtfcHk0lhgYr4OTGdRiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12ms7%252FP&md5=1c1eaa48bef87463cdd3f2b1e1bd400d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnature13527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13527%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DB%25C3%25B6hm%26aufirst%3DK.%26aulast%3DLydeard%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStadler%26aufirst%3DM.%2BB.%26aulast%3DCavadini%26aufirst%3DS.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DAcker%26aufirst%3DV.%26aulast%3DLingaraju%26aufirst%3DG.%2BM.%26aulast%3DTichkule%26aufirst%3DR.%2BB.%26aulast%3DSchebesta%26aufirst%3DM.%26aulast%3DForrester%26aufirst%3DW.%2BC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DOttl%26aufirst%3DJ.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DBeckwith%26aufirst%3DR.%2BE.%2BJ.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DJenkins%26aufirst%3DJ.%2BL.%26aulast%3DThom%25C3%25A4%26aufirst%3DN.%2BH.%26atitle%3DStructure%2520of%2520the%2520DDB1-CRBN%2520E3%2520Ubiquitin%2520Ligase%2520in%2520Complex%2520with%2520Thalidomide%26jtitle%3DNature%26date%3D2014%26volume%3D512%26issue%3D7512%26spage%3D49%26epage%3D53%26doi%3D10.1038%2Fnature13527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Sakamoto, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumagai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span> </span><span class="NLM_article-title">Protacs: Chimeric Molecules That Target Proteins to the Skp1-Cullin-F Box Complex for Ubiquitination and Degradation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">8554</span><span class="NLM_x">â</span> <span class="NLM_lpage">8559</span><span class="refDoi">Â DOI: 10.1073/pnas.141230798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1073%2Fpnas.141230798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=11438690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Wisbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=8554-8559&issue=15&author=K.+M.+Sakamotoauthor=K.+B.+Kimauthor=A.+Kumagaiauthor=F.+Mercurioauthor=C.+M.+Crewsauthor=R.+J.+Deshaies&title=Protacs%3A+Chimeric+Molecules+That+Target+Proteins+to+the+Skp1-Cullin-F+Box+Complex+for+Ubiquitination+and+Degradation&doi=10.1073%2Fpnas.141230798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation</span></div><div class="casAuthors">Sakamoto, Kathleen M.; Kim, Kyung B.; Kumagai, Akiko; Mercurio, Frank; Crews, Craig M.; Deshaies, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8554-8559</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The intracellular levels of many proteins are regulated by ubiquitin-dependent proteolysis.  One of the best-characterized enzymes that catalyzes the attachment of ubiquitin to proteins is a ubiquitin ligase complex, Skp1-Cullin-F box complex contg. Hrt1 (SCF).  We sought to artificially target a protein to the SCF complex for ubiquitination and degrdn.  To this end, we tested methionine aminopeptidase-2 (MetAP-2), which covalently binds the angiogenesis inhibitor ovalicin.  A chimeric compd., protein-targeting chimeric mol. 1 (Protac-1), was synthesized to recruit MetAP-2 to SCF.  One domain of Protac-1 contains the IÎºBÎ± phosphopeptide that is recognized by the F-box protein Î²-TRCP, whereas the other domain is composed of ovalicin.  We show that MetAP-2 can be tethered to SCFÎ²-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner.  In the future, this approach may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp49fYtuEVlJrVg90H21EOLACvtfcHk0lhpIV2Q1Ui0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Wisbk%253D&md5=540358035222f745f7b6367b38781a21</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1073%2Fpnas.141230798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.141230798%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DKumagai%26aufirst%3DA.%26aulast%3DMercurio%26aufirst%3DF.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DProtacs%253A%2520Chimeric%2520Molecules%2520That%2520Target%2520Proteins%2520to%2520the%2520Skp1-Cullin-F%2520Box%2520Complex%2520for%2520Ubiquitination%2520and%2520Degradation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26issue%3D15%26spage%3D8554%26epage%3D8559%26doi%3D10.1073%2Fpnas.141230798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Posttranslational Protein Knockdown Coupled to Receptor Tyrosine Kinase Activation with phosphoPROTACs</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">8942</span><span class="NLM_x">â</span> <span class="NLM_lpage">8947</span><span class="refDoi">Â DOI: 10.1073/pnas.1217206110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1073%2Fpnas.1217206110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23674677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFait7zN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=8942-8947&issue=22&author=J.+Hinesauthor=J.+D.+Goughauthor=T.+W.+Corsonauthor=C.+M.+Crews&title=Posttranslational+Protein+Knockdown+Coupled+to+Receptor+Tyrosine+Kinase+Activation+with+phosphoPROTACs&doi=10.1073%2Fpnas.1217206110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs</span></div><div class="casAuthors">Hines, John; Gough, Jonathan D.; Corson, Timothy W.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8942-8947, S8942/1-S8942/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Posttranslational knockdown of a specific protein is an attractive approach for examg. its function within a system.  Here we introduce phospho-dependent proteolysis targeting chimeras (phosphoPROTACs), a method to couple the conditional degrdn. of targeted proteins to the activation state of particular kinase-signaling pathways.  We generated two phosphoPROTACs that couple the tyrosine phosphorylation sequences of either the nerve growth factor receptor, TrkA (tropomyosin receptor kinase A), or the neuregulin receptor, ErbB3 (erythroblastosis oncogene B3), with a peptide ligand for the E3 ubiquitin ligase von Hippel Lindau protein.  These phosphoPROTACs recruit either the neurotrophic signaling effector fibroblast growth factor receptor substrate 2a or the survival-promoting phosphatidylinositol-3-kinase, resp., to be ubiquitinated and degraded upon activation of specific receptor tyrosine kinases and phosphorylation of the phosphoPROTACs.  We demonstrate the ability of these phosphoPROTACs to suppress the short- and long-term effects of their resp. activating receptor tyrosine kinase pathways both in vitro and in vivo.  In addn., we show that activation of phosphoPROTACs is entirely dependent on their kinase-mediated phosphorylation, as phenylalanine-contg. null variants are inactive.  Furthermore, stimulation of unrelated growth factor receptors does not induce target protein knockdown.  Although comparable in efficiency to RNAi, this approach has the added advantage of providing a degree of temporal and dosing control as well as cell-type selectivity unavailable using nucleic acid-based strategies.  By varying the autophosphorylation sequence of a phosphoPROTAC, it is conceivable that other receptor tyrosine kinase/effector pairings could be similarly exploited to achieve other biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsZZWSv0W2uLVg90H21EOLACvtfcHk0lhpIV2Q1Ui0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFait7zN&md5=27e5bc310a45be8ecb23314daa582944</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217206110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217206110%26sid%3Dliteratum%253Aachs%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DJ.%2BD.%26aulast%3DCorson%26aufirst%3DT.%2BW.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DPosttranslational%2520Protein%2520Knockdown%2520Coupled%2520to%2520Receptor%2520Tyrosine%2520Kinase%2520Activation%2520with%2520phosphoPROTACs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D22%26spage%3D8942%26epage%3D8947%26doi%3D10.1073%2Fpnas.1217206110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darricarrere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miah, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1831</span><span class="NLM_x">â</span> <span class="NLM_lpage">1837</span><span class="refDoi">Â DOI: 10.1021/acschembio.5b00442</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00442" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSht7fN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1831-1837&issue=8&author=D.+L.+Buckleyauthor=K.+Rainaauthor=N.+Darricarrereauthor=J.+Hinesauthor=J.+L.+Gustafsonauthor=I.+E.+Smithauthor=A.+H.+Miahauthor=J.+D.+Harlingauthor=C.+M.+Crews&title=HaloPROTACS%3A+Use+of+Small+Molecule+PROTACs+to+Induce+Degradation+of+HaloTag+Fusion+Proteins&doi=10.1021%2Facschembio.5b00442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins</span></div><div class="casAuthors">Buckley, Dennis L.; Raina, Kanak; Darricarrere, Nicole; Hines, John; Gustafson, Jeffrey L.; Smith, Ian E.; Miah, Afjal H.; Harling, John D.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1831-1837</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small mol.-induced protein degrdn. is an attractive strategy for the development of chem. probes.  One method for inducing targeted protein degrdn. involves the use of PROTACs, heterobifunctional mols. that can recruit specific E3 ligases to a desired protein of interest.  PROTACs have been successfully used to degrade numerous proteins in cells, but the peptidic E3 ligase ligands used in previous PROTACs have hindered their development into more mature chem. probes or therapeutics.  The authors report the design of a novel class of PROTACs that incorporate small mol. VHL ligands to successfully degrade HaloTag7 fusion proteins.  These HaloPROTACs will inspire the development of future PROTACs with more drug-like properties.  Addnl., these HaloPROTACs are useful chem. genetic tools, due to their ability to chem. knock down widely used HaloTag7 fusion proteins in a general fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotj-Sgj4TyKrVg90H21EOLACvtfcHk0lhpIV2Q1Ui0Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSht7fN&md5=b074c58e983f15c384818777b25e248d</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00442%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DDarricarrere%26aufirst%3DN.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DI.%2BE.%26aulast%3DMiah%26aufirst%3DA.%2BH.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHaloPROTACS%253A%2520Use%2520of%2520Small%2520Molecule%2520PROTACs%2520to%2520Induce%2520Degradation%2520of%2520HaloTag%2520Fusion%2520Proteins%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3D1831%26epage%3D1837%26doi%3D10.1021%2Facschembio.5b00442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Bondeson, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miah, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulholland, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routly, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faelth-Savitski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casillas, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">den Besten, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Famm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruidenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churcher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Catalytic in Vivo Protein Knockdown by Small-Molecule PROTACs</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">611</span><span class="NLM_x">â</span> <span class="NLM_lpage">617</span><span class="refDoi">Â DOI: 10.1038/nchembio.1858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=26075522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7rP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=611-617&issue=8&author=D.+P.+Bondesonauthor=A.+Maresauthor=I.+E.+D.+Smithauthor=E.+Koauthor=S.+Camposauthor=A.+H.+Miahauthor=K.+E.+Mulhollandauthor=N.+Routlyauthor=D.+L.+Buckleyauthor=J.+L.+Gustafsonauthor=N.+Zinnauthor=P.+Grandiauthor=S.+Shimamuraauthor=G.+Bergaminiauthor=M.+Faelth-Savitskiauthor=M.+Bantscheffauthor=C.+Coxauthor=D.+A.+Gordonauthor=R.+R.+Willardauthor=J.+J.+Flanaganauthor=L.+N.+Casillasauthor=B.+J.+Vottaauthor=W.+den+Bestenauthor=K.+Fammauthor=L.+Kruidenierauthor=P.+S.+Carterauthor=J.+D.+Harlingauthor=I.+Churcherauthor=C.+M.+Crews&title=Catalytic+in+Vivo+Protein+Knockdown+by+Small-Molecule+PROTACs&doi=10.1038%2Fnchembio.1858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic in vivo protein knockdown by small-molecule PROTACs</span></div><div class="casAuthors">Bondeson, Daniel P.; Mares, Alina; Smith, Ian E. D.; Ko, Eunhwa; Campos, Sebastien; Miah, Afjal H.; Mulholland, Katie E.; Routly, Natasha; Buckley, Dennis L.; Gustafson, Jeffrey L.; Zinn, Nico; Grandi, Paola; Shimamura, Satoko; Bergamini, Giovanna; Faelth-Savitski, Maria; Bantscheff, Marcus; Cox, Carly; Gordon, Deborah A.; Willard, Ryan R.; Flanagan, John J.; Casillas, Linda N.; Votta, Bartholomew J.; den Besten, Willem; Famm, Kristoffer; Kruidenier, Laurens; Carter, Paul S.; Harling, John D.; Churcher, Ian; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The current predominant therapeutic paradigm is based on maximizing drug-receptor occupancy to achieve clin. benefit.  This strategy, however, generally requires excessive drug concns. to ensure sufficient occupancy, often leading to adverse side effects.  Here, we describe major improvements to the proteolysis targeting chimeras (PROTACs) method, a chem. knockdown strategy in which a heterobifunctional mol. recruits a specific protein target to an E3 ubiquitin ligase, resulting in the target's ubiquitination and degrdn.  These compds. behave catalytically in their ability to induce the ubiquitination of super-stoichiometric quantities of proteins, providing efficacy that is not limited by equil. occupancy.  We present two PROTACs that are capable of specifically reducing protein levels by >90% at nanomolar concns.  In addn., mouse studies indicate that they provide broad tissue distribution and knockdown of the targeted protein in tumor xenografts.  Together, these data demonstrate a protein knockdown system combining many of the favorable properties of small-mol. agents with the potent protein knockdown of RNAi and CRISPR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonhnajD3CxS7Vg90H21EOLACvtfcHk0ljzXTv2Eqpziw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7rP&md5=31eb8756c5661f78ab4527a50dc1e251</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1858%26sid%3Dliteratum%253Aachs%26aulast%3DBondeson%26aufirst%3DD.%2BP.%26aulast%3DMares%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DI.%2BE.%2BD.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DCampos%26aufirst%3DS.%26aulast%3DMiah%26aufirst%3DA.%2BH.%26aulast%3DMulholland%26aufirst%3DK.%2BE.%26aulast%3DRoutly%26aufirst%3DN.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DShimamura%26aufirst%3DS.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DFaelth-Savitski%26aufirst%3DM.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DGordon%26aufirst%3DD.%2BA.%26aulast%3DWillard%26aufirst%3DR.%2BR.%26aulast%3DFlanagan%26aufirst%3DJ.%2BJ.%26aulast%3DCasillas%26aufirst%3DL.%2BN.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3Dden%2BBesten%26aufirst%3DW.%26aulast%3DFamm%26aufirst%3DK.%26aulast%3DKruidenier%26aufirst%3DL.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DCatalytic%2520in%2520Vivo%2520Protein%2520Knockdown%2520by%2520Small-Molecule%2520PROTACs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D8%26spage%3D611%26epage%3D617%26doi%3D10.1038%2Fnchembio.1858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Winter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">DRUG DEVELOPMENT. Phthalimide Conjugation as a Strategy for in Vivo Target Protein Degradation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x"> (</span><span class="NLM_issue">6241</span><span class="NLM_x">) </span> <span class="NLM_fpage">1376</span><span class="NLM_x">â</span> <span class="NLM_lpage">1381</span><span class="refDoi">Â DOI: 10.1126/science.aab1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.aab1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25999370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=1376-1381&issue=6241&author=G.+E.+Winterauthor=D.+L.+Buckleyauthor=J.+Paulkauthor=J.+M.+Robertsauthor=A.+Souzaauthor=S.+Dhe-Paganonauthor=J.+E.+Bradner&title=DRUG+DEVELOPMENT.+Phthalimide+Conjugation+as+a+Strategy+for+in+Vivo+Target+Protein+Degradation&doi=10.1126%2Fscience.aab1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Phthalimide conjugation as a strategy for in vivo target protein degradation</span></div><div class="casAuthors">Winter, Georg E.; Buckley, Dennis L.; Paulk, Joshiawa; Roberts, Justin M.; Souza, Amanda; Dhe-Paganon, Sirano; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6241</span>),
    <span class="NLM_cas:pages">1376-1381</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The development of effective pharmacol. inhibitors of multidomain scaffold proteins, notably transcription factors, is a particularly challenging problem.  In part, this is because many small-mol. antagonists disrupt the activity of only one domain in the target protein.  The authors devised a chem. strategy that promotes ligand-dependent target protein degrdn. using as an example the transcriptional coactivator BRD4, a protein crit. for cancer cell growth and survival.  The authors appended a competitive antagonist of BET bromodomains to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex.  The resultant compd., dBET1, induced highly selective cereblon-dependent BET protein degrdn. in vitro and in vivo and delayed leukemia progression in mice.  A second series of probes resulted in selective degrdn. of the cytosolic protein FKBP12.  This chem. strategy for controlling target protein stability may have implications for therapeutically targeting previously intractable proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ZW4zjRjXi7Vg90H21EOLACvtfcHk0ljzXTv2Eqpziw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D&md5=b0277cc95d318d926b96e7a119066e3b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1126%2Fscience.aab1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aab1433%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%2BE.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DPaulk%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DDRUG%2520DEVELOPMENT.%2520Phthalimide%2520Conjugation%2520as%2520a%2520Strategy%2520for%2520in%2520Vivo%2520Target%2520Protein%2520Degradation%26jtitle%3DScience%26date%3D2015%26volume%3D348%26issue%3D6241%26spage%3D1376%26epage%3D1381%26doi%3D10.1126%2Fscience.aab1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">755</span><span class="NLM_x">â</span> <span class="NLM_lpage">763</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.chembiol.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=26051217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=755-763&issue=6&author=J.+Luauthor=Y.+Qianauthor=M.+Altieriauthor=H.+Dongauthor=J.+Wangauthor=K.+Rainaauthor=J.+Hinesauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=K.+Colemanauthor=C.+M.+Crews&title=Hijacking+the+E3+Ubiquitin+Ligase+Cereblon+to+Efficiently+Target+BRD4&doi=10.1016%2Fj.chembiol.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span></div><div class="casAuthors">Lu, Jing; Qian, Yimin; Altieri, Martha; Dong, Hanqing; Wang, Jing; Raina, Kanak; Hines, John; Winkler, James D.; Crew, Andrew P.; Coleman, Kevin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-763</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathol. settings, particularly cancer.  While BRD4 inhibitors have shown some promise in MYC-driven malignancies such as Burkitt's lymphoma (BL), we show that BRD4 inhibitors lead to robust BRD4 protein accumulation, which may account for their limited suppression of MYC expression, modest antiproliferative activity, and lack of apoptotic induction.  To address these limitations we designed ARV-825, a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degrdn. of BRD4 in all BL cell lines tested.  Consequently, ARV-825 more effectively suppresses c-MYC levels and downstream signaling than small-mol. BRD4 inhibitors, resulting in more effective cell proliferation inhibition and apoptosis induction in BL.  Our findings provide strong evidence that cereblon-based PROTACs provide a better and more efficient strategy in targeting BRD4 than traditional small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Ol4grCG2RbVg90H21EOLACvtfcHk0ljzXTv2Eqpziw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM&md5=a64675e7a0cd006a8737be9730f447e3</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHijacking%2520the%2520E3%2520Ubiquitin%2520Ligase%2520Cereblon%2520to%2520Efficiently%2520Target%2520BRD4%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26issue%3D6%26spage%3D755%26epage%3D763%26doi%3D10.1016%2Fj.chembiol.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1770</span><span class="NLM_x">â</span> <span class="NLM_lpage">1777</span><span class="refDoi">Â DOI: 10.1021/acschembio.5b00216</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00216" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1770-1777&issue=8&author=M.+Zengerleauthor=K.-H.+Chanauthor=A.+Ciulli&title=Selective+Small+Molecule+Induced+Degradation+of+the+BET+Bromodomain+Protein+BRD4&doi=10.1021%2Facschembio.5b00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span></div><div class="casAuthors">Zengerle, Michael; Chan, Kwok-Ho; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1770-1777</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Bromo- and Extra-Terminal (BET) proteins BRD2, BRD3, and BRD4 play important roles in transcriptional regulation, epigenetics, and cancer and are the targets of pan-BET selective bromodomain inhibitor JQ1.  However, the lack of intra-BET selectivity limits the scope of current inhibitors as probes for target validation and could lead to unwanted side effects or toxicity in a therapeutic setting.  We designed Proteolysis Targeted Chimeras (PROTACs) that tether JQ1 to a ligand for the E3 ubiquitin ligase VHL, aimed at triggering the intracellular destruction of BET proteins.  Compd. MZ1 potently and rapidly induces reversible, long-lasting, and unexpectedly selective removal of BRD4 over BRD2 and BRD3.  The activity of MZ1 is dependent on binding to VHL but is achieved at a sufficiently low concn. not to induce stabilization of HIF-1Î±.  Gene expression profiles of selected cancer-related genes responsive to JQ1 reveal distinct and more limited transcriptional responses induced by MZ1, consistent with selective suppression of BRD4.  Our discovery opens up new opportunities to elucidate the cellular phenotypes and therapeutic implications assocd. with selective targeting of BRD4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEmSv7p9MZOrVg90H21EOLACvtfcHk0ljJ4hAR_NXMWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D&md5=b7514fd274eff8e4bb6a771f5aaf9ab5</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00216%26sid%3Dliteratum%253Aachs%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DK.-H.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSelective%2520Small%2520Molecule%2520Induced%2520Degradation%2520of%2520the%2520BET%2520Bromodomain%2520Protein%2520BRD4%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3D1770%26epage%3D1777%26doi%3D10.1021%2Facschembio.5b00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Toure, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small Molecule PROTACs: New Approaches to Protein Degradation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1966</span><span class="NLM_x">â</span> <span class="NLM_lpage">1973</span><span class="refDoi">Â DOI: 10.1002/anie.201507978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2Fanie.201507978" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=1966-1973&issue=6&author=M.+Toureauthor=C.+M.+Crews&title=Small+Molecule+PROTACs%3A+New+Approaches+to+Protein+Degradation&doi=10.1002%2Fanie.201507978"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507978%26sid%3Dliteratum%253Aachs%26aulast%3DToure%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall%2520Molecule%2520PROTACs%253A%2520New%2520Approaches%2520to%2520Protein%2520Degradation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D6%26spage%3D1966%26epage%3D1973%26doi%3D10.1002%2Fanie.201507978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clague, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">UrbÃ©, S.</span><span> </span><span class="NLM_article-title">Breaking the Chains: Structure and Function of the Deubiquitinases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">550</span><span class="NLM_x">â</span> <span class="NLM_lpage">563</span><span class="refDoi">Â DOI: 10.1038/nrm2731</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm2731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19626045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFSru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=550-563&issue=8&author=D.+Komanderauthor=M.+J.+Clagueauthor=S.+Urb%C3%A9&title=Breaking+the+Chains%3A+Structure+and+Function+of+the+Deubiquitinases&doi=10.1038%2Fnrm2731"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Breaking the chains: structure and function of the deubiquitinases</span></div><div class="casAuthors">Komander, David; Clague, Michael J.; Urbe, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">550-563</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ubiquitination is a reversible protein modification that is implicated in many cellular functions.  Recently, much progress has been made in the characterization of a superfamily of isopeptidases that remove ubiquitin: the deubiquitinases (DUBs; also known as deubiquitinating enzymes).  Far from being uniform in structure and function, these enzymes display a myriad of distinct mechanistic features.  The small no. (<100) of DUBs might at 1st suggest a low degree of selectivity; however, DUBs are subject to multiple layers of regulation that modulate both their activity and their specificity.  Due to their wide-ranging involvement in key regulatory processes, these enzymes might provide new therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Woj6hOAP5rVg90H21EOLACvtfcHk0ljJ4hAR_NXMWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFSru74%253D&md5=9268e6c24101ff8137937a5c851d5bb8</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fnrm2731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2731%26sid%3Dliteratum%253Aachs%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DClague%26aufirst%3DM.%2BJ.%26aulast%3DUrb%25C3%25A9%26aufirst%3DS.%26atitle%3DBreaking%2520the%2520Chains%253A%2520Structure%2520and%2520Function%2520of%2520the%2520Deubiquitinases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26issue%3D8%26spage%3D550%26epage%3D563%26doi%3D10.1038%2Fnrm2731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Nijman, S. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luna-Vargas, M. P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velds, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brummelkamp, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirac, A. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">A Genomic and Functional Inventory of Deubiquitinating Enzymes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">773</span><span class="NLM_x">â</span> <span class="NLM_lpage">786</span><span class="refDoi">Â DOI: 10.1016/j.cell.2005.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2005.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16325574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWntLjP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2005&pages=773-786&issue=5&author=S.+M.+B.+Nijmanauthor=M.+P.+A.+Luna-Vargasauthor=A.+Veldsauthor=T.+R.+Brummelkampauthor=A.+M.+G.+Diracauthor=T.+K.+Sixmaauthor=R.+Bernards&title=A+Genomic+and+Functional+Inventory+of+Deubiquitinating+Enzymes&doi=10.1016%2Fj.cell.2005.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A genomic and functional inventory of deubiquitinating enzymes</span></div><div class="casAuthors">Nijman, Sebastian M. B.; Luna-Vargas, Mark P. A.; Velds, Arno; Brummelkamp, Thijn R.; Dirac, Annette M. G.; Sixma, Titia K.; Bernards, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-786</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Posttranslational modification of proteins by the small mol. ubiquitin is a key regulatory event, and the enzymes catalyzing these modifications have been the focus of many studies.  Deubiquitinating enzymes, which mediate the removal and processing of ubiquitin, may be functionally as important but are less well understood.  Here, we present an inventory of the deubiquitinating enzymes encoded in the human genome.  In addn., we review the literature concerning these enzymes, with particular emphasis on their function, specificity, and the regulation of their activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCJuLc26n4uLVg90H21EOLACvtfcHk0ljNmuiqdz5ppw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWntLjP&md5=e2956e3fa40683da71e558265806d3d6</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DNijman%26aufirst%3DS.%2BM.%2BB.%26aulast%3DLuna-Vargas%26aufirst%3DM.%2BP.%2BA.%26aulast%3DVelds%26aufirst%3DA.%26aulast%3DBrummelkamp%26aufirst%3DT.%2BR.%26aulast%3DDirac%26aufirst%3DA.%2BM.%2BG.%26aulast%3DSixma%26aufirst%3DT.%2BK.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DA%2520Genomic%2520and%2520Functional%2520Inventory%2520of%2520Deubiquitinating%2520Enzymes%26jtitle%3DCell%26date%3D2005%26volume%3D123%26issue%3D5%26spage%3D773%26epage%3D786%26doi%3D10.1016%2Fj.cell.2005.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Abdul Rehman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristariyanto, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nkosi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidlich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labib, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulathu, Y.</span><span> </span><span class="NLM_article-title">MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">146</span><span class="NLM_x">â</span> <span class="NLM_lpage">155</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2016.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2016.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=27292798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2016&pages=146-155&issue=1&author=S.+A.+Abdul+Rehmanauthor=Y.+A.+Kristariyantoauthor=S.-Y.+Choiauthor=P.+J.+Nkosiauthor=S.+Weidlichauthor=K.+Labibauthor=K.+Hofmannauthor=Y.+Kulathu&title=MINDY-1+Is+a+Member+of+an+Evolutionarily+Conserved+and+Structurally+Distinct+New+Family+of+Deubiquitinating+Enzymes&doi=10.1016%2Fj.molcel.2016.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes</span></div><div class="casAuthors">Abdul Rehman, Syed Arif; Kristariyanto, Yosua Adi; Choi, Soo-Youn; Nkosi, Pedro, Jr.; Weidlich, Simone; Labib, Karim; Hofmann, Kay; Kulathu, Yogesh</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-155</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes (DUBs) remove ubiquitin (Ub) from Ub-conjugated substrates to regulate the functional outcome of ubiquitylation.  Here we report the discovery of a new family of DUBs, which we have named MINDY (motif interacting with Ub-contg. novel DUB family).  Found in all eukaryotes, MINDY-family DUBs are highly selective at cleaving K48-linked polyUb, a signal that targets proteins for degrdn.  We identify the catalytic activity to be encoded within a previously unannotated domain, the crystal structure of which reveals a distinct protein fold with no homol. to any of the known DUBs.  The crystal structure of MINDY-1 (also known as FAM63A) in complex with propargylated Ub reveals conformational changes that realign the active site for catalysis.  MINDY-1 prefers cleaving long polyUb chains and works by trimming chains from the distal end.  Collectively, our results reveal a new family of DUBs that may have specialized roles in regulating proteostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPJ1o32zd56LVg90H21EOLACvtfcHk0ljNmuiqdz5ppw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWltL0%253D&md5=80c78d5cd1d2d70e0e2c71c7524f5798</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2016.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2016.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul%2BRehman%26aufirst%3DS.%2BA.%26aulast%3DKristariyanto%26aufirst%3DY.%2BA.%26aulast%3DChoi%26aufirst%3DS.-Y.%26aulast%3DNkosi%26aufirst%3DP.%2BJ.%26aulast%3DWeidlich%26aufirst%3DS.%26aulast%3DLabib%26aufirst%3DK.%26aulast%3DHofmann%26aufirst%3DK.%26aulast%3DKulathu%26aufirst%3DY.%26atitle%3DMINDY-1%2520Is%2520a%2520Member%2520of%2520an%2520Evolutionarily%2520Conserved%2520and%2520Structurally%2520Distinct%2520New%2520Family%2520of%2520Deubiquitinating%2520Enzymes%26jtitle%3DMol.%2520Cell%26date%3D2016%26volume%3D63%26issue%3D1%26spage%3D146%26epage%3D155%26doi%3D10.1016%2Fj.molcel.2016.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Amerik, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, M.</span><span> </span><span class="NLM_article-title">Mechanism and Function of Deubiquitinating Enzymes</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1695</span><span class="NLM_x"> (</span><span class="NLM_issue">1â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">189</span><span class="NLM_x">â</span> <span class="NLM_lpage">207</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2004.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbamcr.2004.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15571815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1695&publication_year=2004&pages=189-207&issue=1%E2%80%933&author=A.+Y.+Amerikauthor=M.+Hochstrasser&title=Mechanism+and+Function+of+Deubiquitinating+Enzymes&doi=10.1016%2Fj.bbamcr.2004.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and function of deubiquitinating enzymes</span></div><div class="casAuthors">Amerik, Alexander Y.; Hochstrasser, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1695</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">189-207</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The attachment of ubiquitin (I) to proteins is a crucial step in many cellular regulatory mechanisms and contributes to numerous biol. processes, including embryonic development, the cell cycle, growth control, and prevention of neurodegeneration.  In these diverse regulatory settings, the most widespread mechanism of I action is probably in the context of protein degrdn.  Polyubiquitin attachment targets many intracellular proteins for degrdn. by the proteasome, and (mono)ubiquitination is often required for down-regulating plasma membrane proteins by targeting them to the vacuole (lysosome).  Ubiquitin-protein conjugates are highly dynamic structures.  Whereas an array of enzymes directs the conjugation of I to substrates, there are also dozens of deubiquitinating enzymes (DUBs) that can reverse the process.  Several lines of evidence indicate that DUBs are important regulators of the I system.  These enzymes are responsible for processing inactive I precursors, proofreading I-protein conjugates, removing I from cellular adducts, and keeping the 26S proteasome free of inhibitory I chains.  The present review focuses on recent discoveries that have led to a better understanding the mechanisms and physiol. roles of this diverse and still poorly understood group of enzymes.  The authors also discuss briefly some of the proteases that act on ubiquitin-like protein (UBL) conjugates and compare them to DUBs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4r5Q5j5cVbrVg90H21EOLACvtfcHk0ljNmuiqdz5ppw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzF&md5=4be57f84af923c82da6b84c6da73a9d9</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2004.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2004.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DAmerik%26aufirst%3DA.%2BY.%26aulast%3DHochstrasser%26aufirst%3DM.%26atitle%3DMechanism%2520and%2520Function%2520of%2520Deubiquitinating%2520Enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2004%26volume%3D1695%26issue%3D1%25E2%2580%25933%26spage%3D189%26epage%3D207%26doi%3D10.1016%2Fj.bbamcr.2004.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Goldenberg, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattern, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, B.</span><span> </span><span class="NLM_article-title">Strategies for the Identification of Novel Inhibitors of Deubiquitinating Enzymes</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">828</span><span class="NLM_x">â</span> <span class="NLM_lpage">832</span><span class="refDoi">Â DOI: 10.1042/BST0360828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1042%2FBST0360828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=18793145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSrt77J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=828-832&issue=5&author=S.+J.+Goldenbergauthor=J.+L.+McDermottauthor=T.+R.+Buttauthor=M.+R.+Matternauthor=B.+Nicholson&title=Strategies+for+the+Identification+of+Novel+Inhibitors+of+Deubiquitinating+Enzymes&doi=10.1042%2FBST0360828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the identification of novel inhibitors of deubiquitinating enzymes</span></div><div class="casAuthors">Goldenberg, Seth J.; McDermott, Jeffrey L.; Butt, Tauseef R.; Mattern, Michael R.; Nicholson, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">828-832</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Dysregulation of the UPS (ubiquitin-proteasome system) has been implicated in a wide range of pathologies including cancer, neurodegeneration and viral infection.  Inhibiting the proteasome has been shown to be an effective therapeutic strategy in humans; yet toxicity with this target remains high.  DUBs (deubiquitinating enzymes) represent an alternative target in the UPS with low predicted toxicity.  Currently, there are no DUB inhibitors that have been used clin.  To address this situation, Progenra has developed a novel assay to measure the proteolytic cleavage of Ub (ubiquitin) or UBL (Ub-like protein) conjugates such as SUMO (small Ub-related modifier), NEDD8 (neural-precursor-cell-expressed, developmentally down-regulated 8) or ISG15 (interferon-stimulated gene 15) by isopeptidases.  In this review, current platforms for detecting DUB inhibitors are discussed and the advantages and disadvantages of the approaches are underlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0x67KYwgCbVg90H21EOLACvtfcHk0lj7qi1KC2kcjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrt77J&md5=b8ec5a0826d6b233130156418afc1b2e</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1042%2FBST0360828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0360828%26sid%3Dliteratum%253Aachs%26aulast%3DGoldenberg%26aufirst%3DS.%2BJ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BL.%26aulast%3DButt%26aufirst%3DT.%2BR.%26aulast%3DMattern%26aufirst%3DM.%2BR.%26aulast%3DNicholson%26aufirst%3DB.%26atitle%3DStrategies%2520for%2520the%2520Identification%2520of%2520Novel%2520Inhibitors%2520of%2520Deubiquitinating%2520Enzymes%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2008%26volume%3D36%26issue%3D5%26spage%3D828%26epage%3D832%26doi%3D10.1042%2FBST0360828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Ndubaku, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span> </span><span class="NLM_article-title">Inhibiting the Deubiquitinating Enzymes (DUBs)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1581</span><span class="NLM_x">â</span> <span class="NLM_lpage">1595</span><span class="refDoi">Â DOI: 10.1021/jm501061a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501061a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLrL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1581-1595&issue=4&author=C.+Ndubakuauthor=V.+Tsui&title=Inhibiting+the+Deubiquitinating+Enzymes+%28DUBs%29&doi=10.1021%2Fjm501061a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the Deubiquitinating Enzymes (DUBs)</span></div><div class="casAuthors">Ndubaku, Chudi; Tsui, Vickie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1581-1595</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The diverse roles of deubiquitinating enzymes, or DUBs, in detg. the fate of specific proteins continue to unfold.  Concurrent with the revelation of DUBs as potential therapeutic targets are publications of small mol. inhibitors of these enzymes.  In this review, we summarize these mols. and their assocd. data and suggest addnl. expts. to further validate and characterize these compds.  We believe the field of drug discovery against DUBs is still in its infancy, but advances in assay development, biophys. techniques, and screening libraries hold promise for identifying suitable agents that could advance into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsiPtPfBsxNrVg90H21EOLACvtfcHk0lj7qi1KC2kcjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLrL&md5=8ec54b033ba6fd8acb3187e4fc004296</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm501061a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501061a%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DTsui%26aufirst%3DV.%26atitle%3DInhibiting%2520the%2520Deubiquitinating%2520Enzymes%2520%2528DUBs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D4%26spage%3D1581%26epage%3D1595%26doi%3D10.1021%2Fjm501061a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Krutauz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakasone, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fushman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickman, M. H.</span><span> </span><span class="NLM_article-title">Extended Ubiquitin Species Are Protein-Based DUB Inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">664</span><span class="NLM_x">â</span> <span class="NLM_lpage">670</span><span class="refDoi">Â DOI: 10.1038/nchembio.1574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24997605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=664-670&issue=8&author=D.+Krutauzauthor=N.+Reisauthor=M.+A.+Nakasoneauthor=P.+Simanauthor=D.+Zhangauthor=D.+S.+Kirkpatrickauthor=S.+P.+Gygiauthor=A.+Brikauthor=D.+Fushmanauthor=M.+H.+Glickman&title=Extended+Ubiquitin+Species+Are+Protein-Based+DUB+Inhibitors&doi=10.1038%2Fnchembio.1574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Extended ubiquitin species are protein-based DUB inhibitors</span></div><div class="casAuthors">Krutauz, Daria; Reis, Noa; Nakasone, Mark A.; Siman, Peter; Zhang, Daoning; Kirkpatrick, Donald S.; Gygi, Steven P.; Brik, Ashraf; Fushman, David; Glickman, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">664-670</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A frameshift mutation in the transcript of the ubiquitin-B gene leads to a ubiquitin (Ub) protein extended by 19 residues at its C-terminus; this stable Ub variant is designated UBB+1 (for "+1" reading frame shift).  UBB+1 has been considered to inhibit proteasomes and as such to be the underlying cause for toxic protein buildup correlated with certain neuropathol. conditions.  We demonstrate that expression of extended Ub variants leads to accumulation of heterogeneously linked polyubiquitin conjugates, indicating a pervasive effect on Ub-dependent turnover.  20S proteasomes selectively proteolyzed Ub extensions, yet no evidence for inhibition of 26S holoenzymes was found.  However, among susceptible targets for inhibition was Ubp6, the primary enzyme responsible for disassembly of Lys48 linkages at 26S proteasomes.  Processing of Lys48 and Lys63 linkages by other deubiquitinating enzymes (DUBs) was also inhibited.  Disruption of Ub-dependent degrdn. by extended Ub variants may therefore be attributed to their inhibitory effect on select DUBs, thus shifting research efforts related to protein accumulation in neurodegenerative processes from proteasomes to DUBs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJYMvK4ehKSbVg90H21EOLACvtfcHk0lj7qi1KC2kcjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrJ&md5=b9ea4f2571c6753f3fe4eeaae0053c4c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1574%26sid%3Dliteratum%253Aachs%26aulast%3DKrutauz%26aufirst%3DD.%26aulast%3DReis%26aufirst%3DN.%26aulast%3DNakasone%26aufirst%3DM.%2BA.%26aulast%3DSiman%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DBrik%26aufirst%3DA.%26aulast%3DFushman%26aufirst%3DD.%26aulast%3DGlickman%26aufirst%3DM.%2BH.%26atitle%3DExtended%2520Ubiquitin%2520Species%2520Are%2520Protein-Based%2520DUB%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D8%26spage%3D664%26epage%3D670%26doi%3D10.1038%2Fnchembio.1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Mullally, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moos, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, F. A.</span><span> </span><span class="NLM_article-title">Cyclopentenone Prostaglandins of the J Series Inhibit the Ubiquitin Isopeptidase Activity of the Proteasome Pathway</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">32</span><span class="NLM_x">) </span> <span class="NLM_fpage">30366</span><span class="NLM_x">â</span> <span class="NLM_lpage">30373</span><span class="refDoi">Â DOI: 10.1074/jbc.M102198200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1074%2Fjbc.M102198200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=30366-30373&issue=32&author=J.+E.+Mullallyauthor=P.+J.+Moosauthor=K.+Edesauthor=F.+A.+Fitzpatrick&title=Cyclopentenone+Prostaglandins+of+the+J+Series+Inhibit+the+Ubiquitin+Isopeptidase+Activity+of+the+Proteasome+Pathway&doi=10.1074%2Fjbc.M102198200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M102198200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M102198200%26sid%3Dliteratum%253Aachs%26aulast%3DMullally%26aufirst%3DJ.%2BE.%26aulast%3DMoos%26aufirst%3DP.%2BJ.%26aulast%3DEdes%26aufirst%3DK.%26aulast%3DFitzpatrick%26aufirst%3DF.%2BA.%26atitle%3DCyclopentenone%2520Prostaglandins%2520of%2520the%2520J%2520Series%2520Inhibit%2520the%2520Ubiquitin%2520Isopeptidase%2520Activity%2520of%2520the%2520Proteasome%2520Pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D32%26spage%3D30366%26epage%3D30373%26doi%3D10.1074%2Fjbc.M102198200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">DâArcy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linder, S.</span><span> </span><span class="NLM_article-title">Deubiquitinase Inhibition as a Cancer Therapeutic Strategy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">â</span> <span class="NLM_lpage">54</span><span class="refDoi">Â DOI: 10.1016/j.pharmthera.2014.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.pharmthera.2014.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25444757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSmtLvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2015&pages=32-54&author=P.+D%E2%80%99Arcyauthor=X.+Wangauthor=S.+Linder&title=Deubiquitinase+Inhibition+as+a+Cancer+Therapeutic+Strategy&doi=10.1016%2Fj.pharmthera.2014.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Deubiquitinase inhibition as a cancer therapeutic strategy</span></div><div class="casAuthors">D'Arcy, Padraig; Wang, Xin; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-54</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The ubiquitin proteasome system (UPS) is the main system for controlled protein degrdn. and a key regulator of fundamental cellular processes.  The dependency of cancer cells on a functioning UPS has made this an attractive target for development of drugs that show selectivity for tumor cells.  Deubiquitinases (DUBs, ubiquitin isopeptidases) are components of the UPS that catalyze the removal of ubiquitin moieties from target proteins or polyubiquitin chains, resulting in altered signaling or changes in protein stability.  A no. of DUBs regulate processes assocd. with cell proliferation and apoptosis, and as such represent candidate targets for cancer therapeutics.  The majority of DUBs are cysteine proteases and are likely to be more "druggable" than E3 ligases.  Cysteine residues in the active sites of DUBs are expected to be reactive to various electrophiles.  Various compds. contg. Î±,Î²-unsatd. ketones have indeed been demonstrated to inhibit cellular DUB activity.  Inhibition of proteasomal cysteine DUB enzymes (i.e.  USP14 and UCHL5) can be predicted to be particularly cytotoxic to cancer cells as it leads to blocking of proteasome function and accumulation of proteasomal substrates.  We here provide an overall review of DUBs relevant to cancer and of various small mols. which have been demonstrated to inhibit DUB activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo83foTkFPMX7Vg90H21EOLACvtfcHk0lgD0x4HxVuE-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSmtLvO&md5=0d916afe785eb52e76d1d3a1e5628e3b</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DDeubiquitinase%2520Inhibition%2520as%2520a%2520Cancer%2520Therapeutic%2520Strategy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D147%26spage%3D32%26epage%3D54%26doi%3D10.1016%2Fj.pharmthera.2014.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melandri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valbrun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueiredo-Pereira, M. E.</span><span> </span><span class="NLM_article-title">Delta12-Prostaglandin J2 Inhibits the Ubiquitin Hydrolase UCH-L1 and Elicits Ubiquitin-Protein Aggregation Without Proteasome Inhibition</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1171</span><span class="NLM_x">â</span> <span class="NLM_lpage">1180</span><span class="refDoi">Â DOI: 10.1016/j.bbrc.2004.05.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbrc.2004.05.098" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2004&pages=1171-1180&issue=4&author=Z.+Liauthor=F.+Melandriauthor=I.+Berdoauthor=M.+Jansenauthor=L.+Hunterauthor=S.+Wrightauthor=D.+Valbrunauthor=M.+E.+Figueiredo-Pereira&title=Delta12-Prostaglandin+J2+Inhibits+the+Ubiquitin+Hydrolase+UCH-L1+and+Elicits+Ubiquitin-Protein+Aggregation+Without+Proteasome+Inhibition&doi=10.1016%2Fj.bbrc.2004.05.098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.05.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.05.098%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMelandri%26aufirst%3DF.%26aulast%3DBerdo%26aufirst%3DI.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DHunter%26aufirst%3DL.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DValbrun%26aufirst%3DD.%26aulast%3DFigueiredo-Pereira%26aufirst%3DM.%2BE.%26atitle%3DDelta12-Prostaglandin%2520J2%2520Inhibits%2520the%2520Ubiquitin%2520Hydrolase%2520UCH-L1%2520and%2520Elicits%2520Ubiquitin-Protein%2520Aggregation%2520Without%2520Proteasome%2520Inhibition%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D319%26issue%3D4%26spage%3D1171%26epage%3D1180%26doi%3D10.1016%2Fj.bbrc.2004.05.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Targeting Proteases: Successes, Failures and Future Prospects</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">785</span><span class="NLM_x">â</span> <span class="NLM_lpage">799</span><span class="refDoi">Â DOI: 10.1038/nrd2092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrd2092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16955069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=785-799&issue=9&author=B.+Turk&title=Targeting+Proteases%3A+Successes%2C+Failures+and+Future+Prospects&doi=10.1038%2Fnrd2092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting proteases: successes, failures and future prospects</span></div><div class="casAuthors">Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">785-799</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Until fairly recently, proteases were considered primarily to be protein-degrading enzymes.  However, this view has dramatically changed and proteases are now seen as extremely important signalling mols. that are involved in numerous vital processes.  Protease signalling pathways are strictly regulated, and the dysregulation of protease activity can lead to pathologies such as cardiovascular and inflammatory diseases, cancer, osteoporosis and neurol. disorders.  Several small-mol. drugs targeting proteases are already on the market and many more are in development.  The status of human protease research and prospects for future protease-targeted drugs are reviewed here, with ref. to some key examples where protease drugs have succeeded or failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_X9u2oqlzrVg90H21EOLACvtfcHk0lgD0x4HxVuE-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltrs%253D&md5=00111ddbeafb283cbe88f7b0ee7bb404</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fnrd2092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2092%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DTargeting%2520Proteases%253A%2520Successes%252C%2520Failures%2520and%2520Future%2520Prospects%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26issue%3D9%26spage%3D785%26epage%3D799%26doi%3D10.1038%2Fnrd2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Colland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formstecher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacq, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reverdy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planquette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trouplin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aushev, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camonis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg-Capra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rain, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guedat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delansorne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daviet, L.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitor of USP7/HAUSP Ubiquitin Protease Stabilizes and Activates P53 in Cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2286</span><span class="NLM_x">â</span> <span class="NLM_lpage">2295</span><span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-09-0097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F1535-7163.MCT-09-0097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19671755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFCmsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2286-2295&issue=8&author=F.+Collandauthor=E.+Formstecherauthor=X.+Jacqauthor=C.+Reverdyauthor=C.+Planquetteauthor=S.+Conrathauthor=V.+Trouplinauthor=J.+Bianchiauthor=V.+N.+Aushevauthor=J.+Camonisauthor=A.+Calabreseauthor=C.+Borg-Capraauthor=W.+Sipplauthor=V.+Colluraauthor=G.+Boissyauthor=J.-C.+Rainauthor=P.+Guedatauthor=R.+Delansorneauthor=L.+Daviet&title=Small-Molecule+Inhibitor+of+USP7%2FHAUSP+Ubiquitin+Protease+Stabilizes+and+Activates+P53+in+Cells&doi=10.1158%2F1535-7163.MCT-09-0097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells</span></div><div class="casAuthors">Colland, Frederic; Formstecher, Etienne; Jacq, Xavier; Reverdy, Celine; Planquette, Cecile; Conrath, Susan; Trouplin, Virginie; Bianchi, Julie; Aushev, Vasily N.; Camonis, Jacques; Calabrese, Alessandra; Borg-Capra, Catherine; Sippl, Wolfgang; Collura, Vincent; Boissy, Guillaume; Rain, Jean-Christophe; Guedat, Philippe; Delansorne, Remi; Daviet, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2286-2295</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Deregulation of the ubiquitin/proteasome system has been implicated in the pathogenesis of many human diseases, including cancer.  Ubiquitin-specific proteases (USP) are cysteine proteases involved in the deubiquitination of protein substrates.  Functional connections between USP7 and essential viral proteins and oncogenic pathways, such as the p53/Mdm2 and phosphatidylinositol 3-kinase/protein kinase B networks, strongly suggest that the targeting of USP7 with small-mol. inhibitors may be useful for the treatment of cancers and viral diseases.  Using high-throughput screening, we have discovered HBX 41,108, a small-mol. compd. that inhibits USP7 deubiquitinating activity with an IC50 in the submicromolar range.  Kinetics data indicate an uncompetitive reversible inhibition mechanism.  HBX 41,108 was shown to affect USP7-mediated p53 deubiquitination in vitro and in cells.  As RNA interference-mediated USP7 silencing in cancer cells, HBX 41,108 treatment stabilized p53, activated the transcription of a p53 target gene without inducing genotoxic stress, and inhibited cancer cell growth.  Finally, HBX 41,108 induced p53-dependent apoptosis as shown in p53 wild-type and null isogenic cancer cell lines.  We thus report the identification of the first lead-like inhibitor against USP7, providing a structural basis for the development of new anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN5f2O-cNWmbVg90H21EOLACvtfcHk0lgD0x4HxVuE-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFCmsrw%253D&md5=bb84e2bd3cf54d0a6842b39e2784eea9</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0097%26sid%3Dliteratum%253Aachs%26aulast%3DColland%26aufirst%3DF.%26aulast%3DFormstecher%26aufirst%3DE.%26aulast%3DJacq%26aufirst%3DX.%26aulast%3DReverdy%26aufirst%3DC.%26aulast%3DPlanquette%26aufirst%3DC.%26aulast%3DConrath%26aufirst%3DS.%26aulast%3DTrouplin%26aufirst%3DV.%26aulast%3DBianchi%26aufirst%3DJ.%26aulast%3DAushev%26aufirst%3DV.%2BN.%26aulast%3DCamonis%26aufirst%3DJ.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DBorg-Capra%26aufirst%3DC.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DCollura%26aufirst%3DV.%26aulast%3DBoissy%26aufirst%3DG.%26aulast%3DRain%26aufirst%3DJ.-C.%26aulast%3DGuedat%26aufirst%3DP.%26aulast%3DDelansorne%26aufirst%3DR.%26aulast%3DDaviet%26aufirst%3DL.%26atitle%3DSmall-Molecule%2520Inhibitor%2520of%2520USP7%252FHAUSP%2520Ubiquitin%2520Protease%2520Stabilizes%2520and%2520Activates%2520P53%2520in%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D8%26spage%3D2286%26epage%3D2295%26doi%3D10.1158%2F1535-7163.MCT-09-0097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Song, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carracedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo-Coco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teruya-Feldstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">The Deubiquitinylation and Localization of PTEN Are Regulated by a HAUSP-PML Network</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7214</span><span class="NLM_x">) </span> <span class="NLM_fpage">813</span><span class="NLM_x">â</span> <span class="NLM_lpage">817</span><span class="refDoi">Â DOI: 10.1038/nature07290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature07290" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=813-817&issue=7214&author=M.+S.+Songauthor=L.+Salmenaauthor=A.+Carracedoauthor=A.+Egiaauthor=F.+Lo-Cocoauthor=J.+Teruya-Feldsteinauthor=P.+P.+Pandolfi&title=The+Deubiquitinylation+and+Localization+of+PTEN+Are+Regulated+by+a+HAUSP-PML+Network&doi=10.1038%2Fnature07290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1038%2Fnature07290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07290%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DM.%2BS.%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DCarracedo%26aufirst%3DA.%26aulast%3DEgia%26aufirst%3DA.%26aulast%3DLo-Coco%26aufirst%3DF.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DThe%2520Deubiquitinylation%2520and%2520Localization%2520of%2520PTEN%2520Are%2520Regulated%2520by%2520a%2520HAUSP-PML%2520Network%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7214%26spage%3D813%26epage%3D817%26doi%3D10.1038%2Fnature07290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Becker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchenko, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, U. M.</span><span> </span><span class="NLM_article-title">A Role of HAUSP in Tumor Suppression in a Human Colon Carcinoma Xenograft Model</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1205</span><span class="NLM_x">â</span> <span class="NLM_lpage">1213</span><span class="refDoi">Â DOI: 10.4161/cc.7.9.5756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.4161%2Fcc.7.9.5756" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1205-1213&issue=9&author=K.+Beckerauthor=N.+D.+Marchenkoauthor=G.+Palaciosauthor=U.+M.+Moll&title=A+Role+of+HAUSP+in+Tumor+Suppression+in+a+Human+Colon+Carcinoma+Xenograft+Model&doi=10.4161%2Fcc.7.9.5756"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.4161%2Fcc.7.9.5756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.7.9.5756%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DMarchenko%26aufirst%3DN.%2BD.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DMoll%26aufirst%3DU.%2BM.%26atitle%3DA%2520Role%2520of%2520HAUSP%2520in%2520Tumor%2520Suppression%2520in%2520a%2520Human%2520Colon%2520Carcinoma%2520Xenograft%2520Model%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26issue%3D9%26spage%3D1205%26epage%3D1213%26doi%3D10.4161%2Fcc.7.9.5756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Dang, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melandri, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. L.</span><span> </span><span class="NLM_article-title">Kinetic and Mechanistic Studies on the Hydrolysis of Ubiquitin C-Terminal 7-Amido-4-Methylcoumarin by Deubiquitinating Enzymes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1868</span><span class="NLM_x">â</span> <span class="NLM_lpage">1879</span><span class="refDoi">Â DOI: 10.1021/bi9723360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9723360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1cXms1OjsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=1868-1879&issue=7&author=L.+C.+Dangauthor=F.+D.+Melandriauthor=R.+L.+Stein&title=Kinetic+and+Mechanistic+Studies+on+the+Hydrolysis+of+Ubiquitin+C-Terminal+7-Amido-4-Methylcoumarin+by+Deubiquitinating+Enzymes&doi=10.1021%2Fbi9723360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and Mechanistic Studies on the Hydrolysis of Ubiquitin C-Terminal 7-Amido-4-Methylcoumarin by Deubiquitinating Enzymes</span></div><div class="casAuthors">Dang, Luan C.; Melandri, Francesco D.; Stein, Ross L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1868-1879</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes constitute a family of cysteine hydrolases that specifically cleave ubiquitin-derived substrates of general structure Ub-X, where X can be any no. of leaving groups ranging from small thiols and amines to Ub and other proteins (Ub, ubiquitin).  We have developed a general assay for deubiquitinating enzymes based on the substrate ubiquitin C-terminal 7-amido-4-methylcoumarin (Ub-AMC).  Ub-AMC is efficiently hydrolyzed with liberation of highly fluorescent AMC by two rabbit reticulocyte deubiquitinating enzymes: isopeptidase T (IPaseT), a member of the gene family of ubiquitin-specific processing enzymes, and UCH-L3, a member of the family of ubiquitin C-terminal hydrolases.  We used this new assay to probe kinetic and mechanistic aspects of catalysis by IPaseT and UCH-L3.  Results from four series of expts. are discussed: (1) For UCH-L3, we detd. steady-state kinetic parameters that suggest a diffusion-limited reaction of UCH-L3 with Ub-AMC.  To probe this, we detd. the viscosity dependence of kc/Km, as well as kc.  We found complex viscosity dependencies and interpreted these in the context of a model in which assocn. and acylation are viscosity-dependent but deacylation is viscosity-independent.  (2) The kinetics of inhibition of UCH-L3 by ubiquitin C-terminal aldehyde (Ub-H) were detd. and reveal a Ki that is less than 10-14 M.  Several mechanisms are considered to account for the extreme inhibition.  (3) The IPaseT-catalyzed hydrolysis of Ub-AMC is modulated by Ub with activation at low [Ub] and inhibition at high [Ub].  (4) Finally, we compare kc/Km values for deubiquitinating enzyme-catalyzed hydrolysis of Ub-AMC and Z-Leu-Arg-Gly-Gly-AMC.  For IPaseT, the ratio of rate consts. is 104, while for UCH-L3 this ratio is >107.  These results suggest the following: (i) Deubiquitinating enzymes are able to utilize the free energy that is released from remote interactions with Ub-contg. substrates for stabilization of catalytic transition states, and (ii) UCHs are more efficient at utilizing the energy from these interactions, presumably because they do not possess a binding domain for a Ub "leaving group".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOpMDRjOWV2LVg90H21EOLACvtfcHk0liVGtwMzzg57A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1OjsA%253D%253D&md5=078fe0b916c22ef4ea7d4fc77aca75c1</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fbi9723360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9723360%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%2BC.%26aulast%3DMelandri%26aufirst%3DF.%2BD.%26aulast%3DStein%26aufirst%3DR.%2BL.%26atitle%3DKinetic%2520and%2520Mechanistic%2520Studies%2520on%2520the%2520Hydrolysis%2520of%2520Ubiquitin%2520C-Terminal%25207-Amido-4-Methylcoumarin%2520by%2520Deubiquitinating%2520Enzymes%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D7%26spage%3D1868%26epage%3D1879%26doi%3D10.1021%2Fbi9723360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Pal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donato, N. J.</span><span> </span><span class="NLM_article-title">Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4955</span><span class="NLM_x">â</span> <span class="NLM_lpage">4966</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-14-1211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F0008-5472.CAN-14-1211" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=4955-4966&issue=18&author=A.+Palauthor=M.+A.+Youngauthor=N.+J.+Donato&title=Emerging+Potential+of+Therapeutic+Targeting+of+Ubiquitin-Specific+Proteases+in+the+Treatment+of+Cancer&doi=10.1158%2F0008-5472.CAN-14-1211"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1211%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DM.%2BA.%26aulast%3DDonato%26aufirst%3DN.%2BJ.%26atitle%3DEmerging%2520Potential%2520of%2520Therapeutic%2520Targeting%2520of%2520Ubiquitin-Specific%2520Proteases%2520in%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D18%26spage%3D4955%26epage%3D4966%26doi%3D10.1158%2F0008-5472.CAN-14-1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Huang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nijman, S. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirchandani, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galardy, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploegh, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâAndrea, A. D.</span><span> </span><span class="NLM_article-title">Regulation of Monoubiquitinated PCNA by DUB Autocleavage</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">â</span> <span class="NLM_lpage">347</span><span class="refDoi">Â DOI: 10.1038/ncb1378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fncb1378" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=341-347&issue=4&author=T.+T.+Huangauthor=S.+M.+B.+Nijmanauthor=K.+D.+Mirchandaniauthor=P.+J.+Galardyauthor=M.+A.+Cohnauthor=W.+Haasauthor=S.+P.+Gygiauthor=H.+L.+Ploeghauthor=R.+Bernardsauthor=A.+D.+D%E2%80%99Andrea&title=Regulation+of+Monoubiquitinated+PCNA+by+DUB+Autocleavage&doi=10.1038%2Fncb1378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1038%2Fncb1378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1378%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DNijman%26aufirst%3DS.%2BM.%2BB.%26aulast%3DMirchandani%26aufirst%3DK.%2BD.%26aulast%3DGalardy%26aufirst%3DP.%2BJ.%26aulast%3DCohn%26aufirst%3DM.%2BA.%26aulast%3DHaas%26aufirst%3DW.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DBernards%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26atitle%3DRegulation%2520of%2520Monoubiquitinated%2520PCNA%2520by%2520DUB%2520Autocleavage%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2006%26volume%3D8%26issue%3D4%26spage%3D341%26epage%3D347%26doi%3D10.1038%2Fncb1378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Nijman, S. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirac, A. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brummelkamp, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkhoven, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâAndrea, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">331</span><span class="NLM_x">â</span> <span class="NLM_lpage">339</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2005.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2005.01.008" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=331-339&issue=3&author=S.+M.+B.+Nijmanauthor=T.+T.+Huangauthor=A.+M.+G.+Diracauthor=T.+R.+Brummelkampauthor=R.+M.+Kerkhovenauthor=A.+D.+D%E2%80%99Andreaauthor=R.+Bernards&title=The+Deubiquitinating+Enzyme+USP1+Regulates+the+Fanconi+Anemia+Pathway&doi=10.1016%2Fj.molcel.2005.01.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DNijman%26aufirst%3DS.%2BM.%2BB.%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DDirac%26aufirst%3DA.%2BM.%2BG.%26aulast%3DBrummelkamp%26aufirst%3DT.%2BR.%26aulast%3DKerkhoven%26aufirst%3DR.%2BM.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DThe%2520Deubiquitinating%2520Enzyme%2520USP1%2520Regulates%2520the%2520Fanconi%2520Anemia%2520Pathway%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D17%26issue%3D3%26spage%3D331%26epage%3D339%26doi%3D10.1016%2Fj.molcel.2005.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexheimer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamil, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z.</span><span> </span><span class="NLM_article-title">Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-Small Cell Lung Cancer Cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1390</span><span class="NLM_x">â</span> <span class="NLM_lpage">1400</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2011.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.chembiol.2011.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22118673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeqs7nO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1390-1400&issue=11&author=J.+Chenauthor=T.+S.+Dexheimerauthor=Y.+Aiauthor=Q.+Liangauthor=M.+A.+Villamilauthor=J.+Ingleseauthor=D.+J.+Maloneyauthor=A.+Jadhavauthor=A.+Simeonovauthor=Z.+Zhuang&title=Selective+and+Cell-Active+Inhibitors+of+the+USP1%2F+UAF1+Deubiquitinase+Complex+Reverse+Cisplatin+Resistance+in+Non-Small+Cell+Lung+Cancer+Cells&doi=10.1016%2Fj.chembiol.2011.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells</span></div><div class="casAuthors">Chen, Junjun; Dexheimer, Thomas S.; Ai, Yongxing; Liang, Qin; Villamil, Mark A.; Inglese, James; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton; Zhuang, Zhihao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1390-1400</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Ubiquitin-specific proteases (USPs) have in recent years emerged as a promising therapeutic target class.  We identified selective small-mol. inhibitors against a deubiquitinase complex, the human USP1/UAF1, through quant. high throughput screening (qHTS) of a collection of bioactive mols.  The top inhibitors, pimozide and GW7647, inhibited USP1/UAF1 noncompetitively with a K i of 0.5 and 0.7 Î¼M, resp., and displayed selectivity against a no. of deubiquitinases, deSUMOylase, and cysteine proteases.  The USP1/UAF1 inhibitors act synergistically with cisplatin in inhibiting cisplatin-resistant non-small cell lung cancer (NSCLC) cell proliferation.  USP1/UAF1 represents a promising target for drug intervention because of its involvement in translesion synthesis and Fanconi anemia pathway important for normal DNA damage response.  Our results support USP1/UAF1 as a potential therapeutic target and provide an example of targeting the USP/WD40 repeat protein complex for inhibitor discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroZXpbpHBJmbVg90H21EOLACvtfcHk0lhkLWyqswBvPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeqs7nO&md5=301cd5d56de1548464c8372a0e4ad4ba</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DVillamil%26aufirst%3DM.%2BA.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DZhuang%26aufirst%3DZ.%26atitle%3DSelective%2520and%2520Cell-Active%2520Inhibitors%2520of%2520the%2520USP1%252F%2520UAF1%2520Deubiquitinase%2520Complex%2520Reverse%2520Cisplatin%2520Resistance%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Cells%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26issue%3D11%26spage%3D1390%26epage%3D1400%26doi%3D10.1016%2Fj.chembiol.2011.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eidhoff, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulber, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodendorf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorthiois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span> </span><span class="NLM_article-title">A Sensitive Fluorescence Intensity Assay for Deubiquitinating Proteases Using Ubiquitin-Rhodamine110-Glycine as Substrate</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">201</span><span class="NLM_x">â</span> <span class="NLM_lpage">207</span><span class="refDoi">Â DOI: 10.1016/j.ab.2007.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.ab.2007.07.034" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2007&pages=201-207&issue=2&author=U.+Hassiepenauthor=U.+Eidhoffauthor=G.+Mederauthor=J.-F.+Bulberauthor=A.+Heinauthor=U.+Bodendorfauthor=E.+Lorthioisauthor=B.+Martoglio&title=A+Sensitive+Fluorescence+Intensity+Assay+for+Deubiquitinating+Proteases+Using+Ubiquitin-Rhodamine110-Glycine+as+Substrate&doi=10.1016%2Fj.ab.2007.07.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2007.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2007.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DEidhoff%26aufirst%3DU.%26aulast%3DMeder%26aufirst%3DG.%26aulast%3DBulber%26aufirst%3DJ.-F.%26aulast%3DHein%26aufirst%3DA.%26aulast%3DBodendorf%26aufirst%3DU.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DMartoglio%26aufirst%3DB.%26atitle%3DA%2520Sensitive%2520Fluorescence%2520Intensity%2520Assay%2520for%2520Deubiquitinating%2520Proteases%2520Using%2520Ubiquitin-Rhodamine110-Glycine%2520as%2520Substrate%26jtitle%3DAnal.%2520Biochem.%26date%3D2007%26volume%3D371%26issue%3D2%26spage%3D201%26epage%3D207%26doi%3D10.1016%2Fj.ab.2007.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Kelman, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peresie, H. J.</span><span> </span><span class="NLM_article-title">Mode of DNA Binding of Cis-Platinum(II) Antitumor Drugs: a Base Sequence-Dependent Mechanism Is Proposed</span> <span class="citation_source-journal">Cancer Treat. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">9â10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1445</span><span class="NLM_x">â</span> <span class="NLM_lpage">1452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=387222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaL3cXhsV2kuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=1445-1452&issue=9%E2%80%9310&author=A.+D.+Kelmanauthor=H.+J.+Peresie&title=Mode+of+DNA+Binding+of+Cis-Platinum%28II%29+Antitumor+Drugs%3A+a+Base+Sequence-Dependent+Mechanism+Is+Proposed"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Mode of DNA binding of cis-platinum(II) antitumor drugs:  a base sequence-dependent mechanism is proposed</span></div><div class="casAuthors">Kelman, Asher D.; Peresie, Henry J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reports</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">1445-52</span>CODEN:
                <span class="NLM_cas:coden">CTRRDO</span>;
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">A review with 27 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogo75t1B-UorVg90H21EOLACvtfcHk0lhkLWyqswBvPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhsV2kuw%253D%253D&md5=456298ecec8416718c41b83b31af2888</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelman%26aufirst%3DA.%2BD.%26aulast%3DPeresie%26aufirst%3DH.%2BJ.%26atitle%3DMode%2520of%2520DNA%2520Binding%2520of%2520Cis-Platinum%2528II%2529%2520Antitumor%2520Drugs%253A%2520a%2520Base%2520Sequence-Dependent%2520Mechanism%2520Is%2520Proposed%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1979%26volume%3D63%26issue%3D9%25E2%2580%259310%26spage%3D1445%26epage%3D1452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Siddik, Z. H.</span><span> </span><span class="NLM_article-title">Cisplatin: Mode of Cytotoxic Action and Molecular Basis of Resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">47</span><span class="NLM_x">) </span> <span class="NLM_fpage">7265</span><span class="NLM_x">â</span> <span class="NLM_lpage">7279</span><span class="refDoi">Â DOI: 10.1038/sj.onc.1206933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fsj.onc.1206933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=14576837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotlajtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7265-7279&issue=47&author=Z.+H.+Siddik&title=Cisplatin%3A+Mode+of+Cytotoxic+Action+and+Molecular+Basis+of+Resistance&doi=10.1038%2Fsj.onc.1206933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Cisplatin: mode of cytotoxic action and molecular basis of resistance</span></div><div class="casAuthors">Siddik, Zahid H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">7265-7279</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cisplatin is one of the most potent antitumor agents known, displaying clin. activity against a wide variety of solid tumors.  Its cytotoxic mode of action is mediated by its interaction with DNA to form DNA adducts, primarily intrastrand crosslink adducts, which activate several signal transduction pathways, including those involving ATR, p53, p73, and MAPK, and culminate in the activation of apoptosis.  DNA damage-mediated apoptotic signals, however, can be attenuated, and the resistance that ensues is a major limitation of cisplatin-based chemotherapy.  The mechanisms responsible for cisplatin resistance are several, and contribute to the multifactorial nature of the problem.  Resistance mechanisms that limit the extent of DNA damage include reduced drug uptake, increased drug inactivation, and increased DNA adduct repair.  Origins of these pharmacol.-based mechanisms, however, are at the mol. level.  Mechanisms that inhibit propagation of the DNA damage signal to the apoptotic machinery include loss of damage recognition, overexpression of HER-2/neu, activation of the PI3-K/Akt (also known as PI3-K/PKB) pathway, loss of p53 function, overexpression of antiapoptotic bcl-2, and interference in caspase activation.  The mol. signature defining the resistant phenotype varies between tumors, and the no. of resistance mechanisms activated in response to selection pressures dictates the overall extent of cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3k2Fki_ax2rVg90H21EOLACvtfcHk0ljsk6FdzY1CJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotlajtbY%253D&md5=8520a82f029717c4352d23e4bd7166fe</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206933%26sid%3Dliteratum%253Aachs%26aulast%3DSiddik%26aufirst%3DZ.%2BH.%26atitle%3DCisplatin%253A%2520Mode%2520of%2520Cytotoxic%2520Action%2520and%2520Molecular%2520Basis%2520of%2520Resistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26issue%3D47%26spage%3D7265%26epage%3D7279%26doi%3D10.1038%2Fsj.onc.1206933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senovilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castedo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Molecular Mechanisms of Cisplatin Resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1869</span><span class="NLM_x">â</span> <span class="NLM_lpage">1883</span><span class="refDoi">Â DOI: 10.1038/onc.2011.384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fonc.2011.384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=21892204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWrsr7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=1869-1883&issue=15&author=L.+Galluzziauthor=L.+Senovillaauthor=I.+Vitaleauthor=J.+Michelsauthor=I.+Martinsauthor=O.+Keppauthor=M.+Castedoauthor=G.+Kroemer&title=Molecular+Mechanisms+of+Cisplatin+Resistance&doi=10.1038%2Fonc.2011.384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cisplatin resistance</span></div><div class="casAuthors">Galluzzi, L.; Senovilla, L.; Vitale, I.; Michels, J.; Martins, I.; Kepp, O.; Castedo, M.; Kroemer, G.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1869-1883</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Platinum-based drugs, and in particular cis-diamminedichloroplatinum(II) (best known as cisplatin), are employed for the treatment of a wide array of solid malignancies, including testicular, ovarian, head and neck, colorectal, bladder and lung cancers.  Cisplatin exerts anticancer effects via multiple mechanisms, yet its most prominent (and best understood) mode of action involves the generation of DNA lesions followed by the activation of the DNA damage response and the induction of mitochondrial apoptosis.  Despite a consistent rate of initial responses, cisplatin treatment often results in the development of chemoresistance, leading to therapeutic failure.  An intense research has been conducted during the past 30 years and several mechanisms that account for the cisplatin-resistant phenotype of tumor cells have been described.  Here, we provide a systematic discussion of these mechanism by classifying them in alterations (1) that involve steps preceding the binding of cisplatin to DNA (pre-target resistance), (2) that directly relate to DNA-cisplatin adducts (on-target resistance), (3) concerning the lethal signaling pathway(s) elicited by cisplatin-mediated DNA damage (post-target resistance) and (4) affecting mol. circuitries that do not present obvious links with cisplatin-elicited signals (off-target resistance).  As in some clin. settings cisplatin constitutes the major therapeutic option, the development of chemosensitization strategies constitute a goal with important clin. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxTrgUhh4V17Vg90H21EOLACvtfcHk0ljsk6FdzY1CJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWrsr7E&md5=4f947e6d5b834673b819e88b06309a53</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.384%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DSenovilla%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DMichels%26aufirst%3DJ.%26aulast%3DMartins%26aufirst%3DI.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DCastedo%26aufirst%3DM.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520Mechanisms%2520of%2520Cisplatin%2520Resistance%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26issue%3D15%26spage%3D1869%26epage%3D1883%26doi%3D10.1038%2Fonc.2011.384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Chou, T.-C.</span><span> </span><span class="NLM_article-title">Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">440</span><span class="NLM_x">â</span> <span class="NLM_lpage">446</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-09-1947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F0008-5472.CAN-09-1947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=20068163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=440-446&issue=2&author=T.-C.+Chou&title=Drug+Combination+Studies+and+Their+Synergy+Quantification+Using+the+Chou-Talalay+Method&doi=10.1158%2F0008-5472.CAN-09-1947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method</span></div><div class="casAuthors">Chou, Ting-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">440-446</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  This brief perspective article focuses on the most common errors and pitfalls, as well as the do's and don'ts in drug combination studies, in terms of exptl. design, data acquisition, data interpretation, and computerized simulation.  The Chou-Talalay method for drug combination is based on the median-effect equation, derived from the mass-action law principle, which is the unified theory that provides the common link between single entity and multiple entities, and first order and higher order dynamics.  This general equation encompasses the Michaelis-Menten, Hill, Henderson-Hasselbalch, and Scatchard equations in biochem. and biophysics.  The resulting combination index (CI) theorem of Chou-Talalay offers quant. definition for additive effect (CI = 1), synergism (CI < 1), and antagonism (CI > 1) in drug combinations.  This theory also provides algorithms for automated computer simulation for synergism and/or antagonism at any effect and dose level, as shown in the CI plot and isobologram, resp.  Cancer Res; 70(2); 440-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpECUlVzkYExbVg90H21EOLACvtfcHk0ljsk6FdzY1CJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWksA%253D%253D&md5=d0713e60852fc656bc91719ccb27eb1a</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1947%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.-C.%26atitle%3DDrug%2520Combination%2520Studies%2520and%2520Their%2520Synergy%2520Quantification%2520Using%2520the%2520Chou-Talalay%2520Method%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D2%26spage%3D440%26epage%3D446%26doi%3D10.1158%2F0008-5472.CAN-09-1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Ritorto, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Oliva, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knebel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhrlage, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wightman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virdee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrice, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trost, M.</span><span> </span><span class="NLM_article-title">Screening of DUB Activity and Specificity by MALDI-TOF Mass Spectrometry</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4763</span><span class="refDoi">Â DOI: 10.1038/ncomms5763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fncomms5763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25159004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFentro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4763&author=M.+S.+Ritortoauthor=R.+Ewanauthor=A.+B.+Perez-Olivaauthor=A.+Knebelauthor=S.+J.+Buhrlageauthor=M.+Wightmanauthor=S.+M.+Kellyauthor=N.+T.+Woodauthor=S.+Virdeeauthor=N.+S.+Grayauthor=N.+A.+Morriceauthor=D.+R.+Alessiauthor=M.+Trost&title=Screening+of+DUB+Activity+and+Specificity+by+MALDI-TOF+Mass+Spectrometry&doi=10.1038%2Fncomms5763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of DUB activity and specificity by MALDI-TOF mass spectrometry</span></div><div class="casAuthors">Ritorto, Maria Stella; Ewan, Richard; Perez-Oliva, Ana B.; Knebel, Axel; Buhrlage, Sara J.; Wightman, Melanie; Kelly, Sharon M.; Wood, Nicola T.; Virdee, Satpal; Gray, Nathanael S.; Morrice, Nicholas A.; Alessi, Dario R.; Trost, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4763</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deubiquitylases (DUBs) are key regulators of the ubiquitin system which cleave ubiquitin moieties from proteins and polyubiquitin chains.  Several DUBs have been implicated in various diseases and are attractive drug targets.  We have developed a sensitive and fast assay to quantify in vitro DUB enzyme activity using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.  Unlike other current assays, this method uses unmodified substrates, such as diubiquitin topoisomers.  By analyzing 42 human DUBs against all diubiquitin topoisomers we provide an extensive characterization of DUB activity and specificity.  Our results confirm the high specificity of many members of the OTU and JAB/MPN/Mov34 metalloenzyme DUB families and highlight that all USPs tested display low linkage selectivity.  We also demonstrate that this assay can be deployed to assess the potency and specificity of DUB inhibitors by profiling 11 compds. against a panel of 32 DUBs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf9lg-hgw78rVg90H21EOLACvtfcHk0li-_oOANMIV8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFentro%253D&md5=614edc01e83206811d3e27a2ca11ae3b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fncomms5763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5763%26sid%3Dliteratum%253Aachs%26aulast%3DRitorto%26aufirst%3DM.%2BS.%26aulast%3DEwan%26aufirst%3DR.%26aulast%3DPerez-Oliva%26aufirst%3DA.%2BB.%26aulast%3DKnebel%26aufirst%3DA.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DWightman%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DS.%2BM.%26aulast%3DWood%26aufirst%3DN.%2BT.%26aulast%3DVirdee%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DMorrice%26aufirst%3DN.%2BA.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DTrost%26aufirst%3DM.%26atitle%3DScreening%2520of%2520DUB%2520Activity%2520and%2520Specificity%2520by%2520MALDI-TOF%2520Mass%2520Spectrometry%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4763%26doi%3D10.1038%2Fncomms5763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexheimer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamil, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luci, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z.</span><span> </span><span class="NLM_article-title">A Selective USP1-UAF1 Inhibitor Links Deubiquitination to DNA Damage Responses</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">298</span><span class="NLM_x">â</span> <span class="NLM_lpage">304</span><span class="refDoi">Â DOI: 10.1038/nchembio.1455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24531842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOgtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=298-304&issue=4&author=Q.+Liangauthor=T.+S.+Dexheimerauthor=P.+Zhangauthor=A.+S.+Rosenthalauthor=M.+A.+Villamilauthor=C.+Youauthor=Q.+Zhangauthor=J.+Chenauthor=C.+A.+Ottauthor=H.+Sunauthor=D.+K.+Luciauthor=B.+Yuanauthor=A.+Simeonovauthor=A.+Jadhavauthor=H.+Xiaoauthor=Y.+Wangauthor=D.+J.+Maloneyauthor=Z.+Zhuang&title=A+Selective+USP1-UAF1+Inhibitor+Links+Deubiquitination+to+DNA+Damage+Responses&doi=10.1038%2Fnchembio.1455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses</span></div><div class="casAuthors">Liang, Qin; Dexheimer, Thomas S.; Zhang, Ping; Rosenthal, Andrew S.; Villamil, Mark A.; You, Changjun; Zhang, Qiuting; Chen, Junjun; Ott, Christine A.; Sun, Hongmao; Luci, Diane K.; Yuan, Bifeng; Simeonov, Anton; Jadhav, Ajit; Xiao, Hui; Wang, Yinsheng; Maloney, David J.; Zhuang, Zhihao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">298-304</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein ubiquitination and deubiquitination are central to the control of a large no. of cellular pathways and signaling networks in eukaryotes.  Although the essential roles of ubiquitination have been established in the eukaryotic DNA damage response, the deubiquitination process remains poorly defined.  Chem. probes that perturb the activity of deubiquitinases (DUBs) are needed to characterize the cellular function of deubiquitination.  Here the authors report ML323 , a highly potent inhibitor of the USP1-UAF1 deubiquitinase complex with excellent selectivity against human DUBs, deSUMOylase, deneddylase and unrelated proteases.  Using ML323, the authors interrogated deubiquitination in the cellular response to UV- and cisplatin-induced DNA damage and revealed new insights into the requirement of deubiquitination in the DNA translesion synthesis and Fanconi anemia pathways.  Moreover, ML323 potentiates cisplatin cytotoxicity in non-small cell lung cancer and osteosarcoma cells.  The authors' findings point to USP1-UAF1 as a key regulator of the DNA damage response and a target for overcoming resistance to the platinum-based anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqra2Cr2SOx7bVg90H21EOLACvtfcHk0li-_oOANMIV8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOgtrw%253D&md5=3486f59d79d15b197ea384e9df9291ee</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1455%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DRosenthal%26aufirst%3DA.%2BS.%26aulast%3DVillamil%26aufirst%3DM.%2BA.%26aulast%3DYou%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DOtt%26aufirst%3DC.%2BA.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLuci%26aufirst%3DD.%2BK.%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DZhuang%26aufirst%3DZ.%26atitle%3DA%2520Selective%2520USP1-UAF1%2520Inhibitor%2520Links%2520Deubiquitination%2520to%2520DNA%2520Damage%2520Responses%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D4%26spage%3D298%26epage%3D304%26doi%3D10.1038%2Fnchembio.1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Wu</span>, <span class="hlFld-ContribAuthor ">Suresh  Kumar</span>, <span class="hlFld-ContribAuthor ">Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Lijia  Chen</span>, <span class="hlFld-ContribAuthor ">Patrick  Arsenault</span>, <span class="hlFld-ContribAuthor ">Michael  Mattern</span>, and <span class="hlFld-ContribAuthor ">Joseph  Weinstock</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (2)
                                     , 422-443. <a href="https://doi.org/10.1021/acs.jmedchem.7b00498" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00498%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252BApproaches%252Bto%252BIntervening%252Bin%252BUbiquitin%252BSpecific%252BProtease%252B7%252B%252528USP7%252529%252BFunction%252Bfor%252BOncology%252Band%252BImmune%252BOncology%252BTherapies%26aulast%3DWu%26aufirst%3DJian%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D30032017%26date%3D18082017%26date%3D25012018%26date%3D02082017%26volume%3D61%26issue%3D2%26spage%3D422%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig M.  Crews</span> (<span class="NLM_role">Guest Editor</span>). </span><span class="cited-content_cbyCitation_article-title">Inducing Protein Degradation as a Therapeutic Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (2)
                                     , 403-404. <a href="https://doi.org/10.1021/acs.jmedchem.7b01333" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01333%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInducing%252BProtein%252BDegradation%252Bas%252Ba%252BTherapeutic%252BStrategy%26aulast%3DCrews%26aufirst%3DCraig%2BM.%26date%3D2018%26date%3D2017%26date%3D13092017%26date%3D22112017%26date%3D25012018%26volume%3D61%26issue%3D2%26spage%3D403%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geun Taek  Lee</span>, <span class="hlFld-ContribAuthor ">Naoya  Nagaya</span>, <span class="hlFld-ContribAuthor ">Jenny  Desantis</span>, <span class="hlFld-ContribAuthor ">Kiran  Madura</span>, <span class="hlFld-ContribAuthor ">Hatem E.  Sabaawy</span>, <span class="hlFld-ContribAuthor ">Wun-Jae  Kim</span>, <span class="hlFld-ContribAuthor ">Roy J.  Vaz</span>, <span class="hlFld-ContribAuthor ">Gabriele  Cruciani</span>, <span class="hlFld-ContribAuthor ">Isaac Yi  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7
                        and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen
                        Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2021,</strong> <em>20 </em>
                                    (3)
                                     , 490-499. <a href="https://doi.org/10.1158/1535-7163.MCT-20-0417" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-20-0417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-20-0417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-20-0417%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DEffects%252Bof%252BMTX-23%25252C%252Ba%252BNovel%252BPROTAC%252Bof%252BAndrogen%252BReceptor%252BSplice%252BVariant-7%252Band%252BAndrogen%252BReceptor%25252C%252Bon%252BCRPC%252BResistant%252Bto%252BSecond-Line%252BAntiandrogen%252BTherapy%26aulast%3DLee%26aufirst%3DGeun%2BTaek%26date%3D2021%26date%3D2020%26volume%3D20%26issue%3D3%26spage%3D490%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Xie</span>, <span class="hlFld-ContribAuthor ">Jian-Jia  Liang</span>, <span class="hlFld-ContribAuthor ">Ya-Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Tian-Xing  Hu</span>, <span class="hlFld-ContribAuthor ">Jin-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Rui-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Jun-Ke  Yan</span>, <span class="hlFld-ContribAuthor ">Qiu-Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xia  Xu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Yu  Ke</span>. </span><span class="cited-content_cbyCitation_article-title">The design, synthesis and anti-tumor mechanism study of new androgen receptor degrader. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112512. <a href="https://doi.org/10.1016/j.ejmech.2020.112512" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112512%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdesign%25252C%252Bsynthesis%252Band%252Banti-tumor%252Bmechanism%252Bstudy%252Bof%252Bnew%252Bandrogen%252Breceptor%252Bdegrader%26aulast%3DXie%26aufirst%3DHang%26date%3D2020%26volume%3D204%26spage%3D112512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhiraj  Kumar</span>, <span class="hlFld-ContribAuthor ">Rashmi K.  Ambasta</span>, <span class="hlFld-ContribAuthor ">Pravir  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Ageing Research Reviews</span><span> <strong>2020,</strong> <em>61 </em>, 101078. <a href="https://doi.org/10.1016/j.arr.2020.101078" title="DOI URL">https://doi.org/10.1016/j.arr.2020.101078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arr.2020.101078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arr.2020.101078%26sid%3Dliteratum%253Aachs%26jtitle%3DAgeing%2520Research%2520Reviews%26atitle%3DUbiquitin%252Bbiology%252Bin%252Bneurodegenerative%252Bdisorders%25253A%252BFrom%252Bimpairment%252Bto%252Btherapeutic%252Bstrategies%26aulast%3DKumar%26aufirst%3DDhiraj%26date%3D2020%26volume%3D61%26spage%3D101078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pimyupa  Manaswiyoungkul</span>, <span class="hlFld-ContribAuthor ">Elvin D.  de Araujo</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting prenylation inhibition through the mevalonate pathway. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 51-71. <a href="https://doi.org/10.1039/C9MD00442D" title="DOI URL">https://doi.org/10.1039/C9MD00442D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00442D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00442D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bprenylation%252Binhibition%252Bthrough%252Bthe%252Bmevalonate%252Bpathway%26aulast%3DManaswiyoungkul%26aufirst%3DPimyupa%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D51%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ingrid E.  Wertz</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">From Discovery to Bedside: Targeting the Ubiquitin System. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (2)
                                     , 156-177. <a href="https://doi.org/10.1016/j.chembiol.2018.10.022" title="DOI URL">https://doi.org/10.1016/j.chembiol.2018.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2018.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DFrom%252BDiscovery%252Bto%252BBedside%25253A%252BTargeting%252Bthe%252BUbiquitin%252BSystem%26aulast%3DWertz%26aufirst%3DIngrid%2BE.%26date%3D2019%26volume%3D26%26issue%3D2%26spage%3D156%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miriam  Di Marco</span>, <span class="hlFld-ContribAuthor ">Matteo  Lambrughi</span>, <span class="hlFld-ContribAuthor ">Elena  Papaleo</span>. </span><span class="cited-content_cbyCitation_article-title">Using Biomolecular Simulations to Target Cdc34 in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 325-341. <a href="https://doi.org/10.1002/9783527806836.ch13" title="DOI URL">https://doi.org/10.1002/9783527806836.ch13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527806836.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527806836.ch13%26sid%3Dliteratum%253Aachs%26atitle%3DUsing%252BBiomolecular%252BSimulations%252Bto%252BTarget%252BCdc34%252Bin%252BCancer%26aulast%3DDi%2BMarco%26aufirst%3DMiriam%26date%3D2018%26date%3D2018%26spage%3D325%26epage%3D341%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DBiomolecular%252BSimulations%252Bin%252BStructure-Based%252BDrug%252BDiscovery%26aulast%3DGervasio%26aufirst%3DFrancesco%2BL.%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/medium/jm-2016-01346d_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/large/jm-2016-01346d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01346&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/medium/jm-2016-01346d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/large/jm-2016-01346d_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Ubiquitin/Ubl enzymatic cascade for protein labeling with ubiquitin or other Ubls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-2/acs.jmedchem.6b01346/20180119/images/large/jm-2016-01346d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01346&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 157 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kerscher, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felberbaum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, M.</span><span> </span><span class="NLM_article-title">Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">â</span> <span class="NLM_lpage">180</span><span class="refDoi">Â DOI: 10.1146/annurev.cellbio.22.010605.093503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1146%2Fannurev.cellbio.22.010605.093503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16753028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yjs7vI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2006&pages=159-180&author=O.+Kerscherauthor=R.+Felberbaumauthor=M.+Hochstrasser&title=Modification+of+Proteins+by+Ubiquitin+and+Ubiquitin-Like+Proteins&doi=10.1146%2Fannurev.cellbio.22.010605.093503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of proteins by ubiquitin and ubiquitin-like proteins</span></div><div class="casAuthors">Kerscher, Oliver; Felberbaum, Rachael; Hochstrasser, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-180</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Following the discovery of protein modification by the small, highly conserved ubiquitin polypeptide, a no. of distinct ubiquitin-like proteins (Ubls) have been found to function as protein modifiers as well.  These Ubls, which include SUMO, ISG15, Nedd8, and Atg8, function as crit. regulators of many cellular processes, including transcription, DNA repair, signal transduction, autophagy, and cell-cycle control.  A growing body of data also implicates the dysregulation of Ubl-substrate modification and mutations in the Ubl-conjugation machinery in the etiol. and progression of a no. of human diseases.  The primary aim of this review is to summarize the latest developments in the understanding of the different Ubl-protein modification systems, including the shared and unique features of these related pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6upobPhWlRrVg90H21EOLACvtfcHk0li1I_GktKrK8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yjs7vI&md5=a57eca21879c93167a900caa0b72d008</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.22.010605.093503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.22.010605.093503%26sid%3Dliteratum%253Aachs%26aulast%3DKerscher%26aufirst%3DO.%26aulast%3DFelberbaum%26aufirst%3DR.%26aulast%3DHochstrasser%26aufirst%3DM.%26atitle%3DModification%2520of%2520Proteins%2520by%2520Ubiquitin%2520and%2520Ubiquitin-Like%2520Proteins%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2006%26volume%3D22%26spage%3D159%26epage%3D180%26doi%3D10.1146%2Fannurev.cellbio.22.010605.093503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hershko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciechanover, A.</span><span> </span><span class="NLM_article-title">The Ubiquitin System</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">â</span> <span class="NLM_lpage">479</span><span class="refDoi">Â DOI: 10.1146/annurev.biochem.67.1.425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1146%2Fannurev.biochem.67.1.425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=9759494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFOmsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1998&pages=425-479&author=A.+Hershkoauthor=A.+Ciechanover&title=The+Ubiquitin+System&doi=10.1146%2Fannurev.biochem.67.1.425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin system</span></div><div class="casAuthors">Hershko, Avram; Ciechanover, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">425-479</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with â¼298 refs.  The selective degrdn. of many short-lived proteins in eukaryotic cells is carried out by the ubiquitin system.  In this pathway, proteins are targeted for degrdn. by covalent ligation to ubiquitin, a highly conserved small protein.  Ubiquitin-mediated degrdn. of regulatory proteins plays important roles in the control of numerous processes, including cell-cycle progression, signal transduction, transcriptional regulation, receptor down-regulation, and endocytosis.  The ubiquitin system has been implicated in the immune response, development, and programmed cell death.  Abnormalities in ubiquitin-mediated processes have been shown to cause pathol. conditions, including malignant transformation.  In this review we discuss recent information on functions and mechanisms of the ubiquitin system.  Since the selectivity of protein degrdn. is detd. mainly at the stage of ligation to ubiquitin, special attention is focused on what we know, and would like to know, about the mode of action of ubiquitin-protein ligation systems and about signals in proteins recognized by these systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqo5VhDx0kSLVg90H21EOLACvtfcHk0ljTpgqNxeCsyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFOmsLc%253D&md5=7c3c0a6df9c07baf55b5000eae13ef49</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.67.1.425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.67.1.425%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DA.%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DThe%2520Ubiquitin%2520System%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1998%26volume%3D67%26spage%3D425%26epage%3D479%26doi%3D10.1146%2Fannurev.biochem.67.1.425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pickart, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, M. J.</span><span> </span><span class="NLM_article-title">Ubiquitin: Structures, Functions, Mechanisms</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1695</span><span class="NLM_x"> (</span><span class="NLM_issue">1â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">72</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2004.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbamcr.2004.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15571809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1695&publication_year=2004&pages=55-72&issue=1%E2%80%933&author=C.+M.+Pickartauthor=M.+J.+Eddins&title=Ubiquitin%3A+Structures%2C+Functions%2C+Mechanisms&doi=10.1016%2Fj.bbamcr.2004.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin: structures, functions, mechanisms</span></div><div class="casAuthors">Pickart, Cecile M.; Eddins, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1695</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">55-72</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ubiquitin (Ub) is the founding member of a family of structurally conserved proteins that regulate a host of processes in eukaryotic cells.  Ub and its relatives carry out their functions through covalent attachment to other cellular proteins, thereby changing the stability, localization, or activity of the target protein.  Here, the authors review the basic biochem. of these protein conjugation reactions, focusing on Ub itself and emphasizing recent insights into mechanism and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZlvpyTnAFurVg90H21EOLACvtfcHk0ljTpgqNxeCsyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzO&md5=05bee85acf076fed3ade4b76109d8f7d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2004.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2004.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DPickart%26aufirst%3DC.%2BM.%26aulast%3DEddins%26aufirst%3DM.%2BJ.%26atitle%3DUbiquitin%253A%2520Structures%252C%2520Functions%252C%2520Mechanisms%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2004%26volume%3D1695%26issue%3D1%25E2%2580%25933%26spage%3D55%26epage%3D72%26doi%3D10.1016%2Fj.bbamcr.2004.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsischky, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roelofs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span> </span><span class="NLM_article-title">A Proteomics Approach to Understanding Protein Ubiquitination</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">921</span><span class="NLM_x">â</span> <span class="NLM_lpage">926</span><span class="refDoi">Â DOI: 10.1038/nbt849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnbt849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=12872131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVKgur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=921-926&issue=8&author=J.+Pengauthor=D.+Schwartzauthor=J.+E.+Eliasauthor=C.+C.+Thoreenauthor=D.+Chengauthor=G.+Marsischkyauthor=J.+Roelofsauthor=D.+Finleyauthor=S.+P.+Gygi&title=A+Proteomics+Approach+to+Understanding+Protein+Ubiquitination&doi=10.1038%2Fnbt849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A proteomics approach to understanding protein ubiquitination</span></div><div class="casAuthors">Peng, Junmin; Schwartz, Daniel; Elias, Joshua E.; Thoreen, Carson C.; Cheng, Dongmei; Marsischky, Gerald; Roelofs, Jeroen; Finley, Daniel; Gygi, Steven P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-926</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">There is a growing need for techniques that can identify and characterize protein modifications on a large or global scale.  We report here a proteomics approach to enrich, recover, and identify ubiquitin conjugates from Saccharomyces cerevisiae lysate.  Ubiquitin conjugates from a strain expressing 6xHis-tagged ubiquitin were isolated, proteolyzed with trypsin and analyzed by multidimensional liq. chromatog. coupled with tandem mass spectrometry (LC/LC-MS/MS) for amino acid sequence detn.  We identified 1,075 proteins from the sample.  In addn., we detected 110 precise ubiquitination sites present in 72 ubiquitin-protein conjugates.  Finally, ubiquitin itself was found to be modified at seven lysine residues providing evidence for unexpected diversity in polyubiquitin chain topol. in vivo.  The methodol. described here provides a general tool for the large-scale anal. and characterization of protein ubiquitination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl8rBjGO_qrLVg90H21EOLACvtfcHk0ljTpgqNxeCsyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVKgur0%253D&md5=391327b0d4d6c74bac31e01ee5b20a65</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnbt849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt849%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DSchwartz%26aufirst%3DD.%26aulast%3DElias%26aufirst%3DJ.%2BE.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DMarsischky%26aufirst%3DG.%26aulast%3DRoelofs%26aufirst%3DJ.%26aulast%3DFinley%26aufirst%3DD.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26atitle%3DA%2520Proteomics%2520Approach%2520to%2520Understanding%2520Protein%2520Ubiquitination%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26issue%3D8%26spage%3D921%26epage%3D926%26doi%3D10.1038%2Fnbt849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Scheffner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuber, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huibregtse, J. M.</span><span> </span><span class="NLM_article-title">Protein Ubiquitination Involving an E1-E2-E3 Enzyme Ubiquitin Thioester Cascade</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x"> (</span><span class="NLM_issue">6509</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">â</span> <span class="NLM_lpage">83</span><span class="refDoi">Â DOI: 10.1038/373081a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2F373081a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=1995&pages=81-83&issue=6509&author=M.+Scheffnerauthor=U.+Nuberauthor=J.+M.+Huibregtse&title=Protein+Ubiquitination+Involving+an+E1-E2-E3+Enzyme+Ubiquitin+Thioester+Cascade&doi=10.1038%2F373081a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F373081a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F373081a0%26sid%3Dliteratum%253Aachs%26aulast%3DScheffner%26aufirst%3DM.%26aulast%3DNuber%26aufirst%3DU.%26aulast%3DHuibregtse%26aufirst%3DJ.%2BM.%26atitle%3DProtein%2520Ubiquitination%2520Involving%2520an%2520E1-E2-E3%2520Enzyme%2520Ubiquitin%2520Thioester%2520Cascade%26jtitle%3DNature%26date%3D1995%26volume%3D373%26issue%3D6509%26spage%3D81%26epage%3D83%26doi%3D10.1038%2F373081a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wilkinson, K. D.</span><span> </span><span class="NLM_article-title">Regulation of Ubiquitin-Dependent Processes by Deubiquitinating Enzymes</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">1245</span><span class="NLM_x">â</span> <span class="NLM_lpage">1256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=1245-1256&issue=14&author=K.+D.+Wilkinson&title=Regulation+of+Ubiquitin-Dependent+Processes+by+Deubiquitinating+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DK.%2BD.%26atitle%3DRegulation%2520of%2520Ubiquitin-Dependent%2520Processes%2520by%2520Deubiquitinating%2520Enzymes%26jtitle%3DFASEB%2520J.%26date%3D1997%26volume%3D11%26issue%3D14%26spage%3D1245%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Clague, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heride, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">UrbÃ©, S.</span><span> </span><span class="NLM_article-title">The Demographics of the Ubiquitin System</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">417</span><span class="NLM_x">â</span> <span class="NLM_lpage">426</span><span class="refDoi">Â DOI: 10.1016/j.tcb.2015.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.tcb.2015.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25906909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVGqtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=417-426&issue=7&author=M.+J.+Clagueauthor=C.+Herideauthor=S.+Urb%C3%A9&title=The+Demographics+of+the+Ubiquitin+System&doi=10.1016%2Fj.tcb.2015.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The demographics of the ubiquitin system</span></div><div class="casAuthors">Clague, Michael J.; Heride, Claire; Urbe, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">417-426</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The ubiquitin system is a major coordinator of cellular physiol. through regulation of both protein degrdn. and signalling pathways.  A key building block of a systems-level understanding has been generated by global proteomic studies, which provide copy no. ests. for each component.  The aggregate of ubiquitin, conjugating enzymes (E1, E2, and E3s), and deubiquitylases (DUBs) represents â¼1.3% of total cellular protein.  Complementary approaches have generated quant. measurements of various ubiquitin pools and further subdivision into different ubiquitin chain topologies.  Systematic studies aimed at assocg. specific enzymes (E2s and DUBs) with the dynamics of these different pools have also made significant progress.  Here, we delineate the emerging picture of the most significant determinants of the cellular ubiquitin economy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQMwzCvXv5bVg90H21EOLACvtfcHk0lgBga0knB6V7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVGqtbw%253D&md5=38563c26b5d83eab2bb0dc193041d1e5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2015.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2015.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DClague%26aufirst%3DM.%2BJ.%26aulast%3DHeride%26aufirst%3DC.%26aulast%3DUrb%25C3%25A9%26aufirst%3DS.%26atitle%3DThe%2520Demographics%2520of%2520the%2520Ubiquitin%2520System%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D417%26epage%3D426%26doi%3D10.1016%2Fj.tcb.2015.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Michelle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vourcâh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, C. R.</span><span> </span><span class="NLM_article-title">What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor?</span> <span class="citation_source-journal">J. Mol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">616</span><span class="NLM_x">â</span> <span class="NLM_lpage">628</span><span class="refDoi">Â DOI: 10.1007/s00239-009-9225-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1007%2Fs00239-009-9225-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=616-628&issue=6&author=C.+Michelleauthor=P.+Vourc%E2%80%99hauthor=L.+Mignonauthor=C.+R.+Andres&title=What+Was+the+Set+of+Ubiquitin+and+Ubiquitin-Like+Conjugating+Enzymes+in+the+Eukaryote+Common+Ancestor%3F&doi=10.1007%2Fs00239-009-9225-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00239-009-9225-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00239-009-9225-6%26sid%3Dliteratum%253Aachs%26aulast%3DMichelle%26aufirst%3DC.%26aulast%3DVourc%25E2%2580%2599h%26aufirst%3DP.%26aulast%3DMignon%26aufirst%3DL.%26aulast%3DAndres%26aufirst%3DC.%2BR.%26atitle%3DWhat%2520Was%2520the%2520Set%2520of%2520Ubiquitin%2520and%2520Ubiquitin-Like%2520Conjugating%2520Enzymes%2520in%2520the%2520Eukaryote%2520Common%2520Ancestor%253F%26jtitle%3DJ.%2520Mol.%2520Evol.%26date%3D2009%26volume%3D68%26issue%3D6%26spage%3D616%26epage%3D628%26doi%3D10.1007%2Fs00239-009-9225-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtson, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulbrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batalov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joazeiro, C. A. P.</span><span> </span><span class="NLM_article-title">Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 That Regulates the Organelleâs Dynamics and Signaling</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">e1487</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0001487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1371%2Fjournal.pone.0001487" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e1487&issue=1&author=W.+Liauthor=M.+H.+Bengtsonauthor=A.+Ulbrichauthor=A.+Matsudaauthor=V.+A.+Reddyauthor=A.+Orthauthor=S.+K.+Chandaauthor=S.+Batalovauthor=C.+A.+P.+Joazeiro&title=Genome-Wide+and+Functional+Annotation+of+Human+E3+Ubiquitin+Ligases+Identifies+MULAN%2C+a+Mitochondrial+E3+That+Regulates+the+Organelle%E2%80%99s+Dynamics+and+Signaling&doi=10.1371%2Fjournal.pone.0001487"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001487%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DBengtson%26aufirst%3DM.%2BH.%26aulast%3DUlbrich%26aufirst%3DA.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DV.%2BA.%26aulast%3DOrth%26aufirst%3DA.%26aulast%3DChanda%26aufirst%3DS.%2BK.%26aulast%3DBatalov%26aufirst%3DS.%26aulast%3DJoazeiro%26aufirst%3DC.%2BA.%2BP.%26atitle%3DGenome-Wide%2520and%2520Functional%2520Annotation%2520of%2520Human%2520E3%2520Ubiquitin%2520Ligases%2520Identifies%2520MULAN%252C%2520a%2520Mitochondrial%2520E3%2520That%2520Regulates%2520the%2520Organelle%25E2%2580%2599s%2520Dynamics%2520and%2520Signaling%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26issue%3D1%26spage%3De1487%26doi%3D10.1371%2Fjournal.pone.0001487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, A. L.</span><span> </span><span class="NLM_article-title">Human Disorders of Ubiquitination and Proteasomal Degradation</span> <span class="citation_source-journal">Curr. Opin. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">â</span> <span class="NLM_lpage">426</span><span class="refDoi">Â DOI: 10.1097/01.mop.0000133634.79661.cd</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1097%2F01.mop.0000133634.79661.cd" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15273504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A280%3ADC%252BD2czntVKhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=419-426&issue=4&author=Y.-H.+Jiangauthor=A.+L.+Beaudet&title=Human+Disorders+of+Ubiquitination+and+Proteasomal+Degradation&doi=10.1097%2F01.mop.0000133634.79661.cd"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Human disorders of ubiquitination and proteasomal degradation</span></div><div class="casAuthors">Jiang Yong-hui; Beaudet Arthur L</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in pediatrics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-26</span>
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  The goal of this review is to provide an overview of rapidly evolving information on a new group of genetic inborn errors affecting ubiquitination and proteasomal degradation of proteins and to suggest a classification scheme for these disorders.  The relevant genes encode ubiquitin, ubiquitin enzymes (E1 and many E2s and E3s), deubiquitinating enzymes, proteasomal subunits, and substrates undergoing ubiquitination.  RECENT FINDINGS:  Since the initial recognition that Angelman syndrome is caused by maternal deficiency of the E6-AP ubiquitin E3 ligase (gene symbol UBE3A), several. other disorders of E3 ligases have been identified, including autosomal recessive juvenile Parkinson disease, the APECED form of autoimmune polyendocrinopathy syndrome, von Hippel-Lindau syndrome, and congenital polycythemia.  Disorders that disturb ubiquitin regulatory signaling include at least two subtypes of Fanconi anemia, the BRCA1 and BRCA2 forms of breast and ovarian cancer susceptibility, incontinentia pigmenti, and cylindromatosis.  Many disorders affect ubiquitin pathways secondarily.  SUMMARY:  The authors propose both a genetic and a functional classification for disorders of ubiquitination and proteasomal degradation, as follows.  Genetic classes include mutations in (1) the UBB ubiquitin gene; (2) enzymes of ubiquitination including E1, E2, E3, and related proteins; (3) deubiquitinases; (4) proteasomal subunits; and (5) substrates of ubiquitination.  Functional classes include defects in (1) proteolytic degradation, (2) ubiquitin signaling, and (3) subcellular localization of substrates.  Additional functional classes are likely to be defined, and individual disorders may involve multiple functional defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTybSvsnOaHrBBrI9DTGjC0fW6udTcc2eZvY6wDlxoID7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czntVKhtg%253D%253D&md5=809667f28ec41bae34e2e20af8984a2b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1097%2F01.mop.0000133634.79661.cd&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.mop.0000133634.79661.cd%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.-H.%26aulast%3DBeaudet%26aufirst%3DA.%2BL.%26atitle%3DHuman%2520Disorders%2520of%2520Ubiquitination%2520and%2520Proteasomal%2520Degradation%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2004%26volume%3D16%26issue%3D4%26spage%3D419%26epage%3D426%26doi%3D10.1097%2F01.mop.0000133634.79661.cd" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Popovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikic, I.</span><span> </span><span class="NLM_article-title">Ubiquitination in Disease Pathogenesis and Treatment</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1242</span><span class="NLM_x">â</span> <span class="NLM_lpage">1253</span><span class="refDoi">Â DOI: 10.1038/nm.3739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnm.3739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25375928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyku73J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1242-1253&issue=11&author=D.+Popovicauthor=D.+Vucicauthor=I.+Dikic&title=Ubiquitination+in+Disease+Pathogenesis+and+Treatment&doi=10.1038%2Fnm.3739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitination in disease pathogenesis and treatment</span></div><div class="casAuthors">Popovic, Doris; Vucic, Domagoj; Dikic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1242-1253</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ubiquitination is crucial for a plethora of physiol. processes, including cell survival and differentiation and innate and adaptive immunity.  In recent years, considerable progress has been made in the understanding of the mol. action of ubiquitin in signaling pathways and how alterations in the ubiquitin system lead to the development of distinct human diseases.  Here we describe the role of ubiquitination in the onset and progression of cancer, metabolic syndromes, neurodegenerative diseases, autoimmunity, inflammatory disorders, infection and muscle dystrophies.  Moreover, we indicate how current knowledge could be exploited for the development of new clin. therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTMeFCgBByjbVg90H21EOLACvtfcHk0lgvTybvjvYrAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyku73J&md5=3d943ec2721c980b971d02d4905d5348</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm.3739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3739%26sid%3Dliteratum%253Aachs%26aulast%3DPopovic%26aufirst%3DD.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DDikic%26aufirst%3DI.%26atitle%3DUbiquitination%2520in%2520Disease%2520Pathogenesis%2520and%2520Treatment%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26issue%3D11%26spage%3D1242%26epage%3D1253%26doi%3D10.1038%2Fnm.3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Genschik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumara, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, E.</span><span> </span><span class="NLM_article-title">The Emerging Family of CULLIN3-RING Ubiquitin Ligases (CRL3s): Cellular Functions and Disease Implications</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2307</span><span class="NLM_x">â</span> <span class="NLM_lpage">2320</span><span class="refDoi">Â DOI: 10.1038/emboj.2013.173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Femboj.2013.173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23912815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Srsr7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2307-2320&issue=17&author=P.+Genschikauthor=I.+Sumaraauthor=E.+Lechner&title=The+Emerging+Family+of+CULLIN3-RING+Ubiquitin+Ligases+%28CRL3s%29%3A+Cellular+Functions+and+Disease+Implications&doi=10.1038%2Femboj.2013.173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications</span></div><div class="casAuthors">Genschik, Pascal; Sumara, Izabela; Lechner, Esther</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2307-2320</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein ubiquitylation is a post-translational modification that controls all aspects of eukaryotic cell functionality, and its defective regulation is manifested in various human diseases.  The ubiquitylation process requires a set of enzymes, of which the ubiquitin ligases (E3s) are the substrate recognition components.  Modular CULLIN-RING ubiquitin ligases (CRLs) are the most prevalent class of E3s, comprising hundreds of distinct CRL complexes with the potential to recruit as many and even more protein substrates.  Best understood at both structural and functional levels are CRL1 or SCF (SKP1/CUL1/F-box protein) complexes, representing the founding member of this class of multimeric E3s.  Another CRL subfamily, called CRL3, is composed of the mol. scaffold CULLIN3 and the RING protein RBX1, in combination with one of numerous BTB domain proteins acting as substrate adaptors.  Recent work has firmly established CRL3s as major regulators of different cellular and developmental processes as well as stress responses in both metazoans and higher plants.  In humans, functional alterations of CRL3s have been assocd. with various pathologies, including metabolic disorders, muscle, and nerve degeneration, as well as cancer.  In this review, we summarize recent discoveries on the function of CRL3s in both metazoans and plants, and discuss their mode of regulation and specificities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9a4_A8lI_TrVg90H21EOLACvtfcHk0lgvTybvjvYrAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Srsr7J&md5=1828d71b4c75b110ba16b7c52afeb600</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Femboj.2013.173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2013.173%26sid%3Dliteratum%253Aachs%26aulast%3DGenschik%26aufirst%3DP.%26aulast%3DSumara%26aufirst%3DI.%26aulast%3DLechner%26aufirst%3DE.%26atitle%3DThe%2520Emerging%2520Family%2520of%2520CULLIN3-RING%2520Ubiquitin%2520Ligases%2520%2528CRL3s%2529%253A%2520Cellular%2520Functions%2520and%2520Disease%2520Implications%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26issue%3D17%26spage%3D2307%26epage%3D2320%26doi%3D10.1038%2Femboj.2013.173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Soucy, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhollen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doucette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnsey, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaulin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershman, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lublinsky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peluso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talreja, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyskocil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, S. P.</span><span> </span><span class="NLM_article-title">An Inhibitor of NEDD8-Activating Enzyme as a New Approach to Treat Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x"> (</span><span class="NLM_issue">7239</span><span class="NLM_x">) </span> <span class="NLM_fpage">732</span><span class="NLM_x">â</span> <span class="NLM_lpage">736</span><span class="refDoi">Â DOI: 10.1038/nature07884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature07884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19360080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVenu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=732-736&issue=7239&author=T.+A.+Soucyauthor=P.+G.+Smithauthor=M.+A.+Milhollenauthor=A.+J.+Bergerauthor=J.+M.+Gavinauthor=S.+Adhikariauthor=J.+E.+Brownellauthor=K.+E.+Burkeauthor=D.+P.+Cardinauthor=S.+Critchleyauthor=C.+A.+Cullisauthor=A.+Doucetteauthor=J.+J.+Garnseyauthor=J.+L.+Gaulinauthor=R.+E.+Gershmanauthor=A.+R.+Lublinskyauthor=A.+McDonaldauthor=H.+Mizutaniauthor=U.+Narayananauthor=E.+J.+Olhavaauthor=S.+Pelusoauthor=M.+Rezaeiauthor=M.+D.+Sintchakauthor=T.+Talrejaauthor=M.+P.+Thomasauthor=T.+Traoreauthor=S.+Vyskocilauthor=G.+S.+Weatherheadauthor=J.+Yuauthor=J.+Zhangauthor=L.+R.+Dickauthor=C.+F.+Claiborneauthor=M.+Rolfeauthor=J.+B.+Bolenauthor=S.+P.+Langston&title=An+Inhibitor+of+NEDD8-Activating+Enzyme+as+a+New+Approach+to+Treat+Cancer&doi=10.1038%2Fnature07884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer</span></div><div class="casAuthors">Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.; Berger, Allison J.; Gavin, James M.; Adhikari, Sharmila; Brownell, James E.; Burke, Kristine E.; Cardin, David P.; Critchley, Stephen; Cullis, Courtney A.; Doucette, Amanda; Garnsey, James J.; Gaulin, Jeffrey L.; Gershman, Rachel E.; Lublinsky, Anna R.; McDonald, Alice; Mizutani, Hirotake; Narayanan, Usha; Olhava, Edward J.; Peluso, Stephane; Rezaei, Mansoureh; Sintchak, Michael D.; Talreja, Tina; Thomas, Michael P.; Traore, Tary; Vyskocil, Stepan; Weatherhead, Gabriel S.; Yu, Jie; Zhang, Julie; Dick, Lawrence R.; Claiborne, Christopher F.; Rolfe, Mark; Bolen, Joseph B.; Langston, Steven P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7239</span>),
    <span class="NLM_cas:pages">732-736</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. development of an inhibitor of cellular proteasome function suggests that compds. targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies.  NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome.  Substrates of cullin-RING ligases have important roles in cellular processes assocd. with cancer cell growth and survival pathways.  Here we describe MLN4924, a potent and selective inhibitor of NAE.  MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumor cells by a new mechanism of action, the deregulation of S-phase DNA synthesis.  MLN4924 suppressed the growth of human tumor xenografts in mice at compd. exposures that were well tolerated.  Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8fx7OnZtYjbVg90H21EOLACvtfcHk0lg5b34zMDSZDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVenu7Y%253D&md5=365d4b4feac3994849050e00f1aae5e0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature07884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07884%26sid%3Dliteratum%253Aachs%26aulast%3DSoucy%26aufirst%3DT.%2BA.%26aulast%3DSmith%26aufirst%3DP.%2BG.%26aulast%3DMilhollen%26aufirst%3DM.%2BA.%26aulast%3DBerger%26aufirst%3DA.%2BJ.%26aulast%3DGavin%26aufirst%3DJ.%2BM.%26aulast%3DAdhikari%26aufirst%3DS.%26aulast%3DBrownell%26aufirst%3DJ.%2BE.%26aulast%3DBurke%26aufirst%3DK.%2BE.%26aulast%3DCardin%26aufirst%3DD.%2BP.%26aulast%3DCritchley%26aufirst%3DS.%26aulast%3DCullis%26aufirst%3DC.%2BA.%26aulast%3DDoucette%26aufirst%3DA.%26aulast%3DGarnsey%26aufirst%3DJ.%2BJ.%26aulast%3DGaulin%26aufirst%3DJ.%2BL.%26aulast%3DGershman%26aufirst%3DR.%2BE.%26aulast%3DLublinsky%26aufirst%3DA.%2BR.%26aulast%3DMcDonald%26aufirst%3DA.%26aulast%3DMizutani%26aufirst%3DH.%26aulast%3DNarayanan%26aufirst%3DU.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DPeluso%26aufirst%3DS.%26aulast%3DRezaei%26aufirst%3DM.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DTalreja%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DTraore%26aufirst%3DT.%26aulast%3DVyskocil%26aufirst%3DS.%26aulast%3DWeatherhead%26aufirst%3DG.%2BS.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DLangston%26aufirst%3DS.%2BP.%26atitle%3DAn%2520Inhibitor%2520of%2520NEDD8-Activating%2520Enzyme%2520as%2520a%2520New%2520Approach%2520to%2520Treat%2520Cancer%26jtitle%3DNature%26date%3D2009%26volume%3D458%26issue%3D7239%26spage%3D732%26epage%3D736%26doi%3D10.1038%2Fnature07884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nawrocki, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carew, J. S.</span><span> </span><span class="NLM_article-title">MLN4924: a Novel First-in-Class Inhibitor of NEDD8-Activating Enzyme for Cancer Therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1563</span><span class="NLM_x">â</span> <span class="NLM_lpage">1573</span><span class="refDoi">Â DOI: 10.1517/13543784.2012.707192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1517%2F13543784.2012.707192" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=1563-1573&issue=10&author=S.+T.+Nawrockiauthor=P.+Griffinauthor=K.+R.+Kellyauthor=J.+S.+Carew&title=MLN4924%3A+a+Novel+First-in-Class+Inhibitor+of+NEDD8-Activating+Enzyme+for+Cancer+Therapy&doi=10.1517%2F13543784.2012.707192"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543784.2012.707192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2012.707192%26sid%3Dliteratum%253Aachs%26aulast%3DNawrocki%26aufirst%3DS.%2BT.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DK.%2BR.%26aulast%3DCarew%26aufirst%3DJ.%2BS.%26atitle%3DMLN4924%253A%2520a%2520Novel%2520First-in-Class%2520Inhibitor%2520of%2520NEDD8-Activating%2520Enzyme%2520for%2520Cancer%2520Therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26issue%3D10%26spage%3D1563%26epage%3D1573%26doi%3D10.1517%2F13543784.2012.707192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tcherpakov, M.</span><span> </span><span class="NLM_article-title">Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">686</span><span class="NLM_x">â</span> <span class="NLM_lpage">693</span><span class="refDoi">Â DOI: 10.1016/j.cell.2010.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2010.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=21111230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVygsLbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2010&pages=686-693&issue=5&author=P.+Cohenauthor=M.+Tcherpakov&title=Will+the+Ubiquitin+System+Furnish+as+Many+Drug+Targets+as+Protein+Kinases%3F&doi=10.1016%2Fj.cell.2010.11.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?</span></div><div class="casAuthors">Cohen, Philip; Tcherpakov, Marianna</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">686-693</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Protein phosphorylation and protein ubiquitination regulate most aspects of cell life, and defects in these control mechanisms cause cancer and many other diseases.  In the past decade, protein kinases have become one of the most important classes of drug targets for the pharmaceutical industry.  In contrast, drug discovery programs that target components of the ubiquitin system have lagged behind.  In this Perspective, we discuss the reasons for the delay in this pipeline, the drugs targeting the ubiquitin system that have been developed, and new approaches that may popularize this area of drug discovery in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqocw2eBP5US7Vg90H21EOLACvtfcHk0lj92Ow-DaZjuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVygsLbI&md5=b273310afef9fd544a534d9f39b0afb2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DTcherpakov%26aufirst%3DM.%26atitle%3DWill%2520the%2520Ubiquitin%2520System%2520Furnish%2520as%2520Many%2520Drug%2520Targets%2520as%2520Protein%2520Kinases%253F%26jtitle%3DCell%26date%3D2010%26volume%3D143%26issue%3D5%26spage%3D686%26epage%3D693%26doi%3D10.1016%2Fj.cell.2010.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Adams, J.</span><span> </span><span class="NLM_article-title">Development of the Proteasome Inhibitor PS-341</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span><span class="refDoi">Â DOI: 10.1634/theoncologist.7-1-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1634%2Ftheoncologist.7-1-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=9-16&issue=1&author=J.+Adams&title=Development+of+the+Proteasome+Inhibitor+PS-341&doi=10.1634%2Ftheoncologist.7-1-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.7-1-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.7-1-9%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520the%2520Proteasome%2520Inhibitor%2520PS-341%26jtitle%3DOncologist%26date%3D2002%26volume%3D7%26issue%3D1%26spage%3D9%26epage%3D16%26doi%3D10.1634%2Ftheoncologist.7-1-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">From Epoxomicin to Carfilzomib: Chemistry, Biology, and Medical Outcomes</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">600</span><span class="NLM_x">â</span> <span class="NLM_lpage">604</span><span class="refDoi">Â DOI: 10.1039/c3np20126k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1039%2Fc3np20126k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23575525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVWqsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=600-604&issue=5&author=K.+B.+Kimauthor=C.+M.+Crews&title=From+Epoxomicin+to+Carfilzomib%3A+Chemistry%2C+Biology%2C+and+Medical+Outcomes&doi=10.1039%2Fc3np20126k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes</span></div><div class="casAuthors">Kim, Kyung Bo; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">600-604</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 1992 to 2012The initial enthusiasm following the discovery of a pharmacol. active natural product is often fleeting due to the poor prospects for its ultimate clin. application.  Despite this, the ever-changing landscape of modern biol. has a const. need for mol. probes that can aid in our understanding of biol. processes.  After its initial discovery by Bristol-Myers Squibb as a microbial anti-tumor natural product, epoxomicin was deemed unfit for development due to its peptide structure and potentially labile epoxyketone pharmacophore.  Despite its drawbacks, epoxomicin's pharmacophore was found to provide unprecedented selectivity for the proteasome.  Epoxomicin also served as a scaffold for the generation of a synthetic tetrapeptide epoxyketone with improved activity, YU-101, which became the parent lead compd. of carfilzomib (KyprolisÂ®), the recently approved therapeutic agent for multiple myeloma.  In this era of rational drug design and high-throughput screening, the prospects for turning an active natural product into an approved therapy are often slim.  However, by understanding the journey that began with the discovery of epoxomicin and ended with the successful use of carfilzomib in the clinic, we may find new insights into the keys for success in natural product-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ZmojYh4VybVg90H21EOLACvtfcHk0lj92Ow-DaZjuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVWqsrY%253D&md5=fa9d90ac327e5383f6d80512ecec8db4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2Fc3np20126k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3np20126k%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DFrom%2520Epoxomicin%2520to%2520Carfilzomib%253A%2520Chemistry%252C%2520Biology%252C%2520and%2520Medical%2520Outcomes%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2013%26volume%3D30%26issue%3D5%26spage%3D600%26epage%3D604%26doi%3D10.1039%2Fc3np20126k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Elofsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Splittgerber, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Towards Subunit-Specific Proteasome Inhibitors: Synthesis and Evaluation of Peptide Alphaâ,Beta-âEpoxyketones</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">811</span><span class="NLM_x">â</span> <span class="NLM_lpage">822</span><span class="refDoi">Â DOI: 10.1016/S1074-5521(99)80128-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS1074-5521%2899%2980128-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10574782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1MXnsVGmsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=811-822&issue=11&author=M.+Elofssonauthor=U.+Splittgerberauthor=J.+Myungauthor=R.+Mohanauthor=C.+M.+Crews&title=Towards+Subunit-Specific+Proteasome+Inhibitors%3A+Synthesis+and+Evaluation+of+Peptide+Alpha%E2%80%9C%2CBeta-%E2%80%9DEpoxyketones&doi=10.1016%2FS1074-5521%2899%2980128-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide Î±',Î²'-epoxyketones</span></div><div class="casAuthors">Elofsson, Mikael; Splittgerber, Ute; Myung, Jayhyuk; Mohan, Royce; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">811-822</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Background: The proteasome is a large multicatalytic protease complex (700 kDa) involved in a no. of highly regulated processes.  It has three major catalytic activities: a chymotrypsin-like activity, a trypsin-like activity and a post-glutamyl peptide hydrolyzing (PGPH) activity.  To be useful as mol. probes which could help dissect the cellular functions of the proteasome, inhibitors should be specific for the proteasome, active in vivo, and selectively block only one of the three catalytic activities.  To date, few inhibitors fulfill these requirements so we set out to make novel proteasome inhibitors that incorporate these characteristics.  Results: A panel of amino-terminally acetylated peptide Î±',Î²'-epoxyketones with leucine in P1 and various aliph. or arom. amino acids in P2-P4 were prepd. and evaluated.  Most compds. selectively inhibited the chymotrypsin-like activity, while only weakly inhibiting the trypsin-like and PGPH activities.  After optimization, one inhibitor, Ac-hFLFL-epoxide, was found to be more potent and selective for the inhibition of the chymotrypsin-like activity than several previously described inhibitors.  This inhibitor also exhibited strong in vivo anti-inflammatory activity.  Conclusions: Optimization of amino-terminally acetylated peptide Î±',Î²'-epoxyketones furnished a potent proteasome inhibitor, Ac-hFLFL-epoxide, that has an excellent selectivity for the chymotrypsin-like activity.  The inhibitor also proved to be a potent antiproliferative and anti-inflammatory agent.  The strong in vivo and in vitro activities suggest that this class of proteasome inhibitors could be both mol. probes and therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAHPwh58N7j7Vg90H21EOLACvtfcHk0lj92Ow-DaZjuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsVGmsrg%253D&md5=3c64b736004246226d33ce7f6dfefbed</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980128-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980128-8%26sid%3Dliteratum%253Aachs%26aulast%3DElofsson%26aufirst%3DM.%26aulast%3DSplittgerber%26aufirst%3DU.%26aulast%3DMyung%26aufirst%3DJ.%26aulast%3DMohan%26aufirst%3DR.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTowards%2520Subunit-Specific%2520Proteasome%2520Inhibitors%253A%2520Synthesis%2520and%2520Evaluation%2520of%2520Peptide%2520Alpha%25E2%2580%259C%252CBeta-%25E2%2580%259DEpoxyketones%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26issue%3D11%26spage%3D811%26epage%3D822%26doi%3D10.1016%2FS1074-5521%2899%2980128-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Siegel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vij, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowiak, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukreti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahlis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanan-Khan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reu, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadtmauer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wear, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span> </span><span class="NLM_article-title">A Phase 2 Study of Single-Agent Carfilzomib (PX-171-003-A1) in Patients with Relapsed and Refractory Multiple Myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2817</span><span class="NLM_x">â</span> <span class="NLM_lpage">2825</span><span class="refDoi">Â DOI: 10.1182/blood-2012-05-425934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1182%2Fblood-2012-05-425934" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2817-2825&issue=14&author=D.+S.+Siegelauthor=T.+Martinauthor=M.+Wangauthor=R.+Vijauthor=A.+J.+Jakubowiakauthor=S.+Lonialauthor=S.+Trudelauthor=V.+Kukretiauthor=N.+Bahlisauthor=M.+Alsinaauthor=A.+Chanan-Khanauthor=F.+Buadiauthor=F.+J.+Reuauthor=G.+Somloauthor=J.+Zonderauthor=K.+Songauthor=A.+K.+Stewartauthor=E.+Stadtmauerauthor=L.+Kunkelauthor=S.+Wearauthor=A.+F.+Wongauthor=R.+Z.+Orlowskiauthor=S.+Jagannath&title=A+Phase+2+Study+of+Single-Agent+Carfilzomib+%28PX-171-003-A1%29+in+Patients+with+Relapsed+and+Refractory+Multiple+Myeloma&doi=10.1182%2Fblood-2012-05-425934"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-05-425934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-05-425934%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DVij%26aufirst%3DR.%26aulast%3DJakubowiak%26aufirst%3DA.%2BJ.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DKukreti%26aufirst%3DV.%26aulast%3DBahlis%26aufirst%3DN.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DChanan-Khan%26aufirst%3DA.%26aulast%3DBuadi%26aufirst%3DF.%26aulast%3DReu%26aufirst%3DF.%2BJ.%26aulast%3DSomlo%26aufirst%3DG.%26aulast%3DZonder%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DK.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DStadtmauer%26aufirst%3DE.%26aulast%3DKunkel%26aufirst%3DL.%26aulast%3DWear%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%2BF.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DJagannath%26aufirst%3DS.%26atitle%3DA%2520Phase%25202%2520Study%2520of%2520Single-Agent%2520Carfilzomib%2520%2528PX-171-003-A1%2529%2520in%2520Patients%2520with%2520Relapsed%2520and%2520Refractory%2520Multiple%2520Myeloma%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26issue%3D14%26spage%3D2817%26epage%3D2825%26doi%3D10.1182%2Fblood-2012-05-425934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Vij, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowiak, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukreti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonagh, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahlis, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reu, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrail, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matous, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesole, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wear, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D. S.</span><span> </span><span class="NLM_article-title">An Open-Label, Single-Arm, Phase 2 (PX-171-004) Study of Single-Agent Carfilzomib in Bortezomib-Naive Patients with Relapsed and/or Refractory Multiple Myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">5661</span><span class="NLM_x">â</span> <span class="NLM_lpage">5670</span><span class="refDoi">Â DOI: 10.1182/blood-2012-03-414359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1182%2Fblood-2012-03-414359" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=5661-5670&issue=24&author=R.+Vijauthor=M.+Wangauthor=J.+L.+Kaufmanauthor=S.+Lonialauthor=A.+J.+Jakubowiakauthor=A.+K.+Stewartauthor=V.+Kukretiauthor=S.+Jagannathauthor=K.+T.+McDonaghauthor=M.+Alsinaauthor=N.+J.+Bahlisauthor=F.+J.+Reuauthor=N.+Y.+Gabrailauthor=A.+Belchauthor=J.+V.+Matousauthor=P.+Leeauthor=P.+Rosenauthor=M.+Sebagauthor=D.+H.+Vesoleauthor=L.+A.+Kunkelauthor=S.+M.+Wearauthor=A.+F.+Wongauthor=R.+Z.+Orlowskiauthor=D.+S.+Siegel&title=An+Open-Label%2C+Single-Arm%2C+Phase+2+%28PX-171-004%29+Study+of+Single-Agent+Carfilzomib+in+Bortezomib-Naive+Patients+with+Relapsed+and%2For+Refractory+Multiple+Myeloma&doi=10.1182%2Fblood-2012-03-414359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-03-414359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-03-414359%26sid%3Dliteratum%253Aachs%26aulast%3DVij%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DKaufman%26aufirst%3DJ.%2BL.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DJakubowiak%26aufirst%3DA.%2BJ.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DKukreti%26aufirst%3DV.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DMcDonagh%26aufirst%3DK.%2BT.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DBahlis%26aufirst%3DN.%2BJ.%26aulast%3DReu%26aufirst%3DF.%2BJ.%26aulast%3DGabrail%26aufirst%3DN.%2BY.%26aulast%3DBelch%26aufirst%3DA.%26aulast%3DMatous%26aufirst%3DJ.%2BV.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DRosen%26aufirst%3DP.%26aulast%3DSebag%26aufirst%3DM.%26aulast%3DVesole%26aufirst%3DD.%2BH.%26aulast%3DKunkel%26aufirst%3DL.%2BA.%26aulast%3DWear%26aufirst%3DS.%2BM.%26aulast%3DWong%26aufirst%3DA.%2BF.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26atitle%3DAn%2520Open-Label%252C%2520Single-Arm%252C%2520Phase%25202%2520%2528PX-171-004%2529%2520Study%2520of%2520Single-Agent%2520Carfilzomib%2520in%2520Bortezomib-Naive%2520Patients%2520with%2520Relapsed%2520and%252For%2520Refractory%2520Multiple%2520Myeloma%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26issue%3D24%26spage%3D5661%26epage%3D5670%26doi%3D10.1182%2Fblood-2012-03-414359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vij, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowiak, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahlis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunkel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D. S.</span><span> </span><span class="NLM_article-title">An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma</span> <span class="citation_source-journal">Clin Lymphoma Myeloma Leuk</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">310</span><span class="NLM_x">â</span> <span class="NLM_lpage">318</span><span class="refDoi">Â DOI: 10.1016/j.clml.2012.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.clml.2012.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23040437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVyhsbrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=310-318&issue=5&author=S.+Jagannathauthor=R.+Vijauthor=A.+K.+Stewartauthor=S.+Trudelauthor=A.+J.+Jakubowiakauthor=T.+Reimanauthor=G.+Somloauthor=N.+Bahlisauthor=S.+Lonialauthor=L.+A.+Kunkelauthor=A.+Wongauthor=R.+Z.+Orlowskiauthor=D.+S.+Siegel&title=An+Open-Label+Single-Arm+Pilot+Phase+II+Study+%28PX-171-003-A0%29+of+Low-Dose%2C+Single-Agent+Carfilzomib+in+Patients+with+Relapsed+and+Refractory+Multiple+Myeloma&doi=10.1016%2Fj.clml.2012.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma</span></div><div class="casAuthors">Jagannath, Sundar; Vij, Ravi; Stewart, A. Keith; Trudel, Suzanne; Jakubowiak, Andrzej J.; Reiman, Tony; Somlo, George; Bahlis, Nizar; Lonial, Sagar; Kunkel, Lori A.; Wong, Alvin; Orlowski, Robert Z.; Siegel, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Lymphoma, Myeloma & Leukemia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">310-318</span>CODEN:
                <span class="NLM_cas:coden">CLMLCQ</span>;
        ISSN:<span class="NLM_cas:issn">2152-2669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Carfilzomib is a next-generation selective proteasome inhibitor that irreversibly binds its target and has demonstrated single-agent activity in patients with bortezomib-resistant multiple myeloma (MM).  PX-171-003-A0, an open-label single-arm multicenter pilot phase II study, enrolled 46 patients with relapsed MM after â¥ 2 previous therapies including bortezomib and an immunomodulator (thalidomide or lenalidomide) and disease refractory to the last treatment regimen preceding study entry.  Patients received carfilzomib 20 mg/m2 i.v. on days 1, 2, 8, 9, 15, and 16 every 28 days for up to 12 cycles.  Responses in 42 evaluable patients were assessed per International Myeloma Working Group Uniform Response Criteria, with minimal response assessed per European Group for Blood and Marrow Transplantation (EBMT) criteria.  The primary endpoint of best ORR was 16.7%, including 7 partial responses.  Median duration of response was 7.2 mo.  Clin. benefit response (CBR) rate was 23.8% with a median duration of response of 13.8 mo.  The most common treatment-emergent adverse events (AEs) of any grade were anemia (73.9%), fatigue (69.6%), and thrombocytopenia (50.0%).  Notably, peripheral neuropathy and neuropathy-related AEs were generally mild and infrequent.  This pilot study was the first phase II single-agent trial conducted with carfilzomib.  Based on these findings, the study was amended to test a higher carfilzomib dose in an addnl. 250 patients (PX-171-003-A1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPRBkDDHNX8bVg90H21EOLACvtfcHk0likCywv4aBAkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVyhsbrP&md5=66d006c6d3b3324cbb198d8426f294d9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.clml.2012.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clml.2012.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DVij%26aufirst%3DR.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DJakubowiak%26aufirst%3DA.%2BJ.%26aulast%3DReiman%26aufirst%3DT.%26aulast%3DSomlo%26aufirst%3DG.%26aulast%3DBahlis%26aufirst%3DN.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DKunkel%26aufirst%3DL.%2BA.%26aulast%3DWong%26aufirst%3DA.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26atitle%3DAn%2520Open-Label%2520Single-Arm%2520Pilot%2520Phase%2520II%2520Study%2520%2528PX-171-003-A0%2529%2520of%2520Low-Dose%252C%2520Single-Agent%2520Carfilzomib%2520in%2520Patients%2520with%2520Relapsed%2520and%2520Refractory%2520Multiple%2520Myeloma%26jtitle%3DClin%2520Lymphoma%2520Myeloma%2520Leuk%26date%3D2012%26volume%3D12%26issue%3D5%26spage%3D310%26epage%3D318%26doi%3D10.1016%2Fj.clml.2012.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Kinase Drug Discovery--Whatâs Next in the Field?</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">96</span><span class="NLM_x">â</span> <span class="NLM_lpage">104</span><span class="refDoi">Â DOI: 10.1021/cb300610s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300610s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvF2q" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=96-104&issue=1&author=P.+Cohenauthor=D.+R.+Alessi&title=Kinase+Drug+Discovery%2D%2DWhat%E2%80%99s+Next+in+the+Field%3F&doi=10.1021%2Fcb300610s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Drug Discovery - What's Next in the Field?</span></div><div class="casAuthors">Cohen, Philip; Alessi, Dario R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-104</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past 15 years protein kinases have become the pharmaceutical industry's most important class of drug target in the field of cancer.  Some 20 drugs that target kinases have been approved for clin. use over the past decade, and hundreds more are undergoing clin. trials.  However, the recent approval of the first protein kinase inhibitors for the treatment of inflammatory diseases, coupled with an enhanced understanding of the signaling networks that control the immune system, suggests that there will be a surge of interest in this area over the next 10 years.  In this connection, we discuss opportunities for targeting protein kinases in the MyD88 signaling network for the development of drugs to treat chronic inflammatory and autoimmune diseases.  Activating mutations in protein kinases underlie many other diseases and conditions, and we also discuss why the protein kinases SPAK/OSR1 and LRRK2 have recently become interesting targets for the treatment of hypertension and Parkinson's disease, resp., and the progress that has been made in developing LRRK2 inhibitors.  Finally we suggest that more focus on the identification of inhibitors of kinase activation, rather than kinase activity, may pay dividends in identifying exquisitely specific inhibitors of signal transduction cascades, and we also highlight "pseudo-kinases" as an attractive and unexplored area for drug development that merits much more attention in the years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9qmfkcqZ3ILVg90H21EOLACvtfcHk0lgmq4w2H8dk3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvF2q&md5=5bf2ced4163b6ae70e604b2916a6a068</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fcb300610s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300610s%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKinase%2520Drug%2520Discovery--What%25E2%2580%2599s%2520Next%2520in%2520the%2520Field%253F%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D1%26spage%3D96%26epage%3D104%26doi%3D10.1021%2Fcb300610s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, M. H.</span><span> </span><span class="NLM_article-title">FDA-Approved Small-Molecule Kinase Inhibitors</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">422</span><span class="NLM_x">â</span> <span class="NLM_lpage">439</span><span class="refDoi">Â DOI: 10.1016/j.tips.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.tips.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25975227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=422-439&issue=7&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=FDA-Approved+Small-Molecule+Kinase+Inhibitors&doi=10.1016%2Fj.tips.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">FDA-approved small-molecule kinase inhibitors</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">422-439</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Kinases have emerged as one of the most intensively pursued targets in current pharmacol. research, esp. for cancer, due to their crit. roles in cellular signaling.  To date, the US FDA has approved 28 small-mol. kinase inhibitors, half of which were approved in the past 3 years.  While the clin. data of these approved mols. are widely presented and structure-activity relationship (SAR) has been reported for individual mols., an updated review that analyzes all approved mols. and summarizes current achievements and trends in the field has yet to be found.  Here we present all approved small-mol. kinase inhibitors with an emphasis on binding mechanism and structural features, summarize current challenges, and discuss future directions in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrudyvM3eO09bVg90H21EOLACvtfcHk0lgmq4w2H8dk3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1KisLg%253D&md5=a6aa3dbb11e6fe3001fa5fa03a4c950a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DFDA-Approved%2520Small-Molecule%2520Kinase%2520Inhibitors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26issue%3D7%26spage%3D422%26epage%3D439%26doi%3D10.1016%2Fj.tips.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span> </span><span class="NLM_article-title">The Druggable Genome</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">727</span><span class="NLM_x">â</span> <span class="NLM_lpage">730</span><span class="refDoi">Â DOI: 10.1038/nrd892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrd892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=12209152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD38XmslamtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=727-730&issue=9&author=A.+L.+Hopkinsauthor=C.+R.+Groom&title=The+Druggable+Genome&doi=10.1038%2Fnrd892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: The druggable genome</span></div><div class="casAuthors">Hopkins, Andrew L.; Groom, Colin R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">727-730</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  An assessment of the no. of mol. targets that represent an opportunity for therapeutic intervention is crucial to the development of post-genomic research strategies within the pharmaceutical industry.  Now that we know the size of the human genome, it is interesting to consider just how many mol. targets this opportunity represents.  We start from the position that we understand the properties that are required for a good drug, and therefore must be able to understand what makes a good drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Uvqi8O9wzrVg90H21EOLACvtfcHk0lgiX7E1iKHu1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmslamtrY%253D&md5=d6dc7c67822661fe03e920695def1329</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrd892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd892%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26atitle%3DThe%2520Druggable%2520Genome%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26issue%3D9%26spage%3D727%26epage%3D730%26doi%3D10.1038%2Fnrd892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">MÃ¼ller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The Ins and Outs of Selective Kinase Inhibitor Development</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">818</span><span class="NLM_x">â</span> <span class="NLM_lpage">821</span><span class="refDoi">Â DOI: 10.1038/nchembio.1938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=26485069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=818-821&issue=11&author=S.+M%C3%BCllerauthor=A.+Chaikuadauthor=N.+S.+Grayauthor=S.+Knapp&title=The+Ins+and+Outs+of+Selective+Kinase+Inhibitor+Development&doi=10.1038%2Fnchembio.1938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The ins and outs of selective kinase inhibitor development</span></div><div class="casAuthors">Muller, Susanne; Chaikuad, Apirat; Gray, Nathanael S.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-821</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases have emerged as one of the most successful families of drug targets.  To date, most selective kinase inhibitors have been discovered serendipitously either through broad selectivity screening or through the discovery of unique binding modes.  Here the authors discuss design strategies that could lead to a broader coverage of the kinome with selective inhibitors and to a more rational approach for developing them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQzaMrxSYx_rVg90H21EOLACvtfcHk0lgiX7E1iKHu1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF&md5=f5adf0bbaa388c87b26bae23cfad0bae</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1938%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520Ins%2520and%2520Outs%2520of%2520Selective%2520Kinase%2520Inhibitor%2520Development%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D11%26spage%3D818%26epage%3D821%26doi%3D10.1038%2Fnchembio.1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Furman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutre, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelenetz, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipps, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eradat, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ervin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamanna, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coiffier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettitt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilgenbauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahn, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansey, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, S. M.</span><span> </span><span class="NLM_article-title">Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">997</span><span class="NLM_x">â</span> <span class="NLM_lpage">1007</span><span class="refDoi">Â DOI: 10.1056/NEJMoa1315226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1056%2FNEJMoa1315226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24450857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVyqtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=997-1007&issue=11&author=R.+R.+Furmanauthor=J.+P.+Sharmanauthor=S.+E.+Coutreauthor=B.+D.+Chesonauthor=J.+M.+Pagelauthor=P.+Hillmenauthor=J.+C.+Barrientosauthor=A.+D.+Zelenetzauthor=T.+J.+Kippsauthor=I.+Flinnauthor=P.+Ghiaauthor=H.+Eradatauthor=T.+Ervinauthor=N.+Lamannaauthor=B.+Coiffierauthor=A.+R.+Pettittauthor=S.+Maauthor=S.+Stilgenbauerauthor=P.+Cramerauthor=M.+Aielloauthor=D.+M.+Johnsonauthor=L.+L.+Millerauthor=D.+Liauthor=T.+M.+Jahnauthor=R.+D.+Danseyauthor=M.+Hallekauthor=S.+M.+O%E2%80%99Brien&title=Idelalisib+and+Rituximab+in+Relapsed+Chronic+Lymphocytic+Leukemia&doi=10.1056%2FNEJMoa1315226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Idelalisib and rituximab in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Furman, Richard R.; Sharman, Jeff P.; Coutre, Steven E.; Cheson, Bruce D.; Pagel, John M.; Hillmen, Peter; Barrientos, Jacqueline C.; Zelenetz, Andrew D.; Kipps, Thomas J.; Flinn, Ian; Ghia, Paolo; Eradat, Herbert; Ervin, Thomas; Lamanna, Nicole; Coiffier, Bertrand; Pettitt, Andrew R.; Ma, Shuo; Stilgenbauer, Stephan; Cramer, Paula; Aiello, Maria; Johnson, Dave M.; Miller, Langdon L.; Li, Daniel; Jahn, Thomas M.; Dansey, Roger D.; Hallek, Michael; O'Brien, Susan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">997-1007</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Patients with relapsed chronic lymphocytic leukemia (CLL) who have clin. significant coexisting medical conditions are less able to undergo std. chemotherapy.  Effective therapies with acceptable side-effect profiles are needed for this patient population.  In this multicenter, randomized, double-blind, placebo-controlled, phase 3 study, the authors assessed the efficacy and safety of idelalisib, an oral inhibitor of the delta isoform of phosphatidylinositol 3-kinase, in combination with rituximab vs. rituximab plus placebo.  The authors randomly assigned 220 patients with decreased renal function, previous therapy-induced myelosuppression, or major coexisting illnesses to receive rituximab and either idelalisib (at a dose of 150 mg) or placebo twice daily.  The primary end point was progression-free survival.  At the first prespecified interim anal., the study was stopped early on the recommendation of the data and safety monitoring board owing to overwhelming efficacy.  The median progression-free survival was 5.5 mo in the placebo group and was not reached in the idelalisib group (hazard ratio for progression or death in the idelalisib group, 0.15; P<0.001).  Patients receiving idelalisib vs. those receiving placebo had improved rates of overall response (81% vs. 13%; odds ratio, 29.92; P<0.001) and overall survival at 12 mo (92% vs. 80%; hazard ratio for death, 0.28; P = 0.02).  Serious adverse events occurred in 40% of the patients receiving idelalisib and rituximab and in 35% of those receiving placebo and rituximab.  The combination of idelalisib and rituximab, as compared with placebo and rituximab, significantly improved progression-free survival, response rate, and overall survival among patients with relapsed CLL who were less able to undergo chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhnTsUaIOybVg90H21EOLACvtfcHk0lhLpmI-cA_7Rw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVyqtLs%253D&md5=4bce9ab0dae94360abfcd4f312691503</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1315226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1315226%26sid%3Dliteratum%253Aachs%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26aulast%3DCheson%26aufirst%3DB.%2BD.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DEradat%26aufirst%3DH.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DLamanna%26aufirst%3DN.%26aulast%3DCoiffier%26aufirst%3DB.%26aulast%3DPettitt%26aufirst%3DA.%2BR.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DStilgenbauer%26aufirst%3DS.%26aulast%3DCramer%26aufirst%3DP.%26aulast%3DAiello%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BM.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DJahn%26aufirst%3DT.%2BM.%26aulast%3DDansey%26aufirst%3DR.%2BD.%26aulast%3DHallek%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BM.%26atitle%3DIdelalisib%2520and%2520Rituximab%2520in%2520Relapsed%2520Chronic%2520Lymphocytic%2520Leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26issue%3D11%26spage%3D997%26epage%3D1007%26doi%3D10.1056%2FNEJMoa1315226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Berndt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hon, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¼ckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">The P110 Delta Structure: Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">117</span><span class="NLM_x">â</span> <span class="NLM_lpage">124</span><span class="refDoi">Â DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&issue=2&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+R%C3%BCckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williams&title=The+P110+Delta+Structure%3A+Mechanisms+for+Selectivity+and+Potency+of+New+PI%283%29K+Inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The p110Î´ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110Î´.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110Î´ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110Î´ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0lhLpmI-cA_7Rw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DThe%2520P110%2520Delta%2520Structure%253A%2520Mechanisms%2520for%2520Selectivity%2520and%2520Potency%2520of%2520New%2520PI%25283%2529K%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D2%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lannutti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, S. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span> </span><span class="NLM_article-title">CAL-101, a P110delta Selective Phosphatidylinositol-3-Kinase Inhibitor for the Treatment of B-Cell Malignancies, Inhibits PI3K Signaling and Cellular Viability</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">591</span><span class="NLM_x">â</span> <span class="NLM_lpage">594</span><span class="refDoi">Â DOI: 10.1182/blood-2010-03-275305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1182%2Fblood-2010-03-275305" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=591-594&issue=2&author=B.+J.+Lannuttiauthor=S.+A.+Meadowsauthor=S.+E.+M.+Hermanauthor=A.+Kashishianauthor=B.+Steinerauthor=A.+J.+Johnsonauthor=J.+C.+Byrdauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=M.+Deiningerauthor=B.+J.+Drukerauthor=K.+D.+Puriauthor=R.+G.+Ulrichauthor=N.+A.+Giese&title=CAL-101%2C+a+P110delta+Selective+Phosphatidylinositol-3-Kinase+Inhibitor+for+the+Treatment+of+B-Cell+Malignancies%2C+Inhibits+PI3K+Signaling+and+Cellular+Viability&doi=10.1182%2Fblood-2010-03-275305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-03-275305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-03-275305%26sid%3Dliteratum%253Aachs%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DHerman%26aufirst%3DS.%2BE.%2BM.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDeininger%26aufirst%3DM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26atitle%3DCAL-101%252C%2520a%2520P110delta%2520Selective%2520Phosphatidylinositol-3-Kinase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520B-Cell%2520Malignancies%252C%2520Inhibits%2520PI3K%2520Signaling%2520and%2520Cellular%2520Viability%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26issue%3D2%26spage%3D591%26epage%3D594%26doi%3D10.1182%2Fblood-2010-03-275305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koditek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VillaseÃ±or, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novikov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liclican, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagpacan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papalia, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span> </span><span class="NLM_article-title">Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase Î</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">8439</span><span class="NLM_x">â</span> <span class="NLM_lpage">8446</span><span class="refDoi">Â DOI: 10.1074/jbc.M114.634683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1074%2Fjbc.M114.634683" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=8439-8446&issue=13&author=J.+R.+Somozaauthor=D.+Koditekauthor=A.+G.+Villase%C3%B1orauthor=N.+Novikovauthor=M.+H.+Wongauthor=A.+Liclicanauthor=W.+Xingauthor=L.+Lagpacanauthor=R.+Wangauthor=B.+E.+Schultzauthor=G.+A.+Papaliaauthor=D.+Samuelauthor=L.+Ladauthor=M.+E.+McGrath&title=Structural%2C+Biochemical%2C+and+Biophysical+Characterization+of+Idelalisib+Binding+to+Phosphoinositide+3-Kinase+%CE%94&doi=10.1074%2Fjbc.M114.634683"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.634683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.634683%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DXing%26aufirst%3DW.%26aulast%3DLagpacan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DPapalia%26aufirst%3DG.%2BA.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26atitle%3DStructural%252C%2520Biochemical%252C%2520and%2520Biophysical%2520Characterization%2520of%2520Idelalisib%2520Binding%2520to%2520Phosphoinositide%25203-Kinase%2520%25CE%2594%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D13%26spage%3D8439%26epage%3D8446%26doi%3D10.1074%2Fjbc.M114.634683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakefuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurachi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakegawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmartin, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquerre, S. G.</span><span> </span><span class="NLM_article-title">Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">320</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span><span class="refDoi">Â DOI: 10.1021/ml200004g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200004g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=320-324&issue=4&author=H.+Abeauthor=S.+Kikuchiauthor=K.+Hayakawaauthor=T.+Iidaauthor=N.+Nagahashiauthor=K.+Maedaauthor=J.+Sakamotoauthor=N.+Matsumotoauthor=T.+Miuraauthor=K.+Matsumuraauthor=N.+Sekiauthor=T.+Inabaauthor=H.+Kawasakiauthor=T.+Yamaguchiauthor=R.+Kakefudaauthor=T.+Nanayamaauthor=H.+Kurachiauthor=Y.+Horiauthor=T.+Yoshidaauthor=J.+Kakegawaauthor=Y.+Watanabeauthor=A.+G.+Gilmartinauthor=M.+C.+Richterauthor=K.+G.+Mossauthor=S.+G.+Laquerre&title=Discovery+of+a+Highly+Potent+and+Selective+MEK+Inhibitor%3A+GSK1120212+%28JTP-74057+DMSO+Solvate%29&doi=10.1021%2Fml200004g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fml200004g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200004g%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DS.%26aulast%3DHayakawa%26aufirst%3DK.%26aulast%3DIida%26aufirst%3DT.%26aulast%3DNagahashi%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DSakamoto%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DInaba%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DKakefuda%26aufirst%3DR.%26aulast%3DNanayama%26aufirst%3DT.%26aulast%3DKurachi%26aufirst%3DH.%26aulast%3DHori%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKakegawa%26aufirst%3DJ.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DRichter%26aufirst%3DM.%2BC.%26aulast%3DMoss%26aufirst%3DK.%2BG.%26aulast%3DLaquerre%26aufirst%3DS.%2BG.%26atitle%3DDiscovery%2520of%2520a%2520Highly%2520Potent%2520and%2520Selective%2520MEK%2520Inhibitor%253A%2520GSK1120212%2520%2528JTP-74057%2520DMSO%2520Solvate%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26issue%3D4%26spage%3D320%26epage%3D324%26doi%3D10.1021%2Fml200004g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Dong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halkowycz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanouni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span> </span><span class="NLM_article-title">Discovery of TAK-733, a Potent and Selective MEK Allosteric Site Inhibitor for the Treatment of Cancer</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1315</span><span class="NLM_x">â</span> <span class="NLM_lpage">1319</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.01.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bmcl.2011.01.071" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1315-1319&issue=5&author=Q.+Dongauthor=D.+R.+Douganauthor=X.+Gongauthor=P.+Halkowyczauthor=B.+Jinauthor=T.+Kanouniauthor=S.+M.+O%E2%80%99Connellauthor=N.+Scorahauthor=L.+Shiauthor=M.+B.+Wallaceauthor=F.+Zhou&title=Discovery+of+TAK-733%2C+a+Potent+and+Selective+MEK+Allosteric+Site+Inhibitor+for+the+Treatment+of+Cancer&doi=10.1016%2Fj.bmcl.2011.01.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.071%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DHalkowycz%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DB.%26aulast%3DKanouni%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DS.%2BM.%26aulast%3DScorah%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DZhou%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520TAK-733%252C%2520a%2520Potent%2520and%2520Selective%2520MEK%2520Allosteric%2520Site%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D5%26spage%3D1315%26epage%3D1319%26doi%3D10.1016%2Fj.bmcl.2011.01.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Flaherty, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kefford, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuchter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudchadkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchook, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Algazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzanov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebowitz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allred, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J.</span><span> </span><span class="NLM_article-title">Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1694</span><span class="NLM_x">â</span> <span class="NLM_lpage">1703</span><span class="refDoi">Â DOI: 10.1056/NEJMoa1210093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1056%2FNEJMoa1210093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23020132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eksLrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=1694-1703&issue=18&author=K.+T.+Flahertyauthor=J.+R.+Infanteauthor=A.+Daudauthor=R.+Gonzalezauthor=R.+F.+Keffordauthor=J.+Sosmanauthor=O.+Hamidauthor=L.+Schuchterauthor=J.+Cebonauthor=N.+Ibrahimauthor=R.+Kudchadkarauthor=H.+A.+Burrisauthor=G.+Falchookauthor=A.+Algaziauthor=K.+Lewisauthor=G.+V.+Longauthor=I.+Puzanovauthor=P.+Lebowitzauthor=A.+Singhauthor=S.+Littleauthor=P.+Sunauthor=A.+Allredauthor=D.+Ouelletauthor=K.+B.+Kimauthor=K.+Patelauthor=J.+Weber&title=Combined+BRAF+and+MEK+Inhibition+in+Melanoma+with+BRAF+V600+Mutations&doi=10.1056%2FNEJMoa1210093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations</span></div><div class="casAuthors">Flaherty, Keith T.; Infante, Jeffery R.; Daud, Adil; Gonzalez, Rene; Kefford, Richard F.; Sosman, Jeffrey; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan; Ibrahim, Nageatte; Kudchadkar, Ragini; Burris, Howard A., III; Falchook, Gerald; Algazi, Alain; Lewis, Karl; Long, Georgina V.; Puzanov, Igor; Lebowitz, Peter; Singh, Ajay; Little, Shonda; Sun, Peng; Allred, Alicia; Ouellet, Daniele; Kim, Kevin B.; Patel, Kiran; Weber, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1694-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Resistance to therapy with BRAF kinase inhibitors is assocd. with reactivation of the mitogen-activated protein kinase (MAPK) pathway.  To address this problem, we conducted a phase 1 and 2 trial of combined treatment with dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK) inhibitor.  METHODS In this open-label study involving 247 patients with metastatic melanoma and BRAF V600 mutations, we evaluated the pharmacokinetic activity and safety of oral dabrafenib (75 or 150 mg twice daily) and trametinib (1, 1.5, or 2 mg daily) in 85 patients and then randomly assigned 162 patients to receive combination therapy with dabrafenib (150 mg) plus trametinib (1 or 2 mg) or dabrafenib monotherapy.  The primary end points were the incidence of cutaneous squamous-cell carcinoma, survival free of melanoma progression, and response.  Secondary end points were overall survival and pharmacokinetic activity.  RESULTS Dose-limiting toxic effects were infrequently obsd. in patients receiving combination therapy with 150 mg of dabrafenib and 2 mg of trametinib (combination 150/2).  Cutaneous squamous-cell carcinoma was seen in 7% of patients receiving combination 150/2 and in 19% receiving monotherapy (P = 0.09), whereas pyrexia was more common in the combination 150/2 group than in the monotherapy group (71% vs. 26%).  Median progression-free survival in the combination 150/2 group was 9.4 mo, as compared with 5.8 mo in the monotherapy group (hazard ratio for progression or death, 0.39; 95% confidence interval, 0.25 to 0.62; P<0.001).  The rate of complete or partial response with combination 150/2 therapy was 76%, as compared with 54% with monotherapy (P = 0.03).  CONCLUSIONS Dabrafenib and trametinib were safely combined at full monotherapy doses.  The rate of pyrexia was increased with combination therapy, whereas the rate of proliferative skin lesions was nonsignificantly reduced.  Progression-free survival was significantly improved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk7I8zrGTVbVg90H21EOLACvtfcHk0liNKlHW7a_aSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eksLrJ&md5=199ae281d44c3b41309b934d88674cd3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1210093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1210093%26sid%3Dliteratum%253Aachs%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DDaud%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DR.%26aulast%3DKefford%26aufirst%3DR.%2BF.%26aulast%3DSosman%26aufirst%3DJ.%26aulast%3DHamid%26aufirst%3DO.%26aulast%3DSchuchter%26aufirst%3DL.%26aulast%3DCebon%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DN.%26aulast%3DKudchadkar%26aufirst%3DR.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DFalchook%26aufirst%3DG.%26aulast%3DAlgazi%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DK.%26aulast%3DLong%26aufirst%3DG.%2BV.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DLebowitz%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DLittle%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DAllred%26aufirst%3DA.%26aulast%3DOuellet%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DJ.%26atitle%3DCombined%2520BRAF%2520and%2520MEK%2520Inhibition%2520in%2520Melanoma%2520with%2520BRAF%2520V600%2520Mutations%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26issue%3D18%26spage%3D1694%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1210093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Long, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroyakovskiy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levchenko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Braud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jouary, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauschild, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarion Sileni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MandalÃ , M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millward, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arance, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarenko, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanen, J. B. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utikal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraresi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovalenko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probachai, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadendorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMarini, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irani, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, K.</span><span> </span><span class="NLM_article-title">Combined BRAF and MEK Inhibition Versus BRAF Inhibition Alone in Melanoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">1877</span><span class="NLM_x">â</span> <span class="NLM_lpage">1888</span><span class="refDoi">Â DOI: 10.1056/NEJMoa1406037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1056%2FNEJMoa1406037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25265492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslGnuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=1877-1888&issue=20&author=G.+V.+Longauthor=D.+Stroyakovskiyauthor=H.+Gogasauthor=E.+Levchenkoauthor=F.+de+Braudauthor=J.+Larkinauthor=C.+Garbeauthor=T.+Jouaryauthor=A.+Hauschildauthor=J.+J.+Grobauthor=V.+Chiarion+Sileniauthor=C.+Lebbeauthor=M.+Mandal%C3%A0author=M.+Millwardauthor=A.+Aranceauthor=I.+Bondarenkoauthor=J.+B.+A.+G.+Haanenauthor=J.+Hanssonauthor=J.+Utikalauthor=V.+Ferraresiauthor=N.+Kovalenkoauthor=P.+Mohrauthor=V.+Probachaiauthor=D.+Schadendorfauthor=P.+Nathanauthor=C.+Robertauthor=A.+Ribasauthor=D.+J.+DeMariniauthor=J.+G.+Iraniauthor=M.+Caseyauthor=D.+Ouelletauthor=A.-M.+Martinauthor=N.+Leauthor=K.+Patelauthor=K.+Flaherty&title=Combined+BRAF+and+MEK+Inhibition+Versus+BRAF+Inhibition+Alone+in+Melanoma&doi=10.1056%2FNEJMoa1406037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma</span></div><div class="casAuthors">Long, G. V.; Stroyakovskiy, D.; Gogas, H.; Levchenko, E.; de Braud, F.; Larkin, J.; Garbe, C.; Jouary, T.; Hauschild, A.; Grob, J. J.; Sileni, V. Chiarion; Lebbe, C.; Mandala, M.; Millward, M.; Arance, A.; Bondarenko, I.; Haanen, J. B. A. G.; Hansson, J.; Utikal, J.; Ferraresi, V.; Kovalenko, N.; Mohr, P.; Probachai, V.; Schadendorf, D.; Nathan, P.; Robert, C.; Ribas, A.; De Marini, D. J.; Irani, J. G.; Casey, M.; Ouellet, D.; Martin, A.-M.; Le, N.; Patel, K.; Flaherty, K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1877-1888, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Combined BRAF and MEK inhibition, as compared with BRAF inhibition alone, delays the emergence of resistance and reduces toxic effects in patients who have melanoma with BRAF V600E or V600K mutations.  Methods: In this phase 3 trial, we randomly assigned 423 previously untreated patients who had unresectable stage IIIC or stage IV melanoma with a BRAF V600E or V600K mutation to receive a combination of dabrafenib (150 mg orally twice daily) and trametinib (2 mg orally once daily) or dabrafenib and placebo.  The primary end point was progression-free survival.  Secondary end points included overall survival, response rate, response duration, and safety.  A preplanned interim overall survival anal. was conducted. Results: The median progression-free survival was 9.3 mo in the dabrafenib-trametinib group and 8.8 mo in the dabrafenib-only group (hazard ratio for progression or death in the dabrafenib-trametinib group, 0.75; 95% confidence interval [CI], 0.57 to 0.99; P = 0.03).  The overall response rate was 67% in the dabrafenib-trametinib group and 51% in the dabrafenib-only group (P = 0.002).  At 6 mo, the interim overall survival rate was 93% with dabrafenib-trametinib and 85% with dabrafenib alone (hazard ratio for death, 0.63; 95% CI, 0.42 to 0.94; P = 0.02).  However, a specified efficacy-stopping boundary (two-sided P = 0.00028) was not crossed.  Rates of adverse events were similar in the two groups, although more dose modifications occurred in the dabrafenib-trametinib group.  The rate of cutaneous squamous-cell carcinoma was lower in the dabrafenib-trametinib group than in the dabrafenib-only group (2% vs. 9%), whereas pyrexia occurred in more patients (51% vs. 28%) and was more often severe (grade 3, 6% vs. 2%) in the dabrafenib-trametinib group. Conclusions: A combination of dabrafenib and trametinib, as compared with dabrafenib alone, improved the rate of progression-free survival in previously untreated patients who had metastatic melanoma with BRAF V600E or V600K mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV_cVsKKBhY7Vg90H21EOLACvtfcHk0liNKlHW7a_aSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslGnuw%253D%253D&md5=65dbfbb0d9d16017ac58729326835724</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1406037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1406037%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DG.%2BV.%26aulast%3DStroyakovskiy%26aufirst%3DD.%26aulast%3DGogas%26aufirst%3DH.%26aulast%3DLevchenko%26aufirst%3DE.%26aulast%3Dde%2BBraud%26aufirst%3DF.%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DGarbe%26aufirst%3DC.%26aulast%3DJouary%26aufirst%3DT.%26aulast%3DHauschild%26aufirst%3DA.%26aulast%3DGrob%26aufirst%3DJ.%2BJ.%26aulast%3DChiarion%2BSileni%26aufirst%3DV.%26aulast%3DLebbe%26aufirst%3DC.%26aulast%3DMandal%25C3%25A0%26aufirst%3DM.%26aulast%3DMillward%26aufirst%3DM.%26aulast%3DArance%26aufirst%3DA.%26aulast%3DBondarenko%26aufirst%3DI.%26aulast%3DHaanen%26aufirst%3DJ.%2BB.%2BA.%2BG.%26aulast%3DHansson%26aufirst%3DJ.%26aulast%3DUtikal%26aufirst%3DJ.%26aulast%3DFerraresi%26aufirst%3DV.%26aulast%3DKovalenko%26aufirst%3DN.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DProbachai%26aufirst%3DV.%26aulast%3DSchadendorf%26aufirst%3DD.%26aulast%3DNathan%26aufirst%3DP.%26aulast%3DRobert%26aufirst%3DC.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DDeMarini%26aufirst%3DD.%2BJ.%26aulast%3DIrani%26aufirst%3DJ.%2BG.%26aulast%3DCasey%26aufirst%3DM.%26aulast%3DOuellet%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DA.-M.%26aulast%3DLe%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DFlaherty%26aufirst%3DK.%26atitle%3DCombined%2520BRAF%2520and%2520MEK%2520Inhibition%2520Versus%2520BRAF%2520Inhibition%2520Alone%2520in%2520Melanoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26issue%3D20%26spage%3D1877%26epage%3D1888%26doi%3D10.1056%2FNEJMoa1406037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Wilkinson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taggart, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berges, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, T.</span><span> </span><span class="NLM_article-title">A Specific Inhibitor of the Ubiquitin Activating Enzyme: Synthesis and Characterization of Adenosyl-Phospho-Ubiquitinol, a Nonhydrolyzable Ubiquitin Adenylate Analog</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">32</span><span class="NLM_x">) </span> <span class="NLM_fpage">7373</span><span class="NLM_x">â</span> <span class="NLM_lpage">7380</span><span class="refDoi">Â DOI: 10.1021/bi00484a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00484a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=7373-7380&issue=32&author=K.+D.+Wilkinsonauthor=S.+E.+Smithauthor=L.+O%E2%80%99Connorauthor=E.+Sternbergauthor=J.+J.+Taggartauthor=D.+A.+Bergesauthor=T.+Butt&title=A+Specific+Inhibitor+of+the+Ubiquitin+Activating+Enzyme%3A+Synthesis+and+Characterization+of+Adenosyl-Phospho-Ubiquitinol%2C+a+Nonhydrolyzable+Ubiquitin+Adenylate+Analog&doi=10.1021%2Fbi00484a004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi00484a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00484a004%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DK.%2BD.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%26aulast%3DSternberg%26aufirst%3DE.%26aulast%3DTaggart%26aufirst%3DJ.%2BJ.%26aulast%3DBerges%26aufirst%3DD.%2BA.%26aulast%3DButt%26aufirst%3DT.%26atitle%3DA%2520Specific%2520Inhibitor%2520of%2520the%2520Ubiquitin%2520Activating%2520Enzyme%253A%2520Synthesis%2520and%2520Characterization%2520of%2520Adenosyl-Phospho-Ubiquitinol%252C%2520a%2520Nonhydrolyzable%2520Ubiquitin%2520Adenylate%2520Analog%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26issue%3D32%26spage%3D7373%26epage%3D7380%26doi%3D10.1021%2Fbi00484a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorick, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davydov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberoi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenten, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beutler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vousden, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">9472</span><span class="NLM_x">â</span> <span class="NLM_lpage">9481</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-0568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F0008-5472.CAN-07-0568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=17909057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnurvI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=9472-9481&issue=19&author=Y.+Yangauthor=J.+Kitagakiauthor=R.+M.+Daiauthor=Y.+C.+Tsaiauthor=K.+L.+Lorickauthor=R.+L.+Ludwigauthor=S.+A.+Pierreauthor=J.+P.+Jensenauthor=I.+V.+Davydovauthor=P.+Oberoiauthor=C.+C.+H.+Liauthor=J.+H.+Kentenauthor=J.+A.+Beutlerauthor=K.+H.+Vousdenauthor=A.+M.+Weissman&title=Inhibitors+of+Ubiquitin-Activating+Enzyme+%28E1%29%2C+a+New+Class+of+Potential+Cancer+Therapeutics&doi=10.1158%2F0008-5472.CAN-07-0568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics</span></div><div class="casAuthors">Yang, Yili; Kitagaki, Jirouta; Dai, Ren-Ming; Tsai, Yien Che; Lorick, Kevin L.; Ludwig, Robert L.; Pierre, Shervon A.; Jensen, Jane P.; Davydov, Ilia V.; Oberoi, Pankaj; Li, Chou-Chi H.; Kenten, John H.; Beutler, John A.; Vousden, Karen H.; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9472-9481</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The conjugation of proteins with ubiquitin plays numerous regulatory roles through both proteasomal-dependent and nonproteasomal-dependent functions.  Alterations in ubiquitylation are obsd. in a wide range of pathol. conditions, including numerous malignancies.  For this reason, there is great interest in targeting the ubiquitin-proteasome system in cancer.  Several classes of proteasome inhibitors, which block degrdn. of ubiquitylated proteins, are widely used in research, and one, Bortezomib, is now in clin. use.  Despite the well-defined and central role of the ubiquitin-activating enzyme (E1), no cell permeable inhibitors of E1 have been identified.  Such inhibitors should, in principle, block all functions of ubiquitylation.  We now report 4[4-(5-nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl]-benzoic acid Et ester (PYR-41) as the first such inhibitor.  Unexpectedly, in addn. to blocking ubiquitylation, PYR-41 increased total sumoylation in cells.  The mol. basis for this is unknown; however, increased sumoylation was also obsd. in cells harboring temp.-sensitive E1.  Functionally, PYR-41 attenuates cytokine-mediated nuclear factor-ÎºB activation.  This correlates with inhibition of nonproteasomal (Lys-63) ubiquitylation of TRAF6, which is essential to IÎºB kinase activation.  PYR-41 also prevents the downstream ubiquitylation and proteasomal degrdn. of IÎºBÎ±.  Furthermore, PYR-41 inhibits degrdn. of p53 and activates the transcriptional activity of this tumor suppressor.  Consistent with this, it differentially kills transformed p53-expressing cells.  Thus, PYR-41 and related pyrazones provide proof of principle for the capacity to differentially kill transformed cells, suggesting the potential for E1 inhibitors as therapeutics in cancer.  These inhibitors can also be valuable tools for studying ubiquitylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMJJHvHs0qWLVg90H21EOLACvtfcHk0lgQdVABg4Fnwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnurvI&md5=6d75d1f0131d6d84db1b896743726119</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0568%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DKitagaki%26aufirst%3DJ.%26aulast%3DDai%26aufirst%3DR.%2BM.%26aulast%3DTsai%26aufirst%3DY.%2BC.%26aulast%3DLorick%26aufirst%3DK.%2BL.%26aulast%3DLudwig%26aufirst%3DR.%2BL.%26aulast%3DPierre%26aufirst%3DS.%2BA.%26aulast%3DJensen%26aufirst%3DJ.%2BP.%26aulast%3DDavydov%26aufirst%3DI.%2BV.%26aulast%3DOberoi%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DC.%2BC.%2BH.%26aulast%3DKenten%26aufirst%3DJ.%2BH.%26aulast%3DBeutler%26aufirst%3DJ.%2BA.%26aulast%3DVousden%26aufirst%3DK.%2BH.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DInhibitors%2520of%2520Ubiquitin-Activating%2520Enzyme%2520%2528E1%2529%252C%2520a%2520New%2520Class%2520of%2520Potential%2520Cancer%2520Therapeutics%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D19%26spage%3D9472%26epage%3D9481%26doi%3D10.1158%2F0008-5472.CAN-07-0568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Toth, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, M. D.</span><span> </span><span class="NLM_article-title">A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">309</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span><span class="refDoi">Â DOI: 10.1016/j.celrep.2012.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.celrep.2012.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kns7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=309-316&issue=4&author=J.+I.+Tothauthor=L.+Yangauthor=R.+Dahlauthor=M.+D.+Petroski&title=A+Gatekeeper+Residue+for+NEDD8-Activating+Enzyme+Inhibition+by+MLN4924&doi=10.1016%2Fj.celrep.2012.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A gatekeeper residue for NEDD8-activating enzyme inhibition by MLN4924</span></div><div class="casAuthors">Toth, Julia I.; Yang, Li; Dahl, Russell; Petroski, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-316</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of NEDD8-activating enzyme (NAE) has emerged as a highly promising approach to treat cancer through the adenosine sulfamate analog MLN4924.  Here, we show that selective pressure results in HCT116 colorectal carcinoma cells with decreased MLN4924 sensitivity and identify a single-nucleotide transition that changes alanine 171 to threonine (A171T) of the NAE subunit UBA3.  This reduces the enzyme's affinity for MLN4924 and ATP while increasing NEDD8 activation at physiol. ATP concns.  Expression of UBA3 A171T is sufficient to decrease MLN4924 sensitivity of naive HCT116 cells, indicating that it is a dominant suppressor of MLN4924-mediated cell death.  Our data suggest that the on-target potency of MLN4924 selects for a point mutation in NAE that overcomes the mol.'s inhibitory effects, allowing cancer cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocylKrTKZGhbVg90H21EOLACvtfcHk0lgrlGKw7LJqbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kns7g%253D&md5=344f4226d224d51611f693985e89df4a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DJ.%2BI.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DPetroski%26aufirst%3DM.%2BD.%26atitle%3DA%2520Gatekeeper%2520Residue%2520for%2520NEDD8-Activating%2520Enzyme%2520Inhibition%2520by%2520MLN4924%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D1%26issue%3D4%26spage%3D309%26epage%3D316%26doi%3D10.1016%2Fj.celrep.2012.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">da Silva, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paiva, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bancerz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geletu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukkarila, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">A Selective Inhibitor of the UFM1-Activating Enzyme, UBA5</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4542</span><span class="NLM_x">â</span> <span class="NLM_lpage">4547</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bmcl.2015.10.015" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4542-4547&issue=18&author=S.+R.+da+Silvaauthor=S.-L.+Paivaauthor=M.+Bancerzauthor=M.+Geletuauthor=A.+M.+Lewisauthor=J.+Chenauthor=Y.+Caiauthor=J.+L.+Lukkarilaauthor=H.+Liauthor=P.+T.+Gunning&title=A+Selective+Inhibitor+of+the+UFM1-Activating+Enzyme%2C+UBA5&doi=10.1016%2Fj.bmcl.2015.10.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.015%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BSilva%26aufirst%3DS.%2BR.%26aulast%3DPaiva%26aufirst%3DS.-L.%26aulast%3DBancerz%26aufirst%3DM.%26aulast%3DGeletu%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLukkarila%26aufirst%3DJ.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DA%2520Selective%2520Inhibitor%2520of%2520the%2520UFM1-Activating%2520Enzyme%252C%2520UBA5%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D18%26spage%3D4542%26epage%3D4547%26doi%3D10.1016%2Fj.bmcl.2015.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capili, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cisar, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. S.</span><span> </span><span class="NLM_article-title">Designed Semisynthetic Protein Inhibitors of Ub/Ubl E1 Activating Enzymes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1748</span><span class="NLM_x">â</span> <span class="NLM_lpage">1749</span><span class="refDoi">Â DOI: 10.1021/ja9088549</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9088549" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSiurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=1748-1749&issue=6&author=X.+Luauthor=S.+K.+Olsenauthor=A.+D.+Capiliauthor=J.+S.+Cisarauthor=C.+D.+Limaauthor=D.+S.+Tan&title=Designed+Semisynthetic+Protein+Inhibitors+of+Ub%2FUbl+E1+Activating+Enzymes&doi=10.1021%2Fja9088549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Semisynthetic Protein Inhibitors of Ub/Ubl E1 Activating Enzymes</span></div><div class="casAuthors">Lu, Xuequan; Olsen, Shaun K.; Capili, Allan D.; Cisar, Justin S.; Lima, Christopher D.; Tan, Derek S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1748-1749</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Semisynthetic, mechanism-based protein inhibitors of ubiquitin (Ub) and ubiquitin-like modifier (Ubl) activating enzymes (E1s) have been developed to target E1-catalyzed adenylation and thioesterification of the Ub/Ubl C-terminus during the processes of protein SUMOylation and ubiquitination.  The inhibitors were generated by intein-mediated expressed protein ligation using a truncated Ub/Ubl protein (SUMO residues 1-94; Ub residues 1-71) with a C-terminal thioester and synthetic tripeptides having a C-terminal adenosine analog and an N-terminal cysteine residue.  SUMO-AMSN (4a) and Ub-AMSN (4b) contain a sulfamide group as a nonhydrolyzable mimic of the phosphate group in the cognate Ub/Ubl-AMP adenylate intermediate in the first half-reaction, and these constructs selectively inhibit SUMO E1 and Ub E1, resp., in a dose-dependent manner.  SUMO-AVSN (5a) and Ub-AVSN (5b) contain an electrophilic vinyl sulfonamide designed to trap the incoming E1 cysteine nucleophile (Uba2 Cys173 in SUMO E1; Uba1 Cys593 in Ub E1) in the second half-reaction, and these constructs selectively, covalently, and stably cross-link to SUMO E1 and Ub E1, resp., in a cysteine nucleophile-dependent manner.  These inhibitors are powerful tools to probe outstanding mechanistic questions in E1 function and can also be used to study the biol. functions of E1 enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFrlstIrtwC7Vg90H21EOLACvtfcHk0lgCmPgu5M5LCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSiurY%253D&md5=2c7015f7594aa5fb6f540c8679101fce</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja9088549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9088549%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DOlsen%26aufirst%3DS.%2BK.%26aulast%3DCapili%26aufirst%3DA.%2BD.%26aulast%3DCisar%26aufirst%3DJ.%2BS.%26aulast%3DLima%26aufirst%3DC.%2BD.%26aulast%3DTan%26aufirst%3DD.%2BS.%26atitle%3DDesigned%2520Semisynthetic%2520Protein%2520Inhibitors%2520of%2520Ub%252FUbl%2520E1%2520Activating%2520Enzymes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26issue%3D6%26spage%3D1748%26epage%3D1749%26doi%3D10.1021%2Fja9088549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Olsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capili, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, C. D.</span><span> </span><span class="NLM_article-title">Active Site Remodelling Accompanies Thioester Bond Formation in the SUMO E1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x"> (</span><span class="NLM_issue">7283</span><span class="NLM_x">) </span> <span class="NLM_fpage">906</span><span class="NLM_x">â</span> <span class="NLM_lpage">912</span><span class="refDoi">Â DOI: 10.1038/nature08765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature08765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=20164921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=906-912&issue=7283&author=S.+K.+Olsenauthor=A.+D.+Capiliauthor=X.+Luauthor=D.+S.+Tanauthor=C.+D.+Lima&title=Active+Site+Remodelling+Accompanies+Thioester+Bond+Formation+in+the+SUMO+E1&doi=10.1038%2Fnature08765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Active site remodelling accompanies thioester bond formation in the SUMO E1</span></div><div class="casAuthors">Olsen, Shaun K.; Capili, Allan D.; Lu, Xuequan; Tan, Derek S.; Lima, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7283</span>),
    <span class="NLM_cas:pages">906-912</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">E1 enzymes activate ubiquitin (Ub) and ubiquitin-like (Ubl) proteins in two steps by carboxy-terminal adenylation and thioester bond formation to a conserved catalytic cysteine in the E1 Cys domain.  The structural basis for these intermediates remains unknown.  Here we report crystal structures for human SUMO E1 in complex with SUMO adenylate and tetrahedral intermediate analogs at 2.45 and 2.6 Ã, resp.  These structures show that side chain contacts to ATPÂ·Mg are released after adenylation to facilitate a 130 degree rotation of the Cys domain during thioester bond formation that is accompanied by remodeling of key structural elements including the helix that contains the E1 catalytic cysteine, the crossover and re-entry loops, and refolding of two helixes that are required for adenylation.  These changes displace side chains required for adenylation with side chains required for thioester bond formation.  Mutational and biochem. analyses indicate these mechanisms are conserved in other E1s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9k1BOu5nwaLVg90H21EOLACvtfcHk0lgCmPgu5M5LCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsr8%253D&md5=1c21dabaaa4d831db0bb9bb343ffe555</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnature08765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08765%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DS.%2BK.%26aulast%3DCapili%26aufirst%3DA.%2BD.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DTan%26aufirst%3DD.%2BS.%26aulast%3DLima%26aufirst%3DC.%2BD.%26atitle%3DActive%2520Site%2520Remodelling%2520Accompanies%2520Thioester%2520Bond%2520Formation%2520in%2520the%2520SUMO%2520E1%26jtitle%3DNature%26date%3D2010%26volume%3D463%26issue%3D7283%26spage%3D906%26epage%3D912%26doi%3D10.1038%2Fnature08765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hong, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H. K.</span><span> </span><span class="NLM_article-title">Insights Into Noncanonical E1 Enzyme Activation From the Structure of Autophagic E1 Atg7 with Atg8</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1323</span><span class="NLM_x">â</span> <span class="NLM_lpage">1330</span><span class="refDoi">Â DOI: 10.1038/nsmb.2165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnsmb.2165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22056771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1323-1330&issue=12&author=S.+B.+Hongauthor=B.-W.+Kimauthor=K.-E.+Leeauthor=S.+W.+Kimauthor=H.+Jeonauthor=J.+Kimauthor=H.+K.+Song&title=Insights+Into+Noncanonical+E1+Enzyme+Activation+From+the+Structure+of+Autophagic+E1+Atg7+with+Atg8&doi=10.1038%2Fnsmb.2165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into noncanonical E1 enzyme activation from the structure of autophagic E1 Atg7 with Atg8</span></div><div class="casAuthors">Hong, Seung Beom; Kim, Byeong-Won; Lee, Kyung-Eun; Kim, Se Woong; Jeon, Hyesung; Kim, Joon; Song, Hyun Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1323-1330</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagy is the degrdn. of cellular organelles via the lysosomal pathway.  The autophagic ubiquitin-like (Ubl) mol. Atg8 is activated by the E1-like enzyme Atg7.  As this noncanonical E1 enzyme's domain organization is unique among Ubl-activating E1 enzymes, the structural basis for its interactions with Atg8 and partner E2 enzymes remains obscure.  Here we present the structure of the N-terminal domain of Atg7, revealing a unique protein fold and interactions with both autophagic E2 enzymes Atg3 and Atg10.  The structure of the C-terminal domain of Atg7 in complex with Atg8 shows the mode of dimerization and mechanism of recognition of Atg8.  Notably, the catalytic cysteine residue in Atg7 is positioned close to the C-terminal glycine of Atg8, its target for thioester formation, potentially eliminating the need for large conformational rearrangements characteristic of other E1s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-uZfo9Vpv4LVg90H21EOLACvtfcHk0lit-vf_eKEhDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtbvE&md5=2023d2b2c6c395e5bfdd6845424b317a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2165%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%2BB.%26aulast%3DKim%26aufirst%3DB.-W.%26aulast%3DLee%26aufirst%3DK.-E.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DH.%2BK.%26atitle%3DInsights%2520Into%2520Noncanonical%2520E1%2520Enzyme%2520Activation%2520From%2520the%2520Structure%2520of%2520Autophagic%2520E1%2520Atg7%2520with%2520Atg8%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D18%26issue%3D12%26spage%3D1323%26epage%3D1330%26doi%3D10.1038%2Fnsmb.2165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Noda, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumeta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatogawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, F.</span><span> </span><span class="NLM_article-title">Structural Basis of Atg8 Activation by a Homodimeric E1, Atg7</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">462</span><span class="NLM_x">â</span> <span class="NLM_lpage">475</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2011.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2011.08.035" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=462-475&issue=3&author=N.+N.+Nodaauthor=K.+Satooauthor=Y.+Fujiokaauthor=H.+Kumetaauthor=K.+Oguraauthor=H.+Nakatogawaauthor=Y.+Ohsumiauthor=F.+Inagaki&title=Structural+Basis+of+Atg8+Activation+by+a+Homodimeric+E1%2C+Atg7&doi=10.1016%2Fj.molcel.2011.08.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DNoda%26aufirst%3DN.%2BN.%26aulast%3DSatoo%26aufirst%3DK.%26aulast%3DFujioka%26aufirst%3DY.%26aulast%3DKumeta%26aufirst%3DH.%26aulast%3DOgura%26aufirst%3DK.%26aulast%3DNakatogawa%26aufirst%3DH.%26aulast%3DOhsumi%26aufirst%3DY.%26aulast%3DInagaki%26aufirst%3DF.%26atitle%3DStructural%2520Basis%2520of%2520Atg8%2520Activation%2520by%2520a%2520Homodimeric%2520E1%252C%2520Atg7%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26issue%3D3%26spage%3D462%26epage%3D475%26doi%3D10.1016%2Fj.molcel.2011.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Oweis, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassouna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Kfir, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndsen, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiener, R.</span><span> </span><span class="NLM_article-title">Trans-Binding Mechanism of Ubiquitin-Like Protein Activation Revealed by a UBA5-UFM1 Complex</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3113</span><span class="NLM_x">â</span> <span class="NLM_lpage">3120</span><span class="refDoi">Â DOI: 10.1016/j.celrep.2016.08.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.celrep.2016.08.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=27653677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2rsrvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=3113-3120&issue=12&author=W.+Oweisauthor=P.+Padalaauthor=F.+Hassounaauthor=E.+Cohen-Kfirauthor=D.+R.+Gibbsauthor=E.+A.+Toddauthor=C.+E.+Berndsenauthor=R.+Wiener&title=Trans-Binding+Mechanism+of+Ubiquitin-Like+Protein+Activation+Revealed+by+a+UBA5-UFM1+Complex&doi=10.1016%2Fj.celrep.2016.08.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Trans-Binding Mechanism of Ubiquitin-like Protein Activation Revealed by a UBA5-UFM1 Complex</span></div><div class="casAuthors">Oweis, Walaa; Padala, Prasanth; Hassouna, Fouad; Cohen-Kfir, Einav; Gibbs, Dalton R.; Todd, Emily A.; Berndsen, Christopher E.; Wiener, Reuven</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3113-3120</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Modification of proteins by ubiquitin or ubiquitin-like proteins (UBLs) is a crit. cellular process implicated in a variety of cellular states and outcomes.  A prerequisite for target protein modification by a UBL is the activation of the latter by activating enzymes (E1s).  Here, we present the crystal structure of the non-canonical homodimeric E1, UBA5, in complex with its cognate UBL, UFM1, and supporting biochem. expts.  We find that UBA5 binds to UFM1 via a trans-binding mechanism in which UFM1 interacts with distinct sites in both subunits of the UBA5 dimer.  This binding mechanism requires a region C-terminal to the adenylation domain that brings UFM1 to the active site of the adjacent UBA5 subunit.  We also find that transfer of UFM1 from UBA5 to the E2, UFC1, occurs via a trans mechanism, thereby requiring a homodimer of UBA5.  These findings explicitly elucidate the role of UBA5 dimerization in UFM1 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoofFrTwO-4RLVg90H21EOLACvtfcHk0liVVBWZPBtOgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2rsrvP&md5=91095efef92e9253ec45908fbbd4654f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.08.067%26sid%3Dliteratum%253Aachs%26aulast%3DOweis%26aufirst%3DW.%26aulast%3DPadala%26aufirst%3DP.%26aulast%3DHassouna%26aufirst%3DF.%26aulast%3DCohen-Kfir%26aufirst%3DE.%26aulast%3DGibbs%26aufirst%3DD.%2BR.%26aulast%3DTodd%26aufirst%3DE.%2BA.%26aulast%3DBerndsen%26aufirst%3DC.%2BE.%26aulast%3DWiener%26aufirst%3DR.%26atitle%3DTrans-Binding%2520Mechanism%2520of%2520Ubiquitin-Like%2520Protein%2520Activation%2520Revealed%2520by%2520a%2520UBA5-UFM1%2520Complex%26jtitle%3DCell%2520Rep.%26date%3D2016%26volume%3D16%26issue%3D12%26spage%3D3113%26epage%3D3120%26doi%3D10.1016%2Fj.celrep.2016.08.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Stewart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritterhoff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzovic, P. S.</span><span> </span><span class="NLM_article-title">E2 Enzymes: More Than Just Middle Men</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">423</span><span class="NLM_x">â</span> <span class="NLM_lpage">440</span><span class="refDoi">Â DOI: 10.1038/cr.2016.35</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fcr.2016.35" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=27002219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVyhs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=423-440&issue=4&author=M.+D.+Stewartauthor=T.+Ritterhoffauthor=R.+E.+Klevitauthor=P.+S.+Brzovic&title=E2+Enzymes%3A+More+Than+Just+Middle+Men&doi=10.1038%2Fcr.2016.35"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">E2 enzymes: more than just middle men</span></div><div class="casAuthors">Stewart, Mikaela D.; Ritterhoff, Tobias; Klevit, Rachel E.; Brzovic, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">423-440</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">A review.  Ubiquitin-conjugating enzymes (E2s) are the central players in the trio of enzymes responsible for the attachment of ubiquitin (Ub) to cellular proteins.  Humans have â¼40 E2s that are involved in the transfer of Ub or Ub-like (Ubl) proteins (e.g., SUMO and NEDD8).  Although the majority of E2s are only twice the size of Ub, this remarkable family of enzymes performs a variety of functional roles.  In this review, we summarize common functional and structural features that define unifying themes among E2s and highlight emerging concepts in the mechanism and regulation of E2s.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3nz4HNwXLKLVg90H21EOLACvtfcHk0liVVBWZPBtOgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVyhs7s%253D&md5=de200ea92123a8aeabd2ecc3d0c3cf65</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fcr.2016.35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2016.35%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DM.%2BD.%26aulast%3DRitterhoff%26aufirst%3DT.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26aulast%3DBrzovic%26aufirst%3DP.%2BS.%26atitle%3DE2%2520Enzymes%253A%2520More%2520Than%2520Just%2520Middle%2520Men%26jtitle%3DCell%2520Res.%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D423%26epage%3D440%26doi%3D10.1038%2Fcr.2016.35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rape, M.</span><span> </span><span class="NLM_article-title">Building Ubiquitin Chains: E2 Enzymes at Work</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">755</span><span class="NLM_x">â</span> <span class="NLM_lpage">764</span><span class="refDoi">Â DOI: 10.1038/nrm2780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm2780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19851334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSjtbfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=755-764&issue=11&author=Y.+Yeauthor=M.+Rape&title=Building+Ubiquitin+Chains%3A+E2+Enzymes+at+Work&doi=10.1038%2Fnrm2780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Building ubiquitin chains: E2 enzymes at work</span></div><div class="casAuthors">Ye, Yihong; Rape, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">755-764</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The modification of proteins with ubiquitin chains can change their localization, activity and/or stability.  Although ubiquitination requires the concerted action of ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin ligases (E3s), it is the E2s that have recently emerged as key mediators of chain assembly.  These enzymes are able to govern the switch from ubiquitin chain initiation to elongation, regulate the processivity of chain formation, and establish the topol. of assembled chains, thereby detg. the consequences of ubiquitination for the modified proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2haRlZHjrzrVg90H21EOLACvtfcHk0lgyTncCl_HgQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSjtbfM&md5=49c663b981cbdb877a5c2b592d9f4112</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrm2780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2780%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DRape%26aufirst%3DM.%26atitle%3DBuilding%2520Ubiquitin%2520Chains%253A%2520E2%2520Enzymes%2520at%2520Work%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26issue%3D11%26spage%3D755%26epage%3D764%26doi%3D10.1038%2Fnrm2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hershko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciechanover, A.</span><span> </span><span class="NLM_article-title">Components of Ubiquitin-Protein Ligase System. Resolution, Affinity Purification, and Role in Protein Breakdown</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">8206</span><span class="NLM_x">â</span> <span class="NLM_lpage">8214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1983&pages=8206-8214&issue=13&author=A.+Hershkoauthor=H.+Hellerauthor=S.+Eliasauthor=A.+Ciechanover&title=Components+of+Ubiquitin-Protein+Ligase+System.+Resolution%2C+Affinity+Purification%2C+and+Role+in+Protein+Breakdown"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DA.%26aulast%3DHeller%26aufirst%3DH.%26aulast%3DElias%26aufirst%3DS.%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DComponents%2520of%2520Ubiquitin-Protein%2520Ligase%2520System.%2520Resolution%252C%2520Affinity%2520Purification%252C%2520and%2520Role%2520in%2520Protein%2520Breakdown%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1983%26volume%3D258%26issue%3D13%26spage%3D8206%26epage%3D8214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Haas, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, V. E.</span><span> </span><span class="NLM_article-title">Functional Diversity Among Putative E2 Isozymes in the Mechanism of Ubiquitin-Histone Ligation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">13268</span><span class="NLM_x">â</span> <span class="NLM_lpage">13275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1988&pages=13268-13275&issue=26&author=A.+L.+Haasauthor=P.+M.+Brightauthor=V.+E.+Jackson&title=Functional+Diversity+Among+Putative+E2+Isozymes+in+the+Mechanism+of+Ubiquitin-Histone+Ligation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaas%26aufirst%3DA.%2BL.%26aulast%3DBright%26aufirst%3DP.%2BM.%26aulast%3DJackson%26aufirst%3DV.%2BE.%26atitle%3DFunctional%2520Diversity%2520Among%2520Putative%2520E2%2520Isozymes%2520in%2520the%2520Mechanism%2520of%2520Ubiquitin-Histone%2520Ligation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1988%26volume%3D263%26issue%3D26%26spage%3D13268%26epage%3D13275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Lee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindelin, H.</span><span> </span><span class="NLM_article-title">Structural Insights Into E1-Catalyzed Ubiquitin Activation and Transfer to Conjugating Enzymes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">268</span><span class="NLM_x">â</span> <span class="NLM_lpage">278</span><span class="refDoi">Â DOI: 10.1016/j.cell.2008.05.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2008.05.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=18662542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlalur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=268-278&issue=2&author=I.+Leeauthor=H.+Schindelin&title=Structural+Insights+Into+E1-Catalyzed+Ubiquitin+Activation+and+Transfer+to+Conjugating+Enzymes&doi=10.1016%2Fj.cell.2008.05.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes</span></div><div class="casAuthors">Lee, Imsang; Schindelin, Hermann</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-278</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ubiquitin (Ub) and ubiquitin-like proteins (Ubls) are conjugated to their targets by specific cascades involving three classes of enzymes, E1, E2, and E3.  Each E1 adenylates the C terminus of its cognate Ubl, forms a E1â¼Ubl thioester intermediate, and ultimately generates a thioester-linked E2â¼Ubl product.  We have detd. the crystal structure of yeast Uba1, revealing a modular architecture with individual domains primarily mediating these specific activities.  The neg. charged C-terminal ubiquitin-fold domain (UFD) is primed for binding of E2s and recognizes their pos. charged first Î± helix via electrostatic interactions.  In addn., a mobile loop from the domain harboring the E1 catalytic cysteine contributes to E2 binding.  Significant, exptl. obsd. motions in the UFD around a hinge in the linker connecting this domain to the rest of the enzyme suggest a conformation-dependent mechanism for the transthioesterification function of Uba1; however, this mechanism clearly differs from that of other E1 enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppxkaPQW_VQLVg90H21EOLACvtfcHk0liwlwKZr9S-IA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlalur8%253D&md5=1721bdfa7bc015eb5e69203aae1ad081</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.05.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.05.046%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DI.%26aulast%3DSchindelin%26aufirst%3DH.%26atitle%3DStructural%2520Insights%2520Into%2520E1-Catalyzed%2520Ubiquitin%2520Activation%2520and%2520Transfer%2520to%2520Conjugating%2520Enzymes%26jtitle%3DCell%26date%3D2008%26volume%3D134%26issue%3D2%26spage%3D268%26epage%3D278%26doi%3D10.1016%2Fj.cell.2008.05.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Eletr, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhlman, B.</span><span> </span><span class="NLM_article-title">E2 Conjugating Enzymes Must Disengage From Their E1 Enzymes Before E3-Dependent Ubiquitin and Ubiquitin-Like Transfer</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">933</span><span class="NLM_x">â</span> <span class="NLM_lpage">934</span><span class="refDoi">Â DOI: 10.1038/nsmb984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnsmb984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16142244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKnsrjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=933-934&issue=10&author=Z.+M.+Eletrauthor=D.+T.+Huangauthor=D.+M.+Dudaauthor=B.+A.+Schulmanauthor=B.+Kuhlman&title=E2+Conjugating+Enzymes+Must+Disengage+From+Their+E1+Enzymes+Before+E3-Dependent+Ubiquitin+and+Ubiquitin-Like+Transfer&doi=10.1038%2Fnsmb984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer</span></div><div class="casAuthors">Eletr, Ziad M.; Huang, Danny T.; Duda, David M.; Schulman, Brenda A.; Kuhlman, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">933-934</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">During ubiquitin ligation, an E2 conjugating enzyme receives ubiquitin from an E1 enzyme and then interacts with an E3 ligase to modify substrates.  Competitive binding expts. with three human E2-E3 protein pairs show that the binding of E1s and of E3s to E2s are mutually exclusive.  These results imply that polyubiquitination requires recycling of E2 for addn. of successive ubiquitins to substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEmLtN6jJ_bVg90H21EOLACvtfcHk0liwlwKZr9S-IA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKnsrjM&md5=2123d3087230cca0b2b5f2581c981945</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnsmb984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb984%26sid%3Dliteratum%253Aachs%26aulast%3DEletr%26aufirst%3DZ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BT.%26aulast%3DDuda%26aufirst%3DD.%2BM.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26aulast%3DKuhlman%26aufirst%3DB.%26atitle%3DE2%2520Conjugating%2520Enzymes%2520Must%2520Disengage%2520From%2520Their%2520E1%2520Enzymes%2520Before%2520E3-Dependent%2520Ubiquitin%2520and%2520Ubiquitin-Like%2520Transfer%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D10%26spage%3D933%26epage%3D934%26doi%3D10.1038%2Fnsmb984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Gstaiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catzavelos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingerland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krek, W.</span><span> </span><span class="NLM_article-title">Skp2 Is Oncogenic and Overexpressed in Human Cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">5043</span><span class="NLM_x">â</span> <span class="NLM_lpage">5048</span><span class="refDoi">Â DOI: 10.1073/pnas.081474898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1073%2Fpnas.081474898" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=5043-5048&issue=9&author=M.+Gstaigerauthor=R.+Jordanauthor=M.+Limauthor=C.+Catzavelosauthor=J.+Mestanauthor=J.+Slingerlandauthor=W.+Krek&title=Skp2+Is+Oncogenic+and+Overexpressed+in+Human+Cancers&doi=10.1073%2Fpnas.081474898"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.081474898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.081474898%26sid%3Dliteratum%253Aachs%26aulast%3DGstaiger%26aufirst%3DM.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DM.%26aulast%3DCatzavelos%26aufirst%3DC.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DSlingerland%26aufirst%3DJ.%26aulast%3DKrek%26aufirst%3DW.%26atitle%3DSkp2%2520Is%2520Oncogenic%2520and%2520Overexpressed%2520in%2520Human%2520Cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26issue%3D9%26spage%3D5043%26epage%3D5048%26doi%3D10.1073%2Fpnas.081474898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Ceccarelli, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlicky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plantevin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neculai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogunjimi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Hakim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varelas, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koszela, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasney, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durocher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloche, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1075</span><span class="NLM_x">â</span> <span class="NLM_lpage">1087</span><span class="refDoi">Â DOI: 10.1016/j.cell.2011.05.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2011.05.039" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2011&pages=1075-1087&issue=7&author=D.+F.+Ceccarelliauthor=X.+Tangauthor=B.+Pelletierauthor=S.+Orlickyauthor=W.+Xieauthor=V.+Plantevinauthor=D.+Neculaiauthor=Y.-C.+Chouauthor=A.+Ogunjimiauthor=A.+Al-Hakimauthor=X.+Varelasauthor=J.+Koszelaauthor=G.+A.+Wasneyauthor=M.+Vedadiauthor=S.+Dhe-Paganonauthor=S.+Coxauthor=S.+Xuauthor=A.+Lopez-Gironaauthor=F.+Mercurioauthor=J.+Wranaauthor=D.+Durocherauthor=S.+Melocheauthor=D.+R.+Webbauthor=M.+Tyersauthor=F.+Sicheri&title=An+Allosteric+Inhibitor+of+the+Human+Cdc34+Ubiquitin-Conjugating+Enzyme&doi=10.1016%2Fj.cell.2011.05.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.05.039%26sid%3Dliteratum%253Aachs%26aulast%3DCeccarelli%26aufirst%3DD.%2BF.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DPelletier%26aufirst%3DB.%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DPlantevin%26aufirst%3DV.%26aulast%3DNeculai%26aufirst%3DD.%26aulast%3DChou%26aufirst%3DY.-C.%26aulast%3DOgunjimi%26aufirst%3DA.%26aulast%3DAl-Hakim%26aufirst%3DA.%26aulast%3DVarelas%26aufirst%3DX.%26aulast%3DKoszela%26aufirst%3DJ.%26aulast%3DWasney%26aufirst%3DG.%2BA.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DCox%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DMercurio%26aufirst%3DF.%26aulast%3DWrana%26aufirst%3DJ.%26aulast%3DDurocher%26aufirst%3DD.%26aulast%3DMeloche%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DAn%2520Allosteric%2520Inhibitor%2520of%2520the%2520Human%2520Cdc34%2520Ubiquitin-Conjugating%2520Enzyme%26jtitle%3DCell%26date%3D2011%26volume%3D145%26issue%3D7%26spage%3D1075%26epage%3D1087%26doi%3D10.1016%2Fj.cell.2011.05.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarelli, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlicky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Cyr, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plamondon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">E2 Enzyme Inhibition by Stabilization of a Low-Affinity Interface with Ubiquitin</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">156</span><span class="NLM_x">â</span> <span class="NLM_lpage">163</span><span class="refDoi">Â DOI: 10.1038/nchembio.1412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24316736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=156-163&issue=2&author=H.+Huangauthor=D.+F.+Ceccarelliauthor=S.+Orlickyauthor=D.+J.+St-Cyrauthor=A.+Ziembaauthor=P.+Gargauthor=S.+Plamondonauthor=M.+Auerauthor=S.+Sidhuauthor=A.+Marinierauthor=G.+Kleigerauthor=M.+Tyersauthor=F.+Sicheri&title=E2+Enzyme+Inhibition+by+Stabilization+of+a+Low-Affinity+Interface+with+Ubiquitin&doi=10.1038%2Fnchembio.1412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin</span></div><div class="casAuthors">Huang, Hao; Ceccarelli, Derek F.; Orlicky, Stephen; St-Cyr, Daniel J.; Ziemba, Amy; Garg, Pankaj; Plamondon, Serge; Auer, Manfred; Sidhu, Sachdev; Marinier, Anne; Kleiger, Gary; Tyers, Mike; Sicheri, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-163</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Weak protein interactions between ubiquitin and the ubiquitin-proteasome system (UPS) enzymes that mediate its covalent attachment to substrates serve to position ubiquitin for optimal catalytic transfer.  We show that a small-mol. inhibitor of the E2 ubiquitin-conjugating enzyme Cdc34A, called CC0651, acts by trapping a weak interaction between ubiquitin and the E2 donor ubiquitin-binding site.  A structure of the ternary CC0651-Cdc34A-ubiquitin complex reveals that the inhibitor engages a composite binding pocket formed from Cdc34A and ubiquitin.  CC0651 also suppresses the spontaneous hydrolysis rate of the Cdc34A-ubiquitin thioester without decreasing the interaction between Cdc34A and the RING domain subunit of the E3 enzyme.  Stabilization of the numerous other weak interactions between ubiquitin and UPS enzymes by small mols. may be a feasible strategy to selectively inhibit different UPS activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprbECDLrogwbVg90H21EOLACvtfcHk0ljYk231B6dEBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3F&md5=a2c97bdba9beb82c2e7efb0aeb83705e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1412%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DCeccarelli%26aufirst%3DD.%2BF.%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DSt-Cyr%26aufirst%3DD.%2BJ.%26aulast%3DZiemba%26aufirst%3DA.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DPlamondon%26aufirst%3DS.%26aulast%3DAuer%26aufirst%3DM.%26aulast%3DSidhu%26aufirst%3DS.%26aulast%3DMarinier%26aufirst%3DA.%26aulast%3DKleiger%26aufirst%3DG.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DE2%2520Enzyme%2520Inhibition%2520by%2520Stabilization%2520of%2520a%2520Low-Affinity%2520Interface%2520with%2520Ubiquitin%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D2%26spage%3D156%26epage%3D163%26doi%3D10.1038%2Fnchembio.1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Metzger, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hristova, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">HECT and RING Finger Families of E3 Ubiquitin Ligases at a Glance</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">531</span><span class="NLM_x">â</span> <span class="NLM_lpage">537</span><span class="refDoi">Â DOI: 10.1242/jcs.091777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1242%2Fjcs.091777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22389392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Oltbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=531-537&issue=3&author=M.+B.+Metzgerauthor=V.+A.+Hristovaauthor=A.+M.+Weissman&title=HECT+and+RING+Finger+Families+of+E3+Ubiquitin+Ligases+at+a+Glance&doi=10.1242%2Fjcs.091777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">HECT and RING finger families of E3 ubiquitin ligases at a glance</span></div><div class="casAuthors">Metzger, Meredith B.; Hristova, Ventzislava A.; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">531-537</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  This article is part of a Minifocus on Ubiquitin.  The authors review the HECT and RING finger families of E3 ubiquitin ligases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD1zjEVIxdpbVg90H21EOLACvtfcHk0ljYk231B6dEBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Oltbc%253D&md5=80112ede647eb3742c268e63ebd0ce88</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1242%2Fjcs.091777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.091777%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DM.%2BB.%26aulast%3DHristova%26aufirst%3DV.%2BA.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DHECT%2520and%2520RING%2520Finger%2520Families%2520of%2520E3%2520Ubiquitin%2520Ligases%2520at%2520a%2520Glance%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2012%26volume%3D125%26issue%3D3%26spage%3D531%26epage%3D537%26doi%3D10.1242%2Fjcs.091777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Rotin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span> </span><span class="NLM_article-title">Physiological Functions of the HECT Family of Ubiquitin Ligases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">398</span><span class="NLM_x">â</span> <span class="NLM_lpage">409</span><span class="refDoi">Â DOI: 10.1038/nrm2690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm2690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19436320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslGntbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=398-409&issue=6&author=D.+Rotinauthor=S.+Kumar&title=Physiological+Functions+of+the+HECT+Family+of+Ubiquitin+Ligases&doi=10.1038%2Fnrm2690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological functions of the HECT family of ubiquitin ligases</span></div><div class="casAuthors">Rotin, Daniela; Kumar, Sharad</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">398-409</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The ubiquitination of proteins is carried out by E1, E2, and E3 (ubiquitin ligase) enzymes, and targets them for degrdn. or for other cellular fates.  The HECT enzymes, including Nedd4 family members, are a major group of E3 enzymes that dictate the specificity of ubiquitination.  In addn. to ubiquitinating proteins for degrdn. by the 26S proteasome, HECT E3 enzymes regulate the trafficking of many receptors, channels, transporters, and viral proteins.  The physiol. functions of yeast HECT E3 ligase Rsp5 are the best known, but the functions of HECT E3 enzymes in metazoans are now becoming clearer from in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBtUzlKovNi7Vg90H21EOLACvtfcHk0ljYk231B6dEBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslGntbw%253D&md5=8f09fb0d84b7f3cd55bf65aab1fc882c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnrm2690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2690%26sid%3Dliteratum%253Aachs%26aulast%3DRotin%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DPhysiological%2520Functions%2520of%2520the%2520HECT%2520Family%2520of%2520Ubiquitin%2520Ligases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26issue%3D6%26spage%3D398%26epage%3D409%26doi%3D10.1038%2Fnrm2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Hatakeyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K. I.</span><span> </span><span class="NLM_article-title">U Box Proteins as a New Family of Ubiquitin-Protein Ligases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">33111</span><span class="NLM_x">â</span> <span class="NLM_lpage">33120</span><span class="refDoi">Â DOI: 10.1074/jbc.M102755200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1074%2Fjbc.M102755200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=33111-33120&issue=35&author=S.+Hatakeyamaauthor=M.+Yadaauthor=M.+Matsumotoauthor=N.+Ishidaauthor=K.+I.+Nakayama&title=U+Box+Proteins+as+a+New+Family+of+Ubiquitin-Protein+Ligases&doi=10.1074%2Fjbc.M102755200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M102755200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M102755200%26sid%3Dliteratum%253Aachs%26aulast%3DHatakeyama%26aufirst%3DS.%26aulast%3DYada%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DN.%26aulast%3DNakayama%26aufirst%3DK.%2BI.%26atitle%3DU%2520Box%2520Proteins%2520as%2520a%2520New%2520Family%2520of%2520Ubiquitin-Protein%2520Ligases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D35%26spage%3D33111%26epage%3D33120%26doi%3D10.1074%2Fjbc.M102755200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Dove, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">RING-Between-RINGsâKeeping the Safety on Loaded Guns</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">3792</span><span class="NLM_x">â</span> <span class="NLM_lpage">3794</span><span class="refDoi">Â DOI: 10.1038/emboj.2012.260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Femboj.2012.260" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3792-3794&issue=19&author=K.+K.+Doveauthor=R.+E.+Klevit&title=RING-Between-RINGs%E2%80%94Keeping+the+Safety+on+Loaded+Guns&doi=10.1038%2Femboj.2012.260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Femboj.2012.260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2012.260%26sid%3Dliteratum%253Aachs%26aulast%3DDove%26aufirst%3DK.%2BK.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DRING-Between-RINGs%25E2%2580%2594Keeping%2520the%2520Safety%2520on%2520Loaded%2520Guns%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26issue%3D19%26spage%3D3792%26epage%3D3794%26doi%3D10.1038%2Femboj.2012.260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Coscoy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganem, D.</span><span> </span><span class="NLM_article-title">PHD Domains and E3 Ubiquitin Ligases: Viruses Make the Connection</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">12</span><span class="refDoi">Â DOI: 10.1016/S0962-8924(02)00005-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS0962-8924%2802%2900005-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=12480335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A280%3ADC%252BD38jhvFWjtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=7-12&issue=1&author=L.+Coscoyauthor=D.+Ganem&title=PHD+Domains+and+E3+Ubiquitin+Ligases%3A+Viruses+Make+the+Connection&doi=10.1016%2FS0962-8924%2802%2900005-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">PHD domains and E3 ubiquitin ligases: viruses make the connection</span></div><div class="casAuthors">Coscoy Laurent; Ganem Don</div><div class="citationInfo"><span class="NLM_cas:title">Trends in cell biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-12</span>
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    </div><div class="casAbstract">PHD domains constitute a widely distributed subfamily of zinc fingers whose biochemical functions have been unclear until now.  Recently, several PHD-containing viral proteins have been identified that promote immune evasion by downregulating proteins that govern immune recognition.  Studies show that these viral regulators lead to ubiquitination of their targets by functioning as E3 ubiquitin ligases -- an activity that requires the PHD motif.  These are the first examples linking the PHD domain to E3 activity, but the recent discovery of PHD-dependent E3 activity in the cellular kinase MEKK1 and the close structural relation of PHD domains to RING fingers hint that many other PHD proteins might share this activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9v4qmAzG4Kk2yPDyEFiigfW6udTcc2eZBLjdFvQPJXrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jhvFWjtQ%253D%253D&md5=a391e86e8a68bca16daf28151f68e71c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2802%2900005-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252802%252900005-3%26sid%3Dliteratum%253Aachs%26aulast%3DCoscoy%26aufirst%3DL.%26aulast%3DGanem%26aufirst%3DD.%26atitle%3DPHD%2520Domains%2520and%2520E3%2520Ubiquitin%2520Ligases%253A%2520Viruses%2520Make%2520the%2520Connection%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2003%26volume%3D13%26issue%3D1%26spage%3D7%26epage%3D12%26doi%3D10.1016%2FS0962-8924%2802%2900005-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Vittal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzovic, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">21244</span><span class="NLM_x">â</span> <span class="NLM_lpage">21251</span><span class="refDoi">Â DOI: 10.1074/jbc.R115.675165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1074%2Fjbc.R115.675165" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=21244-21251&issue=35&author=V.+Vittalauthor=M.+D.+Stewartauthor=P.+S.+Brzovicauthor=R.+E.+Klevit&title=Regulating+the+Regulators%3A+Recent+Revelations+in+the+Control+of+E3+Ubiquitin+Ligases&doi=10.1074%2Fjbc.R115.675165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R115.675165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R115.675165%26sid%3Dliteratum%253Aachs%26aulast%3DVittal%26aufirst%3DV.%26aulast%3DStewart%26aufirst%3DM.%2BD.%26aulast%3DBrzovic%26aufirst%3DP.%2BS.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DRegulating%2520the%2520Regulators%253A%2520Recent%2520Revelations%2520in%2520the%2520Control%2520of%2520E3%2520Ubiquitin%2520Ligases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D35%26spage%3D21244%26epage%3D21251%26doi%3D10.1074%2Fjbc.R115.675165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Nakayama, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span> </span><span class="NLM_article-title">Ubiquitin Ligases: Cell-Cycle Control and Cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">369</span><span class="NLM_x">â</span> <span class="NLM_lpage">381</span><span class="refDoi">Â DOI: 10.1038/nrc1881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrc1881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16633365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslGitb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=369-381&issue=5&author=K.+I.+Nakayamaauthor=K.+Nakayama&title=Ubiquitin+Ligases%3A+Cell-Cycle+Control+and+Cancer&doi=10.1038%2Fnrc1881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin ligases: cell-cycle control and cancer</span></div><div class="casAuthors">Nakayama, Keiichi I.; Nakayama, Keiko</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">369-381</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A driving force of the cell cycle is the activation of cyclin-dependent kinases (CDKs), the activities of which are controlled by the ubiquitin-mediated proteolysis of key regulators such as cyclins and CDK inhibitors.  Two ubiquitin ligases, the SKP1-CUL1-F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), are responsible for the specific ubiquitylation of many of these regulators.  Deregulation of the proteolytic system might result in uncontrolled proliferation, genomic instability and cancer.  Cumulative clin. evidence shows alterations in the ubiquitylation of cell-cycle regulators in the etiol. of many human malignancies.  A better understanding of the ubiquitylation machinery will provide new insights into the regulatory biol. of cell-cycle transitions and the development of anti-cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQVKJ7pAqq7Vg90H21EOLACvtfcHk0lhz6L6ifDhBFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslGitb4%253D&md5=23f2eff17be746153edf5be9e733bb21</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnrc1881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1881%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DK.%2BI.%26aulast%3DNakayama%26aufirst%3DK.%26atitle%3DUbiquitin%2520Ligases%253A%2520Cell-Cycle%2520Control%2520and%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26issue%3D5%26spage%3D369%26epage%3D381%26doi%3D10.1038%2Fnrc1881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Metzger, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruneda, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">RING-Type E3 Ligases: Master Manipulators of E2 Ubiquitin-Conjugating Enzymes and Ubiquitination</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1843</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">â</span> <span class="NLM_lpage">60</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2013.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbamcr.2013.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23747565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgsbzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1843&publication_year=2014&pages=47-60&issue=1&author=M.+B.+Metzgerauthor=J.+N.+Prunedaauthor=R.+E.+Klevitauthor=A.+M.+Weissman&title=RING-Type+E3+Ligases%3A+Master+Manipulators+of+E2+Ubiquitin-Conjugating+Enzymes+and+Ubiquitination&doi=10.1016%2Fj.bbamcr.2013.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination</span></div><div class="casAuthors">Metzger, Meredith B.; Pruneda, Jonathan N.; Klevit, Rachel E.; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1843</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-60</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  RING finger domain and RING finger-like ubiquitin ligases (E3s), such as U-box proteins, constitute the vast majority of known E3s.  RING-type E3s function together with ubiquitin-conjugating enzymes (E2s) to mediate ubiquitination and are implicated in numerous cellular processes.  In part because of their importance in human physiol. and disease, these proteins and their cellular functions represent an intense area of study.  Here we review recent advances in RING-type E3 recognition of substrates, their cellular regulation, and their varied architecture.  Addnl., recent structural insights into RING-type E3 function, with a focus on important interactions with E2s and ubiquitin, are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbslkCQsg5BrVg90H21EOLACvtfcHk0li_R8gzyJ-FAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgsbzO&md5=3ecbadbe2b6eb405d47b89211607306b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2013.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2013.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DM.%2BB.%26aulast%3DPruneda%26aufirst%3DJ.%2BN.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DRING-Type%2520E3%2520Ligases%253A%2520Master%2520Manipulators%2520of%2520E2%2520Ubiquitin-Conjugating%2520Enzymes%2520and%2520Ubiquitination%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2014%26volume%3D1843%26issue%3D1%26spage%3D47%26epage%3D60%26doi%3D10.1016%2Fj.bbamcr.2013.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Brown, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderLinden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, C. R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dube, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ei Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Actis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span> </span><span class="NLM_article-title">RING E3 Mechanism for Ubiquitin Ligation to a Disordered Substrate Visualized for Human Anaphase-Promoting Complex</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5272</span><span class="NLM_x">â</span> <span class="NLM_lpage">5279</span><span class="refDoi">Â DOI: 10.1073/pnas.1504161112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1073%2Fpnas.1504161112" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=5272-5279&issue=17&author=N.+G.+Brownauthor=R.+VanderLindenauthor=E.+R.+Watsonauthor=R.+Qiaoauthor=C.+R.+R.+Graceauthor=M.+Yamaguchiauthor=F.+Weissmannauthor=J.+J.+Fryeauthor=P.+Dubeauthor=S.+Ei+Choauthor=M.+L.+Actisauthor=P.+Rodriguesauthor=N.+Fujiiauthor=J.-M.+Petersauthor=H.+Starkauthor=B.+A.+Schulman&title=RING+E3+Mechanism+for+Ubiquitin+Ligation+to+a+Disordered+Substrate+Visualized+for+Human+Anaphase-Promoting+Complex&doi=10.1073%2Fpnas.1504161112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1504161112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1504161112%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BG.%26aulast%3DVanderLinden%26aufirst%3DR.%26aulast%3DWatson%26aufirst%3DE.%2BR.%26aulast%3DQiao%26aufirst%3DR.%26aulast%3DGrace%26aufirst%3DC.%2BR.%2BR.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DWeissmann%26aufirst%3DF.%26aulast%3DFrye%26aufirst%3DJ.%2BJ.%26aulast%3DDube%26aufirst%3DP.%26aulast%3DEi%2BCho%26aufirst%3DS.%26aulast%3DActis%26aufirst%3DM.%2BL.%26aulast%3DRodrigues%26aufirst%3DP.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DJ.-M.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26atitle%3DRING%2520E3%2520Mechanism%2520for%2520Ubiquitin%2520Ligation%2520to%2520a%2520Disordered%2520Substrate%2520Visualized%2520for%2520Human%2520Anaphase-Promoting%2520Complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D17%26spage%3D5272%26epage%3D5279%26doi%3D10.1073%2Fpnas.1504161112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Deshaies, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joazeiro, C. A. P.</span><span> </span><span class="NLM_article-title">RING Domain E3 Ubiquitin Ligases</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">399</span><span class="NLM_x">â</span> <span class="NLM_lpage">434</span><span class="refDoi">Â DOI: 10.1146/annurev.biochem.78.101807.093809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1146%2Fannurev.biochem.78.101807.093809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19489725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Ghur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=399-434&issue=1&author=R.+J.+Deshaiesauthor=C.+A.+P.+Joazeiro&title=RING+Domain+E3+Ubiquitin+Ligases&doi=10.1146%2Fannurev.biochem.78.101807.093809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">RING domain E3 ubiquitin ligases</span></div><div class="casAuthors">Deshaies, Raymond J.; Joazeiro, Claudio A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">399-434</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  E3 ubiquitin ligases confer specificity to ubiquitination by recognizing target substrates and mediating the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to the substrate.  The activity of most E3 enzymes is specified by a RING domain, which binds to an E2-ubiquitin thioester and activates discharge of its ubiquitin cargo.  E2-E3 complexes can either monoubiquitinate a substrate protein Lys residue or synthesize polyubiquitin chains assembled via different Lys residues of ubiquitin.  These modifications can have diverse effects on the substrate, ranging from proteasome-dependent proteolysis to modulation of protein function, structure, assembly, and/or localization.  Not surprisingly, RING E3-mediated ubiquitination can be regulated in a no. of ways.  RING-based E3 enzymes are specified by >600 human genes, surpassing the 518 protein kinase genes.  Accordingly, RING E3 enzymes have been linked to the control of many cellular processes and to multiple human diseases.  Despite their crit. importance, a knowledge of the physiol. partners, biol. functions, substrates, and mechanism of action for most RING E3 enzymess remains at a rudimentary stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMbk3gX4ei9LVg90H21EOLACvtfcHk0li_R8gzyJ-FAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Ghur4%253D&md5=f51600c73ae9a74e4e0212d5f25eefc0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.78.101807.093809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.78.101807.093809%26sid%3Dliteratum%253Aachs%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DJoazeiro%26aufirst%3DC.%2BA.%2BP.%26atitle%3DRING%2520Domain%2520E3%2520Ubiquitin%2520Ligases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2009%26volume%3D78%26issue%3D1%26spage%3D399%26epage%3D434%26doi%3D10.1146%2Fannurev.biochem.78.101807.093809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Lipkowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">RINGs of Good and Evil: RING Finger Ubiquitin Ligases at the Crossroads of Tumour Suppression and Oncogenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">629</span><span class="NLM_x">â</span> <span class="NLM_lpage">643</span><span class="refDoi">Â DOI: 10.1038/nrc3120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrc3120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=21863050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKit73E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=629-643&issue=9&author=S.+Lipkowitzauthor=A.+M.+Weissman&title=RINGs+of+Good+and+Evil%3A+RING+Finger+Ubiquitin+Ligases+at+the+Crossroads+of+Tumour+Suppression+and+Oncogenesis&doi=10.1038%2Fnrc3120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis</span></div><div class="casAuthors">Lipkowitz, Stanley; Weissman, Allan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">629-643</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome system has numerous crucial roles in physiol. and pathophysiol.  Fundamental to the specificity of this system are ubiquitin-protein ligases (E3s).  Of these, the majority are RING finger and RING finger-related E3s.  Many RING finger E3s have roles in processes that are central to the maintenance of genomic integrity and cellular homeostasis, such as the anaphase promoting complex/cyclosome (APC/C), the SKP1-cullin 1-F-box protein (SCF) E3s, MDM2, BRCA1, Fanconi anemia proteins, CBL proteins, von Hippel-Lindau tumor suppressor (VHL) and SIAH proteins.  As a result, many RING finger E3s are implicated in either the suppression or the progression of cancer.  This Review summarizes current knowledge in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7dkRvaNdibLVg90H21EOLACvtfcHk0lhgQr3qVmtiTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKit73E&md5=9f722fc9920bd2a0b8d29cc959271ad4</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrc3120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3120%26sid%3Dliteratum%253Aachs%26aulast%3DLipkowitz%26aufirst%3DS.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DRINGs%2520of%2520Good%2520and%2520Evil%253A%2520RING%2520Finger%2520Ubiquitin%2520Ligases%2520at%2520the%2520Crossroads%2520of%2520Tumour%2520Suppression%2520and%2520Oncogenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D9%26spage%3D629%26epage%3D643%26doi%3D10.1038%2Fnrc3120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Morreale, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, H.</span><span> </span><span class="NLM_article-title">Types of Ubiquitin Ligases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">248</span><span class="NLM_x">â</span> <span class="NLM_lpage">248.e1</span><span class="refDoi">Â DOI: 10.1016/j.cell.2016.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2016.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=27015313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVamurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=248-248.e1&issue=1&author=F.+E.+Morrealeauthor=H.+Walden&title=Types+of+Ubiquitin+Ligases&doi=10.1016%2Fj.cell.2016.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Types of ubiquitin ligases</span></div><div class="casAuthors">Morreale, Francesca Ester; Walden, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-248.e1</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Ubiquitination is a post-translational modification of proteins involved in a variety of cellular processes.  Ubiquitination requires the sequential action of 3 enzymes: E1 (ubiquitin-activating enzymes), E2 (ubiquitin-conjugating enzymes), and E3 (ubiquitin ligases).  Here, the authors highlight the main types of E3 ubiquitin ligases, which can be classified in 3 families depending on the presence of characteristic domains and on the mechanism of ubiquitin transfer to the substrate protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaGjtLCe1p8LVg90H21EOLACvtfcHk0lhgQr3qVmtiTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVamurg%253D&md5=f819525b60b95ed16340612d6bf51a13</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DMorreale%26aufirst%3DF.%2BE.%26aulast%3DWalden%26aufirst%3DH.%26atitle%3DTypes%2520of%2520Ubiquitin%2520Ligases%26jtitle%3DCell%26date%3D2016%26volume%3D165%26issue%3D1%26spage%3D248%26epage%3D248.e1%26doi%3D10.1016%2Fj.cell.2016.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Pruneda, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlefield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soss, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordquist, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chazin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzovic, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">Structure of an E3:E2$Ub Complex Reveals an Allosteric Mechanism Sharedamong RING/U-Box Ligases</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">933</span><span class="NLM_x">â</span> <span class="NLM_lpage">942</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2012.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2012.07.001" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=933-942&issue=6&author=J.+N.+Prunedaauthor=P.+J.+Littlefieldauthor=S.+E.+Sossauthor=K.+A.+Nordquistauthor=W.+J.+Chazinauthor=P.+S.+Brzovicauthor=R.+E.+Klevit&title=Structure+of+an+E3%3AE2%24Ub+Complex+Reveals+an+Allosteric+Mechanism+Sharedamong+RING%2FU-Box+Ligases&doi=10.1016%2Fj.molcel.2012.07.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DPruneda%26aufirst%3DJ.%2BN.%26aulast%3DLittlefield%26aufirst%3DP.%2BJ.%26aulast%3DSoss%26aufirst%3DS.%2BE.%26aulast%3DNordquist%26aufirst%3DK.%2BA.%26aulast%3DChazin%26aufirst%3DW.%2BJ.%26aulast%3DBrzovic%26aufirst%3DP.%2BS.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DStructure%2520of%2520an%2520E3%253AE2%2524Ub%2520Complex%2520Reveals%2520an%2520Allosteric%2520Mechanism%2520Sharedamong%2520RING%252FU-Box%2520Ligases%26jtitle%3DMol.%2520Cell%26date%3D2012%26volume%3D47%26issue%3D6%26spage%3D933%26epage%3D942%26doi%3D10.1016%2Fj.molcel.2012.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">PlechanovovÃ¡, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffray, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatham, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naismith, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, R. T.</span><span> </span><span class="NLM_article-title">Structure of a RING E3 Ligase and Ubiquitin-Loaded E2 Primed for Catalysis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">489</span><span class="NLM_x"> (</span><span class="NLM_issue">7414</span><span class="NLM_x">) </span> <span class="NLM_fpage">115</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span><span class="refDoi">Â DOI: 10.1038/nature11376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature11376" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=489&publication_year=2012&pages=115-120&issue=7414&author=A.+Plechanovov%C3%A1author=E.+G.+Jaffrayauthor=M.+H.+Tathamauthor=J.+H.+Naismithauthor=R.+T.+Hay&title=Structure+of+a+RING+E3+Ligase+and+Ubiquitin-Loaded+E2+Primed+for+Catalysis&doi=10.1038%2Fnature11376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fnature11376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11376%26sid%3Dliteratum%253Aachs%26aulast%3DPlechanovov%25C3%25A1%26aufirst%3DA.%26aulast%3DJaffray%26aufirst%3DE.%2BG.%26aulast%3DTatham%26aufirst%3DM.%2BH.%26aulast%3DNaismith%26aufirst%3DJ.%2BH.%26aulast%3DHay%26aufirst%3DR.%2BT.%26atitle%3DStructure%2520of%2520a%2520RING%2520E3%2520Ligase%2520and%2520Ubiquitin-Loaded%2520E2%2520Primed%2520for%2520Catalysis%26jtitle%3DNature%26date%3D2012%26volume%3D489%26issue%3D7414%26spage%3D115%26epage%3D120%26doi%3D10.1038%2Fnature11376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Dou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buetow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibbet, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. T.</span><span> </span><span class="NLM_article-title">BIRC7-E2 Ubiquitin Conjugate Structure Reveals the Mechanism of Ubiquitin Transfer by a RING Dimer</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">876</span><span class="NLM_x">â</span> <span class="NLM_lpage">883</span><span class="refDoi">Â DOI: 10.1038/nsmb.2379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnsmb.2379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22902369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Wkt77E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=876-883&issue=9&author=H.+Douauthor=L.+Buetowauthor=G.+J.+Sibbetauthor=K.+Cameronauthor=D.+T.+Huang&title=BIRC7-E2+Ubiquitin+Conjugate+Structure+Reveals+the+Mechanism+of+Ubiquitin+Transfer+by+a+RING+Dimer&doi=10.1038%2Fnsmb.2379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer</span></div><div class="casAuthors">Dou, Hao; Buetow, Lori; Sibbet, Gary J.; Cameron, Kenneth; Huang, Danny T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">876-883</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Certain RING ubiquitin ligases (E3s) dimerize to facilitate ubiquitin (Ub) transfer from ubiquitin-conjugating enzyme (E2) to substrate, but structural evidence on how this process promotes Ub transfer is lacking.  Here we report the structure of the human dimeric RING domain from BIRC7 in complex with the E2 UbcH5B covalently linked to Ub (UbcH5Bâ¼Ub).  The structure reveals extensive noncovalent donor Ub interactions with UbcH5B and both subunits of the RING domain dimer that stabilize the globular body and C-terminal tail of Ub.  Mutations that disrupt these noncovalent interactions or RING dimerization reduce UbcH5Bâ¼Ub binding affinity and ubiquitination activity.  Moreover, NMR analyses demonstrate that BIRC7 binding to UbcH5Bâ¼Ub induces peak-shift perturbations in the donor Ub consistent with the crystallog.-obsd. Ub interactions.  Our results provide structural insights into how dimeric RING E3s recruit E2â¼Ub and optimize the donor Ub configuration for transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxnWgmAyO2_LVg90H21EOLACvtfcHk0lhgQr3qVmtiTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Wkt77E&md5=ef021a79ae5e914838bc7f8ad7e43942</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2379%26sid%3Dliteratum%253Aachs%26aulast%3DDou%26aufirst%3DH.%26aulast%3DBuetow%26aufirst%3DL.%26aulast%3DSibbet%26aufirst%3DG.%2BJ.%26aulast%3DCameron%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DD.%2BT.%26atitle%3DBIRC7-E2%2520Ubiquitin%2520Conjugate%2520Structure%2520Reveals%2520the%2520Mechanism%2520of%2520Ubiquitin%2520Transfer%2520by%2520a%2520RING%2520Dimer%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D9%26spage%3D876%26epage%3D883%26doi%3D10.1038%2Fnsmb.2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Berndsen, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span> </span><span class="NLM_article-title">New Insights Into Ubiquitin E3 Ligase Mechanism</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">301</span><span class="NLM_x">â</span> <span class="NLM_lpage">307</span><span class="refDoi">Â DOI: 10.1038/nsmb.2780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnsmb.2780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24699078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1aisrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=301-307&issue=4&author=C.+E.+Berndsenauthor=C.+Wolberger&title=New+Insights+Into+Ubiquitin+E3+Ligase+Mechanism&doi=10.1038%2Fnsmb.2780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into ubiquitin E3 ligase mechanism</span></div><div class="casAuthors">Berndsen, Christopher E.; Wolberger, Cynthia</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-307</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  E3 ligases carry out the final step in the ubiquitination cascade, catalyzing transfer of ubiquitin from an E2 enzyme to form a covalent bond with a substrate lysine.  Three distinct classes of E3 ligases have been identified that stimulate transfer of ubiquitin and ubiquitin-like proteins through either a direct or an indirect mechanism.  Only recently have the catalytic mechanisms of E3 ligases begun to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovYmD2sLo2RrVg90H21EOLACvtfcHk0liZpG_cECcI1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1aisrk%253D&md5=fd44f6d69f85067b70322ca304aed507</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2780%26sid%3Dliteratum%253Aachs%26aulast%3DBerndsen%26aufirst%3DC.%2BE.%26aulast%3DWolberger%26aufirst%3DC.%26atitle%3DNew%2520Insights%2520Into%2520Ubiquitin%2520E3%2520Ligase%2520Mechanism%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D21%26issue%3D4%26spage%3D301%26epage%3D307%26doi%3D10.1038%2Fnsmb.2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Das, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalathur, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarasov, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFeeters, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">Allosteric Activation of E2-RING Finger-Mediated Ubiquitylation by a Structurally Defined Specific E2-Binding Region of Gp78</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">674</span><span class="NLM_x">â</span> <span class="NLM_lpage">685</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2009.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2009.05.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=674-685&issue=6&author=R.+Dasauthor=J.+Marianoauthor=Y.+C.+Tsaiauthor=R.+C.+Kalathurauthor=Z.+Kostovaauthor=J.+Liauthor=S.+G.+Tarasovauthor=R.+L.+McFeetersauthor=A.+S.+Altieriauthor=X.+Jiauthor=R.+A.+Byrdauthor=A.+M.+Weissman&title=Allosteric+Activation+of+E2-RING+Finger-Mediated+Ubiquitylation+by+a+Structurally+Defined+Specific+E2-Binding+Region+of+Gp78&doi=10.1016%2Fj.molcel.2009.05.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2009.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2009.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DR.%26aulast%3DMariano%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DY.%2BC.%26aulast%3DKalathur%26aufirst%3DR.%2BC.%26aulast%3DKostova%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTarasov%26aufirst%3DS.%2BG.%26aulast%3DMcFeeters%26aufirst%3DR.%2BL.%26aulast%3DAltieri%26aufirst%3DA.%2BS.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DByrd%26aufirst%3DR.%2BA.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DAllosteric%2520Activation%2520of%2520E2-RING%2520Finger-Mediated%2520Ubiquitylation%2520by%2520a%2520Structurally%2520Defined%2520Specific%2520E2-Binding%2520Region%2520of%2520Gp78%26jtitle%3DMol.%2520Cell%26date%3D2009%26volume%3D34%26issue%3D6%26spage%3D674%26epage%3D685%26doi%3D10.1016%2Fj.molcel.2009.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Brzovic, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lissounov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyt, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevit, R. E.</span><span> </span><span class="NLM_article-title">A UbcH5/Ubiquitin Noncovalent Complex Is Required for Processive BRCA1-Directed Ubiquitination</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">873</span><span class="NLM_x">â</span> <span class="NLM_lpage">880</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2006.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2006.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16543155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVyisr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=873-880&issue=6&author=P.+S.+Brzovicauthor=A.+Lissounovauthor=D.+E.+Christensenauthor=D.+W.+Hoytauthor=R.+E.+Klevit&title=A+UbcH5%2FUbiquitin+Noncovalent+Complex+Is+Required+for+Processive+BRCA1-Directed+Ubiquitination&doi=10.1016%2Fj.molcel.2006.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination</span></div><div class="casAuthors">Brzovic, Peter S.; Lissounov, Alexei; Christensen, Devin E.; Hoyt, David W.; Klevit, Rachel E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">873-880</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protein ubiquitination is a powerful regulatory modification that influences nearly every aspect of eukaryotic cell biol.  The general pathway for ubiquitin (Ub) modification requires the sequential activities of a Ub-activating enzyme (E1), a Ub transfer enzyme (E2), and a Ub ligase (E3).  The E2 must recognize both the E1 and a cognate E3 in addn. to carrying activated Ub.  These central functions are performed by a topol. conserved Î±/Î²-fold core domain of â¼ 150 residues shared by all E2s.  However, as presented herein, the UbcH5 family of E2s can also bind Ub noncovalently on a surface well removed from the E2 active site.  We present the soln. structure of the UbcH5c/Ub noncovalent complex and demonstrate that this noncovalent interaction permits self-assembly of activated UbcH5c â¼ Ub mols.  Self-assembly has profound consequences for the processive formation of polyubiquitin (poly-Ub) chains in ubiquitination reactions directed by the breast and ovarian cancer tumor susceptibility protein BRCA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlYVF7MSoZiLVg90H21EOLACvtfcHk0liZpG_cECcI1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVyisr4%253D&md5=f2b21298bc25b43ad9c1fcefe9959d9f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DBrzovic%26aufirst%3DP.%2BS.%26aulast%3DLissounov%26aufirst%3DA.%26aulast%3DChristensen%26aufirst%3DD.%2BE.%26aulast%3DHoyt%26aufirst%3DD.%2BW.%26aulast%3DKlevit%26aufirst%3DR.%2BE.%26atitle%3DA%2520UbcH5%252FUbiquitin%2520Noncovalent%2520Complex%2520Is%2520Required%2520for%2520Processive%2520BRCA1-Directed%2520Ubiquitination%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D21%26issue%3D6%26spage%3D873%26epage%3D880%26doi%3D10.1016%2Fj.molcel.2006.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Das, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarasov, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, R. A.</span><span> </span><span class="NLM_article-title">Allosteric Regulation of E2:E3 Interactions Promote a Processive Ubiquitination Machine</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">2504</span><span class="NLM_x">â</span> <span class="NLM_lpage">2516</span><span class="refDoi">Â DOI: 10.1038/emboj.2013.174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Femboj.2013.174" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2504-2516&issue=18&author=R.+Dasauthor=Y.+H.+Liangauthor=J.+Marianoauthor=J.+Liauthor=T.+Huangauthor=A.+Kingauthor=S.+G.+Tarasovauthor=A.+M.+Weissmanauthor=X.+Jiauthor=R.+A.+Byrd&title=Allosteric+Regulation+of+E2%3AE3+Interactions+Promote+a+Processive+Ubiquitination+Machine&doi=10.1038%2Femboj.2013.174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Femboj.2013.174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2013.174%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DR.%26aulast%3DLiang%26aufirst%3DY.%2BH.%26aulast%3DMariano%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DTarasov%26aufirst%3DS.%2BG.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DByrd%26aufirst%3DR.%2BA.%26atitle%3DAllosteric%2520Regulation%2520of%2520E2%253AE3%2520Interactions%2520Promote%2520a%2520Processive%2520Ubiquitination%2520Machine%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26issue%3D18%26spage%3D2504%26epage%3D2516%26doi%3D10.1038%2Femboj.2013.174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Notenboom, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbert, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rossum-Fikkert, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, T. K.</span><span> </span><span class="NLM_article-title">Functional Characterization of Rad18 Domains for Rad6, Ubiquitin, DNA Binding and PCNA Modification</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5819</span><span class="NLM_x">â</span> <span class="NLM_lpage">5830</span><span class="refDoi">Â DOI: 10.1093/nar/gkm615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1093%2Fnar%2Fgkm615" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=5819-5830&issue=17&author=V.+Notenboomauthor=R.+G.+Hibbertauthor=S.+E.+van+Rossum-Fikkertauthor=J.+V.+Olsenauthor=M.+Mannauthor=T.+K.+Sixma&title=Functional+Characterization+of+Rad18+Domains+for+Rad6%2C+Ubiquitin%2C+DNA+Binding+and+PCNA+Modification&doi=10.1093%2Fnar%2Fgkm615"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm615%26sid%3Dliteratum%253Aachs%26aulast%3DNotenboom%26aufirst%3DV.%26aulast%3DHibbert%26aufirst%3DR.%2BG.%26aulast%3Dvan%2BRossum-Fikkert%26aufirst%3DS.%2BE.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DMann%26aufirst%3DM.%26aulast%3DSixma%26aufirst%3DT.%2BK.%26atitle%3DFunctional%2520Characterization%2520of%2520Rad18%2520Domains%2520for%2520Rad6%252C%2520Ubiquitin%252C%2520DNA%2520Binding%2520and%2520PCNA%2520Modification%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26issue%3D17%26spage%3D5819%26epage%3D5830%26doi%3D10.1093%2Fnar%2Fgkm615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Metzger, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, A. M.</span><span> </span><span class="NLM_article-title">A Structurally Unique E2-Binding Domain Activates Ubiquitination by the ERAD E2, Ubc7p, Through Multiple Mechanisms</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">516</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2013.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2013.04.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2013&pages=516-527&issue=4&author=M.+B.+Metzgerauthor=Y.+H.+Liangauthor=R.+Dasauthor=J.+Marianoauthor=S.+Liauthor=J.+Liauthor=Z.+Kostovaauthor=R.+A.+Byrdauthor=X.+Jiauthor=A.+M.+Weissman&title=A+Structurally+Unique+E2-Binding+Domain+Activates+Ubiquitination+by+the+ERAD+E2%2C+Ubc7p%2C+Through+Multiple+Mechanisms&doi=10.1016%2Fj.molcel.2013.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2013.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2013.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DM.%2BB.%26aulast%3DLiang%26aufirst%3DY.%2BH.%26aulast%3DDas%26aufirst%3DR.%26aulast%3DMariano%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKostova%26aufirst%3DZ.%26aulast%3DByrd%26aufirst%3DR.%2BA.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26atitle%3DA%2520Structurally%2520Unique%2520E2-Binding%2520Domain%2520Activates%2520Ubiquitination%2520by%2520the%2520ERAD%2520E2%252C%2520Ubc7p%252C%2520Through%2520Multiple%2520Mechanisms%26jtitle%3DMol.%2520Cell%26date%3D2013%26volume%3D50%26issue%3D4%26spage%3D516%26epage%3D527%26doi%3D10.1016%2Fj.molcel.2013.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koepp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conaway, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF Ubiquitin Ligase Complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x"> (</span><span class="NLM_issue">6882</span><span class="NLM_x">) </span> <span class="NLM_fpage">703</span><span class="NLM_x">â</span> <span class="NLM_lpage">709</span><span class="refDoi">Â DOI: 10.1038/416703a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2F416703a" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2002&pages=703-709&issue=6882&author=N.+Zhengauthor=B.+A.+Schulmanauthor=L.+Songauthor=J.+J.+Millerauthor=P.+D.+Jeffreyauthor=P.+Wangauthor=C.+Chuauthor=D.+M.+Koeppauthor=S.+J.+Elledgeauthor=M.+Paganoauthor=R.+C.+Conawayauthor=J.+W.+Conawayauthor=J.+W.+Harperauthor=N.+P.+Pavletich&title=Structure+of+the+Cul1-Rbx1-Skp1-F+boxSkp2+SCF+Ubiquitin+Ligase+Complex&doi=10.1038%2F416703a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2F416703a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F416703a%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DJ.%2BJ.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DChu%26aufirst%3DC.%26aulast%3DKoepp%26aufirst%3DD.%2BM.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520Cul1-Rbx1-Skp1-F%2520boxSkp2%2520SCF%2520Ubiquitin%2520Ligase%2520Complex%26jtitle%3DNature%26date%3D2002%26volume%3D416%26issue%3D6882%26spage%3D703%26epage%3D709%26doi%3D10.1038%2F416703a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of a C-Cbl-UbcH7 Complex: RING Domain Function in Ubiquitin-Protein Ligases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">533</span><span class="NLM_x">â</span> <span class="NLM_lpage">539</span><span class="refDoi">Â DOI: 10.1016/S0092-8674(00)00057-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS0092-8674%2800%2900057-X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=533-539&issue=4&author=N.+Zhengauthor=P.+Wangauthor=P.+D.+Jeffreyauthor=N.+P.+Pavletich&title=Structure+of+a+C-Cbl-UbcH7+Complex%3A+RING+Domain+Function+in+Ubiquitin-Protein+Ligases&doi=10.1016%2FS0092-8674%2800%2900057-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900057-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900057-X%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520a%2520C-Cbl-UbcH7%2520Complex%253A%2520RING%2520Domain%2520Function%2520in%2520Ubiquitin-Protein%2520Ligases%26jtitle%3DCell%26date%3D2000%26volume%3D102%26issue%3D4%26spage%3D533%26epage%3D539%26doi%3D10.1016%2FS0092-8674%2800%2900057-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Orlicky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">Structural Basis for Phosphodependent Substrate Selection and Orientation by the SCFCdc4 Ubiquitin Ligase</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">243</span><span class="NLM_x">â</span> <span class="NLM_lpage">256</span><span class="refDoi">Â DOI: 10.1016/S0092-8674(03)00034-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS0092-8674%2803%2900034-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=243-256&issue=2&author=S.+Orlickyauthor=X.+Tangauthor=A.+Willemsauthor=M.+Tyersauthor=F.+Sicheri&title=Structural+Basis+for+Phosphodependent+Substrate+Selection+and+Orientation+by+the+SCFCdc4+Ubiquitin+Ligase&doi=10.1016%2FS0092-8674%2803%2900034-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900034-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900034-5%26sid%3Dliteratum%253Aachs%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWillems%26aufirst%3DA.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DStructural%2520Basis%2520for%2520Phosphodependent%2520Substrate%2520Selection%2520and%2520Orientation%2520by%2520the%2520SCFCdc4%2520Ubiquitin%2520Ligase%26jtitle%3DCell%26date%3D2003%26volume%3D112%26issue%3D2%26spage%3D243%26epage%3D256%26doi%3D10.1016%2FS0092-8674%2803%2900034-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Hao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of a Fbw7-Skp1-Cyclin E Complex: Multisite-Phosphorylated Substrate Recognition by SCF Ubiquitin Ligases</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">143</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2007.02.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2007.02.022" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=131-143&issue=1&author=B.+Haoauthor=S.+Oehlmannauthor=M.+E.+Sowaauthor=J.+W.+Harperauthor=N.+P.+Pavletich&title=Structure+of+a+Fbw7-Skp1-Cyclin+E+Complex%3A+Multisite-Phosphorylated+Substrate+Recognition+by+SCF+Ubiquitin+Ligases&doi=10.1016%2Fj.molcel.2007.02.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.02.022%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DB.%26aulast%3DOehlmann%26aufirst%3DS.%26aulast%3DSowa%26aufirst%3DM.%2BE.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520a%2520Fbw7-Skp1-Cyclin%2520E%2520Complex%253A%2520Multisite-Phosphorylated%2520Substrate%2520Recognition%2520by%2520SCF%2520Ubiquitin%2520Ligases%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D26%26issue%3D1%26spage%3D131%26epage%3D143%26doi%3D10.1016%2Fj.molcel.2007.02.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Hao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structural Basis of the Cks1-Dependent Recognition of P27(Kip1) by the SCF(Skp2) Ubiquitin Ligase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">19</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2005.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2005.09.003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=9-19&issue=1&author=B.+Haoauthor=N.+Zhengauthor=B.+A.+Schulmanauthor=G.+Wuauthor=J.+J.+Millerauthor=M.+Paganoauthor=N.+P.+Pavletich&title=Structural+Basis+of+the+Cks1-Dependent+Recognition+of+P27%28Kip1%29+by+the+SCF%28Skp2%29+Ubiquitin+Ligase&doi=10.1016%2Fj.molcel.2005.09.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DMiller%26aufirst%3DJ.%2BJ.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructural%2520Basis%2520of%2520the%2520Cks1-Dependent%2520Recognition%2520of%2520P27%2528Kip1%2529%2520by%2520the%2520SCF%2528Skp2%2529%2520Ubiquitin%2520Ligase%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D20%26issue%3D1%26spage%3D9%26epage%3D19%26doi%3D10.1016%2Fj.molcel.2005.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Kamadurai, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Actis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souphron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurinov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhlman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulman, B. A.</span><span> </span><span class="NLM_article-title">Mechanism of Ubiquitin Ligation and Lysine Prioritization by a HECT E3</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">â</span> <span class="NLM_lpage">26</span><span class="refDoi">Â DOI: 10.7554/eLife.00828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.7554%2FeLife.00828" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=10-26&author=H.+B.+Kamaduraiauthor=Y.+Qiuauthor=A.+Dengauthor=J.+S.+Harrisonauthor=C.+MacDonaldauthor=M.+Actisauthor=P.+Rodriguesauthor=D.+J.+Millerauthor=J.+Souphronauthor=S.+M.+Lewisauthor=I.+Kurinovauthor=N.+Fujiiauthor=M.+Hammelauthor=R.+Piperauthor=B.+Kuhlmanauthor=B.+A.+Schulman&title=Mechanism+of+Ubiquitin+Ligation+and+Lysine+Prioritization+by+a+HECT+E3&doi=10.7554%2FeLife.00828"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.7554%2FeLife.00828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.00828%26sid%3Dliteratum%253Aachs%26aulast%3DKamadurai%26aufirst%3DH.%2BB.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DJ.%2BS.%26aulast%3DMacDonald%26aufirst%3DC.%26aulast%3DActis%26aufirst%3DM.%26aulast%3DRodrigues%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DD.%2BJ.%26aulast%3DSouphron%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DS.%2BM.%26aulast%3DKurinov%26aufirst%3DI.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DHammel%26aufirst%3DM.%26aulast%3DPiper%26aufirst%3DR.%26aulast%3DKuhlman%26aufirst%3DB.%26aulast%3DSchulman%26aufirst%3DB.%2BA.%26atitle%3DMechanism%2520of%2520Ubiquitin%2520Ligation%2520and%2520Lysine%2520Prioritization%2520by%2520a%2520HECT%2520E3%26jtitle%3DeLife%26date%3D2013%26volume%3D2%26spage%3D10%26epage%3D26%26doi%3D10.7554%2FeLife.00828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Bernassola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciechanover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melino, G.</span><span> </span><span class="NLM_article-title">The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">10</span><span class="NLM_x">â</span> <span class="NLM_lpage">21</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.ccr.2008.06.001" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=10-21&issue=1&author=F.+Bernassolaauthor=M.+Karinauthor=A.+Ciechanoverauthor=G.+Melino&title=The+HECT+Family+of+E3+Ubiquitin+Ligases%3A+Multiple+Players+in+Cancer+Development&doi=10.1016%2Fj.ccr.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBernassola%26aufirst%3DF.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DMelino%26aufirst%3DG.%26atitle%3DThe%2520HECT%2520Family%2520of%2520E3%2520Ubiquitin%2520Ligases%253A%2520Multiple%2520Players%2520in%2520Cancer%2520Development%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26issue%3D1%26spage%3D10%26epage%3D21%26doi%3D10.1016%2Fj.ccr.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Spratt, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, G. S.</span><span> </span><span class="NLM_article-title">RBR E3 Ubiquitin Ligases: New Structures, New Insights, New Questions</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">421</span><span class="NLM_x">â</span> <span class="NLM_lpage">437</span><span class="refDoi">Â DOI: 10.1042/BJ20140006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1042%2FBJ20140006" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2014&pages=421-437&issue=3&author=D.+E.+Sprattauthor=H.+Waldenauthor=G.+S.+Shaw&title=RBR+E3+Ubiquitin+Ligases%3A+New+Structures%2C+New+Insights%2C+New+Questions&doi=10.1042%2FBJ20140006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1042%2FBJ20140006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20140006%26sid%3Dliteratum%253Aachs%26aulast%3DSpratt%26aufirst%3DD.%2BE.%26aulast%3DWalden%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DG.%2BS.%26atitle%3DRBR%2520E3%2520Ubiquitin%2520Ligases%253A%2520New%2520Structures%252C%2520New%2520Insights%252C%2520New%2520Questions%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D458%26issue%3D3%26spage%3D421%26epage%3D437%26doi%3D10.1042%2FBJ20140006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Eisenhaber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhaber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, M.-T.</span><span> </span><span class="NLM_article-title">The Ring Between Ring Fingers (RBR) Protein Family</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">209</span><span class="refDoi">Â DOI: 10.1186/gb-2007-8-3-209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1186%2Fgb-2007-8-3-209" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=209&issue=3&author=B.+Eisenhaberauthor=N.+Chumakauthor=F.+Eisenhaberauthor=M.-T.+Hauser&title=The+Ring+Between+Ring+Fingers+%28RBR%29+Protein+Family&doi=10.1186%2Fgb-2007-8-3-209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1186%2Fgb-2007-8-3-209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2007-8-3-209%26sid%3Dliteratum%253Aachs%26aulast%3DEisenhaber%26aufirst%3DB.%26aulast%3DChumak%26aufirst%3DN.%26aulast%3DEisenhaber%26aufirst%3DF.%26aulast%3DHauser%26aufirst%3DM.-T.%26atitle%3DThe%2520Ring%2520Between%2520Ring%2520Fingers%2520%2528RBR%2529%2520Protein%2520Family%26jtitle%3DGenome%2520Biol.%26date%3D2007%26volume%3D8%26issue%3D3%26spage%3D209%26doi%3D10.1186%2Fgb-2007-8-3-209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Molle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gareiss, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tae, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noblin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Targeting the Von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules to Disrupt the VHL/HIF-1Î± Interaction</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">4465</span><span class="NLM_x">â</span> <span class="NLM_lpage">4468</span><span class="refDoi">Â DOI: 10.1021/ja209924v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja209924v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOgurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=4465-4468&issue=10&author=D.+L.+Buckleyauthor=I.+Van+Molleauthor=P.+C.+Gareissauthor=H.+S.+Taeauthor=J.+Michelauthor=D.+J.+Noblinauthor=W.+L.+Jorgensenauthor=A.+Ciulliauthor=C.+M.+Crews&title=Targeting+the+Von+Hippel-Lindau+E3+Ubiquitin+Ligase+Using+Small+Molecules+to+Disrupt+the+VHL%2FHIF-1%CE%B1+Interaction&doi=10.1021%2Fja209924v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1Î± Interaction</span></div><div class="casAuthors">Buckley, Dennis L.; Van Molle, Inge; Gareiss, Peter C.; Tae, Hyun Seop; Michel, Julien; Noblin, Devin J.; Jorgensen, William L.; Ciulli, Alessio; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4465-4468</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases, which bind protein targets, leading to their ubiquitination and subsequent degrdn., are attractive drug targets due to their exquisite substrate specificity.  However, the development of small-mol. inhibitors has proven extraordinarily challenging as modulation of E3 ligase activities requires the targeting of protein-protein interactions.  Using rational design, we have generated the first small mol. targeting the von Hippel-Lindau protein (VHL), the substrate recognition subunit of an E3 ligase, and an important target in cancer, chronic anemia, and ischemia.  We have also obtained the crystal structure of VHL bound to our most potent inhibitor, confirming that the compd. mimics the binding mode of the transcription factor HIF-1Î±, a substrate of VHL.  These results have the potential to guide future development of improved lead compds. as therapeutics for the treatment of chronic anemia and ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolmBVM_mfWzrVg90H21EOLACvtfcHk0liREsAr1hEcag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOgurw%253D&md5=60f7384b6bc932c9828dc12999283a1e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fja209924v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja209924v%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DGareiss%26aufirst%3DP.%2BC.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DMichel%26aufirst%3DJ.%26aulast%3DNoblin%26aufirst%3DD.%2BJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTargeting%2520the%2520Von%2520Hippel-Lindau%2520E3%2520Ubiquitin%2520Ligase%2520Using%2520Small%2520Molecules%2520to%2520Disrupt%2520the%2520VHL%252FHIF-1%25CE%25B1%2520Interaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26issue%3D10%26spage%3D4465%26epage%3D4468%26doi%3D10.1021%2Fja209924v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Molle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tae, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gareiss, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of the Interaction Between the E3 Ligase VHL and HIF1Î±</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">46</span><span class="NLM_x">) </span> <span class="NLM_fpage">11463</span><span class="NLM_x">â</span> <span class="NLM_lpage">11467</span><span class="refDoi">Â DOI: 10.1002/anie.201206231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2Fanie.201206231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rs7nL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=11463-11467&issue=46&author=D.+L.+Buckleyauthor=J.+L.+Gustafsonauthor=I.+Van+Molleauthor=A.+G.+Rothauthor=H.+S.+Taeauthor=P.+C.+Gareissauthor=W.+L.+Jorgensenauthor=A.+Ciulliauthor=C.+M.+Crews&title=Small-Molecule+Inhibitors+of+the+Interaction+Between+the+E3+Ligase+VHL+and+HIF1%CE%B1&doi=10.1002%2Fanie.201206231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1Î±</span></div><div class="casAuthors">Buckley, Dennis L.; Gustafson, Jeffrey L.; Van Molle, Inge; Roth, Anke G.; Tae, Hyun Seop; Gareiss, Peter C.; Jorgensen, William L.; Ciulli, Alessio; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">11463-11467</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This study reports the structure-based design and synthesis of novel VHL ligands, illustrating structure-activity relationships and improving potency.  Two fragments of the ligands were individually optimized, arriving at a new class of N-terminal benzamide fragments.  The interactions made by this new class were then elucidated through X-ray crystallog. of the protein-ligand complex.  Structural studies of this ligand class revealed both a new binding mode as well as a novel water-mediated' hydrogen bond.  Finally, using these optimized fragments, we assembled new VHL ligands in a combinatorial fashion, arriving at (I), the first small-mol. submicromolar inhibitor of the interaction between VHL and a peptide derived from HIF1Î±.  While no cell-based activity has yet been obsd.,we hope to take advantage of the interactions highlighted by the crystal structure of I to design more drug-like inhibitors of VHL with improved cell permeability.  These ligands and the novel interactions and binding modes highlighted have the potential to guide the development of future chem. probes that can target the E3 ligase VHL or stabilize HIF1Î± proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0HINAsXwwLVg90H21EOLACvtfcHk0liREsAr1hEcag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rs7nL&md5=eefeb63a3491737738e94c00be083cfd</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fanie.201206231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201206231%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DGareiss%26aufirst%3DP.%2BC.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520the%2520Interaction%2520Between%2520the%2520E3%2520Ligase%2520VHL%2520and%2520HIF1%25CE%25B1%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26issue%3D46%26spage%3D11463%26epage%3D11467%26doi%3D10.1002%2Fanie.201206231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">In Vivo Activation of the P53 Pathway by Small-Molecule Antagonists of MDM2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x"> (</span><span class="NLM_issue">5659</span><span class="NLM_x">) </span> <span class="NLM_fpage">844</span><span class="NLM_x">â</span> <span class="NLM_lpage">848</span><span class="refDoi">Â DOI: 10.1126/science.1092472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.1092472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=14704432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=844-848&issue=5659&author=L.+T.+Vassilev&title=In+Vivo+Activation+of+the+P53+Pathway+by+Small-Molecule+Antagonists+of+MDM2&doi=10.1126%2Fscience.1092472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2</span></div><div class="casAuthors">Vassilev, Lyubomir T.; Vu, Binh T.; Graves, Bradford; Carvajal, Daisy; Podlaski, Frank; Filipovic, Zoran; Kong, Norman; Kammlott, Ursula; Lukacs, Christine; Klein, Christian; Fotouhi, Nader; Liu, Emily A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5659</span>),
    <span class="NLM_cas:pages">844-848</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">MDM2 binds the p53 tumor suppressor protein with high affinity and neg. modulates its transcriptional activity and stability.  Overexpression of MDM2, found in many human tumors, effectively impairs p53 function.  Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy.  Here, we identify potent and selective small-mol. antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes.  These compds. bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzumitGD6V4bVg90H21EOLACvtfcHk0lh0cW7usRPa9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVKmtA%253D%253D&md5=cf80c399e8eca8766be1023cda438df3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1126%2Fscience.1092472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1092472%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DIn%2520Vivo%2520Activation%2520of%2520the%2520P53%2520Pathway%2520by%2520Small-Molecule%2520Antagonists%2520of%2520MDM2%26jtitle%3DScience%26date%3D2004%26volume%3D303%26issue%3D5659%26spage%3D844%26epage%3D848%26doi%3D10.1126%2Fscience.1092472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Vassilev, L. T.</span><span> </span><span class="NLM_article-title">Small-Molecule Antagonists of P53-MDM2 Binding: Research Tools and Potential Therapeutics</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">417</span><span class="NLM_x">â</span> <span class="NLM_lpage">419</span><span class="refDoi">Â DOI: 10.4161/cc.3.4.801</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.4161%2Fcc.3.4.801" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=417-419&issue=4&author=L.+T.+Vassilev&title=Small-Molecule+Antagonists+of+P53-MDM2+Binding%3A+Research+Tools+and+Potential+Therapeutics&doi=10.4161%2Fcc.3.4.801"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.4161%2Fcc.3.4.801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.3.4.801%26sid%3Dliteratum%253Aachs%26aulast%3DVassilev%26aufirst%3DL.%2BT.%26atitle%3DSmall-Molecule%2520Antagonists%2520of%2520P53-MDM2%2520Binding%253A%2520Research%2520Tools%2520and%2520Potential%2520Therapeutics%26jtitle%3DCell%2520Cycle%26date%3D2004%26volume%3D3%26issue%3D4%26spage%3D417%26epage%3D419%26doi%3D10.4161%2Fcc.3.4.801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of the MDM2-P53 Protein-Protein Interaction to Reactivate P53 Function: a Novel Approach for Cancer Therapy</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">241</span><span class="refDoi">Â DOI: 10.1146/annurev.pharmtox.48.113006.094723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1146%2Fannurev.pharmtox.48.113006.094723" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=223-241&issue=1&author=S.+Shangaryauthor=S.+Wang&title=Small-Molecule+Inhibitors+of+the+MDM2-P53+Protein-Protein+Interaction+to+Reactivate+P53+Function%3A+a+Novel+Approach+for+Cancer+Therapy&doi=10.1146%2Fannurev.pharmtox.48.113006.094723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.48.113006.094723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.48.113006.094723%26sid%3Dliteratum%253Aachs%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520the%2520MDM2-P53%2520Protein-Protein%2520Interaction%2520to%2520Reactivate%2520P53%2520Function%253A%2520a%2520Novel%2520Approach%2520for%2520Cancer%2520Therapy%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2009%26volume%3D49%26issue%3D1%26spage%3D223%26epage%3D241%26doi%3D10.1146%2Fannurev.pharmtox.48.113006.094723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckett, C. S.</span><span> </span><span class="NLM_article-title">IAP Proteins: Blocking the Road to Deathâs Door</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">401</span><span class="NLM_x">â</span> <span class="NLM_lpage">410</span><span class="refDoi">Â DOI: 10.1038/nrm830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=12042762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=401-410&issue=6&author=G.+S.+Salvesenauthor=C.+S.+Duckett&title=IAP+Proteins%3A+Blocking+the+Road+to+Death%E2%80%99s+Door&doi=10.1038%2Fnrm830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: IAP proteins: blocking the road to death's door</span></div><div class="casAuthors">Salvesen, Guy S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-410</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'inhibitor of apoptosis' (IAP) gene family, which was discovered less than a decade ago, encodes a group of structurally related proteins that, in addn. to their ability to suppress apoptotic cell death, are involved in an increasing no. of seemingly unrelated cellular functions.  Here, we review the functional and structural properties of this fascinating group of proteins, and of several recently identified IAP-binding factors that regulate IAP function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMWLW8mAr_LVg90H21EOLACvtfcHk0lh0cW7usRPa9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D&md5=0f967aad318a34d988ad40486950ed62</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnrm830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm830%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520Proteins%253A%2520Blocking%2520the%2520Road%2520to%2520Death%25E2%2580%2599s%2520Door%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26issue%3D6%26spage%3D401%26epage%3D410%26doi%3D10.1038%2Fnrm830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Holcik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korneluk, R. G.</span><span> </span><span class="NLM_article-title">XIAP: Apoptotic Brake and Promising Therapeutic Target</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">253</span><span class="NLM_x">â</span> <span class="NLM_lpage">261</span><span class="refDoi">Â DOI: 10.1023/A:1011379307472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1023%2FA%3A1011379307472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=11445667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsF2qu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=253-261&issue=4&author=M.+Holcikauthor=H.+Gibsonauthor=R.+G.+Korneluk&title=XIAP%3A+Apoptotic+Brake+and+Promising+Therapeutic+Target&doi=10.1023%2FA%3A1011379307472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">XIAP: apoptotic brake and promising therapeutic target</span></div><div class="casAuthors">Holcik, Martin; Gibson, Hilary; Korneluk, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-261</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  The X-linked Inhibitor of Apoptosis, XIAP, is a key member of the newly discovered family of intrinsic inhibitors of apoptosis (IAP) proteins.  IAPs block cell death both in vitro and in vivo by virtue of inhibition of distinct caspases.  Although other proteins were identified which inhibit upstream caspases, only the IAPs were demonstrated to be endogenous repressors of the terminal caspase cascade.  In turn, the caspase inhibiting activity of XIAP is neg. regulated by at least 2 XIAP-interacting proteins, XAF1 and Smac/DIABLO.  In addn. to the inhibition of caspases, recent discoveries from several labs. suggest that XIAP is also involved in a no. of other biol. significant cellular activities including modulation of receptor-mediated signal transduction and protein ubiquitination.  XIAP is also translated by a rare cap-independent mechanism mediated by a specific sequence called IRES (for Internal Ribosome Entry Site) which is found in the XIAP 5' UTR.  XIAP protein is thus synthesized under various conditions of cellular stress such as serum starvation and low dose Î³-irradn. induced apoptosis, conditions that lead to the inhibition of cellular protein synthesis.  The multiple biol. activities of XIAP, its unique translational and post-translational control and the centrality of the caspase cascade make the control of XIAP expression an exceptionally promising mol. target for modulating apoptosis.  Therapeutic benefits can be derived from both the suppression of inappropriate cell death such as in neurodegenerative disorders and ischemic injury or in the activation of latent cell death pathways such as in autoimmune disease and cancer where apoptosis induction is the desired outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqewyDCMlelK7Vg90H21EOLACvtfcHk0lh0cW7usRPa9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsF2qu7g%253D&md5=fa50ae4bab9721c40942d0268085e5a4</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1023%2FA%3A1011379307472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1011379307472%26sid%3Dliteratum%253Aachs%26aulast%3DHolcik%26aufirst%3DM.%26aulast%3DGibson%26aufirst%3DH.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26atitle%3DXIAP%253A%2520Apoptotic%2520Brake%2520and%2520Promising%2520Therapeutic%2520Target%26jtitle%3DApoptosis%26date%3D2001%26volume%3D6%26issue%3D4%26spage%3D253%26epage%3D261%26doi%3D10.1023%2FA%3A1011379307472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A Potent and Orally Active Antagonist (SM-406/at-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2714</span><span class="NLM_x">â</span> <span class="NLM_lpage">2726</span><span class="refDoi">Â DOI: 10.1021/jm101505d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&issue=8&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.-Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+Potent+and+Orally+Active+Antagonist+%28SM-406%2Fat-406%29+of+Multiple+Inhibitor+of+Apoptosis+Proteins+%28IAPs%29+in+Clinical+Development+for+Cancer+Treatment&doi=10.1021%2Fjm101505d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0lgn-HNSFFc9Qg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520Potent%2520and%2520Orally%2520Active%2520Antagonist%2520%2528SM-406%252Fat-406%2529%2520of%2520Multiple%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520%2528IAPs%2529%2520in%2520Clinical%2520Development%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D2714%26epage%3D2726%26doi%3D10.1021%2Fjm101505d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheeti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisner, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Um, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">4101</span><span class="NLM_x">â</span> <span class="NLM_lpage">4113</span><span class="refDoi">Â DOI: 10.1021/jm300060k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300060k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4101-4113&issue=9&author=J.+A.+Flygareauthor=M.+Beresiniauthor=N.+Budhaauthor=H.+Chanauthor=I.+T.+Chanauthor=S.+Cheetiauthor=F.+Cohenauthor=K.+Deshayesauthor=K.+Doernerauthor=S.+G.+Eckhardtauthor=L.+O.+Elliottauthor=B.+Fengauthor=M.+C.+Franklinauthor=S.+F.+Reisnerauthor=L.+Gazzardauthor=J.+Halladayauthor=S.+G.+Hymowitzauthor=H.+Laauthor=P.+LoRussoauthor=B.+Maurerauthor=L.+Murrayauthor=E.+Pliseauthor=C.+Quanauthor=J.-P.+Stephanauthor=S.+G.+Youngauthor=J.+Tomauthor=V.+Tsuiauthor=J.+Umauthor=E.+Varfolomeevauthor=D.+Vucicauthor=A.+J.+Wagnerauthor=H.+J.+A.+Wallweberauthor=L.+Wangauthor=J.+Wareauthor=Z.+Wenauthor=H.+Wongauthor=J.+M.+Wongauthor=M.+Wongauthor=S.+Wongauthor=R.+Yuauthor=K.+Zobelauthor=W.+J.+Fairbrother&title=Discovery+of+a+Potent+Small-Molecule+Antagonist+of+Inhibitor+of+Apoptosis+%28IAP%29+Proteins+and+Clinical+Candidate+for+the+Treatment+of+Cancer+%28GDC-0152%29&doi=10.1021%2Fjm300060k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span></div><div class="casAuthors">Flygare, John A.; Beresini, Maureen; Budha, Nageshwar; Chan, Helen; Chan, Iris T.; Cheeti, Sravanthi; Cohen, Frederick; Deshayes, Kurt; Doerner, Karl; Eckhardt, S. Gail; Elliott, Linda O.; Feng, Bainian; Franklin, Matthew C.; Reisner, Stacy Frankovitz; Gazzard, Lewis; Halladay, Jason; Hymowitz, Sarah G.; La, Hank; LoRusso, Patricia; Maurer, Brigitte; Murray, Lesley; Plise, Emile; Quan, Clifford; Stephan, Jean-Philippe; Young, Shin G.; Tom, Jeffrey; Tsui, Vickie; Um, Joanne; Varfolomeev, Eugene; Vucic, Domagoj; Wagner, Andrew J.; Wallweber, Heidi J. A.; Wang, Lan; Ware, Joseph; Wen, Zhaoyang; Wong, Harvey; Wong, Jonathan M.; Wong, Melisa; Wong, Susan; Yu, Ron; Zobel, Kerry; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4101-4113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac.  Compd. (I) (GDC-0152) has the best profile of these compds.; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with Ki values of 28, 14, 17, and 43 nM, resp.  These compds. promote degrdn. of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Compd. I inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model.  Compd. I was advanced to human clin. trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested.  Mean plasma clearance in humans was 9 Â± 3 mL/min/kg, and the vol. of distribution was 0.6 Â± 0.2 L/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZSPNVJ5gVWrVg90H21EOLACvtfcHk0lgn-HNSFFc9Qg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D&md5=19452878ea834d3c324d567b39a78fb2</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm300060k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300060k%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBudha%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DI.%2BT.%26aulast%3DCheeti%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDoerner%26aufirst%3DK.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DReisner%26aufirst%3DS.%2BF.%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DJ.-P.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DTom%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DJ.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Small-Molecule%2520Antagonist%2520of%2520Inhibitor%2520of%2520Apoptosis%2520%2528IAP%2529%2520Proteins%2520and%2520Clinical%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Cancer%2520%2528GDC-0152%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D9%26spage%3D4101%26epage%3D4113%26doi%3D10.1021%2Fjm300060k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.-C.</span><span> </span><span class="NLM_article-title">AT-406, an IAP Inhibitor, Activates Apoptosis and Induces Radiosensitization of Normoxic and Hypoxic Cervical Cancer Cells</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">56</span><span class="NLM_x">â</span> <span class="NLM_lpage">65</span><span class="refDoi">Â DOI: 10.1254/jphs.14079FP</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1254%2Fjphs.14079FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25168470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OgsLzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2014&pages=56-65&issue=1&author=J.+Luauthor=Q.+Qinauthor=L.-L.+Zhanauthor=J.+Liuauthor=H.-C.+Zhuauthor=X.+Yangauthor=C.+Zhangauthor=L.-P.+Xuauthor=Z.-M.+Liuauthor=D.+Wangauthor=H.-Q.+Cuiauthor=C.-C.+Mengauthor=J.+Caiauthor=H.-Y.+Chengauthor=X.-C.+Sun&title=AT-406%2C+an+IAP+Inhibitor%2C+Activates+Apoptosis+and+Induces+Radiosensitization+of+Normoxic+and+Hypoxic+Cervical+Cancer+Cells&doi=10.1254%2Fjphs.14079FP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">AT-406, an IAP inhibitor, activates apoptosis and induces radiosensitization of normoxic and hypoxic cervical cancer cells</span></div><div class="casAuthors">Lu, Jing; Qin, Qin; Zhan, Liang-Liang; Liu, Jia; Zhu, Hong-Cheng; Yang, Xi; Zhang, Chi; Xu, Li-Ping; Liu, Zhe-Ming; Wang, Di; Cui, He-Qing; Meng, Ciu-Ciu; Cai, Jing; Cheng, Hong-Yan; Sun, Xin-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-65</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">IAP antagonists increased the antitumor efficacy of X-irradn. in some types of cancers, but their effects on hypoxic cancer cells remain unclarified.  We aims to investigate the radiosensitizing effect of an IAP inhibitor AT-406 on cervical cancer cell lines under both normoxia and hypoxia conditions.  Hela and Siha cells were treated to investigate the effects of drug administration on cell proliferation, apoptosis, and radiosensitivity.  Western blot anal. was used to det. the role of AT-406 in inhibition of IAPs.  The pathway of apoptosis was characterized by caspases activity assay.  AT-406 potently sensitized Hela cells but not Siha cells to radiation under normoxia.  Notably, the radiosensitizing effect of AT-406 on hypoxic cells was more evident than on normoxic cells in both cell lines.  Further mechanism studies by western blot showed that under normoxia AT-406 decreased the level of cIAP1 in Hela cells in a dose-dependent manner; while addnl. downregulation of XIAP expression was induced by AT-406 treatment under hypoxia in both cell lines.  Finally, AT-406 works on both extrinsic death receptor and intrinsic mitochondrial apoptosis pathways to activate apoptosis.  Totally, AT-406 acts as a strong radiosensitizer in human cervical cancer cells, esp. in hypoxic condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsFijv1awbnLVg90H21EOLACvtfcHk0lh5_b_nCtOu0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OgsLzO&md5=39d6a5c2fa6e37133ea0b04b86199e76</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1254%2Fjphs.14079FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.14079FP%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DQ.%26aulast%3DZhan%26aufirst%3DL.-L.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.-C.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DL.-P.%26aulast%3DLiu%26aufirst%3DZ.-M.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DH.-Q.%26aulast%3DMeng%26aufirst%3DC.-C.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSun%26aufirst%3DX.-C.%26atitle%3DAT-406%252C%2520an%2520IAP%2520Inhibitor%252C%2520Activates%2520Apoptosis%2520and%2520Induces%2520Radiosensitization%2520of%2520Normoxic%2520and%2520Hypoxic%2520Cervical%2520Cancer%2520Cells%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D126%26issue%3D1%26spage%3D56%26epage%3D65%26doi%3D10.1254%2Fjphs.14079FP" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Brunckhorst, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span> </span><span class="NLM_article-title">AT-406, an Orally Active Antagonist of Multiple Inhibitor of Apoptosis Proteins, Inhibits Progression of Human Ovarian Cancer</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">804</span><span class="NLM_x">â</span> <span class="NLM_lpage">811</span><span class="refDoi">Â DOI: 10.4161/cbt.20563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.4161%2Fcbt.20563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22669575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Chtr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=804-811&issue=9&author=M.+K.+Brunckhorstauthor=D.+Lernerauthor=S.+Wangauthor=Q.+Yu&title=AT-406%2C+an+Orally+Active+Antagonist+of+Multiple+Inhibitor+of+Apoptosis+Proteins%2C+Inhibits+Progression+of+Human+Ovarian+Cancer&doi=10.4161%2Fcbt.20563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer</span></div><div class="casAuthors">Brunckhorst, Melissa K.; Lerner, Dimitry; Wang, Shaomeng; Yu, Qin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">804-811</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Ovarian carcinoma is the most deadly gynecol. malignancy.  Current chemotherapeutic drugs are only transiently effective and patients with advance disease often develop resistance despite significant initial responses.  Mounting evidence suggests that anti-apoptotic proteins, including those of the inhibitor of apoptosis protein (IAP) family, play important roles in the chemoresistance.  There has been a recent emergence of compds. that block the IAP functions.  Here, we evaluated AT-406, a novel and orally active antagonist of multiple IAP proteins, in ovarian cancer cells as a single agent and in the combination with carboplatin for therapeutic efficacy and mechanism of action.  We demonstrate that AT-406 has significant single agent activity in 60% of human ovarian cancer cell lines examd. in vitro and inhibits ovarian cancer progression in vivo and that three out of five carboplatinresistant cell lines are sensitive to AT-406, highlighting the therapeutic potential of AT-406 for patients with inherent or acquired platinum resistance.  Addnl., our in vivo studies show that AT-406 enhances the carboplatin-induced ovarian cancer cell death and increases survival of the exptl. mice, suggesting that AT-406 sensitizes the response of these cells to carboplatin.  Mechanistically, we demonstrate that AT-406 induced apoptosis is correlated with its ability to downregulate XIAP whereas AT-406 induces cIAP1 degrdn. in both AT-406 sensitive and resistance cell lines.  Together, these results demonstrate, for the first time, the anti-ovarian cancer efficacy of AT-406 as a single agent and in the combination with carboplatin, suggesting that AT-406 has potential as a novel therapy for ovarian cancer patients, esp. for patients exhibiting resistance to the platinum-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQv634B1Chy7Vg90H21EOLACvtfcHk0lh5_b_nCtOu0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Chtr7F&md5=bbd34f31d48d33b7a3ddffa3744a7861</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.4161%2Fcbt.20563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.20563%26sid%3Dliteratum%253Aachs%26aulast%3DBrunckhorst%26aufirst%3DM.%2BK.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3DAT-406%252C%2520an%2520Orally%2520Active%2520Antagonist%2520of%2520Multiple%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%252C%2520Inhibits%2520Progression%2520of%2520Human%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2012%26volume%3D13%26issue%3D9%26spage%3D804%26epage%3D811%26doi%3D10.4161%2Fcbt.20563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Dickens, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of MDM2 as New Anticancer Therapeutics</span> <span class="citation_source-journal">Semin. Cancer Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">10</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span><span class="refDoi">Â DOI: 10.1016/j.semcancer.2009.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.semcancer.2009.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19897042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFSisLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=10-18&issue=1&author=M.+P.+Dickensauthor=R.+Fitzgeraldauthor=P.+M.+Fischer&title=Small-Molecule+Inhibitors+of+MDM2+as+New+Anticancer+Therapeutics&doi=10.1016%2Fj.semcancer.2009.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of MDM2 as new anticancer therapeutics</span></div><div class="casAuthors">Dickens, Michael P.; Fitzgerald, Ross; Fischer, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-18</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  It has long been known that traditional anticancer radio- and chemotherapies in part work through direct or indirect activation of the p53 tumor suppressor pathway.  However, many of these strategies are nonselective and genotoxic.  The emerging understanding of the pathways that regulate p53 has led to the notion that it should be possible to activate the p53 pathway in ways that are inherently nongenotoxic.  Important targets for pharmacol. interference in this respect are MDM2 and MDMX, key neg. regulators of p53.  Genetic and pharmacol. studies suggest that blocking the phys. interaction of these proteins with p53, or inhibiting the catalytic role of MDM2 in tagging p53 for proteasomal degrdn., both of which lead to an increase in the transcriptional activity of p53, may indeed be an efficient and safe way to eradicate tumor cells that retain wild-type p53.  Here we review the rationale for such strategies, as well as the current state in the discovery and development of drugs that reactivate p53 by inhibiting its inhibitors MDM2 and MDMX.  The first compds. that have been shown in model systems to be able selectively to kill cancer cells in this way are now entering clin. trials and the promise of MDM2 inhibitors as a new therapeutic anticancer modality should therefore become clear in the not-too-distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtUHhypCp7zbVg90H21EOLACvtfcHk0lij93tnjvZNCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFSisLY%253D&md5=7366b3fc42ff3b5d5b063187ad600f89</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2009.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2009.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DDickens%26aufirst%3DM.%2BP.%26aulast%3DFitzgerald%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520MDM2%2520as%2520New%2520Anticancer%2520Therapeutics%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D10%26epage%3D18%26doi%3D10.1016%2Fj.semcancer.2009.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small-Molecule Control of Intracellular Protein Levels Through Modulation of the Ubiquitin Proteasome System</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2312</span><span class="NLM_x">â</span> <span class="NLM_lpage">2330</span><span class="refDoi">Â DOI: 10.1002/anie.201307761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2Fanie.201307761" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=2312-2330&issue=9&author=D.+L.+Buckleyauthor=C.+M.+Crews&title=Small-Molecule+Control+of+Intracellular+Protein+Levels+Through+Modulation+of+the+Ubiquitin+Proteasome+System&doi=10.1002%2Fanie.201307761"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1002%2Fanie.201307761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201307761%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-Molecule%2520Control%2520of%2520Intracellular%2520Protein%2520Levels%2520Through%2520Modulation%2520of%2520the%2520Ubiquitin%2520Proteasome%2520System%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D9%26spage%3D2312%26epage%3D2330%26doi%3D10.1002%2Fanie.201307761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Small-Molecule SMAC Mimetics as New Cancer Therapeutics</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">82</span><span class="NLM_x">â</span> <span class="NLM_lpage">95</span><span class="refDoi">Â DOI: 10.1016/j.pharmthera.2014.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.pharmthera.2014.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24841289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2ju7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2014&pages=82-95&issue=1&author=L.+Baiauthor=D.+C.+Smithauthor=S.+Wang&title=Small-Molecule+SMAC+Mimetics+as+New+Cancer+Therapeutics&doi=10.1016%2Fj.pharmthera.2014.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule SMAC mimetics as new cancer therapeutics</span></div><div class="casAuthors">Bai, Longchuan; Smith, David C.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-95</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Apoptosis is a tightly regulated cellular process and faulty regulation of apoptosis is a hallmark of human cancers.  Targeting key apoptosis regulators with the goal to restore apoptosis in tumor cells has been pursued as a new cancer therapeutic strategy.  XIAP, cIAP1, and cIAP2, members of inhibitor of apoptosis (IAP) proteins, are crit. regulators of cell death and survival and are attractive targets for new cancer therapy.  The SMAC/DIABLO protein is an endogenous antagonist of XIAP, cIAP1, and cIAP2.  In the last decade, intense research efforts have resulted in the design and development of several small-mol. SMAC mimetics now in clin. trials for cancer treatment.  In this review, we will discuss the roles of XIAP, cIAP1, and cIAP2 in regulation of cell death and survival, and the design and development of small-mol. SMAC mimetics as novel cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJ1zuCJO_xrVg90H21EOLACvtfcHk0lij93tnjvZNCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2ju7k%253D&md5=92404daa1b37f65bee87fa699858a5bf</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-Molecule%2520SMAC%2520Mimetics%2520as%2520New%2520Cancer%2520Therapeutics%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D144%26issue%3D1%26spage%3D82%26epage%3D95%26doi%3D10.1016%2Fj.pharmthera.2014.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Fulda, S.</span><span> </span><span class="NLM_article-title">Promises and Challenges of Smac Mimetics as Cancer Therapeutics</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">5030</span><span class="NLM_x">â</span> <span class="NLM_lpage">5036</span><span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-15-0365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F1078-0432.CCR-15-0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=26567362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=5030-5036&issue=22&author=S.+Fulda&title=Promises+and+Challenges+of+Smac+Mimetics+as+Cancer+Therapeutics&doi=10.1158%2F1078-0432.CCR-15-0365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Promises and Challenges of Smac Mimetics as Cancer Therapeutics</span></div><div class="casAuthors">Fulda, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5030-5036</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Inhibitor of Apoptosis (IAP) proteins block programmed cell death and are expressed at high levels in various human cancers, thus making them attractive targets for cancer drug development.  Second mitochondrial activator of caspases (Smac) mimetics are small-mol. inhibitors that mimic Smac, an endogenous antagonist of IAP proteins.  Preclin. studies have shown that Smac mimetics can directly trigger cancer cell death or, even more importantly, sensitize tumor cells for various cytotoxic therapies, including conventional chemotherapy, radiotherapy, or novel agents.  Currently, several Smac mimetics are under evaluation in early clin. trials as monotherapy or in rational combinations (i.e., GDC-0917/CUDC-427, LCL161, AT-406/Debio1143, HGS1029, and TL32711/birinapant).  This review discusses the promise as well as some challenges at the translational interface of exploiting Smac mimetics as cancer therapeutics.  Clin Cancer Res; 21(22); 5030-6. Â©2015 AACR.  See all articles in this CCR Focus section, "Cell Death and Cancer Therapy.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWYAR8vIR6lbVg90H21EOLACvtfcHk0lij93tnjvZNCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVajsbjL&md5=646d75e8baac70c57aaaed3451cd96a9</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-15-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-15-0365%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26atitle%3DPromises%2520and%2520Challenges%2520of%2520Smac%2520Mimetics%2520as%2520Cancer%2520Therapeutics%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26issue%3D22%26spage%3D5030%26epage%3D5036%26doi%3D10.1158%2F1078-0432.CCR-15-0365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Willems, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span> </span><span class="NLM_article-title">A Hitchhikerâs Guide to the Cullin Ubiquitin Ligases: SCF and Its Kin</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1695</span><span class="NLM_x"> (</span><span class="NLM_issue">1â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">170</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2004.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbamcr.2004.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15571813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1695&publication_year=2004&pages=133-170&issue=1%E2%80%933&author=A.+R.+Willemsauthor=M.+Schwabauthor=M.+Tyers&title=A+Hitchhiker%E2%80%99s+Guide+to+the+Cullin+Ubiquitin+Ligases%3A+SCF+and+Its+Kin&doi=10.1016%2Fj.bbamcr.2004.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin</span></div><div class="casAuthors">Willems, Andrew R.; Schwab, Michael; Tyers, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1695</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">133-170</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase family was discovered through genetic requirements for cell cycle progression in budding yeast.  In these multisubunit enzymes, an invariant core complex, composed of the Skp1 linker protein, the Cdc53/Cul1 scaffold protein, and the Rbx1/Roc1/Hrt1 RING domain protein, engages one of a suite of substrate adaptors called F-box proteins that in turn recruit substrates for ubiquitination by an assocd. E2 enzyme.  The cullin-RING domain-adaptor architecture has diversified through evolution, such that in total many hundreds of distinct SCF and SCF-like complexes enable degrdn. of myriad substrates.  Substrate recognition by adaptors often depends on post-translational modification of the substrate, which thus places substrate stability under dynamic regulation by intracellular signaling events.  SCF complexes control cell proliferation through degrdn. of crit. regulators such as cyclins, CDK inhibitors, and transcription factors.  A plethora of other processes in development and disease are controlled by other SCF-like complexes, including those based on Cul2-SOCS-box adaptor protein and Cul3-BTB domain adaptor protein combinations.  Recent structural insights into SCF-like complexes have begun to illuminate aspects of substrate recognition and catalytic reaction mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWQKFJ6Lc__LVg90H21EOLACvtfcHk0lj2XVpBvLlw6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzL&md5=1831bf96a473e0974584d685eaeb0856</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2004.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2004.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DWillems%26aufirst%3DA.%2BR.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DTyers%26aufirst%3DM.%26atitle%3DA%2520Hitchhiker%25E2%2580%2599s%2520Guide%2520to%2520the%2520Cullin%2520Ubiquitin%2520Ligases%253A%2520SCF%2520and%2520Its%2520Kin%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2004%26volume%3D1695%26issue%3D1%25E2%2580%25933%26spage%3D133%26epage%3D170%26doi%3D10.1016%2Fj.bbamcr.2004.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Petroski, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span> </span><span class="NLM_article-title">Function and Regulation of Cullin-RING Ubiquitin Ligases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">20</span><span class="refDoi">Â DOI: 10.1038/nrm1547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm1547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15688063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVWg" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=9-20&issue=1&author=M.+D.+Petroskiauthor=R.+J.+Deshaies&title=Function+and+Regulation+of+Cullin-RING+Ubiquitin+Ligases&doi=10.1038%2Fnrm1547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Function and regulation of cullin-RING ubiquitin ligases</span></div><div class="casAuthors">Petroski, Matthew D.; Deshaies, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-20</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cullin-RING complexes comprise the largest known class of ubiquitin ligases.  Owing to the great diversity of their substrate-receptor subunits, it is possible that there are hundreds of distinct cullin-RING ubiquitin ligases in eukaryotic cells, which establishes these enzymes as key mediators of post-translational protein regulation.  Here, the authors focus on the compn., regulation, and function of cullin-RING ligases, and describe how these enzymes can be characterized by a set of general principles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFw5LuMMHZoLVg90H21EOLACvtfcHk0lj2XVpBvLlw6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVWg&md5=297f142f44f971c6858306b1adb36254</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fnrm1547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1547%26sid%3Dliteratum%253Aachs%26aulast%3DPetroski%26aufirst%3DM.%2BD.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DFunction%2520and%2520Regulation%2520of%2520Cullin-RING%2520Ubiquitin%2520Ligases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D6%26issue%3D1%26spage%3D9%26epage%3D20%26doi%3D10.1038%2Fnrm1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Verma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huddleston, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span> </span><span class="NLM_article-title">Phosphorylation of Sic1p by G1 Cdk Required for Its Degradation and Entry Into S Phase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x"> (</span><span class="NLM_issue">5337</span><span class="NLM_x">) </span> <span class="NLM_fpage">455</span><span class="NLM_x">â</span> <span class="NLM_lpage">460</span><span class="refDoi">Â DOI: 10.1126/science.278.5337.455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.278.5337.455" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1997&pages=455-460&issue=5337&author=R.+Vermaauthor=R.+S.+Annanauthor=M.+J.+Huddlestonauthor=S.+A.+Carrauthor=G.+Reynardauthor=R.+J.+Deshaies&title=Phosphorylation+of+Sic1p+by+G1+Cdk+Required+for+Its+Degradation+and+Entry+Into+S+Phase&doi=10.1126%2Fscience.278.5337.455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1126%2Fscience.278.5337.455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.278.5337.455%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DR.%26aulast%3DAnnan%26aufirst%3DR.%2BS.%26aulast%3DHuddleston%26aufirst%3DM.%2BJ.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DReynard%26aufirst%3DG.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DPhosphorylation%2520of%2520Sic1p%2520by%2520G1%2520Cdk%2520Required%2520for%2520Its%2520Degradation%2520and%2520Entry%2520Into%2520S%2520Phase%26jtitle%3DScience%26date%3D1997%26volume%3D278%26issue%3D5337%26spage%3D455%26epage%3D460%26doi%3D10.1126%2Fscience.278.5337.455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Welcker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clurman, B. E.</span><span> </span><span class="NLM_article-title">FBW7 Ubiquitin Ligase: a Tumour Suppressor at the Crossroads of Cell Division, Growth and Differentiation</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">93</span><span class="refDoi">Â DOI: 10.1038/nrc2290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrc2290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=18094723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGhs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=83-93&issue=2&author=M.+Welckerauthor=B.+E.+Clurman&title=FBW7+Ubiquitin+Ligase%3A+a+Tumour+Suppressor+at+the+Crossroads+of+Cell+Division%2C+Growth+and+Differentiation&doi=10.1038%2Fnrc2290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation</span></div><div class="casAuthors">Welcker, Markus; Clurman, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-93</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  FBW7 (F-box and WD repeat domain-contg. 7) is the substrate recognition component of an evolutionary conserved SCF (complex of SKP1, CUL1 and F-box protein)-type ubiquitin ligase.  SCFFBW7 degrades several proto-oncogenes that function in cellular growth and division pathways, including MYC, cyclin E, Notch and JUN.  FBW7 is also a tumor suppressor, the regulatory network of which is perturbed in many human malignancies.  Numerous cancer-assocd. mutations in FBW7 and its substrates have been identified, and loss of FBW7 function causes chromosomal instability and tumorigenesis.  This Review focuses on structural and functional aspects of FBW7 and its role in the development of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHyKIRjKOCsLVg90H21EOLACvtfcHk0lj2XVpBvLlw6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVGhs7Y%253D&md5=b053f23d02a77d471723c9e919b9af1f</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fnrc2290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2290%26sid%3Dliteratum%253Aachs%26aulast%3DWelcker%26aufirst%3DM.%26aulast%3DClurman%26aufirst%3DB.%2BE.%26atitle%3DFBW7%2520Ubiquitin%2520Ligase%253A%2520a%2520Tumour%2520Suppressor%2520at%2520the%2520Crossroads%2520of%2520Cell%2520Division%252C%2520Growth%2520and%2520Differentiation%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26issue%3D2%26spage%3D83%26epage%3D93%26doi%3D10.1038%2Fnrc2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Rajagopalan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jallepalli, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span> </span><span class="NLM_article-title">Inactivation of hCDC4 Can Cause Chromosomal Instability</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x"> (</span><span class="NLM_issue">6978</span><span class="NLM_x">) </span> <span class="NLM_fpage">77</span><span class="NLM_x">â</span> <span class="NLM_lpage">81</span><span class="refDoi">Â DOI: 10.1038/nature02313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature02313" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=77-81&issue=6978&author=H.+Rajagopalanauthor=P.+V.+Jallepalliauthor=C.+Ragoauthor=V.+E.+Velculescuauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+Lengauer&title=Inactivation+of+hCDC4+Can+Cause+Chromosomal+Instability&doi=10.1038%2Fnature02313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fnature02313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02313%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopalan%26aufirst%3DH.%26aulast%3DJallepalli%26aufirst%3DP.%2BV.%26aulast%3DRago%26aufirst%3DC.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DC.%26atitle%3DInactivation%2520of%2520hCDC4%2520Can%2520Cause%2520Chromosomal%2520Instability%26jtitle%3DNature%26date%3D2004%26volume%3D428%26issue%3D6978%26spage%3D77%26epage%3D81%26doi%3D10.1038%2Fnature02313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Orlicky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neduva, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elowe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span> </span><span class="NLM_article-title">An Allosteric Inhibitor of Substrate Recognition by the SCFCdc4 Ubiquitin Ligase</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">733</span><span class="NLM_x">â</span> <span class="NLM_lpage">737</span><span class="refDoi">Â DOI: 10.1038/nbt.1646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnbt.1646" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=733-737&issue=7&author=S.+Orlickyauthor=X.+Tangauthor=V.+Neduvaauthor=N.+Eloweauthor=E.+D.+Brownauthor=F.+Sicheriauthor=M.+Tyers&title=An+Allosteric+Inhibitor+of+Substrate+Recognition+by+the+SCFCdc4+Ubiquitin+Ligase&doi=10.1038%2Fnbt.1646"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1646%26sid%3Dliteratum%253Aachs%26aulast%3DOrlicky%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DNeduva%26aufirst%3DV.%26aulast%3DElowe%26aufirst%3DN.%26aulast%3DBrown%26aufirst%3DE.%2BD.%26aulast%3DSicheri%26aufirst%3DF.%26aulast%3DTyers%26aufirst%3DM.%26atitle%3DAn%2520Allosteric%2520Inhibitor%2520of%2520Substrate%2520Recognition%2520by%2520the%2520SCFCdc4%2520Ubiquitin%2520Ligase%26jtitle%3DNat.%2520Biotechnol.%26date%3D2010%26volume%3D28%26issue%3D7%26spage%3D733%26epage%3D737%26doi%3D10.1038%2Fnbt.1646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Aghajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lomenick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damoiseaux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Moral, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span> </span><span class="NLM_article-title">Chemical Genetics Screen for Enhancers of Rapamycin Identifies a Specific Inhibitor of an SCF Family E3 Ubiquitin Ligase</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">738</span><span class="NLM_x">â</span> <span class="NLM_lpage">742</span><span class="refDoi">Â DOI: 10.1038/nbt.1645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnbt.1645" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=738-742&issue=7&author=M.+Aghajanauthor=N.+Jonaiauthor=K.+Flickauthor=F.+Fuauthor=M.+Luoauthor=X.+Caiauthor=I.+Ouniauthor=N.+Pierceauthor=X.+Tangauthor=B.+Lomenickauthor=R.+Damoiseauxauthor=R.+Haoauthor=P.+M.+del+Moralauthor=R.+Vermaauthor=Y.+Liauthor=C.+Liauthor=K.+N.+Houkauthor=M.+E.+Jungauthor=N.+Zhengauthor=L.+Huangauthor=R.+J.+Deshaiesauthor=P.+Kaiserauthor=J.+Huang&title=Chemical+Genetics+Screen+for+Enhancers+of+Rapamycin+Identifies+a+Specific+Inhibitor+of+an+SCF+Family+E3+Ubiquitin+Ligase&doi=10.1038%2Fnbt.1645"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1645%26sid%3Dliteratum%253Aachs%26aulast%3DAghajan%26aufirst%3DM.%26aulast%3DJonai%26aufirst%3DN.%26aulast%3DFlick%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DOuni%26aufirst%3DI.%26aulast%3DPierce%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DLomenick%26aufirst%3DB.%26aulast%3DDamoiseaux%26aufirst%3DR.%26aulast%3DHao%26aufirst%3DR.%26aulast%3Ddel%2BMoral%26aufirst%3DP.%2BM.%26aulast%3DVerma%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DKaiser%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DJ.%26atitle%3DChemical%2520Genetics%2520Screen%2520for%2520Enhancers%2520of%2520Rapamycin%2520Identifies%2520a%2520Specific%2520Inhibitor%2520of%2520an%2520SCF%2520Family%2520E3%2520Ubiquitin%2520Ligase%26jtitle%3DNat.%2520Biotechnol.%26date%3D2010%26volume%3D28%26issue%3D7%26spage%3D738%26epage%3D742%26doi%3D10.1038%2Fnbt.1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Kaiser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, K.</span><span> </span><span class="NLM_article-title">The Yeast Ubiquitin Ligase SCFMet30: Connecting Environmental and Intracellular Conditions to Cell Division</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi">Â DOI: 10.1186/1747-1028-1-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1186%2F1747-1028-1-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16895602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A280%3ADC%252BD28rns1Sruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=16&author=P.+Kaiserauthor=N.-Y.+Suauthor=J.+L.+Yenauthor=I.+Ouniauthor=K.+Flick&title=The+Yeast+Ubiquitin+Ligase+SCFMet30%3A+Connecting+Environmental+and+Intracellular+Conditions+to+Cell+Division&doi=10.1186%2F1747-1028-1-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">The yeast ubiquitin ligase SCFMet30: connecting environmental and intracellular conditions to cell division</span></div><div class="casAuthors">Kaiser Peter; Su Ning-Yuan; Yen James L; Ouni Ikram; Flick Karin</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ubiquitination regulates a host of cellular processes and is well known for its role in progression through the cell division cycle.  In budding yeast, cadmium and arsenic stress, the availability of sulfur containing amino acids, and the intracellular concentration of S-adenosylmethionine are linked to cell cycle regulation through the ubiquitin ligase SCFMet30.  Regulation is achieved by ubiquitination of the transcription factor Met4.  Met4 activity is controlled by a regulatory K48-linked ubiquitin chain that is synthesized by Cdc34/SCFMet30.  A ubiquitin-interacting-motif (UIM) present in Met4 prevents degradation of ubiquitinated Met4 allowing the ubiquitin chain to function as a reversible switch of Met4 activity.  Here we discuss mechanisms of Met4 and SCFMet30 regulation in response to intracellular and environmental conditions, and describe the integration of these signals with cell cycle control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpYW_Qqu2Npo3yKPtYViAGfW6udTcc2ebWSVjTDf67orntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rns1Sruw%253D%253D&md5=deab9cd6ca4eeea4962dbe097a79e19d</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-1-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-1-16%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DN.-Y.%26aulast%3DYen%26aufirst%3DJ.%2BL.%26aulast%3DOuni%26aufirst%3DI.%26aulast%3DFlick%26aufirst%3DK.%26atitle%3DThe%2520Yeast%2520Ubiquitin%2520Ligase%2520SCFMet30%253A%2520Connecting%2520Environmental%2520and%2520Intracellular%2520Conditions%2520to%2520Cell%2520Division%26jtitle%3DCell%2520Div.%26date%3D2006%26volume%3D1%26spage%3D16%26doi%3D10.1186%2F1747-1028-1-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Patton, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyraud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouillon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerjan, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D.</span><span> </span><span class="NLM_article-title">SCFMet30-Mediated Control of the Transcriptional Activator Met4 Is Required for the G1âS Transition</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1613</span><span class="NLM_x">â</span> <span class="NLM_lpage">1624</span><span class="refDoi">Â DOI: 10.1093/emboj/19.7.1613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1093%2Femboj%2F19.7.1613" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=1613-1624&issue=7&author=E.+E.+Pattonauthor=C.+Peyraudauthor=A.+Rouillonauthor=Y.+S.+Kerjanauthor=M.+Tyersauthor=D.+Thomas&title=SCFMet30-Mediated+Control+of+the+Transcriptional+Activator+Met4+Is+Required+for+the+G1%E2%80%93S+Transition&doi=10.1093%2Femboj%2F19.7.1613"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.7.1613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.7.1613%26sid%3Dliteratum%253Aachs%26aulast%3DPatton%26aufirst%3DE.%2BE.%26aulast%3DPeyraud%26aufirst%3DC.%26aulast%3DRouillon%26aufirst%3DA.%26aulast%3DKerjan%26aufirst%3DY.%2BS.%26aulast%3DTyers%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DD.%26atitle%3DSCFMet30-Mediated%2520Control%2520of%2520the%2520Transcriptional%2520Activator%2520Met4%2520Is%2520Required%2520for%2520the%2520G1%25E2%2580%2593S%2520Transition%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26issue%3D7%26spage%3D1613%26epage%3D1624%26doi%3D10.1093%2Femboj%2F19.7.1613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Palframan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meehl, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaspersen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A. W.</span><span> </span><span class="NLM_article-title">Anaphase Inactivation of the Spindle Checkpoint</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x"> (</span><span class="NLM_issue">5787</span><span class="NLM_x">) </span> <span class="NLM_fpage">680</span><span class="NLM_x">â</span> <span class="NLM_lpage">684</span><span class="refDoi">Â DOI: 10.1126/science.1127205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.1127205" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2006&pages=680-684&issue=5787&author=W.+J.+Palframanauthor=J.+B.+Meehlauthor=S.+L.+Jaspersenauthor=M.+Wineyauthor=A.+W.+Murray&title=Anaphase+Inactivation+of+the+Spindle+Checkpoint&doi=10.1126%2Fscience.1127205"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1126%2Fscience.1127205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1127205%26sid%3Dliteratum%253Aachs%26aulast%3DPalframan%26aufirst%3DW.%2BJ.%26aulast%3DMeehl%26aufirst%3DJ.%2BB.%26aulast%3DJaspersen%26aufirst%3DS.%2BL.%26aulast%3DWiney%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DA.%2BW.%26atitle%3DAnaphase%2520Inactivation%2520of%2520the%2520Spindle%2520Checkpoint%26jtitle%3DScience%26date%3D2006%26volume%3D313%26issue%3D5787%26spage%3D680%26epage%3D684%26doi%3D10.1126%2Fscience.1127205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Yu, H.</span><span> </span><span class="NLM_article-title">Cdc20: a WD40 Activator for a Cell Cycle Degradation Machine</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">16</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2007.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2007.06.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=3-16&issue=1&author=H.+Yu&title=Cdc20%3A+a+WD40+Activator+for+a+Cell+Cycle+Degradation+Machine&doi=10.1016%2Fj.molcel.2007.06.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26atitle%3DCdc20%253A%2520a%2520WD40%2520Activator%2520for%2520a%2520Cell%2520Cycle%2520Degradation%2520Machine%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26issue%3D1%26spage%3D3%26epage%3D16%26doi%3D10.1016%2Fj.molcel.2007.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Montero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossella, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span> </span><span class="NLM_article-title">Docetaxel for Treatment of Solid Tumours: a Systematic Review of Clinical Data</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">239</span><span class="refDoi">Â DOI: 10.1016/S1470-2045(05)70094-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2FS1470-2045%2805%2970094-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15811618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWjtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=229-239&issue=4&author=A.+Monteroauthor=F.+Fossellaauthor=G.+Hortobagyiauthor=V.+Valero&title=Docetaxel+for+Treatment+of+Solid+Tumours%3A+a+Systematic+Review+of+Clinical+Data&doi=10.1016%2FS1470-2045%2805%2970094-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Docetaxel for treatment of solid tumours: a systematic review of clinical data</span></div><div class="casAuthors">Montero, Alberto; Fossella, Frank; Hortobagyi, Gabriel; Valero, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-239</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Docetaxel is a semisynthetic taxane, a class of anticancer agents that bind to Î² tubulin, thereby stabilizing microtubules and inducing cell-cycle arrest and apoptosis.  Docetaxel was first approved for the treatment of anthracycline-refractory metastatic breast cancer in the mid-1990s.  Since then, several randomized trials have reported improved time-to-progression, overall survival, or both in metastatic breast cancer treated with single-agent docetaxel or docetaxel-based combination regimens.  Data from two adjuvant trials have shown a survival benefit with the addn. of docetaxel to std. anthracycline-based regimens in patients with high-risk early breast cancer.  In four randomized studies, docetaxel improved survival in locally advanced or metastatic non-small-cell lung cancer.  Moreover, two trials have shown that docetaxel combined with estramustine or corticosteroids improves survival in metastatic androgen-independent prostate cancer.  Here, we review major randomized phase III trials with docetaxel in the treatment of solid malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmwW4zmyYunbVg90H21EOLACvtfcHk0lh_ZnwdsqI67A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWjtLk%253D&md5=d591943c6c6608e2a5915fc616b37056</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2805%2970094-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252805%252970094-2%26sid%3Dliteratum%253Aachs%26aulast%3DMontero%26aufirst%3DA.%26aulast%3DFossella%26aufirst%3DF.%26aulast%3DHortobagyi%26aufirst%3DG.%26aulast%3DValero%26aufirst%3DV.%26atitle%3DDocetaxel%2520for%2520Treatment%2520of%2520Solid%2520Tumours%253A%2520a%2520Systematic%2520Review%2520of%2520Clinical%2520Data%26jtitle%3DLancet%2520Oncol.%26date%3D2005%26volume%3D6%26issue%3D4%26spage%3D229%26epage%3D239%26doi%3D10.1016%2FS1470-2045%2805%2970094-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Bekier, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischbach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. R.</span><span> </span><span class="NLM_article-title">Length of Mitotic Arrest Induced by Microtubule-Stabilizing Drugs Determines Cell Death After Mitotic Exit</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1646</span><span class="NLM_x">â</span> <span class="NLM_lpage">1654</span><span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-08-1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F1535-7163.MCT-08-1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19509263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVKgtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1646-1654&issue=6&author=M.+E.+Bekierauthor=R.+Fischbachauthor=J.+Leeauthor=W.+R.+Taylor&title=Length+of+Mitotic+Arrest+Induced+by+Microtubule-Stabilizing+Drugs+Determines+Cell+Death+After+Mitotic+Exit&doi=10.1158%2F1535-7163.MCT-08-1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit</span></div><div class="casAuthors">Bekier, Michael E.; Fischbach, Robert; Lee, Jennifer; Taylor, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1646-1654</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cell death induced by agents that disrupt microtubules can kill cells by inducing a prolonged mitotic block.  This mitotic block is dependent on the spindle assembly checkpoint, a surveillance system that ensures the bipolar attachment of chromosomes to the mitotic spindle before the onset of anaphase.  Under some conditions, the spindle assembly checkpoint can become weakened, allowing cells to exit mitosis despite the presence of chromosomes that are not properly attached to the mitotic spindle.  Here, we use an Aurora kinase inhibitor to drive mitotic exit and test the effect of mitotic arrest length on death in the subsequent interphase.  Cells that are blocked in mitosis for >15 h die shortly after exiting from mitosis, whereas cells that exit after being blocked for <15 h show variable fates, with some living for days after exiting mitosis.  Cells blocked in mitosis by either Taxol or epothilone B are acutely sensitive to the death ligand tumor necrosis factor-related apoptosis-inducing ligand, suggesting that prolonged mitosis allows the gradual accumulation of internal death signals, rendering cells hypersensitive to addnl. prodeath cues.  Death under these conditions is initiated while cyclin B1 is still present, indicating that cells are in mitosis.  Our expts. suggest that there is a point of no return during prolonged mitotic block after which mitotic exit can no longer block death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpedusWfuBQ_rVg90H21EOLACvtfcHk0lh_ZnwdsqI67A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVKgtrY%253D&md5=acac784a389aa8766b79c12fc35f40ce</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1084%26sid%3Dliteratum%253Aachs%26aulast%3DBekier%26aufirst%3DM.%2BE.%26aulast%3DFischbach%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DW.%2BR.%26atitle%3DLength%2520of%2520Mitotic%2520Arrest%2520Induced%2520by%2520Microtubule-Stabilizing%2520Drugs%2520Determines%2520Cell%2520Death%2520After%2520Mitotic%2520Exit%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D6%26spage%3D1646%26epage%3D1654%26doi%3D10.1158%2F1535-7163.MCT-08-1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, T. J.</span><span> </span><span class="NLM_article-title">Evidence That Mitotic Exit Is a Better Cancer Therapeutic Target Than Spindle Assembly</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">358</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2009.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.ccr.2009.08.020" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=347-358&issue=4&author=H.-C.+Huangauthor=J.+Shiauthor=J.+D.+Orthauthor=T.+J.+Mitchison&title=Evidence+That+Mitotic+Exit+Is+a+Better+Cancer+Therapeutic+Target+Than+Spindle+Assembly&doi=10.1016%2Fj.ccr.2009.08.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2009.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2009.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DJ.%2BD.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DEvidence%2520That%2520Mitotic%2520Exit%2520Is%2520a%2520Better%2520Cancer%2520Therapeutic%2520Target%2520Than%2520Spindle%2520Assembly%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26issue%3D4%26spage%3D347%26epage%3D358%26doi%3D10.1016%2Fj.ccr.2009.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Wolthuis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay-Farrace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Zon, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yekezare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koop, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pines, J.</span><span> </span><span class="NLM_article-title">Cdc20 and Cks Direct the Spindle Checkpoint-Independent Destruction of Cyclin a</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">290</span><span class="NLM_x">â</span> <span class="NLM_lpage">302</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2008.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2008.02.027" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=290-302&issue=3&author=R.+Wolthuisauthor=L.+Clay-Farraceauthor=W.+van+Zonauthor=M.+Yekezareauthor=L.+Koopauthor=J.+Oginkauthor=R.+Medemaauthor=J.+Pines&title=Cdc20+and+Cks+Direct+the+Spindle+Checkpoint-Independent+Destruction+of+Cyclin+a&doi=10.1016%2Fj.molcel.2008.02.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2008.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2008.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DWolthuis%26aufirst%3DR.%26aulast%3DClay-Farrace%26aufirst%3DL.%26aulast%3Dvan%2BZon%26aufirst%3DW.%26aulast%3DYekezare%26aufirst%3DM.%26aulast%3DKoop%26aufirst%3DL.%26aulast%3DOgink%26aufirst%3DJ.%26aulast%3DMedema%26aufirst%3DR.%26aulast%3DPines%26aufirst%3DJ.%26atitle%3DCdc20%2520and%2520Cks%2520Direct%2520the%2520Spindle%2520Checkpoint-Independent%2520Destruction%2520of%2520Cyclin%2520a%26jtitle%3DMol.%2520Cell%26date%3D2008%26volume%3D30%26issue%3D3%26spage%3D290%26epage%3D302%26doi%3D10.1016%2Fj.molcel.2008.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Verma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâOnofrio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochtrop, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffino, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fushman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span> </span><span class="NLM_article-title">Ubistatins Inhibit Proteasome-Dependent Degradation by Binding the Ubiquitin Chain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x"> (</span><span class="NLM_issue">5693</span><span class="NLM_x">) </span> <span class="NLM_fpage">117</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span><span class="refDoi">Â DOI: 10.1126/science.1100946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.1100946" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2004&pages=117-120&issue=5693&author=R.+Vermaauthor=N.+R.+Petersauthor=M.+D%E2%80%99Onofrioauthor=G.+P.+Tochtropauthor=K.+M.+Sakamotoauthor=R.+Varadanauthor=M.+Zhangauthor=P.+Coffinoauthor=D.+Fushmanauthor=R.+J.+Deshaiesauthor=R.+W.+King&title=Ubistatins+Inhibit+Proteasome-Dependent+Degradation+by+Binding+the+Ubiquitin+Chain&doi=10.1126%2Fscience.1100946"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1126%2Fscience.1100946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1100946%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DN.%2BR.%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DM.%26aulast%3DTochtrop%26aufirst%3DG.%2BP.%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26aulast%3DVaradan%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DCoffino%26aufirst%3DP.%26aulast%3DFushman%26aufirst%3DD.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26atitle%3DUbistatins%2520Inhibit%2520Proteasome-Dependent%2520Degradation%2520by%2520Binding%2520the%2520Ubiquitin%2520Chain%26jtitle%3DScience%26date%3D2004%26volume%3D306%26issue%3D5693%26spage%3D117%26epage%3D120%26doi%3D10.1126%2Fscience.1100946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Zeng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigoillot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaff, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hathaway, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span> </span><span class="NLM_article-title">Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces a Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle Damage</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">382</span><span class="NLM_x">â</span> <span class="NLM_lpage">395</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2010.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.ccr.2010.08.010" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=382-395&issue=4&author=X.+Zengauthor=F.+Sigoillotauthor=S.+Gaurauthor=S.+Choiauthor=K.+L.+Pfaffauthor=D.-C.+Ohauthor=N.+Hathawayauthor=N.+Dimovaauthor=G.+D.+Cunyauthor=R.+W.+King&title=Pharmacologic+Inhibition+of+the+Anaphase-Promoting+Complex+Induces+a+Spindle+Checkpoint-Dependent+Mitotic+Arrest+in+the+Absence+of+Spindle+Damage&doi=10.1016%2Fj.ccr.2010.08.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DSigoillot%26aufirst%3DF.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DPfaff%26aufirst%3DK.%2BL.%26aulast%3DOh%26aufirst%3DD.-C.%26aulast%3DHathaway%26aufirst%3DN.%26aulast%3DDimova%26aufirst%3DN.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DKing%26aufirst%3DR.%2BW.%26atitle%3DPharmacologic%2520Inhibition%2520of%2520the%2520Anaphase-Promoting%2520Complex%2520Induces%2520a%2520Spindle%2520Checkpoint-Dependent%2520Mitotic%2520Arrest%2520in%2520the%2520Absence%2520of%2520Spindle%2520Damage%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26issue%3D4%26spage%3D382%26epage%3D395%26doi%3D10.1016%2Fj.ccr.2010.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skehel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barford, D.</span><span> </span><span class="NLM_article-title">Molecular Mechanism of APC/C Activation by Mitotic Phosphorylation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">533</span><span class="NLM_x"> (</span><span class="NLM_issue">7602</span><span class="NLM_x">) </span> <span class="NLM_fpage">260</span><span class="NLM_x">â</span> <span class="NLM_lpage">264</span><span class="refDoi">Â DOI: 10.1038/nature17973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature17973" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=260-264&issue=7602&author=S.+Zhangauthor=L.+Changauthor=C.+Alfieriauthor=Z.+Zhangauthor=J.+Yangauthor=S.+Maslenauthor=M.+Skehelauthor=D.+Barford&title=Molecular+Mechanism+of+APC%2FC+Activation+by+Mitotic+Phosphorylation&doi=10.1038%2Fnature17973"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnature17973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17973%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DL.%26aulast%3DAlfieri%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMaslen%26aufirst%3DS.%26aulast%3DSkehel%26aufirst%3DM.%26aulast%3DBarford%26aufirst%3DD.%26atitle%3DMolecular%2520Mechanism%2520of%2520APC%252FC%2520Activation%2520by%2520Mitotic%2520Phosphorylation%26jtitle%3DNature%26date%3D2016%26volume%3D533%26issue%3D7602%26spage%3D260%26epage%3D264%26doi%3D10.1038%2Fnature17973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Miller, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">StrÃ¶mland, K.</span><span> </span><span class="NLM_article-title">Teratogen Update: Thalidomide: a Review, with a Focus on Ocular Findings and New Potential Uses</span> <span class="citation_source-journal">Teratology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">306</span><span class="NLM_x">â</span> <span class="NLM_lpage">321</span><span class="refDoi">Â DOI: 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2F%28SICI%291096-9926%28199911%2960%3A5%3C306%3A%3AAID-TERA11%3E3.0.CO%3B2-Y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10525208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSgtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1999&pages=306-321&issue=5&author=M.+T.+Millerauthor=K.+Str%C3%B6mland&title=Teratogen+Update%3A+Thalidomide%3A+a+Review%2C+with+a+Focus+on+Ocular+Findings+and+New+Potential+Uses&doi=10.1002%2F%28SICI%291096-9926%28199911%2960%3A5%3C306%3A%3AAID-TERA11%3E3.0.CO%3B2-Y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses</span></div><div class="casAuthors">Miller, Marilyn T.; Stromland, Kerstin</div><div class="citationInfo"><span class="NLM_cas:title">Teratology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">306-321</span>CODEN:
                <span class="NLM_cas:coden">TJADAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-3709</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review and discussion with many refs.  Period of greatest sensitivity, phenotypic affects, and thalidomide uses in 1990s, etc., are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7l2YrrF9-17Vg90H21EOLACvtfcHk0lhMUXJdXM-6oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSgtLo%253D&md5=a486c12fd88acc49bddcc0830182721c</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9926%28199911%2960%3A5%3C306%3A%3AAID-TERA11%3E3.0.CO%3B2-Y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9926%2528199911%252960%253A5%253C306%253A%253AAID-TERA11%253E3.0.CO%253B2-Y%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BT.%26aulast%3DStr%25C3%25B6mland%26aufirst%3DK.%26atitle%3DTeratogen%2520Update%253A%2520Thalidomide%253A%2520a%2520Review%252C%2520with%2520a%2520Focus%2520on%2520Ocular%2520Findings%2520and%2520New%2520Potential%2520Uses%26jtitle%3DTeratology%26date%3D1999%26volume%3D60%26issue%3D5%26spage%3D306%26epage%3D321%26doi%3D10.1002%2F%28SICI%291096-9926%28199911%2960%3A5%3C306%3A%3AAID-TERA11%3E3.0.CO%3B2-Y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Melchert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">List, A.</span><span> </span><span class="NLM_article-title">The Thalidomide Saga</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">7â8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1489</span><span class="NLM_x">â</span> <span class="NLM_lpage">1499</span><span class="refDoi">Â DOI: 10.1016/j.biocel.2007.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.biocel.2007.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=17369076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWltbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=1489-1499&issue=7%E2%80%938&author=M.+Melchertauthor=A.+List&title=The+Thalidomide+Saga&doi=10.1016%2Fj.biocel.2007.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">The thalidomide saga</span></div><div class="casAuthors">Melchert, Magda; List, Alan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1489-1499</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past 50 years, thalidomide has been a target of active investigation in both malignant and inflammatory conditions.  Although initially developed for its sedative properties, decades of investigation have identified a multitude of biol. effects that led to its classification as an immunomodulatory drug (IMiD).  In addn. to suppression of tumor necrosis factor-alpha (TNF-Î±), thalidomide effects the generation and elaboration of a cascade of pro-inflammatory cytokines that activate cytotoxic T-cells even in the absence of co-stimulatory signals.  Furthermore, vascular endothelial growth factor (VEGF) and beta fibroblast growth factor (bFGF) secretion and cellular response are suppressed by thalidomide, thus antagonizing neoangiogenesis and altering the bone marrow stromal microenvironment in hematol. malignancies.  The thalidomide analogs, lenalidomide (CC-5013; Revlimid) and CC-4047 (Actimid), have enhanced potency as inhibitors of TNF-Î± and other inflammatory cytokines, as well as greater capacity to promote T-cell activation and suppress angiogenesis.  Both thalidomide and lenalidomide are effective in the treatment of multiple myeloma and myelodysplastic syndromes for which the Food and Drug Administration granted recent approval.  Nonetheless, each of these IMiDs remains the subject of active investigation in solid tumors, hematol. malignancies, and other inflammatory conditions.  This review will explore the pharmacokinetic and biol. effects of thalidomide and its progeny compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWmbOezWOSg7Vg90H21EOLACvtfcHk0lhMUXJdXM-6oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWltbk%253D&md5=40ef03568f8da5a4d15a908d71d33373</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2007.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2007.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DMelchert%26aufirst%3DM.%26aulast%3DList%26aufirst%3DA.%26atitle%3DThe%2520Thalidomide%2520Saga%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2007%26volume%3D39%26issue%3D7%25E2%2580%25938%26spage%3D1489%26epage%3D1499%26doi%3D10.1016%2Fj.biocel.2007.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Knobloch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RÃ¼ther, U.</span><span> </span><span class="NLM_article-title">Shedding Light on an Old Mystery: Thalidomide Suppresses Survival Pathways to Induce Limb Defects</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1121</span><span class="NLM_x">â</span> <span class="NLM_lpage">1127</span><span class="refDoi">Â DOI: 10.4161/cc.7.9.5793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.4161%2Fcc.7.9.5793" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1121-1127&issue=9&author=J.+Knoblochauthor=U.+R%C3%BCther&title=Shedding+Light+on+an+Old+Mystery%3A+Thalidomide+Suppresses+Survival+Pathways+to+Induce+Limb+Defects&doi=10.4161%2Fcc.7.9.5793"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.4161%2Fcc.7.9.5793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.7.9.5793%26sid%3Dliteratum%253Aachs%26aulast%3DKnobloch%26aufirst%3DJ.%26aulast%3DR%25C3%25BCther%26aufirst%3DU.%26atitle%3DShedding%2520Light%2520on%2520an%2520Old%2520Mystery%253A%2520Thalidomide%2520Suppresses%2520Survival%2520Pathways%2520to%2520Induce%2520Limb%2520Defects%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26issue%3D9%26spage%3D1121%26epage%3D1127%26doi%3D10.4161%2Fcc.7.9.5793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">SHESKIN, J.</span><span> </span><span class="NLM_article-title">Thalidomide in the Treatment of Lepra Reactions</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">â</span> <span class="NLM_lpage">306</span><span class="refDoi">Â DOI: 10.1002/cpt196563303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2Fcpt196563303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=14296027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A280%3ADyaF2M7gtVKgtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1965&pages=303-306&author=J.+SHESKIN&title=Thalidomide+in+the+Treatment+of+Lepra+Reactions&doi=10.1002%2Fcpt196563303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS</span></div><div class="casAuthors">SHESKIN J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">303-6</span>
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuQWQYmYA2ef69nzq6467DfW6udTcc2eatOXYfL-iNiLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF2M7gtVKgtg%253D%253D&md5=51c996c9092f27ac78643f0af03e53ad</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1002%2Fcpt196563303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt196563303%26sid%3Dliteratum%253Aachs%26aulast%3DSHESKIN%26aufirst%3DJ.%26atitle%3DThalidomide%2520in%2520the%2520Treatment%2520of%2520Lepra%2520Reactions%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1965%26volume%3D6%26spage%3D303%26epage%3D306%26doi%3D10.1002%2Fcpt196563303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desikan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddlemon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anaissie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhodapkar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeldis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span> </span><span class="NLM_article-title">Antitumor Activity of Thalidomide in Refractory Multiple Myeloma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">1565</span><span class="NLM_x">â</span> <span class="NLM_lpage">1571</span><span class="refDoi">Â DOI: 10.1056/NEJM199911183412102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1056%2FNEJM199911183412102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10564685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1MXotVSgs78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=1565-1571&issue=21&author=S.+Singhalauthor=J.+Mehtaauthor=R.+Desikanauthor=D.+Ayersauthor=P.+Robersonauthor=P.+Eddlemonauthor=N.+Munshiauthor=E.+Anaissieauthor=C.+Wilsonauthor=M.+Dhodapkarauthor=J.+Zeldisauthor=D.+Siegelauthor=J.+Crowleyauthor=B.+Barlogie&title=Antitumor+Activity+of+Thalidomide+in+Refractory+Multiple+Myeloma&doi=10.1056%2FNEJM199911183412102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of thalidomide in refractory multiple myeloma</span></div><div class="casAuthors">Singhal, Seema; Mehta, Jayesh; Desikan, Raman; Ayers, Dan; Roberson, Paula; Eddlemon, Paul; Munshi, Nikhil; Anaissie, Elias; Wilson, Carla; Dhodapkar, Madhav; Zeldis, Jerome; Barlogie, Bart</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1565-1571</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Patients with myeloma who relapse after high-dose chemotherapy have few therapeutic options.  Since increased bone marrow vascularity imparts a poor prognosis in myeloma, we evaluated the efficacy of thalidomide, which has antiangiogenic properties, in patients with refractory disease.  Methods: Eighty-four previously treated patients with refractory myeloma (76 with a relapse after high-dose chemotherapy) received oral thalidomide as a single agent for a median of 80 days (range, 2 to 465).  The starting dose was 200 mg daily, and the dose was increased by 200 mg every two weeks until it reached 800 mg per day.  Response was assessed on the basis of a redn. of the myeloma protein in serum or Bence Jones protein in urine that lasted for at least six weeks.  Results: The serum or urine levels of paraprotein were reduced by at least 90 % in eight patients (two had a complete remission), at least 75 % in six patients, at least 50 % in seven patients, and at least 25 % in six patients, for a total rate of response of 32 %.  Redns. in the paraprotein levels were apparent within two months in 78 % of the patients with a response and were assocd. with decreased nos. of plasma cells in bone marrow and increased Hb levels.  The microvascular d. of bone marrow did not change significantly in patients with a response.  At least one third of the patients had mild or moderate constipation, weakness or fatigue, or somnolence.  More severe adverse effects were infrequent (occurring in less than 10 % of patients), and hematol. effects were rare.  As of the most recent follow-up, 36 patients had died (30 with no response and 6 with a response).  After 12 mo of follow-up, Kaplan-Meier ests. of the mean (Â±SE) rates of event-free survival and overall survival for all patients were 22Â±5 % and 58Â±5 %, resp.  Conclusions: Thalidomide is active against advanced myeloma.  It can induce marked and durable responses in some patients with multiple myeloma, including those who relapse after high-dose chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIQfXLedh12LVg90H21EOLACvtfcHk0lj-OWemzPgp7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVSgs78%253D&md5=bc018ca21eec485ca7cbf873e7219813</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1056%2FNEJM199911183412102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199911183412102%26sid%3Dliteratum%253Aachs%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DMehta%26aufirst%3DJ.%26aulast%3DDesikan%26aufirst%3DR.%26aulast%3DAyers%26aufirst%3DD.%26aulast%3DRoberson%26aufirst%3DP.%26aulast%3DEddlemon%26aufirst%3DP.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DAnaissie%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDhodapkar%26aufirst%3DM.%26aulast%3DZeldis%26aufirst%3DJ.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DCrowley%26aufirst%3DJ.%26aulast%3DBarlogie%26aufirst%3DB.%26atitle%3DAntitumor%2520Activity%2520of%2520Thalidomide%2520in%2520Refractory%2520Multiple%2520Myeloma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26issue%3D21%26spage%3D1565%26epage%3D1571%26doi%3D10.1056%2FNEJM199911183412102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span> </span><span class="NLM_article-title">Identification of a Primary Target of Thalidomide Teratogenicity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x"> (</span><span class="NLM_issue">5971</span><span class="NLM_x">) </span> <span class="NLM_fpage">1345</span><span class="NLM_x">â</span> <span class="NLM_lpage">1350</span><span class="refDoi">Â DOI: 10.1126/science.1177319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.1177319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=20223979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=1345-1350&issue=5971&author=T.+Itoauthor=H.+Andoauthor=T.+Suzukiauthor=T.+Oguraauthor=K.+Hottaauthor=Y.+Imamuraauthor=Y.+Yamaguchiauthor=H.+Handa&title=Identification+of+a+Primary+Target+of+Thalidomide+Teratogenicity&doi=10.1126%2Fscience.1177319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Primary Target of Thalidomide Teratogenicity</span></div><div class="casAuthors">Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">5971</span>),
    <span class="NLM_cas:pages">1345-1350</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects.  Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown.  Here, we identified cereblon (CRBN) as a thalidomide-binding protein.  CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.  Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the assocd. ubiquitin ligase activity.  This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivs. without teratogenic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPC_7RXLkfabVg90H21EOLACvtfcHk0lj-OWemzPgp7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D&md5=4565a67837e0ec34ede2c93c1036f312</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1126%2Fscience.1177319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1177319%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DHanda%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520Primary%2520Target%2520of%2520Thalidomide%2520Teratogenicity%26jtitle%3DScience%26date%3D2010%26volume%3D327%26issue%3D5971%26spage%3D1345%26epage%3D1350%26doi%3D10.1126%2Fscience.1177319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Lopez-Girona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmoudi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rychak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidarova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span> </span><span class="NLM_article-title">Cereblon Is a Direct Protein Target for Immunomodulatory and Antiproliferative Activities of Lenalidomide and Pomalidomide</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2326</span><span class="NLM_x">â</span> <span class="NLM_lpage">2335</span><span class="refDoi">Â DOI: 10.1038/leu.2012.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fleu.2012.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22552008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Giur%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=2326-2335&issue=11&author=A.+Lopez-Gironaauthor=D.+Mendyauthor=T.+Itoauthor=K.+Millerauthor=A.+K.+Gandhiauthor=J.+Kangauthor=S.+Karasawaauthor=G.+Carmelauthor=P.+Jacksonauthor=M.+Abbasianauthor=A.+Mahmoudiauthor=B.+Cathersauthor=E.+Rychakauthor=S.+Gaidarovaauthor=R.+Chenauthor=P.+H.+Schaferauthor=H.+Handaauthor=T.+O.+Danielauthor=J.+F.+Evansauthor=R.+Chopra&title=Cereblon+Is+a+Direct+Protein+Target+for+Immunomodulatory+and+Antiproliferative+Activities+of+Lenalidomide+and+Pomalidomide&doi=10.1038%2Fleu.2012.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide</span></div><div class="casAuthors">Lopez-Girona, A.; Mendy, D.; Ito, T.; Miller, K.; Gandhi, A. K.; Kang, J.; Karasawa, S.; Carmel, G.; Jackson, P.; Abbasian, M.; Mahmoudi, A.; Cathers, B.; Rychak, E.; Gaidarova, S.; Chen, R.; Schafer, P. H.; Handa, H.; Daniel, T. O.; Evans, J. F.; Chopra, R.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2326-2335</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thalidomide and the immunomodulatory drug, lenalidomide, are therapeutically active in hematol. malignancies.  The ubiquitously expressed E3 ligase protein cereblon (CRBN) has been identified as the primary teratogenic target of thalidomide.  Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.  CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells, as well as lenalidomide- and pomalidomide-induced cytokine prodn. in T cells.  Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBNYW/AA.  Overexpression of CRBN wild-type protein, but not CRBNYW/AA mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated redns. in c-myc and IRF4 expression and increases in p21WAF-1 expression.  Long-term selection for lenalidomide resistance in H929 myeloma cell lines was accompanied by a redn. in CRBN, while in DF15R myeloma cells resistant to both pomalidomide and lenalidomide, CRBN protein was undetectable.  Our biophys., biochem. and gene silencing studies show that CRBN is a proximate, therapeutically important mol. target of lenalidomide and pomalidomide.  Leukemia (2012) 26, 2326-2335; doi:10.1038/leu.2012.119; published online 15 June 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp85RvB33HGjbVg90H21EOLACvtfcHk0lj-OWemzPgp7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Giur%252FI&md5=81f83b5f6c4c043a35a049df3b4d63ae</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fleu.2012.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2012.119%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Girona%26aufirst%3DA.%26aulast%3DMendy%26aufirst%3DD.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DGandhi%26aufirst%3DA.%2BK.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKarasawa%26aufirst%3DS.%26aulast%3DCarmel%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DP.%26aulast%3DAbbasian%26aufirst%3DM.%26aulast%3DMahmoudi%26aufirst%3DA.%26aulast%3DCathers%26aufirst%3DB.%26aulast%3DRychak%26aufirst%3DE.%26aulast%3DGaidarova%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DSchafer%26aufirst%3DP.%2BH.%26aulast%3DHanda%26aufirst%3DH.%26aulast%3DDaniel%26aufirst%3DT.%2BO.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DChopra%26aufirst%3DR.%26atitle%3DCereblon%2520Is%2520a%2520Direct%2520Protein%2520Target%2520for%2520Immunomodulatory%2520and%2520Antiproliferative%2520Activities%2520of%2520Lenalidomide%2520and%2520Pomalidomide%26jtitle%3DLeukemia%26date%3D2012%26volume%3D26%26issue%3D11%26spage%3D2326%26epage%3D2335%26doi%3D10.1038%2Fleu.2012.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Zhu, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlowski, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span> </span><span class="NLM_article-title">Cereblon Expression Is Required for the Antimyeloma Activity of Lenalidomide and Pomalidomide</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4771</span><span class="NLM_x">â</span> <span class="NLM_lpage">4779</span><span class="refDoi">Â DOI: 10.1182/blood-2011-05-356063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1182%2Fblood-2011-05-356063" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=4771-4779&issue=18&author=Y.+X.+Zhuauthor=E.+Braggioauthor=C.-X.+Shiauthor=L.+A.+Bruinsauthor=J.+E.+Schmidtauthor=S.+Van+Wierauthor=X.-B.+Changauthor=C.+C.+Bjorklundauthor=R.+Fonsecaauthor=P.+L.+Bergsagelauthor=R.+Z.+Orlowskiauthor=A.+K.+Stewart&title=Cereblon+Expression+Is+Required+for+the+Antimyeloma+Activity+of+Lenalidomide+and+Pomalidomide&doi=10.1182%2Fblood-2011-05-356063"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-05-356063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-05-356063%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%2BX.%26aulast%3DBraggio%26aufirst%3DE.%26aulast%3DShi%26aufirst%3DC.-X.%26aulast%3DBruins%26aufirst%3DL.%2BA.%26aulast%3DSchmidt%26aufirst%3DJ.%2BE.%26aulast%3DVan%2BWier%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DX.-B.%26aulast%3DBjorklund%26aufirst%3DC.%2BC.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26atitle%3DCereblon%2520Expression%2520Is%2520Required%2520for%2520the%2520Antimyeloma%2520Activity%2520of%2520Lenalidomide%2520and%2520Pomalidomide%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26issue%3D18%26spage%3D4771%26epage%3D4779%26doi%3D10.1182%2Fblood-2011-05-356063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Fischer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BÃ¶hm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydeard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavadini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serluca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingaraju, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichkule, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schebesta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckwith, R. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ThomÃ¤, N. H.</span><span> </span><span class="NLM_article-title">Structure of the DDB1-CRBN E3 Ubiquitin Ligase in Complex with Thalidomide</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">512</span><span class="NLM_x"> (</span><span class="NLM_issue">7512</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span><span class="refDoi">Â DOI: 10.1038/nature13527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature13527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25043012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12ms7%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=512&publication_year=2014&pages=49-53&issue=7512&author=E.+S.+Fischerauthor=K.+B%C3%B6hmauthor=J.+R.+Lydeardauthor=H.+Yangauthor=M.+B.+Stadlerauthor=S.+Cavadiniauthor=J.+Nagelauthor=F.+Serlucaauthor=V.+Ackerauthor=G.+M.+Lingarajuauthor=R.+B.+Tichkuleauthor=M.+Schebestaauthor=W.+C.+Forresterauthor=M.+Schirleauthor=U.+Hassiepenauthor=J.+Ottlauthor=M.+Hildauthor=R.+E.+J.+Beckwithauthor=J.+W.+Harperauthor=J.+L.+Jenkinsauthor=N.+H.+Thom%C3%A4&title=Structure+of+the+DDB1-CRBN+E3+Ubiquitin+Ligase+in+Complex+with+Thalidomide&doi=10.1038%2Fnature13527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide</span></div><div class="casAuthors">Fischer, Eric S.; Bohm, Kerstin; Lydeard, John R.; Yang, Haidi; Stadler, Michael B.; Cavadini, Simone; Nagel, Jane; Serluca, Fabrizio; Acker, Vincent; Lingaraju, Gondichatnahalli M.; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hassiepen, Ulrich; Ottl, Johannes; Hild, Marc; Beckwith, Rohan E. J.; Harper, J. Wade; Jenkins, Jeremy L.; Thoma, Nicolas H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">512</span>
        (<span class="NLM_cas:issue">7512</span>),
    <span class="NLM_cas:pages">49-53</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects.  Despite the teratogenicity of thalidomide and its derivs. lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-assocd. dysplasia.  IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4CRBN.  Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide.  The structure establishes that CRBN is a substrate receptor within CRL4CRBN and enantioselectively binds IMiDs.  Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4CRBN.  Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4CRBN while the ligase complex is recruiting IKZF1 or IKZF3 for degrdn.  This dual activity implies that small mols. can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGt2Y9GecKr7Vg90H21EOLACvtfcHk0lhg8YaAHhfUJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12ms7%252FP&md5=1c1eaa48bef87463cdd3f2b1e1bd400d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnature13527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13527%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DB%25C3%25B6hm%26aufirst%3DK.%26aulast%3DLydeard%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStadler%26aufirst%3DM.%2BB.%26aulast%3DCavadini%26aufirst%3DS.%26aulast%3DNagel%26aufirst%3DJ.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DAcker%26aufirst%3DV.%26aulast%3DLingaraju%26aufirst%3DG.%2BM.%26aulast%3DTichkule%26aufirst%3DR.%2BB.%26aulast%3DSchebesta%26aufirst%3DM.%26aulast%3DForrester%26aufirst%3DW.%2BC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DOttl%26aufirst%3DJ.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DBeckwith%26aufirst%3DR.%2BE.%2BJ.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DJenkins%26aufirst%3DJ.%2BL.%26aulast%3DThom%25C3%25A4%26aufirst%3DN.%2BH.%26atitle%3DStructure%2520of%2520the%2520DDB1-CRBN%2520E3%2520Ubiquitin%2520Ligase%2520in%2520Complex%2520with%2520Thalidomide%26jtitle%3DNature%26date%3D2014%26volume%3D512%26issue%3D7512%26spage%3D49%26epage%3D53%26doi%3D10.1038%2Fnature13527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Sakamoto, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumagai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span> </span><span class="NLM_article-title">Protacs: Chimeric Molecules That Target Proteins to the Skp1-Cullin-F Box Complex for Ubiquitination and Degradation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">8554</span><span class="NLM_x">â</span> <span class="NLM_lpage">8559</span><span class="refDoi">Â DOI: 10.1073/pnas.141230798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1073%2Fpnas.141230798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=11438690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Wisbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=8554-8559&issue=15&author=K.+M.+Sakamotoauthor=K.+B.+Kimauthor=A.+Kumagaiauthor=F.+Mercurioauthor=C.+M.+Crewsauthor=R.+J.+Deshaies&title=Protacs%3A+Chimeric+Molecules+That+Target+Proteins+to+the+Skp1-Cullin-F+Box+Complex+for+Ubiquitination+and+Degradation&doi=10.1073%2Fpnas.141230798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation</span></div><div class="casAuthors">Sakamoto, Kathleen M.; Kim, Kyung B.; Kumagai, Akiko; Mercurio, Frank; Crews, Craig M.; Deshaies, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8554-8559</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The intracellular levels of many proteins are regulated by ubiquitin-dependent proteolysis.  One of the best-characterized enzymes that catalyzes the attachment of ubiquitin to proteins is a ubiquitin ligase complex, Skp1-Cullin-F box complex contg. Hrt1 (SCF).  We sought to artificially target a protein to the SCF complex for ubiquitination and degrdn.  To this end, we tested methionine aminopeptidase-2 (MetAP-2), which covalently binds the angiogenesis inhibitor ovalicin.  A chimeric compd., protein-targeting chimeric mol. 1 (Protac-1), was synthesized to recruit MetAP-2 to SCF.  One domain of Protac-1 contains the IÎºBÎ± phosphopeptide that is recognized by the F-box protein Î²-TRCP, whereas the other domain is composed of ovalicin.  We show that MetAP-2 can be tethered to SCFÎ²-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner.  In the future, this approach may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp49fYtuEVlJrVg90H21EOLACvtfcHk0lhg8YaAHhfUJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Wisbk%253D&md5=540358035222f745f7b6367b38781a21</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1073%2Fpnas.141230798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.141230798%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DKumagai%26aufirst%3DA.%26aulast%3DMercurio%26aufirst%3DF.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26atitle%3DProtacs%253A%2520Chimeric%2520Molecules%2520That%2520Target%2520Proteins%2520to%2520the%2520Skp1-Cullin-F%2520Box%2520Complex%2520for%2520Ubiquitination%2520and%2520Degradation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26issue%3D15%26spage%3D8554%26epage%3D8559%26doi%3D10.1073%2Fpnas.141230798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Posttranslational Protein Knockdown Coupled to Receptor Tyrosine Kinase Activation with phosphoPROTACs</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">8942</span><span class="NLM_x">â</span> <span class="NLM_lpage">8947</span><span class="refDoi">Â DOI: 10.1073/pnas.1217206110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1073%2Fpnas.1217206110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=23674677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFait7zN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=8942-8947&issue=22&author=J.+Hinesauthor=J.+D.+Goughauthor=T.+W.+Corsonauthor=C.+M.+Crews&title=Posttranslational+Protein+Knockdown+Coupled+to+Receptor+Tyrosine+Kinase+Activation+with+phosphoPROTACs&doi=10.1073%2Fpnas.1217206110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs</span></div><div class="casAuthors">Hines, John; Gough, Jonathan D.; Corson, Timothy W.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8942-8947, S8942/1-S8942/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Posttranslational knockdown of a specific protein is an attractive approach for examg. its function within a system.  Here we introduce phospho-dependent proteolysis targeting chimeras (phosphoPROTACs), a method to couple the conditional degrdn. of targeted proteins to the activation state of particular kinase-signaling pathways.  We generated two phosphoPROTACs that couple the tyrosine phosphorylation sequences of either the nerve growth factor receptor, TrkA (tropomyosin receptor kinase A), or the neuregulin receptor, ErbB3 (erythroblastosis oncogene B3), with a peptide ligand for the E3 ubiquitin ligase von Hippel Lindau protein.  These phosphoPROTACs recruit either the neurotrophic signaling effector fibroblast growth factor receptor substrate 2a or the survival-promoting phosphatidylinositol-3-kinase, resp., to be ubiquitinated and degraded upon activation of specific receptor tyrosine kinases and phosphorylation of the phosphoPROTACs.  We demonstrate the ability of these phosphoPROTACs to suppress the short- and long-term effects of their resp. activating receptor tyrosine kinase pathways both in vitro and in vivo.  In addn., we show that activation of phosphoPROTACs is entirely dependent on their kinase-mediated phosphorylation, as phenylalanine-contg. null variants are inactive.  Furthermore, stimulation of unrelated growth factor receptors does not induce target protein knockdown.  Although comparable in efficiency to RNAi, this approach has the added advantage of providing a degree of temporal and dosing control as well as cell-type selectivity unavailable using nucleic acid-based strategies.  By varying the autophosphorylation sequence of a phosphoPROTAC, it is conceivable that other receptor tyrosine kinase/effector pairings could be similarly exploited to achieve other biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsZZWSv0W2uLVg90H21EOLACvtfcHk0liHLHFqE1_Q_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFait7zN&md5=27e5bc310a45be8ecb23314daa582944</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217206110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217206110%26sid%3Dliteratum%253Aachs%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DJ.%2BD.%26aulast%3DCorson%26aufirst%3DT.%2BW.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DPosttranslational%2520Protein%2520Knockdown%2520Coupled%2520to%2520Receptor%2520Tyrosine%2520Kinase%2520Activation%2520with%2520phosphoPROTACs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D22%26spage%3D8942%26epage%3D8947%26doi%3D10.1073%2Fpnas.1217206110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darricarrere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miah, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1831</span><span class="NLM_x">â</span> <span class="NLM_lpage">1837</span><span class="refDoi">Â DOI: 10.1021/acschembio.5b00442</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00442" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSht7fN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1831-1837&issue=8&author=D.+L.+Buckleyauthor=K.+Rainaauthor=N.+Darricarrereauthor=J.+Hinesauthor=J.+L.+Gustafsonauthor=I.+E.+Smithauthor=A.+H.+Miahauthor=J.+D.+Harlingauthor=C.+M.+Crews&title=HaloPROTACS%3A+Use+of+Small+Molecule+PROTACs+to+Induce+Degradation+of+HaloTag+Fusion+Proteins&doi=10.1021%2Facschembio.5b00442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins</span></div><div class="casAuthors">Buckley, Dennis L.; Raina, Kanak; Darricarrere, Nicole; Hines, John; Gustafson, Jeffrey L.; Smith, Ian E.; Miah, Afjal H.; Harling, John D.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1831-1837</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small mol.-induced protein degrdn. is an attractive strategy for the development of chem. probes.  One method for inducing targeted protein degrdn. involves the use of PROTACs, heterobifunctional mols. that can recruit specific E3 ligases to a desired protein of interest.  PROTACs have been successfully used to degrade numerous proteins in cells, but the peptidic E3 ligase ligands used in previous PROTACs have hindered their development into more mature chem. probes or therapeutics.  The authors report the design of a novel class of PROTACs that incorporate small mol. VHL ligands to successfully degrade HaloTag7 fusion proteins.  These HaloPROTACs will inspire the development of future PROTACs with more drug-like properties.  Addnl., these HaloPROTACs are useful chem. genetic tools, due to their ability to chem. knock down widely used HaloTag7 fusion proteins in a general fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotj-Sgj4TyKrVg90H21EOLACvtfcHk0liHLHFqE1_Q_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSht7fN&md5=b074c58e983f15c384818777b25e248d</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00442%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DDarricarrere%26aufirst%3DN.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DI.%2BE.%26aulast%3DMiah%26aufirst%3DA.%2BH.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHaloPROTACS%253A%2520Use%2520of%2520Small%2520Molecule%2520PROTACs%2520to%2520Induce%2520Degradation%2520of%2520HaloTag%2520Fusion%2520Proteins%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3D1831%26epage%3D1837%26doi%3D10.1021%2Facschembio.5b00442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Bondeson, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I. E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miah, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulholland, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routly, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faelth-Savitski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casillas, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">den Besten, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Famm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruidenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churcher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Catalytic in Vivo Protein Knockdown by Small-Molecule PROTACs</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">611</span><span class="NLM_x">â</span> <span class="NLM_lpage">617</span><span class="refDoi">Â DOI: 10.1038/nchembio.1858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=26075522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7rP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=611-617&issue=8&author=D.+P.+Bondesonauthor=A.+Maresauthor=I.+E.+D.+Smithauthor=E.+Koauthor=S.+Camposauthor=A.+H.+Miahauthor=K.+E.+Mulhollandauthor=N.+Routlyauthor=D.+L.+Buckleyauthor=J.+L.+Gustafsonauthor=N.+Zinnauthor=P.+Grandiauthor=S.+Shimamuraauthor=G.+Bergaminiauthor=M.+Faelth-Savitskiauthor=M.+Bantscheffauthor=C.+Coxauthor=D.+A.+Gordonauthor=R.+R.+Willardauthor=J.+J.+Flanaganauthor=L.+N.+Casillasauthor=B.+J.+Vottaauthor=W.+den+Bestenauthor=K.+Fammauthor=L.+Kruidenierauthor=P.+S.+Carterauthor=J.+D.+Harlingauthor=I.+Churcherauthor=C.+M.+Crews&title=Catalytic+in+Vivo+Protein+Knockdown+by+Small-Molecule+PROTACs&doi=10.1038%2Fnchembio.1858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic in vivo protein knockdown by small-molecule PROTACs</span></div><div class="casAuthors">Bondeson, Daniel P.; Mares, Alina; Smith, Ian E. D.; Ko, Eunhwa; Campos, Sebastien; Miah, Afjal H.; Mulholland, Katie E.; Routly, Natasha; Buckley, Dennis L.; Gustafson, Jeffrey L.; Zinn, Nico; Grandi, Paola; Shimamura, Satoko; Bergamini, Giovanna; Faelth-Savitski, Maria; Bantscheff, Marcus; Cox, Carly; Gordon, Deborah A.; Willard, Ryan R.; Flanagan, John J.; Casillas, Linda N.; Votta, Bartholomew J.; den Besten, Willem; Famm, Kristoffer; Kruidenier, Laurens; Carter, Paul S.; Harling, John D.; Churcher, Ian; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The current predominant therapeutic paradigm is based on maximizing drug-receptor occupancy to achieve clin. benefit.  This strategy, however, generally requires excessive drug concns. to ensure sufficient occupancy, often leading to adverse side effects.  Here, we describe major improvements to the proteolysis targeting chimeras (PROTACs) method, a chem. knockdown strategy in which a heterobifunctional mol. recruits a specific protein target to an E3 ubiquitin ligase, resulting in the target's ubiquitination and degrdn.  These compds. behave catalytically in their ability to induce the ubiquitination of super-stoichiometric quantities of proteins, providing efficacy that is not limited by equil. occupancy.  We present two PROTACs that are capable of specifically reducing protein levels by >90% at nanomolar concns.  In addn., mouse studies indicate that they provide broad tissue distribution and knockdown of the targeted protein in tumor xenografts.  Together, these data demonstrate a protein knockdown system combining many of the favorable properties of small-mol. agents with the potent protein knockdown of RNAi and CRISPR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonhnajD3CxS7Vg90H21EOLACvtfcHk0lhK0Jrcu4eQBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7rP&md5=31eb8756c5661f78ab4527a50dc1e251</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1858%26sid%3Dliteratum%253Aachs%26aulast%3DBondeson%26aufirst%3DD.%2BP.%26aulast%3DMares%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DI.%2BE.%2BD.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DCampos%26aufirst%3DS.%26aulast%3DMiah%26aufirst%3DA.%2BH.%26aulast%3DMulholland%26aufirst%3DK.%2BE.%26aulast%3DRoutly%26aufirst%3DN.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DShimamura%26aufirst%3DS.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DFaelth-Savitski%26aufirst%3DM.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DGordon%26aufirst%3DD.%2BA.%26aulast%3DWillard%26aufirst%3DR.%2BR.%26aulast%3DFlanagan%26aufirst%3DJ.%2BJ.%26aulast%3DCasillas%26aufirst%3DL.%2BN.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3Dden%2BBesten%26aufirst%3DW.%26aulast%3DFamm%26aufirst%3DK.%26aulast%3DKruidenier%26aufirst%3DL.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DHarling%26aufirst%3DJ.%2BD.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DCatalytic%2520in%2520Vivo%2520Protein%2520Knockdown%2520by%2520Small-Molecule%2520PROTACs%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D8%26spage%3D611%26epage%3D617%26doi%3D10.1038%2Fnchembio.1858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Winter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">DRUG DEVELOPMENT. Phthalimide Conjugation as a Strategy for in Vivo Target Protein Degradation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x"> (</span><span class="NLM_issue">6241</span><span class="NLM_x">) </span> <span class="NLM_fpage">1376</span><span class="NLM_x">â</span> <span class="NLM_lpage">1381</span><span class="refDoi">Â DOI: 10.1126/science.aab1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1126%2Fscience.aab1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25999370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=1376-1381&issue=6241&author=G.+E.+Winterauthor=D.+L.+Buckleyauthor=J.+Paulkauthor=J.+M.+Robertsauthor=A.+Souzaauthor=S.+Dhe-Paganonauthor=J.+E.+Bradner&title=DRUG+DEVELOPMENT.+Phthalimide+Conjugation+as+a+Strategy+for+in+Vivo+Target+Protein+Degradation&doi=10.1126%2Fscience.aab1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Phthalimide conjugation as a strategy for in vivo target protein degradation</span></div><div class="casAuthors">Winter, Georg E.; Buckley, Dennis L.; Paulk, Joshiawa; Roberts, Justin M.; Souza, Amanda; Dhe-Paganon, Sirano; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6241</span>),
    <span class="NLM_cas:pages">1376-1381</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The development of effective pharmacol. inhibitors of multidomain scaffold proteins, notably transcription factors, is a particularly challenging problem.  In part, this is because many small-mol. antagonists disrupt the activity of only one domain in the target protein.  The authors devised a chem. strategy that promotes ligand-dependent target protein degrdn. using as an example the transcriptional coactivator BRD4, a protein crit. for cancer cell growth and survival.  The authors appended a competitive antagonist of BET bromodomains to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex.  The resultant compd., dBET1, induced highly selective cereblon-dependent BET protein degrdn. in vitro and in vivo and delayed leukemia progression in mice.  A second series of probes resulted in selective degrdn. of the cytosolic protein FKBP12.  This chem. strategy for controlling target protein stability may have implications for therapeutically targeting previously intractable proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ZW4zjRjXi7Vg90H21EOLACvtfcHk0lhK0Jrcu4eQBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D&md5=b0277cc95d318d926b96e7a119066e3b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1126%2Fscience.aab1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aab1433%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%2BE.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DPaulk%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DDRUG%2520DEVELOPMENT.%2520Phthalimide%2520Conjugation%2520as%2520a%2520Strategy%2520for%2520in%2520Vivo%2520Target%2520Protein%2520Degradation%26jtitle%3DScience%26date%3D2015%26volume%3D348%26issue%3D6241%26spage%3D1376%26epage%3D1381%26doi%3D10.1126%2Fscience.aab1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">755</span><span class="NLM_x">â</span> <span class="NLM_lpage">763</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.chembiol.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=26051217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=755-763&issue=6&author=J.+Luauthor=Y.+Qianauthor=M.+Altieriauthor=H.+Dongauthor=J.+Wangauthor=K.+Rainaauthor=J.+Hinesauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=K.+Colemanauthor=C.+M.+Crews&title=Hijacking+the+E3+Ubiquitin+Ligase+Cereblon+to+Efficiently+Target+BRD4&doi=10.1016%2Fj.chembiol.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span></div><div class="casAuthors">Lu, Jing; Qian, Yimin; Altieri, Martha; Dong, Hanqing; Wang, Jing; Raina, Kanak; Hines, John; Winkler, James D.; Crew, Andrew P.; Coleman, Kevin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-763</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathol. settings, particularly cancer.  While BRD4 inhibitors have shown some promise in MYC-driven malignancies such as Burkitt's lymphoma (BL), we show that BRD4 inhibitors lead to robust BRD4 protein accumulation, which may account for their limited suppression of MYC expression, modest antiproliferative activity, and lack of apoptotic induction.  To address these limitations we designed ARV-825, a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degrdn. of BRD4 in all BL cell lines tested.  Consequently, ARV-825 more effectively suppresses c-MYC levels and downstream signaling than small-mol. BRD4 inhibitors, resulting in more effective cell proliferation inhibition and apoptosis induction in BL.  Our findings provide strong evidence that cereblon-based PROTACs provide a better and more efficient strategy in targeting BRD4 than traditional small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Ol4grCG2RbVg90H21EOLACvtfcHk0lhK0Jrcu4eQBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM&md5=a64675e7a0cd006a8737be9730f447e3</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHijacking%2520the%2520E3%2520Ubiquitin%2520Ligase%2520Cereblon%2520to%2520Efficiently%2520Target%2520BRD4%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26issue%3D6%26spage%3D755%26epage%3D763%26doi%3D10.1016%2Fj.chembiol.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1770</span><span class="NLM_x">â</span> <span class="NLM_lpage">1777</span><span class="refDoi">Â DOI: 10.1021/acschembio.5b00216</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00216" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1770-1777&issue=8&author=M.+Zengerleauthor=K.-H.+Chanauthor=A.+Ciulli&title=Selective+Small+Molecule+Induced+Degradation+of+the+BET+Bromodomain+Protein+BRD4&doi=10.1021%2Facschembio.5b00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span></div><div class="casAuthors">Zengerle, Michael; Chan, Kwok-Ho; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1770-1777</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Bromo- and Extra-Terminal (BET) proteins BRD2, BRD3, and BRD4 play important roles in transcriptional regulation, epigenetics, and cancer and are the targets of pan-BET selective bromodomain inhibitor JQ1.  However, the lack of intra-BET selectivity limits the scope of current inhibitors as probes for target validation and could lead to unwanted side effects or toxicity in a therapeutic setting.  We designed Proteolysis Targeted Chimeras (PROTACs) that tether JQ1 to a ligand for the E3 ubiquitin ligase VHL, aimed at triggering the intracellular destruction of BET proteins.  Compd. MZ1 potently and rapidly induces reversible, long-lasting, and unexpectedly selective removal of BRD4 over BRD2 and BRD3.  The activity of MZ1 is dependent on binding to VHL but is achieved at a sufficiently low concn. not to induce stabilization of HIF-1Î±.  Gene expression profiles of selected cancer-related genes responsive to JQ1 reveal distinct and more limited transcriptional responses induced by MZ1, consistent with selective suppression of BRD4.  Our discovery opens up new opportunities to elucidate the cellular phenotypes and therapeutic implications assocd. with selective targeting of BRD4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEmSv7p9MZOrVg90H21EOLACvtfcHk0lgdLOzei5JKWw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D&md5=b7514fd274eff8e4bb6a771f5aaf9ab5</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00216%26sid%3Dliteratum%253Aachs%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DK.-H.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSelective%2520Small%2520Molecule%2520Induced%2520Degradation%2520of%2520the%2520BET%2520Bromodomain%2520Protein%2520BRD4%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3D1770%26epage%3D1777%26doi%3D10.1021%2Facschembio.5b00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Toure, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Small Molecule PROTACs: New Approaches to Protein Degradation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1966</span><span class="NLM_x">â</span> <span class="NLM_lpage">1973</span><span class="refDoi">Â DOI: 10.1002/anie.201507978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1002%2Fanie.201507978" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=1966-1973&issue=6&author=M.+Toureauthor=C.+M.+Crews&title=Small+Molecule+PROTACs%3A+New+Approaches+to+Protein+Degradation&doi=10.1002%2Fanie.201507978"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507978%26sid%3Dliteratum%253Aachs%26aulast%3DToure%26aufirst%3DM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall%2520Molecule%2520PROTACs%253A%2520New%2520Approaches%2520to%2520Protein%2520Degradation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D6%26spage%3D1966%26epage%3D1973%26doi%3D10.1002%2Fanie.201507978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clague, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">UrbÃ©, S.</span><span> </span><span class="NLM_article-title">Breaking the Chains: Structure and Function of the Deubiquitinases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">550</span><span class="NLM_x">â</span> <span class="NLM_lpage">563</span><span class="refDoi">Â DOI: 10.1038/nrm2731</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrm2731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19626045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFSru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=550-563&issue=8&author=D.+Komanderauthor=M.+J.+Clagueauthor=S.+Urb%C3%A9&title=Breaking+the+Chains%3A+Structure+and+Function+of+the+Deubiquitinases&doi=10.1038%2Fnrm2731"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Breaking the chains: structure and function of the deubiquitinases</span></div><div class="casAuthors">Komander, David; Clague, Michael J.; Urbe, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">550-563</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ubiquitination is a reversible protein modification that is implicated in many cellular functions.  Recently, much progress has been made in the characterization of a superfamily of isopeptidases that remove ubiquitin: the deubiquitinases (DUBs; also known as deubiquitinating enzymes).  Far from being uniform in structure and function, these enzymes display a myriad of distinct mechanistic features.  The small no. (<100) of DUBs might at 1st suggest a low degree of selectivity; however, DUBs are subject to multiple layers of regulation that modulate both their activity and their specificity.  Due to their wide-ranging involvement in key regulatory processes, these enzymes might provide new therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Woj6hOAP5rVg90H21EOLACvtfcHk0lgdLOzei5JKWw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFSru74%253D&md5=9268e6c24101ff8137937a5c851d5bb8</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fnrm2731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2731%26sid%3Dliteratum%253Aachs%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DClague%26aufirst%3DM.%2BJ.%26aulast%3DUrb%25C3%25A9%26aufirst%3DS.%26atitle%3DBreaking%2520the%2520Chains%253A%2520Structure%2520and%2520Function%2520of%2520the%2520Deubiquitinases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2009%26volume%3D10%26issue%3D8%26spage%3D550%26epage%3D563%26doi%3D10.1038%2Fnrm2731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Nijman, S. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luna-Vargas, M. P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velds, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brummelkamp, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirac, A. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sixma, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">A Genomic and Functional Inventory of Deubiquitinating Enzymes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">773</span><span class="NLM_x">â</span> <span class="NLM_lpage">786</span><span class="refDoi">Â DOI: 10.1016/j.cell.2005.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.cell.2005.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16325574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWntLjP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2005&pages=773-786&issue=5&author=S.+M.+B.+Nijmanauthor=M.+P.+A.+Luna-Vargasauthor=A.+Veldsauthor=T.+R.+Brummelkampauthor=A.+M.+G.+Diracauthor=T.+K.+Sixmaauthor=R.+Bernards&title=A+Genomic+and+Functional+Inventory+of+Deubiquitinating+Enzymes&doi=10.1016%2Fj.cell.2005.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A genomic and functional inventory of deubiquitinating enzymes</span></div><div class="casAuthors">Nijman, Sebastian M. B.; Luna-Vargas, Mark P. A.; Velds, Arno; Brummelkamp, Thijn R.; Dirac, Annette M. G.; Sixma, Titia K.; Bernards, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-786</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Posttranslational modification of proteins by the small mol. ubiquitin is a key regulatory event, and the enzymes catalyzing these modifications have been the focus of many studies.  Deubiquitinating enzymes, which mediate the removal and processing of ubiquitin, may be functionally as important but are less well understood.  Here, we present an inventory of the deubiquitinating enzymes encoded in the human genome.  In addn., we review the literature concerning these enzymes, with particular emphasis on their function, specificity, and the regulation of their activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCJuLc26n4uLVg90H21EOLACvtfcHk0lgQychS4Luufw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWntLjP&md5=e2956e3fa40683da71e558265806d3d6</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DNijman%26aufirst%3DS.%2BM.%2BB.%26aulast%3DLuna-Vargas%26aufirst%3DM.%2BP.%2BA.%26aulast%3DVelds%26aufirst%3DA.%26aulast%3DBrummelkamp%26aufirst%3DT.%2BR.%26aulast%3DDirac%26aufirst%3DA.%2BM.%2BG.%26aulast%3DSixma%26aufirst%3DT.%2BK.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DA%2520Genomic%2520and%2520Functional%2520Inventory%2520of%2520Deubiquitinating%2520Enzymes%26jtitle%3DCell%26date%3D2005%26volume%3D123%26issue%3D5%26spage%3D773%26epage%3D786%26doi%3D10.1016%2Fj.cell.2005.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Abdul Rehman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristariyanto, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nkosi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidlich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labib, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulathu, Y.</span><span> </span><span class="NLM_article-title">MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">146</span><span class="NLM_x">â</span> <span class="NLM_lpage">155</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2016.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2016.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=27292798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2016&pages=146-155&issue=1&author=S.+A.+Abdul+Rehmanauthor=Y.+A.+Kristariyantoauthor=S.-Y.+Choiauthor=P.+J.+Nkosiauthor=S.+Weidlichauthor=K.+Labibauthor=K.+Hofmannauthor=Y.+Kulathu&title=MINDY-1+Is+a+Member+of+an+Evolutionarily+Conserved+and+Structurally+Distinct+New+Family+of+Deubiquitinating+Enzymes&doi=10.1016%2Fj.molcel.2016.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes</span></div><div class="casAuthors">Abdul Rehman, Syed Arif; Kristariyanto, Yosua Adi; Choi, Soo-Youn; Nkosi, Pedro, Jr.; Weidlich, Simone; Labib, Karim; Hofmann, Kay; Kulathu, Yogesh</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-155</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes (DUBs) remove ubiquitin (Ub) from Ub-conjugated substrates to regulate the functional outcome of ubiquitylation.  Here we report the discovery of a new family of DUBs, which we have named MINDY (motif interacting with Ub-contg. novel DUB family).  Found in all eukaryotes, MINDY-family DUBs are highly selective at cleaving K48-linked polyUb, a signal that targets proteins for degrdn.  We identify the catalytic activity to be encoded within a previously unannotated domain, the crystal structure of which reveals a distinct protein fold with no homol. to any of the known DUBs.  The crystal structure of MINDY-1 (also known as FAM63A) in complex with propargylated Ub reveals conformational changes that realign the active site for catalysis.  MINDY-1 prefers cleaving long polyUb chains and works by trimming chains from the distal end.  Collectively, our results reveal a new family of DUBs that may have specialized roles in regulating proteostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPJ1o32zd56LVg90H21EOLACvtfcHk0lgQychS4Luufw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWltL0%253D&md5=80c78d5cd1d2d70e0e2c71c7524f5798</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2016.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2016.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul%2BRehman%26aufirst%3DS.%2BA.%26aulast%3DKristariyanto%26aufirst%3DY.%2BA.%26aulast%3DChoi%26aufirst%3DS.-Y.%26aulast%3DNkosi%26aufirst%3DP.%2BJ.%26aulast%3DWeidlich%26aufirst%3DS.%26aulast%3DLabib%26aufirst%3DK.%26aulast%3DHofmann%26aufirst%3DK.%26aulast%3DKulathu%26aufirst%3DY.%26atitle%3DMINDY-1%2520Is%2520a%2520Member%2520of%2520an%2520Evolutionarily%2520Conserved%2520and%2520Structurally%2520Distinct%2520New%2520Family%2520of%2520Deubiquitinating%2520Enzymes%26jtitle%3DMol.%2520Cell%26date%3D2016%26volume%3D63%26issue%3D1%26spage%3D146%26epage%3D155%26doi%3D10.1016%2Fj.molcel.2016.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Amerik, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, M.</span><span> </span><span class="NLM_article-title">Mechanism and Function of Deubiquitinating Enzymes</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1695</span><span class="NLM_x"> (</span><span class="NLM_issue">1â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">189</span><span class="NLM_x">â</span> <span class="NLM_lpage">207</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2004.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbamcr.2004.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=15571815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1695&publication_year=2004&pages=189-207&issue=1%E2%80%933&author=A.+Y.+Amerikauthor=M.+Hochstrasser&title=Mechanism+and+Function+of+Deubiquitinating+Enzymes&doi=10.1016%2Fj.bbamcr.2004.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and function of deubiquitinating enzymes</span></div><div class="casAuthors">Amerik, Alexander Y.; Hochstrasser, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1695</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">189-207</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The attachment of ubiquitin (I) to proteins is a crucial step in many cellular regulatory mechanisms and contributes to numerous biol. processes, including embryonic development, the cell cycle, growth control, and prevention of neurodegeneration.  In these diverse regulatory settings, the most widespread mechanism of I action is probably in the context of protein degrdn.  Polyubiquitin attachment targets many intracellular proteins for degrdn. by the proteasome, and (mono)ubiquitination is often required for down-regulating plasma membrane proteins by targeting them to the vacuole (lysosome).  Ubiquitin-protein conjugates are highly dynamic structures.  Whereas an array of enzymes directs the conjugation of I to substrates, there are also dozens of deubiquitinating enzymes (DUBs) that can reverse the process.  Several lines of evidence indicate that DUBs are important regulators of the I system.  These enzymes are responsible for processing inactive I precursors, proofreading I-protein conjugates, removing I from cellular adducts, and keeping the 26S proteasome free of inhibitory I chains.  The present review focuses on recent discoveries that have led to a better understanding the mechanisms and physiol. roles of this diverse and still poorly understood group of enzymes.  The authors also discuss briefly some of the proteases that act on ubiquitin-like protein (UBL) conjugates and compare them to DUBs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4r5Q5j5cVbrVg90H21EOLACvtfcHk0litiFvWPEJBkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzF&md5=4be57f84af923c82da6b84c6da73a9d9</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2004.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2004.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DAmerik%26aufirst%3DA.%2BY.%26aulast%3DHochstrasser%26aufirst%3DM.%26atitle%3DMechanism%2520and%2520Function%2520of%2520Deubiquitinating%2520Enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2004%26volume%3D1695%26issue%3D1%25E2%2580%25933%26spage%3D189%26epage%3D207%26doi%3D10.1016%2Fj.bbamcr.2004.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Goldenberg, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattern, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, B.</span><span> </span><span class="NLM_article-title">Strategies for the Identification of Novel Inhibitors of Deubiquitinating Enzymes</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">828</span><span class="NLM_x">â</span> <span class="NLM_lpage">832</span><span class="refDoi">Â DOI: 10.1042/BST0360828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1042%2FBST0360828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=18793145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSrt77J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=828-832&issue=5&author=S.+J.+Goldenbergauthor=J.+L.+McDermottauthor=T.+R.+Buttauthor=M.+R.+Matternauthor=B.+Nicholson&title=Strategies+for+the+Identification+of+Novel+Inhibitors+of+Deubiquitinating+Enzymes&doi=10.1042%2FBST0360828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the identification of novel inhibitors of deubiquitinating enzymes</span></div><div class="casAuthors">Goldenberg, Seth J.; McDermott, Jeffrey L.; Butt, Tauseef R.; Mattern, Michael R.; Nicholson, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">828-832</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Dysregulation of the UPS (ubiquitin-proteasome system) has been implicated in a wide range of pathologies including cancer, neurodegeneration and viral infection.  Inhibiting the proteasome has been shown to be an effective therapeutic strategy in humans; yet toxicity with this target remains high.  DUBs (deubiquitinating enzymes) represent an alternative target in the UPS with low predicted toxicity.  Currently, there are no DUB inhibitors that have been used clin.  To address this situation, Progenra has developed a novel assay to measure the proteolytic cleavage of Ub (ubiquitin) or UBL (Ub-like protein) conjugates such as SUMO (small Ub-related modifier), NEDD8 (neural-precursor-cell-expressed, developmentally down-regulated 8) or ISG15 (interferon-stimulated gene 15) by isopeptidases.  In this review, current platforms for detecting DUB inhibitors are discussed and the advantages and disadvantages of the approaches are underlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0x67KYwgCbVg90H21EOLACvtfcHk0litiFvWPEJBkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrt77J&md5=b8ec5a0826d6b233130156418afc1b2e</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1042%2FBST0360828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0360828%26sid%3Dliteratum%253Aachs%26aulast%3DGoldenberg%26aufirst%3DS.%2BJ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BL.%26aulast%3DButt%26aufirst%3DT.%2BR.%26aulast%3DMattern%26aufirst%3DM.%2BR.%26aulast%3DNicholson%26aufirst%3DB.%26atitle%3DStrategies%2520for%2520the%2520Identification%2520of%2520Novel%2520Inhibitors%2520of%2520Deubiquitinating%2520Enzymes%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2008%26volume%3D36%26issue%3D5%26spage%3D828%26epage%3D832%26doi%3D10.1042%2FBST0360828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Ndubaku, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span> </span><span class="NLM_article-title">Inhibiting the Deubiquitinating Enzymes (DUBs)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1581</span><span class="NLM_x">â</span> <span class="NLM_lpage">1595</span><span class="refDoi">Â DOI: 10.1021/jm501061a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501061a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLrL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1581-1595&issue=4&author=C.+Ndubakuauthor=V.+Tsui&title=Inhibiting+the+Deubiquitinating+Enzymes+%28DUBs%29&doi=10.1021%2Fjm501061a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the Deubiquitinating Enzymes (DUBs)</span></div><div class="casAuthors">Ndubaku, Chudi; Tsui, Vickie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1581-1595</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The diverse roles of deubiquitinating enzymes, or DUBs, in detg. the fate of specific proteins continue to unfold.  Concurrent with the revelation of DUBs as potential therapeutic targets are publications of small mol. inhibitors of these enzymes.  In this review, we summarize these mols. and their assocd. data and suggest addnl. expts. to further validate and characterize these compds.  We believe the field of drug discovery against DUBs is still in its infancy, but advances in assay development, biophys. techniques, and screening libraries hold promise for identifying suitable agents that could advance into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsiPtPfBsxNrVg90H21EOLACvtfcHk0liK9jk0dId22Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLrL&md5=8ec54b033ba6fd8acb3187e4fc004296</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm501061a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501061a%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DTsui%26aufirst%3DV.%26atitle%3DInhibiting%2520the%2520Deubiquitinating%2520Enzymes%2520%2528DUBs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D4%26spage%3D1581%26epage%3D1595%26doi%3D10.1021%2Fjm501061a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Krutauz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakasone, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fushman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickman, M. H.</span><span> </span><span class="NLM_article-title">Extended Ubiquitin Species Are Protein-Based DUB Inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">664</span><span class="NLM_x">â</span> <span class="NLM_lpage">670</span><span class="refDoi">Â DOI: 10.1038/nchembio.1574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24997605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=664-670&issue=8&author=D.+Krutauzauthor=N.+Reisauthor=M.+A.+Nakasoneauthor=P.+Simanauthor=D.+Zhangauthor=D.+S.+Kirkpatrickauthor=S.+P.+Gygiauthor=A.+Brikauthor=D.+Fushmanauthor=M.+H.+Glickman&title=Extended+Ubiquitin+Species+Are+Protein-Based+DUB+Inhibitors&doi=10.1038%2Fnchembio.1574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Extended ubiquitin species are protein-based DUB inhibitors</span></div><div class="casAuthors">Krutauz, Daria; Reis, Noa; Nakasone, Mark A.; Siman, Peter; Zhang, Daoning; Kirkpatrick, Donald S.; Gygi, Steven P.; Brik, Ashraf; Fushman, David; Glickman, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">664-670</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A frameshift mutation in the transcript of the ubiquitin-B gene leads to a ubiquitin (Ub) protein extended by 19 residues at its C-terminus; this stable Ub variant is designated UBB+1 (for "+1" reading frame shift).  UBB+1 has been considered to inhibit proteasomes and as such to be the underlying cause for toxic protein buildup correlated with certain neuropathol. conditions.  We demonstrate that expression of extended Ub variants leads to accumulation of heterogeneously linked polyubiquitin conjugates, indicating a pervasive effect on Ub-dependent turnover.  20S proteasomes selectively proteolyzed Ub extensions, yet no evidence for inhibition of 26S holoenzymes was found.  However, among susceptible targets for inhibition was Ubp6, the primary enzyme responsible for disassembly of Lys48 linkages at 26S proteasomes.  Processing of Lys48 and Lys63 linkages by other deubiquitinating enzymes (DUBs) was also inhibited.  Disruption of Ub-dependent degrdn. by extended Ub variants may therefore be attributed to their inhibitory effect on select DUBs, thus shifting research efforts related to protein accumulation in neurodegenerative processes from proteasomes to DUBs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJYMvK4ehKSbVg90H21EOLACvtfcHk0liK9jk0dId22Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrJ&md5=b9ea4f2571c6753f3fe4eeaae0053c4c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1574%26sid%3Dliteratum%253Aachs%26aulast%3DKrutauz%26aufirst%3DD.%26aulast%3DReis%26aufirst%3DN.%26aulast%3DNakasone%26aufirst%3DM.%2BA.%26aulast%3DSiman%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DBrik%26aufirst%3DA.%26aulast%3DFushman%26aufirst%3DD.%26aulast%3DGlickman%26aufirst%3DM.%2BH.%26atitle%3DExtended%2520Ubiquitin%2520Species%2520Are%2520Protein-Based%2520DUB%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D8%26spage%3D664%26epage%3D670%26doi%3D10.1038%2Fnchembio.1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Mullally, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moos, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, F. A.</span><span> </span><span class="NLM_article-title">Cyclopentenone Prostaglandins of the J Series Inhibit the Ubiquitin Isopeptidase Activity of the Proteasome Pathway</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">32</span><span class="NLM_x">) </span> <span class="NLM_fpage">30366</span><span class="NLM_x">â</span> <span class="NLM_lpage">30373</span><span class="refDoi">Â DOI: 10.1074/jbc.M102198200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1074%2Fjbc.M102198200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=30366-30373&issue=32&author=J.+E.+Mullallyauthor=P.+J.+Moosauthor=K.+Edesauthor=F.+A.+Fitzpatrick&title=Cyclopentenone+Prostaglandins+of+the+J+Series+Inhibit+the+Ubiquitin+Isopeptidase+Activity+of+the+Proteasome+Pathway&doi=10.1074%2Fjbc.M102198200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M102198200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M102198200%26sid%3Dliteratum%253Aachs%26aulast%3DMullally%26aufirst%3DJ.%2BE.%26aulast%3DMoos%26aufirst%3DP.%2BJ.%26aulast%3DEdes%26aufirst%3DK.%26aulast%3DFitzpatrick%26aufirst%3DF.%2BA.%26atitle%3DCyclopentenone%2520Prostaglandins%2520of%2520the%2520J%2520Series%2520Inhibit%2520the%2520Ubiquitin%2520Isopeptidase%2520Activity%2520of%2520the%2520Proteasome%2520Pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D32%26spage%3D30366%26epage%3D30373%26doi%3D10.1074%2Fjbc.M102198200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">DâArcy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linder, S.</span><span> </span><span class="NLM_article-title">Deubiquitinase Inhibition as a Cancer Therapeutic Strategy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">â</span> <span class="NLM_lpage">54</span><span class="refDoi">Â DOI: 10.1016/j.pharmthera.2014.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.pharmthera.2014.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25444757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSmtLvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2015&pages=32-54&author=P.+D%E2%80%99Arcyauthor=X.+Wangauthor=S.+Linder&title=Deubiquitinase+Inhibition+as+a+Cancer+Therapeutic+Strategy&doi=10.1016%2Fj.pharmthera.2014.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Deubiquitinase inhibition as a cancer therapeutic strategy</span></div><div class="casAuthors">D'Arcy, Padraig; Wang, Xin; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-54</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The ubiquitin proteasome system (UPS) is the main system for controlled protein degrdn. and a key regulator of fundamental cellular processes.  The dependency of cancer cells on a functioning UPS has made this an attractive target for development of drugs that show selectivity for tumor cells.  Deubiquitinases (DUBs, ubiquitin isopeptidases) are components of the UPS that catalyze the removal of ubiquitin moieties from target proteins or polyubiquitin chains, resulting in altered signaling or changes in protein stability.  A no. of DUBs regulate processes assocd. with cell proliferation and apoptosis, and as such represent candidate targets for cancer therapeutics.  The majority of DUBs are cysteine proteases and are likely to be more "druggable" than E3 ligases.  Cysteine residues in the active sites of DUBs are expected to be reactive to various electrophiles.  Various compds. contg. Î±,Î²-unsatd. ketones have indeed been demonstrated to inhibit cellular DUB activity.  Inhibition of proteasomal cysteine DUB enzymes (i.e.  USP14 and UCHL5) can be predicted to be particularly cytotoxic to cancer cells as it leads to blocking of proteasome function and accumulation of proteasomal substrates.  We here provide an overall review of DUBs relevant to cancer and of various small mols. which have been demonstrated to inhibit DUB activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo83foTkFPMX7Vg90H21EOLACvtfcHk0lhJ4rubWSm1Ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSmtLvO&md5=0d916afe785eb52e76d1d3a1e5628e3b</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DDeubiquitinase%2520Inhibition%2520as%2520a%2520Cancer%2520Therapeutic%2520Strategy%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D147%26spage%3D32%26epage%3D54%26doi%3D10.1016%2Fj.pharmthera.2014.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melandri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valbrun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueiredo-Pereira, M. E.</span><span> </span><span class="NLM_article-title">Delta12-Prostaglandin J2 Inhibits the Ubiquitin Hydrolase UCH-L1 and Elicits Ubiquitin-Protein Aggregation Without Proteasome Inhibition</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1171</span><span class="NLM_x">â</span> <span class="NLM_lpage">1180</span><span class="refDoi">Â DOI: 10.1016/j.bbrc.2004.05.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.bbrc.2004.05.098" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2004&pages=1171-1180&issue=4&author=Z.+Liauthor=F.+Melandriauthor=I.+Berdoauthor=M.+Jansenauthor=L.+Hunterauthor=S.+Wrightauthor=D.+Valbrunauthor=M.+E.+Figueiredo-Pereira&title=Delta12-Prostaglandin+J2+Inhibits+the+Ubiquitin+Hydrolase+UCH-L1+and+Elicits+Ubiquitin-Protein+Aggregation+Without+Proteasome+Inhibition&doi=10.1016%2Fj.bbrc.2004.05.098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.05.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.05.098%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMelandri%26aufirst%3DF.%26aulast%3DBerdo%26aufirst%3DI.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DHunter%26aufirst%3DL.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DValbrun%26aufirst%3DD.%26aulast%3DFigueiredo-Pereira%26aufirst%3DM.%2BE.%26atitle%3DDelta12-Prostaglandin%2520J2%2520Inhibits%2520the%2520Ubiquitin%2520Hydrolase%2520UCH-L1%2520and%2520Elicits%2520Ubiquitin-Protein%2520Aggregation%2520Without%2520Proteasome%2520Inhibition%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D319%26issue%3D4%26spage%3D1171%26epage%3D1180%26doi%3D10.1016%2Fj.bbrc.2004.05.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Targeting Proteases: Successes, Failures and Future Prospects</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">785</span><span class="NLM_x">â</span> <span class="NLM_lpage">799</span><span class="refDoi">Â DOI: 10.1038/nrd2092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnrd2092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=16955069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=785-799&issue=9&author=B.+Turk&title=Targeting+Proteases%3A+Successes%2C+Failures+and+Future+Prospects&doi=10.1038%2Fnrd2092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting proteases: successes, failures and future prospects</span></div><div class="casAuthors">Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">785-799</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Until fairly recently, proteases were considered primarily to be protein-degrading enzymes.  However, this view has dramatically changed and proteases are now seen as extremely important signalling mols. that are involved in numerous vital processes.  Protease signalling pathways are strictly regulated, and the dysregulation of protease activity can lead to pathologies such as cardiovascular and inflammatory diseases, cancer, osteoporosis and neurol. disorders.  Several small-mol. drugs targeting proteases are already on the market and many more are in development.  The status of human protease research and prospects for future protease-targeted drugs are reviewed here, with ref. to some key examples where protease drugs have succeeded or failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_X9u2oqlzrVg90H21EOLACvtfcHk0lhJ4rubWSm1Ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltrs%253D&md5=00111ddbeafb283cbe88f7b0ee7bb404</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fnrd2092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2092%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DTargeting%2520Proteases%253A%2520Successes%252C%2520Failures%2520and%2520Future%2520Prospects%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26issue%3D9%26spage%3D785%26epage%3D799%26doi%3D10.1038%2Fnrd2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Colland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formstecher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacq, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reverdy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planquette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trouplin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aushev, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camonis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg-Capra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rain, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guedat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delansorne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daviet, L.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitor of USP7/HAUSP Ubiquitin Protease Stabilizes and Activates P53 in Cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2286</span><span class="NLM_x">â</span> <span class="NLM_lpage">2295</span><span class="refDoi">Â DOI: 10.1158/1535-7163.MCT-09-0097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F1535-7163.MCT-09-0097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=19671755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFCmsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2286-2295&issue=8&author=F.+Collandauthor=E.+Formstecherauthor=X.+Jacqauthor=C.+Reverdyauthor=C.+Planquetteauthor=S.+Conrathauthor=V.+Trouplinauthor=J.+Bianchiauthor=V.+N.+Aushevauthor=J.+Camonisauthor=A.+Calabreseauthor=C.+Borg-Capraauthor=W.+Sipplauthor=V.+Colluraauthor=G.+Boissyauthor=J.-C.+Rainauthor=P.+Guedatauthor=R.+Delansorneauthor=L.+Daviet&title=Small-Molecule+Inhibitor+of+USP7%2FHAUSP+Ubiquitin+Protease+Stabilizes+and+Activates+P53+in+Cells&doi=10.1158%2F1535-7163.MCT-09-0097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells</span></div><div class="casAuthors">Colland, Frederic; Formstecher, Etienne; Jacq, Xavier; Reverdy, Celine; Planquette, Cecile; Conrath, Susan; Trouplin, Virginie; Bianchi, Julie; Aushev, Vasily N.; Camonis, Jacques; Calabrese, Alessandra; Borg-Capra, Catherine; Sippl, Wolfgang; Collura, Vincent; Boissy, Guillaume; Rain, Jean-Christophe; Guedat, Philippe; Delansorne, Remi; Daviet, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2286-2295</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Deregulation of the ubiquitin/proteasome system has been implicated in the pathogenesis of many human diseases, including cancer.  Ubiquitin-specific proteases (USP) are cysteine proteases involved in the deubiquitination of protein substrates.  Functional connections between USP7 and essential viral proteins and oncogenic pathways, such as the p53/Mdm2 and phosphatidylinositol 3-kinase/protein kinase B networks, strongly suggest that the targeting of USP7 with small-mol. inhibitors may be useful for the treatment of cancers and viral diseases.  Using high-throughput screening, we have discovered HBX 41,108, a small-mol. compd. that inhibits USP7 deubiquitinating activity with an IC50 in the submicromolar range.  Kinetics data indicate an uncompetitive reversible inhibition mechanism.  HBX 41,108 was shown to affect USP7-mediated p53 deubiquitination in vitro and in cells.  As RNA interference-mediated USP7 silencing in cancer cells, HBX 41,108 treatment stabilized p53, activated the transcription of a p53 target gene without inducing genotoxic stress, and inhibited cancer cell growth.  Finally, HBX 41,108 induced p53-dependent apoptosis as shown in p53 wild-type and null isogenic cancer cell lines.  We thus report the identification of the first lead-like inhibitor against USP7, providing a structural basis for the development of new anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN5f2O-cNWmbVg90H21EOLACvtfcHk0lhY3VtPdx1D2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFCmsrw%253D&md5=bb84e2bd3cf54d0a6842b39e2784eea9</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0097%26sid%3Dliteratum%253Aachs%26aulast%3DColland%26aufirst%3DF.%26aulast%3DFormstecher%26aufirst%3DE.%26aulast%3DJacq%26aufirst%3DX.%26aulast%3DReverdy%26aufirst%3DC.%26aulast%3DPlanquette%26aufirst%3DC.%26aulast%3DConrath%26aufirst%3DS.%26aulast%3DTrouplin%26aufirst%3DV.%26aulast%3DBianchi%26aufirst%3DJ.%26aulast%3DAushev%26aufirst%3DV.%2BN.%26aulast%3DCamonis%26aufirst%3DJ.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DBorg-Capra%26aufirst%3DC.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DCollura%26aufirst%3DV.%26aulast%3DBoissy%26aufirst%3DG.%26aulast%3DRain%26aufirst%3DJ.-C.%26aulast%3DGuedat%26aufirst%3DP.%26aulast%3DDelansorne%26aufirst%3DR.%26aulast%3DDaviet%26aufirst%3DL.%26atitle%3DSmall-Molecule%2520Inhibitor%2520of%2520USP7%252FHAUSP%2520Ubiquitin%2520Protease%2520Stabilizes%2520and%2520Activates%2520P53%2520in%2520Cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D8%26spage%3D2286%26epage%3D2295%26doi%3D10.1158%2F1535-7163.MCT-09-0097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Song, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carracedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo-Coco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teruya-Feldstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">The Deubiquitinylation and Localization of PTEN Are Regulated by a HAUSP-PML Network</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x"> (</span><span class="NLM_issue">7214</span><span class="NLM_x">) </span> <span class="NLM_fpage">813</span><span class="NLM_x">â</span> <span class="NLM_lpage">817</span><span class="refDoi">Â DOI: 10.1038/nature07290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnature07290" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=813-817&issue=7214&author=M.+S.+Songauthor=L.+Salmenaauthor=A.+Carracedoauthor=A.+Egiaauthor=F.+Lo-Cocoauthor=J.+Teruya-Feldsteinauthor=P.+P.+Pandolfi&title=The+Deubiquitinylation+and+Localization+of+PTEN+Are+Regulated+by+a+HAUSP-PML+Network&doi=10.1038%2Fnature07290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1038%2Fnature07290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07290%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DM.%2BS.%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DCarracedo%26aufirst%3DA.%26aulast%3DEgia%26aufirst%3DA.%26aulast%3DLo-Coco%26aufirst%3DF.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DThe%2520Deubiquitinylation%2520and%2520Localization%2520of%2520PTEN%2520Are%2520Regulated%2520by%2520a%2520HAUSP-PML%2520Network%26jtitle%3DNature%26date%3D2008%26volume%3D455%26issue%3D7214%26spage%3D813%26epage%3D817%26doi%3D10.1038%2Fnature07290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Becker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchenko, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, U. M.</span><span> </span><span class="NLM_article-title">A Role of HAUSP in Tumor Suppression in a Human Colon Carcinoma Xenograft Model</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1205</span><span class="NLM_x">â</span> <span class="NLM_lpage">1213</span><span class="refDoi">Â DOI: 10.4161/cc.7.9.5756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.4161%2Fcc.7.9.5756" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1205-1213&issue=9&author=K.+Beckerauthor=N.+D.+Marchenkoauthor=G.+Palaciosauthor=U.+M.+Moll&title=A+Role+of+HAUSP+in+Tumor+Suppression+in+a+Human+Colon+Carcinoma+Xenograft+Model&doi=10.4161%2Fcc.7.9.5756"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.4161%2Fcc.7.9.5756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.7.9.5756%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DMarchenko%26aufirst%3DN.%2BD.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DMoll%26aufirst%3DU.%2BM.%26atitle%3DA%2520Role%2520of%2520HAUSP%2520in%2520Tumor%2520Suppression%2520in%2520a%2520Human%2520Colon%2520Carcinoma%2520Xenograft%2520Model%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26issue%3D9%26spage%3D1205%26epage%3D1213%26doi%3D10.4161%2Fcc.7.9.5756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Dang, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melandri, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. L.</span><span> </span><span class="NLM_article-title">Kinetic and Mechanistic Studies on the Hydrolysis of Ubiquitin C-Terminal 7-Amido-4-Methylcoumarin by Deubiquitinating Enzymes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1868</span><span class="NLM_x">â</span> <span class="NLM_lpage">1879</span><span class="refDoi">Â DOI: 10.1021/bi9723360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9723360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaK1cXms1OjsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=1868-1879&issue=7&author=L.+C.+Dangauthor=F.+D.+Melandriauthor=R.+L.+Stein&title=Kinetic+and+Mechanistic+Studies+on+the+Hydrolysis+of+Ubiquitin+C-Terminal+7-Amido-4-Methylcoumarin+by+Deubiquitinating+Enzymes&doi=10.1021%2Fbi9723360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and Mechanistic Studies on the Hydrolysis of Ubiquitin C-Terminal 7-Amido-4-Methylcoumarin by Deubiquitinating Enzymes</span></div><div class="casAuthors">Dang, Luan C.; Melandri, Francesco D.; Stein, Ross L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1868-1879</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes constitute a family of cysteine hydrolases that specifically cleave ubiquitin-derived substrates of general structure Ub-X, where X can be any no. of leaving groups ranging from small thiols and amines to Ub and other proteins (Ub, ubiquitin).  We have developed a general assay for deubiquitinating enzymes based on the substrate ubiquitin C-terminal 7-amido-4-methylcoumarin (Ub-AMC).  Ub-AMC is efficiently hydrolyzed with liberation of highly fluorescent AMC by two rabbit reticulocyte deubiquitinating enzymes: isopeptidase T (IPaseT), a member of the gene family of ubiquitin-specific processing enzymes, and UCH-L3, a member of the family of ubiquitin C-terminal hydrolases.  We used this new assay to probe kinetic and mechanistic aspects of catalysis by IPaseT and UCH-L3.  Results from four series of expts. are discussed: (1) For UCH-L3, we detd. steady-state kinetic parameters that suggest a diffusion-limited reaction of UCH-L3 with Ub-AMC.  To probe this, we detd. the viscosity dependence of kc/Km, as well as kc.  We found complex viscosity dependencies and interpreted these in the context of a model in which assocn. and acylation are viscosity-dependent but deacylation is viscosity-independent.  (2) The kinetics of inhibition of UCH-L3 by ubiquitin C-terminal aldehyde (Ub-H) were detd. and reveal a Ki that is less than 10-14 M.  Several mechanisms are considered to account for the extreme inhibition.  (3) The IPaseT-catalyzed hydrolysis of Ub-AMC is modulated by Ub with activation at low [Ub] and inhibition at high [Ub].  (4) Finally, we compare kc/Km values for deubiquitinating enzyme-catalyzed hydrolysis of Ub-AMC and Z-Leu-Arg-Gly-Gly-AMC.  For IPaseT, the ratio of rate consts. is 104, while for UCH-L3 this ratio is >107.  These results suggest the following: (i) Deubiquitinating enzymes are able to utilize the free energy that is released from remote interactions with Ub-contg. substrates for stabilization of catalytic transition states, and (ii) UCHs are more efficient at utilizing the energy from these interactions, presumably because they do not possess a binding domain for a Ub "leaving group".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOpMDRjOWV2LVg90H21EOLACvtfcHk0ljA2KWpI2BO2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1OjsA%253D%253D&md5=078fe0b916c22ef4ea7d4fc77aca75c1</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fbi9723360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9723360%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%2BC.%26aulast%3DMelandri%26aufirst%3DF.%2BD.%26aulast%3DStein%26aufirst%3DR.%2BL.%26atitle%3DKinetic%2520and%2520Mechanistic%2520Studies%2520on%2520the%2520Hydrolysis%2520of%2520Ubiquitin%2520C-Terminal%25207-Amido-4-Methylcoumarin%2520by%2520Deubiquitinating%2520Enzymes%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D7%26spage%3D1868%26epage%3D1879%26doi%3D10.1021%2Fbi9723360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Pal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donato, N. J.</span><span> </span><span class="NLM_article-title">Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4955</span><span class="NLM_x">â</span> <span class="NLM_lpage">4966</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-14-1211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F0008-5472.CAN-14-1211" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=4955-4966&issue=18&author=A.+Palauthor=M.+A.+Youngauthor=N.+J.+Donato&title=Emerging+Potential+of+Therapeutic+Targeting+of+Ubiquitin-Specific+Proteases+in+the+Treatment+of+Cancer&doi=10.1158%2F0008-5472.CAN-14-1211"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1211%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DM.%2BA.%26aulast%3DDonato%26aufirst%3DN.%2BJ.%26atitle%3DEmerging%2520Potential%2520of%2520Therapeutic%2520Targeting%2520of%2520Ubiquitin-Specific%2520Proteases%2520in%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26issue%3D18%26spage%3D4955%26epage%3D4966%26doi%3D10.1158%2F0008-5472.CAN-14-1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Huang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nijman, S. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirchandani, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galardy, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploegh, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâAndrea, A. D.</span><span> </span><span class="NLM_article-title">Regulation of Monoubiquitinated PCNA by DUB Autocleavage</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">â</span> <span class="NLM_lpage">347</span><span class="refDoi">Â DOI: 10.1038/ncb1378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fncb1378" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=341-347&issue=4&author=T.+T.+Huangauthor=S.+M.+B.+Nijmanauthor=K.+D.+Mirchandaniauthor=P.+J.+Galardyauthor=M.+A.+Cohnauthor=W.+Haasauthor=S.+P.+Gygiauthor=H.+L.+Ploeghauthor=R.+Bernardsauthor=A.+D.+D%E2%80%99Andrea&title=Regulation+of+Monoubiquitinated+PCNA+by+DUB+Autocleavage&doi=10.1038%2Fncb1378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1038%2Fncb1378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1378%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DNijman%26aufirst%3DS.%2BM.%2BB.%26aulast%3DMirchandani%26aufirst%3DK.%2BD.%26aulast%3DGalardy%26aufirst%3DP.%2BJ.%26aulast%3DCohn%26aufirst%3DM.%2BA.%26aulast%3DHaas%26aufirst%3DW.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DBernards%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26atitle%3DRegulation%2520of%2520Monoubiquitinated%2520PCNA%2520by%2520DUB%2520Autocleavage%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2006%26volume%3D8%26issue%3D4%26spage%3D341%26epage%3D347%26doi%3D10.1038%2Fncb1378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Nijman, S. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirac, A. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brummelkamp, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkhoven, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DâAndrea, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">331</span><span class="NLM_x">â</span> <span class="NLM_lpage">339</span><span class="refDoi">Â DOI: 10.1016/j.molcel.2005.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.molcel.2005.01.008" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=331-339&issue=3&author=S.+M.+B.+Nijmanauthor=T.+T.+Huangauthor=A.+M.+G.+Diracauthor=T.+R.+Brummelkampauthor=R.+M.+Kerkhovenauthor=A.+D.+D%E2%80%99Andreaauthor=R.+Bernards&title=The+Deubiquitinating+Enzyme+USP1+Regulates+the+Fanconi+Anemia+Pathway&doi=10.1016%2Fj.molcel.2005.01.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DNijman%26aufirst%3DS.%2BM.%2BB.%26aulast%3DHuang%26aufirst%3DT.%2BT.%26aulast%3DDirac%26aufirst%3DA.%2BM.%2BG.%26aulast%3DBrummelkamp%26aufirst%3DT.%2BR.%26aulast%3DKerkhoven%26aufirst%3DR.%2BM.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DThe%2520Deubiquitinating%2520Enzyme%2520USP1%2520Regulates%2520the%2520Fanconi%2520Anemia%2520Pathway%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D17%26issue%3D3%26spage%3D331%26epage%3D339%26doi%3D10.1016%2Fj.molcel.2005.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexheimer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamil, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z.</span><span> </span><span class="NLM_article-title">Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-Small Cell Lung Cancer Cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1390</span><span class="NLM_x">â</span> <span class="NLM_lpage">1400</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2011.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.chembiol.2011.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=22118673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeqs7nO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1390-1400&issue=11&author=J.+Chenauthor=T.+S.+Dexheimerauthor=Y.+Aiauthor=Q.+Liangauthor=M.+A.+Villamilauthor=J.+Ingleseauthor=D.+J.+Maloneyauthor=A.+Jadhavauthor=A.+Simeonovauthor=Z.+Zhuang&title=Selective+and+Cell-Active+Inhibitors+of+the+USP1%2F+UAF1+Deubiquitinase+Complex+Reverse+Cisplatin+Resistance+in+Non-Small+Cell+Lung+Cancer+Cells&doi=10.1016%2Fj.chembiol.2011.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells</span></div><div class="casAuthors">Chen, Junjun; Dexheimer, Thomas S.; Ai, Yongxing; Liang, Qin; Villamil, Mark A.; Inglese, James; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton; Zhuang, Zhihao</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1390-1400</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Ubiquitin-specific proteases (USPs) have in recent years emerged as a promising therapeutic target class.  We identified selective small-mol. inhibitors against a deubiquitinase complex, the human USP1/UAF1, through quant. high throughput screening (qHTS) of a collection of bioactive mols.  The top inhibitors, pimozide and GW7647, inhibited USP1/UAF1 noncompetitively with a K i of 0.5 and 0.7 Î¼M, resp., and displayed selectivity against a no. of deubiquitinases, deSUMOylase, and cysteine proteases.  The USP1/UAF1 inhibitors act synergistically with cisplatin in inhibiting cisplatin-resistant non-small cell lung cancer (NSCLC) cell proliferation.  USP1/UAF1 represents a promising target for drug intervention because of its involvement in translesion synthesis and Fanconi anemia pathway important for normal DNA damage response.  Our results support USP1/UAF1 as a potential therapeutic target and provide an example of targeting the USP/WD40 repeat protein complex for inhibitor discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroZXpbpHBJmbVg90H21EOLACvtfcHk0ljtqSGAjRf_ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeqs7nO&md5=301cd5d56de1548464c8372a0e4ad4ba</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DVillamil%26aufirst%3DM.%2BA.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DZhuang%26aufirst%3DZ.%26atitle%3DSelective%2520and%2520Cell-Active%2520Inhibitors%2520of%2520the%2520USP1%252F%2520UAF1%2520Deubiquitinase%2520Complex%2520Reverse%2520Cisplatin%2520Resistance%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Cells%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26issue%3D11%26spage%3D1390%26epage%3D1400%26doi%3D10.1016%2Fj.chembiol.2011.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eidhoff, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulber, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodendorf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorthiois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martoglio, B.</span><span> </span><span class="NLM_article-title">A Sensitive Fluorescence Intensity Assay for Deubiquitinating Proteases Using Ubiquitin-Rhodamine110-Glycine as Substrate</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">201</span><span class="NLM_x">â</span> <span class="NLM_lpage">207</span><span class="refDoi">Â DOI: 10.1016/j.ab.2007.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1016%2Fj.ab.2007.07.034" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2007&pages=201-207&issue=2&author=U.+Hassiepenauthor=U.+Eidhoffauthor=G.+Mederauthor=J.-F.+Bulberauthor=A.+Heinauthor=U.+Bodendorfauthor=E.+Lorthioisauthor=B.+Martoglio&title=A+Sensitive+Fluorescence+Intensity+Assay+for+Deubiquitinating+Proteases+Using+Ubiquitin-Rhodamine110-Glycine+as+Substrate&doi=10.1016%2Fj.ab.2007.07.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2007.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2007.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DEidhoff%26aufirst%3DU.%26aulast%3DMeder%26aufirst%3DG.%26aulast%3DBulber%26aufirst%3DJ.-F.%26aulast%3DHein%26aufirst%3DA.%26aulast%3DBodendorf%26aufirst%3DU.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DMartoglio%26aufirst%3DB.%26atitle%3DA%2520Sensitive%2520Fluorescence%2520Intensity%2520Assay%2520for%2520Deubiquitinating%2520Proteases%2520Using%2520Ubiquitin-Rhodamine110-Glycine%2520as%2520Substrate%26jtitle%3DAnal.%2520Biochem.%26date%3D2007%26volume%3D371%26issue%3D2%26spage%3D201%26epage%3D207%26doi%3D10.1016%2Fj.ab.2007.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Kelman, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peresie, H. J.</span><span> </span><span class="NLM_article-title">Mode of DNA Binding of Cis-Platinum(II) Antitumor Drugs: a Base Sequence-Dependent Mechanism Is Proposed</span> <span class="citation_source-journal">Cancer Treat. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">9â10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1445</span><span class="NLM_x">â</span> <span class="NLM_lpage">1452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=387222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADyaL3cXhsV2kuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=1445-1452&issue=9%E2%80%9310&author=A.+D.+Kelmanauthor=H.+J.+Peresie&title=Mode+of+DNA+Binding+of+Cis-Platinum%28II%29+Antitumor+Drugs%3A+a+Base+Sequence-Dependent+Mechanism+Is+Proposed"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Mode of DNA binding of cis-platinum(II) antitumor drugs:  a base sequence-dependent mechanism is proposed</span></div><div class="casAuthors">Kelman, Asher D.; Peresie, Henry J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reports</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">1445-52</span>CODEN:
                <span class="NLM_cas:coden">CTRRDO</span>;
        ISSN:<span class="NLM_cas:issn">0361-5960</span>.
    </div><div class="casAbstract">A review with 27 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogo75t1B-UorVg90H21EOLACvtfcHk0ljtqSGAjRf_ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhsV2kuw%253D%253D&md5=456298ecec8416718c41b83b31af2888</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelman%26aufirst%3DA.%2BD.%26aulast%3DPeresie%26aufirst%3DH.%2BJ.%26atitle%3DMode%2520of%2520DNA%2520Binding%2520of%2520Cis-Platinum%2528II%2529%2520Antitumor%2520Drugs%253A%2520a%2520Base%2520Sequence-Dependent%2520Mechanism%2520Is%2520Proposed%26jtitle%3DCancer%2520Treat.%2520Rep.%26date%3D1979%26volume%3D63%26issue%3D9%25E2%2580%259310%26spage%3D1445%26epage%3D1452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Siddik, Z. H.</span><span> </span><span class="NLM_article-title">Cisplatin: Mode of Cytotoxic Action and Molecular Basis of Resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">47</span><span class="NLM_x">) </span> <span class="NLM_fpage">7265</span><span class="NLM_x">â</span> <span class="NLM_lpage">7279</span><span class="refDoi">Â DOI: 10.1038/sj.onc.1206933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fsj.onc.1206933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=14576837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotlajtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7265-7279&issue=47&author=Z.+H.+Siddik&title=Cisplatin%3A+Mode+of+Cytotoxic+Action+and+Molecular+Basis+of+Resistance&doi=10.1038%2Fsj.onc.1206933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Cisplatin: mode of cytotoxic action and molecular basis of resistance</span></div><div class="casAuthors">Siddik, Zahid H.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">7265-7279</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cisplatin is one of the most potent antitumor agents known, displaying clin. activity against a wide variety of solid tumors.  Its cytotoxic mode of action is mediated by its interaction with DNA to form DNA adducts, primarily intrastrand crosslink adducts, which activate several signal transduction pathways, including those involving ATR, p53, p73, and MAPK, and culminate in the activation of apoptosis.  DNA damage-mediated apoptotic signals, however, can be attenuated, and the resistance that ensues is a major limitation of cisplatin-based chemotherapy.  The mechanisms responsible for cisplatin resistance are several, and contribute to the multifactorial nature of the problem.  Resistance mechanisms that limit the extent of DNA damage include reduced drug uptake, increased drug inactivation, and increased DNA adduct repair.  Origins of these pharmacol.-based mechanisms, however, are at the mol. level.  Mechanisms that inhibit propagation of the DNA damage signal to the apoptotic machinery include loss of damage recognition, overexpression of HER-2/neu, activation of the PI3-K/Akt (also known as PI3-K/PKB) pathway, loss of p53 function, overexpression of antiapoptotic bcl-2, and interference in caspase activation.  The mol. signature defining the resistant phenotype varies between tumors, and the no. of resistance mechanisms activated in response to selection pressures dictates the overall extent of cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3k2Fki_ax2rVg90H21EOLACvtfcHk0ljtqSGAjRf_ag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotlajtbY%253D&md5=8520a82f029717c4352d23e4bd7166fe</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206933%26sid%3Dliteratum%253Aachs%26aulast%3DSiddik%26aufirst%3DZ.%2BH.%26atitle%3DCisplatin%253A%2520Mode%2520of%2520Cytotoxic%2520Action%2520and%2520Molecular%2520Basis%2520of%2520Resistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26issue%3D47%26spage%3D7265%26epage%3D7279%26doi%3D10.1038%2Fsj.onc.1206933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senovilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castedo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Molecular Mechanisms of Cisplatin Resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1869</span><span class="NLM_x">â</span> <span class="NLM_lpage">1883</span><span class="refDoi">Â DOI: 10.1038/onc.2011.384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fonc.2011.384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=21892204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWrsr7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=1869-1883&issue=15&author=L.+Galluzziauthor=L.+Senovillaauthor=I.+Vitaleauthor=J.+Michelsauthor=I.+Martinsauthor=O.+Keppauthor=M.+Castedoauthor=G.+Kroemer&title=Molecular+Mechanisms+of+Cisplatin+Resistance&doi=10.1038%2Fonc.2011.384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cisplatin resistance</span></div><div class="casAuthors">Galluzzi, L.; Senovilla, L.; Vitale, I.; Michels, J.; Martins, I.; Kepp, O.; Castedo, M.; Kroemer, G.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1869-1883</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Platinum-based drugs, and in particular cis-diamminedichloroplatinum(II) (best known as cisplatin), are employed for the treatment of a wide array of solid malignancies, including testicular, ovarian, head and neck, colorectal, bladder and lung cancers.  Cisplatin exerts anticancer effects via multiple mechanisms, yet its most prominent (and best understood) mode of action involves the generation of DNA lesions followed by the activation of the DNA damage response and the induction of mitochondrial apoptosis.  Despite a consistent rate of initial responses, cisplatin treatment often results in the development of chemoresistance, leading to therapeutic failure.  An intense research has been conducted during the past 30 years and several mechanisms that account for the cisplatin-resistant phenotype of tumor cells have been described.  Here, we provide a systematic discussion of these mechanism by classifying them in alterations (1) that involve steps preceding the binding of cisplatin to DNA (pre-target resistance), (2) that directly relate to DNA-cisplatin adducts (on-target resistance), (3) concerning the lethal signaling pathway(s) elicited by cisplatin-mediated DNA damage (post-target resistance) and (4) affecting mol. circuitries that do not present obvious links with cisplatin-elicited signals (off-target resistance).  As in some clin. settings cisplatin constitutes the major therapeutic option, the development of chemosensitization strategies constitute a goal with important clin. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxTrgUhh4V17Vg90H21EOLACvtfcHk0lhV5SBBP5wLHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWrsr7E&md5=4f947e6d5b834673b819e88b06309a53</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.384%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DSenovilla%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DMichels%26aufirst%3DJ.%26aulast%3DMartins%26aufirst%3DI.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DCastedo%26aufirst%3DM.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520Mechanisms%2520of%2520Cisplatin%2520Resistance%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26issue%3D15%26spage%3D1869%26epage%3D1883%26doi%3D10.1038%2Fonc.2011.384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Chou, T.-C.</span><span> </span><span class="NLM_article-title">Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">440</span><span class="NLM_x">â</span> <span class="NLM_lpage">446</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-09-1947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1158%2F0008-5472.CAN-09-1947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=20068163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=440-446&issue=2&author=T.-C.+Chou&title=Drug+Combination+Studies+and+Their+Synergy+Quantification+Using+the+Chou-Talalay+Method&doi=10.1158%2F0008-5472.CAN-09-1947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method</span></div><div class="casAuthors">Chou, Ting-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">440-446</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  This brief perspective article focuses on the most common errors and pitfalls, as well as the do's and don'ts in drug combination studies, in terms of exptl. design, data acquisition, data interpretation, and computerized simulation.  The Chou-Talalay method for drug combination is based on the median-effect equation, derived from the mass-action law principle, which is the unified theory that provides the common link between single entity and multiple entities, and first order and higher order dynamics.  This general equation encompasses the Michaelis-Menten, Hill, Henderson-Hasselbalch, and Scatchard equations in biochem. and biophysics.  The resulting combination index (CI) theorem of Chou-Talalay offers quant. definition for additive effect (CI = 1), synergism (CI < 1), and antagonism (CI > 1) in drug combinations.  This theory also provides algorithms for automated computer simulation for synergism and/or antagonism at any effect and dose level, as shown in the CI plot and isobologram, resp.  Cancer Res; 70(2); 440-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpECUlVzkYExbVg90H21EOLACvtfcHk0lhV5SBBP5wLHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWksA%253D%253D&md5=d0713e60852fc656bc91719ccb27eb1a</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1947%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.-C.%26atitle%3DDrug%2520Combination%2520Studies%2520and%2520Their%2520Synergy%2520Quantification%2520Using%2520the%2520Chou-Talalay%2520Method%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D2%26spage%3D440%26epage%3D446%26doi%3D10.1158%2F0008-5472.CAN-09-1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Ritorto, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Oliva, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knebel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhrlage, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wightman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virdee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrice, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trost, M.</span><span> </span><span class="NLM_article-title">Screening of DUB Activity and Specificity by MALDI-TOF Mass Spectrometry</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4763</span><span class="refDoi">Â DOI: 10.1038/ncomms5763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fncomms5763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=25159004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFentro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4763&author=M.+S.+Ritortoauthor=R.+Ewanauthor=A.+B.+Perez-Olivaauthor=A.+Knebelauthor=S.+J.+Buhrlageauthor=M.+Wightmanauthor=S.+M.+Kellyauthor=N.+T.+Woodauthor=S.+Virdeeauthor=N.+S.+Grayauthor=N.+A.+Morriceauthor=D.+R.+Alessiauthor=M.+Trost&title=Screening+of+DUB+Activity+and+Specificity+by+MALDI-TOF+Mass+Spectrometry&doi=10.1038%2Fncomms5763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of DUB activity and specificity by MALDI-TOF mass spectrometry</span></div><div class="casAuthors">Ritorto, Maria Stella; Ewan, Richard; Perez-Oliva, Ana B.; Knebel, Axel; Buhrlage, Sara J.; Wightman, Melanie; Kelly, Sharon M.; Wood, Nicola T.; Virdee, Satpal; Gray, Nathanael S.; Morrice, Nicholas A.; Alessi, Dario R.; Trost, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4763</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deubiquitylases (DUBs) are key regulators of the ubiquitin system which cleave ubiquitin moieties from proteins and polyubiquitin chains.  Several DUBs have been implicated in various diseases and are attractive drug targets.  We have developed a sensitive and fast assay to quantify in vitro DUB enzyme activity using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.  Unlike other current assays, this method uses unmodified substrates, such as diubiquitin topoisomers.  By analyzing 42 human DUBs against all diubiquitin topoisomers we provide an extensive characterization of DUB activity and specificity.  Our results confirm the high specificity of many members of the OTU and JAB/MPN/Mov34 metalloenzyme DUB families and highlight that all USPs tested display low linkage selectivity.  We also demonstrate that this assay can be deployed to assess the potency and specificity of DUB inhibitors by profiling 11 compds. against a panel of 32 DUBs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf9lg-hgw78rVg90H21EOLACvtfcHk0lhV5SBBP5wLHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFentro%253D&md5=614edc01e83206811d3e27a2ca11ae3b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fncomms5763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5763%26sid%3Dliteratum%253Aachs%26aulast%3DRitorto%26aufirst%3DM.%2BS.%26aulast%3DEwan%26aufirst%3DR.%26aulast%3DPerez-Oliva%26aufirst%3DA.%2BB.%26aulast%3DKnebel%26aufirst%3DA.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DWightman%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DS.%2BM.%26aulast%3DWood%26aufirst%3DN.%2BT.%26aulast%3DVirdee%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DMorrice%26aufirst%3DN.%2BA.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DTrost%26aufirst%3DM.%26atitle%3DScreening%2520of%2520DUB%2520Activity%2520and%2520Specificity%2520by%2520MALDI-TOF%2520Mass%2520Spectrometry%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4763%26doi%3D10.1038%2Fncomms5763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexheimer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villamil, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luci, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z.</span><span> </span><span class="NLM_article-title">A Selective USP1-UAF1 Inhibitor Links Deubiquitination to DNA Damage Responses</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">298</span><span class="NLM_x">â</span> <span class="NLM_lpage">304</span><span class="refDoi">Â DOI: 10.1038/nchembio.1455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=10.1038%2Fnchembio.1455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=24531842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOgtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=298-304&issue=4&author=Q.+Liangauthor=T.+S.+Dexheimerauthor=P.+Zhangauthor=A.+S.+Rosenthalauthor=M.+A.+Villamilauthor=C.+Youauthor=Q.+Zhangauthor=J.+Chenauthor=C.+A.+Ottauthor=H.+Sunauthor=D.+K.+Luciauthor=B.+Yuanauthor=A.+Simeonovauthor=A.+Jadhavauthor=H.+Xiaoauthor=Y.+Wangauthor=D.+J.+Maloneyauthor=Z.+Zhuang&title=A+Selective+USP1-UAF1+Inhibitor+Links+Deubiquitination+to+DNA+Damage+Responses&doi=10.1038%2Fnchembio.1455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses</span></div><div class="casAuthors">Liang, Qin; Dexheimer, Thomas S.; Zhang, Ping; Rosenthal, Andrew S.; Villamil, Mark A.; You, Changjun; Zhang, Qiuting; Chen, Junjun; Ott, Christine A.; Sun, Hongmao; Luci, Diane K.; Yuan, Bifeng; Simeonov, Anton; Jadhav, Ajit; Xiao, Hui; Wang, Yinsheng; Maloney, David J.; Zhuang, Zhihao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">298-304</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein ubiquitination and deubiquitination are central to the control of a large no. of cellular pathways and signaling networks in eukaryotes.  Although the essential roles of ubiquitination have been established in the eukaryotic DNA damage response, the deubiquitination process remains poorly defined.  Chem. probes that perturb the activity of deubiquitinases (DUBs) are needed to characterize the cellular function of deubiquitination.  Here the authors report ML323 , a highly potent inhibitor of the USP1-UAF1 deubiquitinase complex with excellent selectivity against human DUBs, deSUMOylase, deneddylase and unrelated proteases.  Using ML323, the authors interrogated deubiquitination in the cellular response to UV- and cisplatin-induced DNA damage and revealed new insights into the requirement of deubiquitination in the DNA translesion synthesis and Fanconi anemia pathways.  Moreover, ML323 potentiates cisplatin cytotoxicity in non-small cell lung cancer and osteosarcoma cells.  The authors' findings point to USP1-UAF1 as a key regulator of the DNA damage response and a target for overcoming resistance to the platinum-based anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqra2Cr2SOx7bVg90H21EOLACvtfcHk0ljvuFVpiRxcVA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOgtrw%253D&md5=3486f59d79d15b197ea384e9df9291ee</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1455%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DDexheimer%26aufirst%3DT.%2BS.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DRosenthal%26aufirst%3DA.%2BS.%26aulast%3DVillamil%26aufirst%3DM.%2BA.%26aulast%3DYou%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DOtt%26aufirst%3DC.%2BA.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLuci%26aufirst%3DD.%2BK.%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DZhuang%26aufirst%3DZ.%26atitle%3DA%2520Selective%2520USP1-UAF1%2520Inhibitor%2520Links%2520Deubiquitination%2520to%2520DNA%2520Damage%2520Responses%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D4%26spage%3D298%26epage%3D304%26doi%3D10.1038%2Fnchembio.1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01346&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-2%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01346%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01346" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0cb5f6b0b1975","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
